UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 20-F
(Mark One)
¨ | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 |
OR
þ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2009 |
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to |
OR
¨ | SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Date of event requiring this shell company report |
Commission file numbers | Barclays PLC | 1-09246 | ||
Barclays Bank PLC | 1-10257 |
BARCLAYS PLC
BARCLAYS BANK PLC
(Exact Names of Registrants as Specified in their Charter[s])
ENGLAND
(Jurisdiction of Incorporation or Organization)
1 CHURCHILL PLACE, LONDON E14 5HP, ENGLAND
(Address of Principal Executive Offices)
PATRICK GONSALVES, +44 (0)20 7116 2901, PATRICK.GONSALVES@BARCLAYS.COM
1 CHURCHILL PLACE, LONDON E14 5HP, ENGLAND
*(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Barclays PLC
Title of Each Class |
Name of Each Exchange On Which Registered | |
25p ordinary shares | New York Stock Exchange* | |
American Depository Shares, each representing four 25p ordinary shares | New York Stock Exchange |
* | Not for trading, but in connection with the registration of American Depository Shares, pursuant to the requirements of the Securities and Exchange Commission. |
Barclays Bank PLC
Title of Each Class |
Name of Each Exchange On Which Registered | |
Callable Floating Rate Notes 2035 | New York Stock Exchange | |
Non-Cumulative Callable Dollar Preference Shares, Series 2 | New York Stock Exchange* | |
American Depository Shares, Series 2, each representing one Non-Cumulative Callable Dollar Preference Share, Series 2 | New York Stock Exchange | |
Non-Cumulative Callable Dollar Preference Shares, Series 3 | New York Stock Exchange* | |
American Depository Shares, Series 3, each representing one Non-Cumulative Callable Dollar Preference Share, Series 3 | New York Stock Exchange | |
Non-Cumulative Callable Dollar Preference Shares, Series 4 | New York Stock Exchange* | |
American Depository Shares, Series 4, each representing one Non-Cumulative Callable Dollar Preference Share, Series 4 | New York Stock Exchange | |
Non-Cumulative Callable Dollar Preference Shares, Series 5 | New York Stock Exchange* | |
American Depository Shares, Series 5, each representing one Non-Cumulative Callable Dollar Preference Share, Series 5 | New York Stock Exchange | |
iPath® Dow Jones UBS Commodity Index Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Agriculture Subindex Total Return SM ETN | NYSE Arca | |
iPath® Dow Jones UBS Aluminum Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Cocoa Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Coffee Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Copper Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Cotton Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Energy Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Grains Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Industrial Metals Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Lead Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Livestock Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Natural Gas Subindex Total Return SM ETN | NYSE Arca | |
iPath® Dow Jones UBS Nickel Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Platinum Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Precious Metals Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Softs Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Sugar Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® Dow Jones UBS Tin Subindex Total ReturnSM ETN | NYSE Arca | |
iPath® S&P GSCI® Total Return Index ETN | NYSE Arca | |
iPath® S&P GSCI® Crude Oil Total Return Index ETN | NYSE Arca | |
iPath® CBOE S&P 500 BuyWrite IndexSM ETN | NYSE Arca | |
iPath® MSCI India IndexSM ETN | NYSE Arca | |
iPath® EUR/USD Exchange Rate ETN | NYSE Arca | |
iPath® GBP/USD Exchange Rate ETN | NYSE Arca | |
iPath® JPY/USD Exchange Rate ETN | NYSE Arca | |
iPath® S&P 500 VIX Short-Term FuturesTM ETN | NYSE Arca | |
iPath® S&P 500 VIX Mid-Term FuturesTM ETN | NYSE Arca | |
iPath® Global Carbon ETN | NYSE Arca | |
iPath® Optimized Currency Carry ETN | NYSE Arca | |
Barclays GEMS IndexTM ETN | NYSE Arca | |
Barclays GEMS Asia 8 ETN | NYSE Arca | |
Barclays Asian and Gulf Currency Revaluation ETN | NYSE Arca | |
Barclays ETN + Short C Leveraged Exchange Traded Notes Linked to the Inverse Performance of the S&P 500® Total Return IndexSM | NYSE Arca | |
Barclays ETN + Short D Leveraged Exchange Traded Notes Linked to the Inverse Performance of the S&P 500® Total Return IndexSM | NYSE Arca | |
Barclays ETN + Long B Leveraged Exchange Traded Notes Linked to the S&P 500® Total Return IndexSM | NYSE Arca | |
Barclays ETN + Short B Leveraged Exchange Traded Notes Linked to the Inverse Performance of the S&P 500® Total Return IndexSM | NYSE Arca | |
Barclays ETN + Long C Leveraged Exchange Traded Notes Linked to the S&P 500® Total Return IndexSM | NYSE Arca |
* | Not for trading, but in connection with the registration of American Depository Shares, pursuant to the requirements of the Securities and Exchange Commission. |
Securities registered or to be registered pursuant to Section 12(g) of the Act: None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report.
Barclays PLC | 25p ordinary shares | 11,411,577,230 | ||
Barclays Bank PLC | £1 ordinary shares | 2,342,558,515 | ||
£1 preference shares | 1,000 | |||
£100 preference shares | 75,000 | |||
100 preference shares | 240,000 | |||
$0.25 preference shares | 237,000,000 | |||
$100 preference shares | 100,000 |
Indicate by check mark if each registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes þ No ¨
If this report is an annual or transition report, indicate by check mark if the registrants are not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934.
Yes ¨ No þ
NoteChecking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.
Indicate by check mark whether the registrants: (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.
Yes þ No ¨
Indicate by check mark whether the registrants have submitted electronically and posted on their corporate Web sites, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).*
Yes þ No ¨
* | This requirement does not apply to the registrants until their fiscal year ending December 31, 2011. |
Indicate by check mark whether each registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act. (Check one):
Barclays PLC | ||||||||||||
Large Accelerated Filer þ | Accelerated Filer ¨ | Non-Accelerated Filer ¨ | ||||||||||
Barclays Bank PLC | ||||||||||||
Large Accelerated Filer ¨ | Accelerated Filer ¨ | Non-Accelerated Filer þ |
* | Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing: |
U.S. GAAP ¨
International Financial Reporting Standards as issued by the International Accounting Standards Board þ
Other ¨
* | If Other has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow: |
Item 17 ¨ Item 18 ¨
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No þ
(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS.)
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.
Yes ¨ No ¨
Certain non-IFRS measures
In this document certain non-IFRS (International Financial Reporting Standards) measures are reported. Barclays management believes that these non-IFRS measures provide valuable information to readers of its financial statements because they enable the reader to focus more directly on the underlying day-to-day performance of its businesses and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays management. However, any non-IFRS measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Among other non-IFRS information, certain information and related discussion are provided in pages 2 to 50 relating to the Groups total results rather than separating out discontinued operations, representing the Barclays Global Investors (BGI) business sold on 1st December 2009. These non-IFRS measures are provided because management considers that including BGI as part of Group operations and separately identifying the gain on this disposal provides useful information about the performance of the Group as a whole and reflects how the operations were managed until the disposal of BGI. The consolidated summary income statement on page 2 provides a reconciliation between continuing and Group results, and the discussion of Group results from page 4 to 10 describe the Groups results on a continuing operations basis, followed by a discussion of the Groups discontinued operations.
Market and other data
This document contains information, including statistical data, about certain of Barclays markets and its competitive position. Except as otherwise indicated, this information is taken or derived from Datastream and other external sources. Barclays cannot guarantee the accuracy of information taken from external sources, or that, in respect of internal estimates, a third party using different methods would obtain the same estimates as Barclays.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to certain Groups plans and its current goals and expectations relating to its future financial conditions and performance. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate to only to historic or current facts. Forward-looking statements sometimes use words such as may, will, seek, continue, aim, anticipate, target, expect, estimate, intend, plan, goal, believe or other words of similar meaning. Examples of forward-looking statements include, among others, statements regarding Groups future financial position, income growth, assets, impairments, charges, business strategy, capital ratios, leverage, payment of dividends, projected levels of growth in the banking and finance markets, projected costs, estimates of capital expenditure, and plans and objectives for future operations and other statements that are not historical by fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances, including, but not limited to, UK domestic and global economic and business conditions, the effect of continued volatility in credit market exposures, changes in valuation of issue notes, the policies and actions of governmental and regulatory authorities, changes in legislation, the further development of standards and interpretations under International Financial Reporting Standards (IFRS) applicable to past, current and future periods, evolving practices with regard to the interpretation and application of standards under IFRS, the outcome of pending and future litigation, the success of future acquisitions and other strategic transactions and the impact of completion a number of such factors being beyond the Groups control. As a result, the Groups actual results may differ materially from plans, goals, and expectations set forth in the Groups forward-looking statement.
Any forward-looking statements made herein speak only as of the date they are made. Expect as required by the U.K. Financial Services Authority (FSA), the London Stock Exchange or applicable laws, Barlcays expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this report to reflect any change in Barclays expectations with regard thereto or any change in events, conditions or circumstance on which any such statement is based. The reader should, however, consult any additional disclosures that Barclays has made or may make in documents it has filed or may file with the U.S. Securities and Exchange Commission.
Certain terms
The term Barclays PLC Group means Barclays PLC together with its subsidiaries and the term Barclays Bank PLC Group means Barclays Bank PLC together with its subsidiaries. Barclays and Group are terms which are used to refer to either of the preceding groups when the subject matter is identical. The term Company, Parent Company or Parent refers to Barclays PLC, and the term Bank refers to Barclays Bank PLC. The term Absa Group Limited is used to refer to Absa Group Limited and its subsidiaries, and the term GRCB Absa is used to the refer to the component of the Global Retail and Commercial Banking segment represented by this business. In this report, the abbreviations £m and £bn represent millions and thousands of millions of pounds sterling, respectively; the abbreviations US$m and US$bn represent millions and thousands of millions of US dollars, respectively, and m and bn represent millions and thousands of millions of euros, respectively.
i
SEC FORM 20-F CROSS REFERENCE INFORMATION
Form 20-F item number |
Page and caption references in this document* | |||
1 | Identity of Directors, Senior Management and Advisers | Not applicable | ||
2 | Offer Statistics and Expected Timetable | Not applicable | ||
3 | Key Information | |||
A. Selected financial data | 11, 12, 304 | |||
B. Capitalization and indebtedness | Not applicable | |||
C. Reason for the offer and use of proceeds | Not applicable | |||
D. Risk factors | 54-58 | |||
4 | Information on the Company | |||
A. History and development of the company | 165, 225 (Note 38)-230 (Note 41), 234 (Note 43), 305, 312 | |||
B. Business overview | 117-118, 193-195 (Note 14), 222 (Note 36), 278-282 (Note 53) | |||
C. Organizational structure | 229-230 (Note 41) | |||
D. Property, plants and equipment | 201 (Note 23), 223-224 (Note 37) | |||
4A | Unresolved staff comments | Not applicable | ||
5 | Operating and Financial Review and Prospects | |||
A. Operating results | 2-50, 117-118, 193-195 (Note 14), 222 (Note 36), 257-261 (Note 48) | |||
B. Liquidity and capital resources | 17-18, 92-93, 102-104, 182, 193-195 (Note 14), 204-209 (Note 27), 209-210 (Note 29), 216-218 (Note 31), 220-221 (Note 34), 261-266 (Note 49), 277-278 (Note 52) | |||
C. Research and development, patents and licenses, etc. | Not applicable | |||
D. Trend information | - | |||
E. Off-balance sheet arrangements | 240-242 (note 45) | |||
F. Tabular disclosure of contractual obligations | 20 | |||
G. Safe harbor | i (Forward-looking statements) | |||
6 | Directors, Senior Management and Employees | |||
A. Directors and senior management | 119-121 | |||
B. Compensation | 145-161, 210-216 (Note 30), 230-234 (Note 42) | |||
C. Board practices | 119-140, 147, 154-156 | |||
D. Employees | 8, 51 | |||
E. Share ownership | 145-161, 233 (Note 42) | |||
7 | Major Shareholders and Related Party Transactions | |||
A. Major shareholders | 123, 165 | |||
B. Related party transactions | 230-234 (Note 42) | |||
C. Interests of experts and counsel | Not applicable | |||
8 | Financial Information | |||
A. Consolidated statements and other financial information | 122, 166-300, 302, 305-306 | |||
B. Significant changes | 125, 234 (Note 43) | |||
9 | The Offer and Listing | |||
A. Offer and listing details | 303 | |||
B. Plan of distribution | Not applicable | |||
C. Markets | 302 | |||
D. Selling shareholders | Not applicable | |||
E. Dilution | Not applicable | |||
F. Expenses of the issue | Not applicable | |||
10 | Additional Information |
ii
Form 20-F item number |
Page and caption references in this document* | |||
A. Share capital | Not applicable | |||
B. Memorandum and Articles of Association | 305-307 | |||
C. Material contracts | 125, 154, 156, 217-218 (Note 31) | |||
D. Exchange controls | 309 | |||
E. Taxation | 308-309 | |||
F. Dividends and paying assets | Not applicable | |||
G. Statement by experts | Not applicable | |||
H. Documents on display | 309 | |||
I. Subsidiary information | 229-230 (Note 41) | |||
11 | Quantitative and Qualitative Disclosure about Market Risk | 53-116, 242 (Note 46)-266 (Note 49) | ||
12 | Description of Securities Other than Equity Securities | |||
A. Debt Securities | Not applicable | |||
B. Warrants and Rights | Not applicable | |||
C. Other Securities | Not applicable | |||
D. American Depositary Shares | 310-311 | |||
13 | Defaults, Dividends Arrearages and Delinquencies | Not applicable | ||
14 | Material Modifications to the Rights of Security Holders and Use of Proceeds | Not applicable | ||
15 | Controls and Procedures | |||
A. Disclosure controls and procedures | 163 | |||
B. Managements annual report on internal control over financial reporting | 162 | |||
C. Attestation report of the registered public accounting firm | 166 | |||
D. Changes in internal control over financial reporting | 162 | |||
15T | Controls and Procedures | 162-163 | ||
16A | Audit Committee Financial Expert | 134 | ||
16B | Code of Ethics | 144 | ||
16C | Principal Accountant Fees and Services | 125, 137 (Non-Audit Services Policy), 188-189 (Note 9) | ||
16D | Exemptions from the Listing Standards for Audit Committees | Not applicable | ||
16E | Purchases of Equity Securities by the Issuer and Affiliated Purchasers | 217 (Share Repurchase) | ||
16F | Change in Registrants Certifying Accountant | Not applicable | ||
16G | Corporate Governance | 127, 144 | ||
17 | Financial Statements | Not applicable | ||
18 | Financial Statements | 164-300 | ||
19 | Exhibits | Exhibit Index |
* | Captions have been included only in respect of pages with multiple sections on the same page in order to identify the relevant caption on that page covered by the corresponding Form 20-F item number. |
iii
2 |
Consolidated summary income statement
Year ended 31st December | 2009 | 2008 | 2007 | ||||||||||||||||||||||||
Continuing operations £m |
Discontinued operations £m |
Total £m |
Continuing operations £m |
Discontinued operations £m |
Total £m |
Continuing operations £m |
Discontinued operations £m |
Total £m |
|||||||||||||||||||
Net interest income |
11,918 | 33 | 11,951 | 11,469 | | 11,469 | 9,598 | 12 | 9,610 | ||||||||||||||||||
Net fee and commission income |
8,418 | 1,759 | 10,177 | 6,491 | 1,916 | 8,407 | 5,771 | 1,937 | 7,708 | ||||||||||||||||||
Principal transactions |
7,057 | 67 | 7,124 | 2,019 | (10 | ) | 2,009 | 4,970 | 5 | 4,975 | |||||||||||||||||
Net premiums from insurance contracts |
1,172 | | 1,172 | 1,090 | | 1,090 | 1,011 | | 1,011 | ||||||||||||||||||
Other income |
1,389 | 4 | 1,393 | 367 | 10 | 377 | 186 | 2 | 188 | ||||||||||||||||||
Total income |
29,954 | 1,863 | 31,817 | 21,436 | 1,916 | 23,352 | 21,536 | 1,956 | 23,492 | ||||||||||||||||||
Net claims and benefits incurred on insurance contracts |
(831 | ) | | (831 | ) | (237 | ) | | (237 | ) | (492 | ) | | (492 | ) | ||||||||||||
Total income net of insurance claims |
29,123 | 1,863 | 30,986 | 21,199 | 1,916 | 23,115 | 21,044 | 1,956 | 23,000 | ||||||||||||||||||
Impairment charges and other credit provisions |
(8,071 | ) | | (8,071 | ) | (5,419 | ) | | (5,419 | ) | (2,795 | ) | | (2,795 | ) | ||||||||||||
Net income |
21,052 | 1,863 | 22,915 | 15,780 | 1,916 | 17,696 | 18,249 | 1,956 | 20,205 | ||||||||||||||||||
Operating expenses |
(16,715 | ) | (1,137 | ) | (17,852 | ) | (13,391 | ) | (975 | ) | (14,366 | ) | (12,096 | ) | (1,103 | ) | (13,199 | ) | |||||||||
Share of post-tax results of associates and joint ventures |
34 | | 34 | 14 | | 14 | 42 | | 42 | ||||||||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
188 | | 188 | 327 | | 327 | 28 | | 28 | ||||||||||||||||||
Gains on acquisitions |
26 | | 26 | 2,406 | | 2,406 | | | | ||||||||||||||||||
Profit before tax and disposal of discontinued operations |
4,585 | 726 | 5,311 | 5,136 | 941 | 6,077 | 6,223 | 853 | 7,076 | ||||||||||||||||||
Profit on disposal of discontinued operations |
| 6,331 | 6,331 | | | | | | | ||||||||||||||||||
Profit before tax |
4,585 | 7,057 | 11,642 | 5,136 | 941 | 6,077 | 6,223 | 853 | 7,076 | ||||||||||||||||||
Tax |
(1,074 | ) | (280 | ) | (1,354 | ) | (453 | ) | (337 | ) | (790 | ) | (1,699 | ) | (282 | ) | (1,981 | ) | |||||||||
Profit after tax |
3,511 | 6,777 | 10,288 | 4,683 | 604 | 5,287 | 4,524 | 571 | 5,095 | ||||||||||||||||||
Profit for the year attributable to |
|||||||||||||||||||||||||||
Equity holders of the Parent |
2,628 | 6,765 | 9,393 | 3,795 | 587 | 4,382 | 3,886 | 531 | 4,417 | ||||||||||||||||||
Non-controlling interests |
883 | 12 | 895 | 888 | 17 | 905 | 638 | 40 | 678 | ||||||||||||||||||
3,511 | 6,777 | 10,288 | 4,683 | 604 | 5,287 | 4,524 | 571 | 5,095 | |||||||||||||||||||
Earnings per share |
|||||||||||||||||||||||||||
Basic earnings per share |
24.1p | 62.1p | 86.2p | 51.4p | 7.9p | 59.3p | 60.6p | 8.3p | 68.9p | ||||||||||||||||||
Diluted earnings per share |
22.7p | 58.9p | 81.6p | 49.8p | 7.7p | 57.5p | 58.8p | 8.1p | 66.9p |
The consolidated summary income statement above sets out the Groups results analysed between continuing and discontinued operations for each income statement line for ease of comparability. The line items from Net interest income to Profit before tax and disposal of discontinued operations shown above under Discontinued operations for 2009 represent the results for the 11 month period to 30 November 2009 of the BGI discontinued operations that were sold on 1st December 2009. In addition, the figures included in the Total columns in 2009, 2008 and 2007 in respect of the line items from Net interest income to Profit before tax and disposal of discontinued operations are non-IFRS measures; see Certain non-IFRS measures on page i for more information with respect to including BGI results within such Group totals. The income statement on page 178 and the five year summary included on page 11 shows the income statement on a continuing basis with profit after tax from discontinued operations shown as a single line under profit after tax from continuing operations, in accordance with IFRS.
3 |
Note
a | Total income net of reinsurance claims, total operating expenses and total cost: income ratio information in the 2009/2008 and 2008/2007 discussions are non-IFRS measures because they present Group operating results that combine continued operations and discontinued operations. See page 2 for a reconciliation between continuing and Group results, see Certain non-IFRS measures on page i for more information with respect to including BGI results within such Group totals. In addition, Top-line income within Barclays Capital is a non-IFRS measure that represents income before gains/losses and credit market write-downs. This measure has been presented as it provides a consistent basis for comparing the business performance between financial periods. For a reconciliation of top-line income to total income of Barclays Capital, see page 43. |
4 |
Financial review
Income statement commentary
continued
5 |
6 |
Financial review
Income statement commentary
continued
Impairment charges and other credit provisions
2009 £m |
2008 £m |
2007 £m |
|||||||
Impairment charges on loans and advances |
|||||||||
New and increased impairment allowances |
8,111 | 5,116 | 2,871 | ||||||
Releases |
(631 | ) | (358 | ) | (338 | ) | |||
Recoveries |
(150 | ) | (174 | ) | (227 | ) | |||
Impairment charges on loans and advances |
7,330 | 4,584 | 2,306 | ||||||
Charge/(release) in respect of provision for undrawn contractually committed facilities and guarantees provided |
28 | 329 | 476 | ||||||
Impairment charges on loans and advances and other credit provisions |
7,358 | 4,913 | 2,782 | ||||||
Impairment charges on reverse repurchase agreements |
43 | 124 | | ||||||
Impairment on available for sale assets |
670 | 382 | 13 | ||||||
Impairment charges and other credit provisions |
8,071 | 5,419 | 2,795 | ||||||
Impairment charges and other credit provisions on ABS CDO Super Senior and other credit market exposures included above: |
|||||||||
Impairment charges on loans and advances |
1,205 | 1,218 | 300 | ||||||
Charges in respect of undrawn facilities and guarantees |
| 299 | 469 | ||||||
Impairment charges on loans and advances and other credit provisions on ABS CDO Super Senior and other credit market exposures |
1,205 | 1,517 | 769 | ||||||
Impairment charges on reverse repurchase agreements |
| 54 | | ||||||
Impairment charges on available for sale assets |
464 | 192 | 13 | ||||||
Impairment charges and other credit provisions on ABS CDO Super Senior and other credit market exposures |
1,669 | 1,763 | 782 |
7 |
8 |
Financial review
Income statement commentary
continued
9 |
10 |
Financial review
Income statement commentary
continued
Tax | |||||||||
2009 £m |
2008 £m |
2007 £m |
|||||||
Profit before tax from continuing operations |
4,585 | 5,136 | 6,223 | ||||||
Tax charge at average UK corporation tax rate of 28% (2008: 28.5%, 2007: 30%) |
1,284 | 1,464 | 1,867 | ||||||
Prior year adjustments |
(220 | ) | (171 | ) | (17 | ) | |||
Differing overseas tax rates |
(27 | ) | 175 | (82 | ) | ||||
Non-taxable gains and income (including amounts offset by unrecognised tax losses) |
(112 | ) | (859 | ) | (136 | ) | |||
Share-based payments |
(38 | ) | 201 | 71 | |||||
Deferred tax assets not recognised/(previously not recognised) |
27 | (504 | ) | (159 | ) | ||||
Change in tax rates |
(12 | ) | (1 | ) | 24 | ||||
Other non-allowable expenses |
172 | 148 | 131 | ||||||
Tax charge |
1,074 | 453 | 1,699 | ||||||
Effective tax rate |
23% | 9% | 27% |
Discontinued operations | ||||||
2009 £m |
2008 £m |
2007 £m | ||||
Profit for the year from discontinued operations, including gain on disposal |
6,777 | 604 | 571 |
11 |
Financial review
Five-year consolidated summary income statement
For the year ended 31st December | |||||||||||||||
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m |
|||||||||||
Continuing operations |
|||||||||||||||
Net interest income |
11,918 | 11,469 | 9,598 | 9,133 | 8,060 | ||||||||||
Non-interest income |
18,036 | 9,967 | 11,938 | 11,372 | 8,600 | ||||||||||
Net claims and benefits incurred on insurance contracts |
(831 | ) | (237 | ) | (492 | ) | (575 | ) | (645 | ) | |||||
Total income net of insurance claims |
29,123 | 21,199 | 21,044 | 19,930 | 16,015 | ||||||||||
Impairment charges and other credit provisions |
(8,071 | ) | (5,419 | ) | (2,795 | ) | (2,154 | ) | (1,571 | ) | |||||
Operating expenses |
(16,715 | ) | (13,391 | ) | (12,096 | ) | (11,723 | ) | (9,748 | ) | |||||
Share of post-tax results of associates and joint ventures |
34 | 14 | 42 | 46 | 45 | ||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
188 | 327 | 28 | 323 | | ||||||||||
Gain on acquisitions |
26 | 2,406 | | | | ||||||||||
Profit before tax from continuing operations |
4,585 | 5,136 | 6,223 | 6,422 | 4,741 | ||||||||||
Tax from continuing operations |
(1,074 | ) | (453 | ) | (1,699 | ) | (1,611 | ) | (1,251 | ) | |||||
Profit after tax from continuing operations |
3,511 | 4,683 | 4,524 | 4,811 | 3,490 | ||||||||||
Profit for the year from discontinued operations, including gain on disposal |
6,777 | 604 | 571 | 384 | 351 | ||||||||||
Net profit for the year |
10,288 | 5,287 | 5,095 | 5,195 | 3,841 | ||||||||||
Profit attributable to equity holders of the Parent |
9,393 | 4,382 | 4,417 | 4,571 | 3,447 | ||||||||||
Profit attributable to non-controlling interests |
895 | 905 | 678 | 624 | 394 | ||||||||||
10,288 | 5,287 | 5,095 | 5,195 | 3,841 | |||||||||||
Selected financial statistics |
|||||||||||||||
Basic earnings per share |
86.2p | 59.3p | 68.9p | 71.9p | 54.4p | ||||||||||
Basic earnings per share from continuing operations |
24.1p | 51.4p | 60.6p | 66.6p | 49.5p | ||||||||||
Diluted earnings per share |
81.6p | 57.5p | 66.9p | 69.8p | 52.6p | ||||||||||
Dividends per ordinary share |
2.5p | 11.5p | 34.0p | 31.0p | 26.6p | ||||||||||
Dividend payout ratio |
2.9% | 19.4% | 49.3% | 43.1% | 48.9% | ||||||||||
Profit attributable to the equity holders of the Parent as a percentage of: |
|||||||||||||||
average shareholders equity |
23.8% | 16.5% | 20.3% | 24.7% | 21.1% | ||||||||||
average total assets |
0.5% | 0.2% | 0.3% | 0.4% | 0.4% | ||||||||||
Average United States Dollar exchange rate used in preparing the accounts |
1.57 | 1.86 | 2.00 | 1.84 | 1.82 | ||||||||||
Average Euro exchange rate used in preparing the accounts |
1.12 | 1.26 | 1.46 | 1.47 | 1.46 | ||||||||||
Average Rand exchange rate used in preparing the accounts |
13.14 | 15.17 | 14.11 | 12.47 | 11.57 |
The financial information above is extracted from the published accounts. This information should be read together with the information included in the accompanying financial statements.
12 |
Financial review
Consolidated summary balance sheet
As at 31st December | ||||||||||
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | ||||||
Assets |
||||||||||
Cash and other short-term funds |
83,076 | 31,714 | 7,637 | 9,753 | 5,807 | |||||
Trading portfolio and financial assets designated at fair value |
193,912 | 306,836 | 341,171 | 292,464 | 251,820 | |||||
Derivative financial instruments |
416,815 | 984,802 | 248,088 | 138,353 | 136,823 | |||||
Loans and advances to banks |
41,135 | 47,707 | 40,120 | 30,926 | 31,105 | |||||
Loans and advances to customers |
420,224 | 461,815 | 345,398 | 282,300 | 268,896 | |||||
Available for sale financial investments |
56,483 | 64,976 | 43,072 | 51,703 | 53,497 | |||||
Reverse repurchase agreements and cash collateral on securities borrowed |
143,431 | 130,354 | 183,075 | 174,090 | 160,398 | |||||
Other assets |
23,853 | 24,776 | 18,800 | 17,198 | 16,011 | |||||
Total assets |
1,378,929 | 2,052,980 | 1,227,361 | 996,787 | 924,357 | |||||
Liabilities |
||||||||||
Deposits and items in the course of collection due to banks |
77,912 | 116,545 | 92,338 | 81,783 | 77,468 | |||||
Customer accounts |
322,429 | 335,505 | 294,987 | 256,754 | 238,684 | |||||
Trading portfolio and financial liabilities designated at fair value |
137,454 | 136,366 | 139,891 | 125,861 | 104,949 | |||||
Liabilities to customers under investment contracts |
1,679 | 69,183 | 92,639 | 84,637 | 85,201 | |||||
Derivative financial instruments |
403,416 | 968,072 | 248,288 | 140,697 | 137,971 | |||||
Debt securities in issue |
135,902 | 149,567 | 120,228 | 111,137 | 103,328 | |||||
Repurchase agreements and cash collateral on securities lent |
198,781 | 182,285 | 169,429 | 136,956 | 121,178 | |||||
Insurance contract liabilities, including unit-linked liabilities |
2,140 | 2,152 | 3,903 | 3,878 | 3,767 | |||||
Subordinated liabilities |
25,816 | 29,842 | 18,150 | 13,786 | 12,463 | |||||
Other liabilities |
14,922 | 16,052 | 15,032 | 13,908 | 14,918 | |||||
Total liabilities |
1,320,451 | 2,005,569 | 1,194,885 | 969,397 | 899,927 | |||||
Shareholders equity |
||||||||||
Shareholders equity excluding non-controlling interests |
47,277 | 36,618 | 23,291 | 19,799 | 17,426 | |||||
Non-controlling interests |
11,201 | 10,793 | 9,185 | 7,591 | 7,004 | |||||
Total shareholders equity |
58,478 | 47,411 | 32,476 | 27,390 | 24,430 | |||||
Total liabilities and shareholders equity |
1,378,929 | 2,052,980 | 1,227,361 | 996,787 | 924,357 | |||||
Risk weighted assets and capital ratios a |
||||||||||
Risk weighted assets |
382,653 | 433,302 | 353,878 | 297,833 | 269,148 | |||||
Tier 1 ratio |
13.0% | 8.6% | 7.6% | 7.7% | 7.0% | |||||
Risk asset ratio |
16.6% | 13.6% | 11.2% | 11.7% | 11.3% | |||||
Selected financial statistics |
||||||||||
Net asset value per ordinary share |
414p | 437p | 353p | 303p | 269p | |||||
Number of ordinary shares of Barclays PLC (in millions) |
11,412 | 8,372 | 6,601 | 6,535 | 6,490 | |||||
Year-end United States Dollar exchange rate used in preparing the accounts |
1.62 | 1.46 | 2.00 | 1.96 | 1.72 | |||||
Year-end Euro exchange rate used in preparing the accounts |
1.12 | 1.04 | 1.36 | 1.49 | 1.46 | |||||
Year-end Rand exchange rate used in preparing the accounts |
11.97 | 13.74 | 13.64 | 13.71 | 10.87 |
The financial information above is extracted from the published accounts. This information should be read together with the information included in the accompanying financial statements.
Note
a | Risk weighted assets and capital ratios for 2006 and 2005 are calculated on a Basel I basis. |
Risk weighted assets and capital ratios for 2009, 2008 and 2007 are calculated on a Basel II basis. |
13 |
Financial review
14 |
Financial review
Balance sheet commentary
continued
15 |
16 |
Financial review
Balance sheet commentary
continued
17 |
Financial review
Capital ratios under Basel II
|
2009 | 2008 | 2007 | |||||||||
Barclays PLC Group |
Barclays Bank PLC Group |
Barclays PLC Group |
Barclays Bank PLC Group |
Barclays PLC Group |
Barclays Bank PLC Group | |||||||
Capital ratios |
% | % | % | % | % | % | ||||||
Core Tier 1 ratio |
10.0 | 10.1 | 5.6 | 5.6 | 4.7 | 4.5 | ||||||
Tier 1 ratio |
13.0 | 13.0 | 8.6 | 8.6 | 7.6 | 7.3 | ||||||
Risk asset ratio |
16.6 | 16.6 | 13.6 | 13.5 | 11.2 | 11.0 | ||||||
Risk weighted assets | £m | £m | £m | £m | £m | £m | ||||||
Credit risk |
252,054 | 252,054 | 266,912 | 266,912 | 244,474 | 244,469 | ||||||
Counterparty risk |
45,450 | 45,450 | 70,902 | 70,902 | 41,203 | 41,203 | ||||||
Market risk |
||||||||||||
Modelled VaR |
10,623 | 10,623 | 14,452 | 14,452 | 7,270 | 7,270 | ||||||
Modelled IRDC a and non-VaR |
5,378 | 5,378 | 7,771 | 7,771 | 5,522 | 5,522 | ||||||
Standardised |
38,525 | 38,525 | 43,149 | 43,149 | 27,020 | 27,020 | ||||||
Operational risk |
30,623 | 30,623 | 30,116 | 30,116 | 28,389 | 28,389 | ||||||
Total risk weighted assets |
382,653 | 382,653 | 433,302 | 433,302 | 353,878 | 353,873 |
Note
a | Incremental Default Risk Charge. |
18 |
Financial review
Capital management
continued
Capital resources continued
Total net capital resources under Basel II
2009 | 2008 | 2007 | ||||||||||||||||
Capital resources (as defined for regulatory purposes) |
Barclays PLC Group £m |
Barclays Bank PLC |
Barclays PLC Group £m |
Barclays Bank PLC Group £m |
Barclays PLC Group £m |
Barclays Bank PLC Group £m |
||||||||||||
Ordinary shareholders funds a |
47,277 | 55,925 | 36,618 | 41,202 | 23,291 | 29,872 | ||||||||||||
Regulatory adjustments: |
||||||||||||||||||
MCNs not yet converted |
| | (3,652 | ) | | | | |||||||||||
Available for sale reserve debt b |
83 | 83 | 372 | 372 | 49 | 49 | ||||||||||||
Available for sale reserve equity |
(309 | ) | (335 | ) | (122 | ) | (63 | ) | (295 | ) | (514 | ) | ||||||
Cash flow hedging reserve |
(252 | ) | (252 | ) | (132 | ) | (132 | ) | (26 | ) | (26 | ) | ||||||
Defined benefit pension scheme |
431 | 431 | 849 | 849 | 1,052 | 1,052 | ||||||||||||
Adjustments for scope of regulatory consolidation |
196 | 196 | 847 | 847 | (191 | ) | (191 | ) | ||||||||||
Foreign exchange on RCIs and upper Tier 2 loan stock |
25 | 25 | (231 | ) | (231 | ) | 499 | 499 | ||||||||||
Adjustment for own credit |
(340 | ) | (340 | ) | (1,650 | ) | (1,650 | ) | (461 | ) | (461 | ) | ||||||
Other adjustments |
144 | 144 | 305 | 304 | 465 | 465 | ||||||||||||
Equity non-controlling interest |
2,351 | 2,351 | 1,981 | 1,981 | 1,608 | 1,608 | ||||||||||||
Less: Intangible assets |
(8,345 | ) | (8,345 | ) | (9,964 | ) | (9,964 | ) | (8,191 | ) | (8,191 | ) | ||||||
Less: Net excess of expected loss over impairment at 50% |
(25 | ) | (25 | ) | (159 | ) | (159 | ) | (743 | ) | (743 | ) | ||||||
Less: Securitisation positions at 50% |
(2,799 | ) | (2,799 | ) | (704 | ) | (704 | ) | (335 | ) | (335 | ) | ||||||
Less: Non Core Tier 1 capital issues included in shareholders funds |
| (8,427 | ) | | (8,421 | ) | | (7,236 | ) | |||||||||
Core Tier 1 Capital |
38,437 | 38,632 | 24,358 | 24,231 | 16,722 | 15,848 | ||||||||||||
Preference shares c |
6,256 | 6,256 | 6,191 | 6,191 | 5,035 | 5,035 | ||||||||||||
Reserve Capital Instruments d |
6,724 | 6,724 | 5,743 | 5,721 | 3,908 | 3,908 | ||||||||||||
Tier 1 Notes e |
1,017 | 1,017 | 1,086 | 1,086 | 899 | 899 | ||||||||||||
Tax on the net excess of expected loss over impairment |
8 | 8 | 46 | 46 | 207 | 207 | ||||||||||||
Less: Material holdings in financial companies at 50% |
(2,805 | ) | (2,915 | ) | (174 | ) | (174 | ) | (28 | ) | (28 | ) | ||||||
Total qualifying Tier 1 capital |
49,637 | 49,722 | 37,250 | 37,101 | 26,743 | 25,869 | ||||||||||||
Revaluation reserves |
26 | 26 | 26 | 26 | 26 | 26 | ||||||||||||
Available for sale reserve equity |
309 | 335 | 122 | 122 | 295 | 295 | ||||||||||||
Collectively assessed impairment allowances |
2,443 | 2,443 | 1,654 | 1,654 | 440 | 440 | ||||||||||||
Tier 2 non-controlling interests |
547 | 547 | 607 | 607 | 442 | 442 | ||||||||||||
Qualifying subordinated liabilities f |
||||||||||||||||||
Undated loan capital |
1,350 | 1,350 | 6,745 | 6,768 | 3,191 | 3,191 | ||||||||||||
Dated loan capital |
15,657 | 15,658 | 14,215 | 14,215 | 10,578 | 10,578 | ||||||||||||
Less: Net excess of expected loss over impairment at 50% |
(25 | ) | (25 | ) | (158 | ) | (158 | ) | (743 | ) | (743 | ) | ||||||
Less: Securitisation positions at 50% |
(2,799 | ) | (2,799 | ) | (704 | ) | (704 | ) | (335 | ) | (335 | ) | ||||||
Less: Material holdings in financial companies at 50% |
(2,805 | ) | (2,915 | ) | (174 | ) | (174 | ) | (28 | ) | (28 | ) | ||||||
Total qualifying Tier 2 capital |
14,703 | 14,620 | 22,333 | 22,356 | 13,866 | 13,866 | ||||||||||||
Less: Other regulatory deductions |
(880 | ) | (880 | ) | (856 | ) | (964 | ) | (826 | ) | (826 | ) | ||||||
Total net capital resources |
63,460 | 63,462 | 58,727 | 58,493 | 39,783 | 38,909 |
Notes
a | For Barclays Bank PLC this balance represents Shareholders equity excluding non-controlling interests. |
b | Adjusted for the scope of regulatory consolidation. |
c | Preference shares are included in the balance sheet under non-controlling interests for Barclays PLC and shareholders equity for Barclays Bank PLC. |
d | Reserve Capital Instruments comprise instruments that are both debt and equity accounted and are included in the balance sheet under subordinated liabilities and non-controlling interests for Barclays PLC and subordinated liabilities and shareholders equity for Barclays Bank PLC. |
e | Tier 1 Notes are included in the balance sheet under subordinated liabilities. |
f | Qualifying subordinated liabilities include excess innovative Tier 1 instruments and are subject to limits laid down in the regulatory requirements. |
19 |
Financial review
Additional financial disclosure
Deposits and short-term borrowings
Deposits
20 |
Financial review
Additional financial disclosure
continued
Commitments and contractual obligations
Commercial commitments include guarantees, contingent liabilities and standby facilities.
Commercial commitments
Amount of commitment expiration per period | ||||||||||
Less than one year £m |
Between one to three years £m |
Between three to five years £m |
After five years £m |
Total amounts committed £m | ||||||
2009 |
||||||||||
Acceptances and endorsements |
372 | 3 | | | 375 | |||||
Guarantees and letters of credit pledged as collateral security |
6,770 | 4,103 | 1,286 | 3,247 | 15,406 | |||||
Securities lending arrangements a |
27,406 | | | | 27,406 | |||||
Other contingent liabilities |
7,637 | 853 | 381 | 716 | 9,587 | |||||
Documentary credits and other short-term trade related transactions |
722 | 38 | 2 | | 762 | |||||
Forward asset purchases and forward deposits placed |
46 | | | | 46 | |||||
Standby facilities, credit lines and other |
145,916 | 44,004 | 9,794 | 6,753 | 206,467 | |||||
2008 |
||||||||||
Acceptances and endorsements |
576 | 6 | 3 | | 585 | |||||
Guarantees and letters of credit pledged as collateral security |
7,272 | 2,529 | 1,781 | 4,070 | 15,652 | |||||
Securities lending arrangements a |
38,290 | | | | 38,290 | |||||
Other contingent liabilities |
7,989 | 1,604 | 372 | 1,818 | 11,783 | |||||
Documentary credits and other short-term trade related transactions |
770 | 88 | 1 | | 859 | |||||
Forward asset purchases and forward deposits placed |
50 | 241 | | | 291 | |||||
Standby facilities, credit lines and other |
195,035 | 29,666 | 26,150 | 8,815 | 259,666 |
Contractual obligations include debt securities, operating lease and purchase obligations.
Contractual obligations
Payments due by period | ||||||||||
Less than one year £m |
Between one to three years £m |
Between three to five years £m |
After five years £m |
Total £m | ||||||
2009 |
||||||||||
Long-term debt |
80,824 | 31,138 | 12,982 | 28,626 | 153,570 | |||||
Operating lease obligations |
468 | 808 | 675 | 2,936 | 4,887 | |||||
Purchase obligations |
1,109 | 940 | 541 | 1,243 | 3,833 | |||||
Total |
82,401 | 32,886 | 14,198 | 32,805 | 162,290 | |||||
2008 |
||||||||||
Long-term debt |
108,172 | 24,701 | 10,855 | 22,008 | 165,736 | |||||
Operating lease obligations |
280 | 690 | 785 | 2,745 | 4,500 | |||||
Purchase obligations |
214 | 225 | 61 | 20 | 520 | |||||
Total |
108,666 | 25,616 | 11,701 | 24,773 | 170,756 |
The long-term debt does not include undated loan capital of £8,148m (2008: £13,673m). Further information on the contractual maturity of the Groups assets and liabilities is given in Note 49.
Note
a | Securities lending arrangements are fully collateralised, and are not expected to result in an outflow of funds from the Group, see Note 34 on page 220 for further details. |
21 |
Securities
The following table analyses the book value of securities which are carried at fair value.
2009 | 2008 | 2007 | ||||||||||
Book value £m |
Amortised cost £m |
Book value £m |
Amortised cost £m |
Book value £m |
Amortised cost £m | |||||||
Investment securities available for sale |
||||||||||||
Debt securities: |
||||||||||||
United Kingdom government |
77 | 74 | 1,238 | 1,240 | 78 | 81 | ||||||
Other government |
10,958 | 8,389 | 11,456 | 11,338 | 7,383 | 7,434 | ||||||
Other public bodies and US Agencies |
3,456 | 3,505 | 14,660 | 14,834 | 5,052 | 5,048 | ||||||
Mortgage and asset backed securities |
2,498 | 2,958 | 3,510 | 4,126 | 1,367 | 1,429 | ||||||
Bank and building society certificates of deposit |
7,697 | 7,343 | 10,478 | 10,535 | 3,028 | 3,029 | ||||||
Corporate and other issuers |
19,202 | 18,986 | 17,489 | 17,908 | 21,765 | 21,803 | ||||||
Equity securities |
6,676 | 6,247 | 2,142 | 1,814 | 1,676 | 1,418 | ||||||
Investment securities available for sale |
50,564 | 47,502 | 60,973 | 61,795 | 40,349 | 40,242 | ||||||
Other securities held for trading |
||||||||||||
Debt securities: |
||||||||||||
United Kingdom government |
6,815 | n/a | 6,955 | n/a | 3,832 | n/a | ||||||
Other government |
54,161 | n/a | 50,727 | n/a | 51,104 | n/a | ||||||
Other public bodies and US Agencies |
20,517 | n/a | 21,909 | n/a | 9,466 | n/a | ||||||
Mortgage and asset backed securities |
12,942 | n/a | 30,748 | n/a | 27,572 | n/a | ||||||
Bank and building society certificates of deposit |
995 | n/a | 7,518 | n/a | 17,751 | n/a | ||||||
Corporate and other issuers |
21,164 | n/a | 30,829 | n/a | 43,053 | n/a | ||||||
Equity securities |
19,602 | n/a | 30,535 | n/a | 36,307 | n/a | ||||||
Other securities held for trading |
136,196 | n/a | 179,221 | n/a | 189,085 | n/a |
Investment debt securities include government securities held as part of the Groups treasury management portfolio for asset and liability, liquidity and regulatory purposes and are for use on a continuing basis in the activities of the Group. In addition, the Group holds as investments listed and unlisted corporate securities.
Bank and building society certificates of deposit are freely negotiable and have original maturities of up to five years, but are typically held for shorter periods.
In addition to UK government securities shown above, the Group held the following government securities which exceeded 10% of shareholders equity in any of the last three years. These securities are held at fair value.
Government securities
2009 | 2008 | 2007 | ||||
Book value £m |
Book value £m |
Book value £m | ||||
United States |
17,356 | 17,165 | 15,156 | |||
Japan |
7,609 | 9,092 | 9,124 | |||
Germany |
9,698 | 5,832 | 5,136 | |||
France |
2,574 | 4,091 | 3,538 | |||
Italy |
6,297 | 6,091 | 5,090 | |||
Spain |
4,948 | 3,647 | 3,674 |
Maturities and yield of available for sale debt securities
Maturing within one year |
Maturing after one but within five years |
Maturing after five but within ten years |
Maturing after ten years |
Total | ||||||||||||||||
Amount £m |
Yield % |
Amount £m |
Yield % |
Amount £m |
Yield % |
Amount £m |
Yield % |
Amount £m |
Yield % | |||||||||||
Government |
971 | 5.3 | 6,647 | 2.5 | 2,147 | 1.8 | 1,270 | 1.2 | 11,035 | 2.5 | ||||||||||
Other public bodies and US Agencies |
14 | 3.6 | 148 | 2.4 | 3,279 | 4.1 | 15 | 4.8 | 3,456 | 4.1 | ||||||||||
Other issuers |
14,727 | 2.7 | 12,983 | 1.4 | 1,075 | 3.0 | 612 | 3.4 | 29,397 | 2.3 | ||||||||||
Total book value |
15,712 | 2.9 | 19,778 | 1.8 | 6,501 | 3.2 | 1,897 | 1.9 | 43,888 | 2.5 |
The yield for each range of maturities is calculated by dividing the annualised interest income prevailing at 31st December 2009 by the fair value of securities held at that date.
22 |
Financial review
Additional financial disclosure
continued
Average balance sheet
Average balance sheet and net interest income (year ended 31st December)
2009 |
2008 |
2007 | ||||||||||||||||||||||
Average balance a £m |
Interest £m |
Average rate % |
Average balance a £m |
Interest £m |
Average rate % |
Average balance a £m |
Interest £m |
Average rate % | ||||||||||||||||
Assets |
||||||||||||||||||||||||
Loans and advances to banks b: |
||||||||||||||||||||||||
in offices in the United Kingdom |
41,912 | 483 | 1.2 | 38,913 | 1,453 | 3.7 | 29,431 | 1,074 | 3.6 | |||||||||||||||
in offices outside the United Kingdom |
35,073 | 271 | 0.8 | 14,379 | 419 | 2.9 | 12,262 | 779 | 6.4 | |||||||||||||||
Loans and advances to customers b: |
||||||||||||||||||||||||
in offices in the United Kingdom |
264,687 | 9,405 | 3.6 | 249,081 | 13,714 | 5.5 | 205,707 | 13,027 | 6.3 | |||||||||||||||
in offices outside the United Kingdom |
135,936 | 8,869 | 6.5 | 116,284 | 9,208 | 7.9 | 88,212 | 6,733 | 7.6 | |||||||||||||||
Lease receivables: |
||||||||||||||||||||||||
in offices in the United Kingdom |
4,316 | 174 | 4.0 | 4,827 | 281 | 5.8 | 4,822 | 283 | 5.9 | |||||||||||||||
in offices outside the United Kingdom |
7,406 | 732 | 9.9 | 6,543 | 752 | 11.5 | 5,861 | 691 | 11.8 | |||||||||||||||
Financial investments: |
||||||||||||||||||||||||
in offices in the United Kingdom |
46,702 | 1,525 | 3.3 | 35,844 | 1,654 | 4.6 | 37,803 | 2,039 | 5.4 | |||||||||||||||
in offices outside the United Kingdom |
13,590 | 485 | 3.6 | 10,450 | 697 | 6.7 | 14,750 | 452 | 3.1 | |||||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed: |
||||||||||||||||||||||||
in offices in the United Kingdom |
163,139 | 1,770 | 1.1 | 207,521 | 8,768 | 4.2 | 211,709 | 9,644 | 4.6 | |||||||||||||||
in offices outside the United Kingdom |
145,606 | 665 | 0.5 | 128,250 | 4,450 | 3.5 | 109,012 | 5,454 | 5.0 | |||||||||||||||
Trading portfolio assets: |
||||||||||||||||||||||||
in offices in the United Kingdom |
96,421 | 3,262 | 3.4 | 107,626 | 4,948 | 4.6 | 120,691 | 5,926 | 4.9 | |||||||||||||||
in offices outside the United Kingdom |
103,789 | 3,228 | 3.1 | 128,287 | 5,577 | 4.3 | 57,535 | 3,489 | 6.1 | |||||||||||||||
Financial assets designated at fair value: |
||||||||||||||||||||||||
in offices in the United Kingdom |
18,881 | 822 | 4.4 | 20,299 | 1,325 | 6.5 | 19,154 | 849 | 4.4 | |||||||||||||||
in offices outside the United Kingdom |
13,552 | 315 | 2.3 | 8,690 | 426 | 4.9 | 11,298 | 713 | 6.3 | |||||||||||||||
Total average interest earning assets |
1,091,010 | 32,006 | 2.9 | 1,076,994 | 53,672 | 5.0 | 928,247 | 51,153 | 5.5 | |||||||||||||||
Impairment allowances/provisions |
(8,705 | ) | (5,749 | ) | (4,435 | ) | ||||||||||||||||||
Non-interest earning assets |
782,378 | 682,867 | 392,382 | |||||||||||||||||||||
Total average assets and interest income |
1,864,683 | 32,006 | 1.7 | 1,754,112 | 53,672 | 3.1 | 1,316,194 | 51,153 | 3.9 | |||||||||||||||
Percentage of total average interest earning assets in offices outside the United Kingdom |
41.7% | 38.3% | 32.2% | |||||||||||||||||||||
Total average interest earning assets related to: |
||||||||||||||||||||||||
Interest income c |
32,006 | 2.9 | 53,672 | 5.0 | 51,153 | 5.5 | ||||||||||||||||||
Interest expense c |
(20,713 | ) | 1.9 | (39,820 | ) | 3.8 | (39,201 | ) | 4.6 | |||||||||||||||
11,293 | 1.0 | 13,852 | 1.2 | 11,952 | 0.9 |
Notes
a | Average balances are based upon daily averages for most UK banking operations and monthly averages elsewhere. |
b | Loans and advances to banks and customers include all doubtful lendings, including non- accrual lendings. Interest receivable on such lendings has been included to the extent to which either cash payments have been received or interest has been accrued in accordance with the income recognition policy of the Group. |
c | In addition to interest income and interest expense shown on the income statement on page 178, interest income and interest expense above includes interest related to principal transactions and available for sale assets and liabilities. |
23 |
Average balance sheet and net interest income (year ended 31st December) |
2009 | 2008 | 2007 | ||||||||||||||||
Average balance a £m |
Interest £m |
Average rate % |
Average balance a £m |
Interest £m |
Average rate % |
Average balance a £m |
Interest £m |
Average rate % | ||||||||||
Liabilities and shareholders equity |
||||||||||||||||||
Deposits by banks: |
||||||||||||||||||
in offices in the United Kingdom |
66,394 | 805 | 1.2 | 70,272 | 2,780 | 4.0 | 63,902 | 2,511 | 3.9 | |||||||||
in offices outside the United Kingdom |
31,091 | 295 | 0.9 | 32,172 | 956 | 3.0 | 27,596 | 1,225 | 4.4 | |||||||||
Customer accounts: |
||||||||||||||||||
demand deposits: |
||||||||||||||||||
in offices in the United Kingdom |
20,989 | 374 | 1.8 | 24,333 | 910 | 3.7 | 29,110 | 858 | 2.9 | |||||||||
in offices outside the United Kingdom |
23,774 | 876 | 3.7 | 14,902 | 572 | 3.8 | 13,799 | 404 | 2.9 | |||||||||
Customer accounts: |
||||||||||||||||||
savings deposits: |
||||||||||||||||||
in offices in the United Kingdom |
71,818 | 388 | 0.5 | 71,062 | 2,143 | 3.0 | 55,064 | 2,048 | 3.7 | |||||||||
in offices outside the |
||||||||||||||||||
United Kingdom |
8,563 | 326 | 3.8 | 7,033 | 413 | 5.9 | 4,848 | 128 | 2.6 | |||||||||
Customer accounts: |
||||||||||||||||||
other time deposits retail: |
||||||||||||||||||
in offices in the United Kingdom |
30,233 | 647 | 2.1 | 32,283 | 1,523 | 4.7 | 30,578 | 1,601 | 5.2 | |||||||||
in offices outside the United Kingdom |
28,612 | 1,728 | 6.0 | 20,055 | 1,350 | 6.7 | 12,425 | 724 | 5.8 | |||||||||
Customer accounts: |
||||||||||||||||||
other time deposits wholesale: |
||||||||||||||||||
in offices in the United Kingdom |
54,459 | 1,140 | 2.1 | 60,574 | 2,362 | 3.9 | 52,147 | 2,482 | 4.8 | |||||||||
in offices outside the United Kingdom |
20,595 | 988 | 4.8 | 31,300 | 2,094 | 6.7 | 24,298 | 1,661 | 6.8 | |||||||||
Debt securities in issue: |
||||||||||||||||||
in offices in the United Kingdom |
75,950 | 2,186 | 2.9 | 41,014 | 1,920 | 4.7 | 41,552 | 2,053 | 4.9 | |||||||||
in offices outside the United Kingdom |
81,077 | 2,278 | 2.8 | 80,768 | 3,734 | 4.6 | 94,271 | 5,055 | 5.4 | |||||||||
Dated and undated loan capital and other subordinated liabilities principally: |
||||||||||||||||||
in offices in the United Kingdom |
26,379 | 1,889 | 7.2 | 22,912 | 1,435 | 6.3 | 12,972 | 763 | 5.9 | |||||||||
Repurchase agreements and cash collateral on securities lent: |
||||||||||||||||||
in offices in the United Kingdom |
169,824 | 1,300 | 0.8 | 203,967 | 8,445 | 4.1 | 169,272 | 7,616 | 4.5 | |||||||||
in offices outside the United Kingdom |
215,714 | 849 | 0.4 | 177,883 | 2,800 | 1.6 | 118,050 | 5,051 | 4.3 | |||||||||
Trading portfolio liabilities: |
||||||||||||||||||
in offices in the United Kingdom |
55,704 | 2,193 | 3.9 | 56,675 | 2,657 | 4.7 | 47,971 | 2,277 | 4.7 | |||||||||
in offices outside the United Kingdom |
36,812 | 999 | 2.7 | 62,239 | 2,087 | 3.4 | 29,838 | 1,435 | 4.8 | |||||||||
Financial liabilities designated at fair value: |
||||||||||||||||||
in offices in the United Kingdom |
32,573 | 1,223 | 3.8 | 32,311 | 1,062 | 3.3 | 16,337 | 1,068 | 6.5 | |||||||||
in offices outside the United Kingdom |
18,484 | 229 | 1.2 | 14,237 | 577 | 4.1 | 9,190 | 241 | 2.6 | |||||||||
Total average interest bearing liabilities |
1,069,045 | 20,713 | 1.9 | 1,055,992 | 39,820 | 3.8 | 853,220 | 39,201 | 4.6 | |||||||||
Interest free customer deposits: |
||||||||||||||||||
in offices in the United Kingdom |
43,897 | 40,439 | 34,109 | |||||||||||||||
in offices outside the United Kingdom |
4,816 | 3,089 | 3,092 | |||||||||||||||
Other non-interest bearing liabilities |
696,478 | 617,910 | 395,946 | |||||||||||||||
Non-controlling and other interests and shareholders equity |
50,447 | 36,682 | 29,827 | |||||||||||||||
Total average liabilities, shareholders equity and interest expense |
1,864,683 | 20,713 | 1.1 | 1,754,112 | 39,820 | 2.3 | 1,316,194 | 39,201 | 3.0 | |||||||||
Percentage of total average interest bearing non-capital liabilities in offices outside the United Kingdom |
43.5% | 41.7% | 39.2% |
Note
a | Average balances are based upon daily averages for most UK banking operations and monthly averages elsewhere. |
24 |
Financial review
Additional financial disclosure
continued
2009/2008 Change due to increase/ (decrease) in: |
2008/2007 Change due to increase/ (decrease) in: |
2007/2006 Change due to increase/ (decrease) in: |
|||||||||||||||||||||||||
Total change £m |
Volume £m |
Rate £m |
Total change £m |
Volume £m |
Rate £m |
Total change £m |
Volume £m |
Rate £m |
|||||||||||||||||||
Interest receivable |
|||||||||||||||||||||||||||
Loans and advances to banks: |
|||||||||||||||||||||||||||
in offices in the UK |
(970 | ) | 104 | (1,074 | ) | 379 | 354 | 25 | 427 | 402 | 25 | ||||||||||||||||
in offices outside the UK |
(148 | ) | 310 | (458 | ) | (360 | ) | 117 | (477 | ) | 291 | (1 | ) | 292 | |||||||||||||
(1,118 | ) | 414 | (1,532 | ) | 19 | 471 | (452 | ) | 718 | 401 | 317 | ||||||||||||||||
Loans and advances to customers: |
|||||||||||||||||||||||||||
in offices in the UK |
(4,309 | ) | 814 | (5,123 | ) | 687 | 2,525 | (1,838 | ) | 1,780 | 1,337 | 443 | |||||||||||||||
in offices outside the UK |
(339 | ) | 1,422 | (1,761 | ) | 2,475 | 2,214 | 261 | 1,802 | 728 | 1,074 | ||||||||||||||||
(4,648 | ) | 2,236 | (6,884 | ) | 3,162 | 4,739 | (1,577 | ) | 3,582 | 2,065 | 1,517 | ||||||||||||||||
Lease receivables: |
|||||||||||||||||||||||||||
in offices in the UK |
(107 | ) | (27 | ) | (80 | ) | (2 | ) | | (2 | ) | (17 | ) | (26 | ) | 9 | |||||||||||
in offices outside the UK |
(20 | ) | 92 | (112 | ) | 61 | 79 | (18 | ) | 96 | (30 | ) | 126 | ||||||||||||||
(127 | ) | 65 | (192 | ) | 59 | 79 | (20 | ) | 79 | (56 | ) | 135 | |||||||||||||||
Financial investments: |
|||||||||||||||||||||||||||
in offices in the UK |
(129 | ) | 426 | (555 | ) | (385 | ) | (102 | ) | (283 | ) | 103 | (165 | ) | 268 | ||||||||||||
in offices outside the UK |
(212 | ) | 171 | (383 | ) | 245 | (163 | ) | 408 | (378 | ) | 32 | (410 | ) | |||||||||||||
(341 | ) | 597 | (938 | ) | (140 | ) | (265 | ) | 125 | (275 | ) | (133 | ) | (142 | ) | ||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed: |
|||||||||||||||||||||||||||
in offices in the UK |
(6,998 | ) | (1,564 | ) | (5,434 | ) | (876 | ) | (188 | ) | (688 | ) | 3,508 | 1,865 | 1,643 | ||||||||||||
in offices outside the UK |
(3,785 | ) | 532 | (4,317 | ) | (1,004 | ) | 855 | (1,859 | ) | 414 | 430 | (16 | ) | |||||||||||||
(10,783 | ) | (1,032 | ) | (9,751 | ) | (1,880 | ) | 667 | (2,547 | ) | 3,922 | 2,295 | 1,627 | ||||||||||||||
Trading portfolio assets: |
|||||||||||||||||||||||||||
in offices in the UK |
(1,686 | ) | (477 | ) | (1,209 | ) | (978 | ) | (616 | ) | (362 | ) | 1,760 | 621 | 1,139 | ||||||||||||
in offices outside the UK |
(2,349 | ) | (943 | ) | (1,406 | ) | 2,088 | 3,303 | (1,215 | ) | 881 | (172 | ) | 1,053 | |||||||||||||
(4,035 | ) | (1,420 | ) | (2,615 | ) | 1,110 | 2,687 | (1,577 | ) | 2,641 | 449 | 2,192 | |||||||||||||||
Financial assets designated at fair value: |
|||||||||||||||||||||||||||
in offices in the UK |
(503 | ) | (87 | ) | (416 | ) | 476 | 53 | 423 | 479 | 534 | (55 | ) | ||||||||||||||
in offices outside the UK |
(111 | ) | 174 | (285 | ) | (287 | ) | (146 | ) | (141 | ) | 478 | 357 | 121 | |||||||||||||
(614 | ) | 87 | (701 | ) | 189 | (93 | ) | 282 | 957 | 891 | 66 | ||||||||||||||||
Total interest receivable: |
|||||||||||||||||||||||||||
in offices in the UK |
(14,702 | ) | (811 | ) | (13,891 | ) | (699 | ) | 2,026 | (2,725 | ) | 8,040 | 4,568 | 3,472 | |||||||||||||
in offices outside the UK |
(6,964 | ) | 1,758 | (8,722 | ) | 3,218 | 6,259 | (3,041 | ) | 3,584 | 1,344 | 2,240 | |||||||||||||||
(21,666 | ) | 947 | (22,613 | ) | 2,519 | 8,285 | (5,766 | ) | 11,624 | 5,912 | 5,712 |
25 |
Changes in net interest income volume and rate analysis |
2009/2008 Change due to increase/ (decrease) in: |
|
2008/2007 Change due to increase/ (decrease) in: |
2007/2006 Change due to increase/ (decrease) in: |
| |||||||||||||||||||||||
Total change £m |
Volume £m |
Rate £m |
Total change £m |
Volume £m |
Rate £m |
Total change £m |
Volume £m |
Rate £m |
|||||||||||||||||||
Interest payable |
|||||||||||||||||||||||||||
Deposits by banks: |
|||||||||||||||||||||||||||
in offices in the UK |
(1,975 | ) | (146 | ) | (1,829 | ) | 269 | 252 | 17 | 47 | 66 | (19 | ) | ||||||||||||||
in offices outside the UK |
(661 | ) | (31 | ) | (630 | ) | (269 | ) | 181 | (450 | ) | 88 | 190 | (102 | ) | ||||||||||||
(2,636 | ) | (177 | ) | (2,459 | ) | | 433 | (433 | ) | 135 | 256 | (121 | ) | ||||||||||||||
Customer accounts demand deposits: |
|||||||||||||||||||||||||||
in offices in the UK |
(536 | ) | (111 | ) | (425 | ) | 52 | (155 | ) | 207 | 178 | 105 | 73 | ||||||||||||||
in offices outside the UK |
304 | 327 | (23 | ) | 168 | 34 | 134 | 150 | 95 | 55 | |||||||||||||||||
(232 | ) | 216 | (448 | ) | 220 | (121 | ) | 341 | 328 | 200 | 128 | ||||||||||||||||
Customer accounts savings deposits: |
|||||||||||||||||||||||||||
in offices in the UK |
(1,755 | ) | 23 | (1,778 | ) | 95 | 527 | (432 | ) | 357 | (81 | ) | 438 | ||||||||||||||
in offices outside the UK |
(87 | ) | 77 | (164 | ) | 285 | 77 | 208 | 54 | 45 | 9 | ||||||||||||||||
(1,842 | ) | 100 | (1,942 | ) | 380 | 604 | (224 | ) | 411 | (36 | ) | 447 | |||||||||||||||
Customer accounts other time deposits retail: |
|||||||||||||||||||||||||||
in offices in the UK |
(876 | ) | (91 | ) | (785 | ) | (78 | ) | 86 | (164 | ) | 53 | (204 | ) | 257 | ||||||||||||
in offices outside the UK |
378 | 529 | (151 | ) | 626 | 500 | 126 | 242 | 200 | 42 | |||||||||||||||||
(498 | ) | 438 | (936 | ) | 548 | 586 | (38 | ) | 295 | (4 | ) | 299 | |||||||||||||||
Customer accounts other time deposits wholesale: |
|||||||||||||||||||||||||||
in offices in the UK |
(1,222 | ) | (219 | ) | (1,003 | ) | (120 | ) | 367 | (487 | ) | 688 | 263 | 425 | |||||||||||||
in offices outside the UK |
(1,106 | ) | (605 | ) | (501 | ) | 433 | 469 | (36 | ) | 470 | 45 | 425 | ||||||||||||||
(2,328 | ) | (824 | ) | (1,504 | ) | 313 | 836 | (523 | ) | 1,158 | 308 | 850 | |||||||||||||||
Debt securities in issue: |
|||||||||||||||||||||||||||
in offices in the UK |
266 | 1,202 | (936 | ) | (133 | ) | (26 | ) | (107 | ) | 203 | (240 | ) | 443 | |||||||||||||
in offices outside the UK |
(1,456 | ) | 14 | (1,470 | ) | (1,321 | ) | (673 | ) | (648 | ) | 1,369 | 1,063 | 306 | |||||||||||||
(1,190 | ) | 1,216 | (2,406 | ) | (1,454 | ) | (699 | ) | (755 | ) | 1,572 | 823 | 749 | ||||||||||||||
Dated and undated loan capital and other subordinated liabilities principally in offices in the UK |
454 | 233 | 221 | 672 | 620 | 52 | (14 | ) | (41 | ) | 27 | ||||||||||||||||
Repurchase agreements and cash collateral on securities lent: |
|||||||||||||||||||||||||||
in offices in the UK |
(7,145 | ) | (1,217 | ) | (5,928 | ) | 829 | 1,471 | (642 | ) | 2,536 | 1,090 | 1,446 | ||||||||||||||
in offices outside the UK |
(1,951 | ) | 497 | (2,448 | ) | (2,251 | ) | 1,840 | (4,091 | ) | 740 | 1,402 | (662 | ) | |||||||||||||
(9,096 | ) | (720 | ) | (8,376 | ) | (1,422 | ) | 3,311 | (4,733 | ) | 3,276 | 2,492 | 784 | ||||||||||||||
Trading portfolio liabilities: |
|||||||||||||||||||||||||||
in offices in the UK |
(464 | ) | (45 | ) | (419 | ) | 380 | 408 | (28 | ) | 263 | (80 | ) | 343 | |||||||||||||
in offices outside the UK |
(1,088 | ) | (742 | ) | (346 | ) | 652 | 1,189 | (537 | ) | 83 | (366 | ) | 449 | |||||||||||||
(1,552 | ) | (787 | ) | (765 | ) | 1,032 | 1,597 | (565 | ) | 346 | (446 | ) | 792 | ||||||||||||||
Financial liabilities designated at fair value: |
|||||||||||||||||||||||||||
in offices in the UK |
161 | 8 | 153 | (6 | ) | 700 | (706 | ) | 571 | 82 | 489 | ||||||||||||||||
in offices outside the UK |
(348 | ) | 137 | (485 | ) | 336 | 168 | 168 | 29 | 29 | | ||||||||||||||||
(187 | ) | 145 | (332 | ) | 330 | 868 | (538 | ) | 600 | 111 | 489 | ||||||||||||||||
Total interest payable: |
|||||||||||||||||||||||||||
in offices in the UK |
(13,092 | ) | (363 | ) | (12,729 | ) | 1,960 | 4,250 | (2,290 | ) | 4,882 | 960 | 3,922 | ||||||||||||||
in offices outside the UK |
(6,015 | ) | 203 | (6,218 | ) | (1,341 | ) | 3785 | (5,126 | ) | 3,225 | 2,703 | 522 | ||||||||||||||
(19,107 | ) | (160 | ) | (18,947 | ) | 619 | 8,035 | (7,416 | ) | 8,107 | 3,663 | 4,444 | |||||||||||||||
Movement in net interest income |
|||||||||||||||||||||||||||
Increase/(decrease) in interest receivable |
(21,666 | ) | 947 | (22,613 | ) | 2,519 | 8,285 | (5,766 | ) | 11,624 | 5,912 | 5,712 | |||||||||||||||
(Increase)/decrease in interest payable |
19,107 | 160 | 18,947 | (619 | ) | (8,035 | ) | 7,416 | (8,107 | ) | (3,663 | ) | (4,444 | ) | |||||||||||||
(2,559 | ) | 1,107 | (3,666 | ) | 1,900 | 250 | 1,650 | 3,517 | 2,249 | 1,268 |
26 |
27 |
Financial review
Additional financial disclosure
continued
28 |
29 |
Financial review
Analysis of results by business
Barclays Overview
Listed in London and New York, Barclays is a major global and financial service provider engaged in retail and commercial banking, credit cards, investment banking, wealth management presence in Europe, United States, Africa and Asia. With a strong long-term credit rating and over 300 years of history and expertise in banking. Barclays moves, lend and invests money for 48 million customer and client worldwide. The following section analyses the Groups performance by business.
For management reporting purposes during 2009, Barclays was organised into the following business groupings:
Global Retail and Commercial Banking
| UK Retail Banking |
| Barclays Commercial Bank |
| Barclaycard |
| GRCB Western Europe |
| GRCB Emerging Markets |
| GRCB Absa |
Investment Banking and Investment Management
| Barclays Capital |
| Barclays Global Investors |
| Barclays Wealth |
Head Office Functions and Other Operations
UK Retail Banking
UK Retail Banking comprises Personal Customers, Home Finance, Local Business, Consumer Lending and Barclays Financial Planning. This cluster of businesses aims to build broader and deeper relationships with its Personal and Local Business customers through providing a wide range of products and financial services. Personal Customers and Home Finance provide access to current account and savings products, Woolwich branded mortgages and general insurance.
Consumer Lending provides unsecured loan and protection products and Barclays Financial Planning provides investment advice and products. Local Business provides banking services, including money transmission, to small businesses.
Barclays Commercial Bank
Barclays Commercial Bank provides banking services to organisations with an annual turnover of more than £1m. Customers are served via a network of relationship and industry sector specialists, which provides solutions constructed from a comprehensive suite of banking products, support, expertise and services, including specialist asset financing and leasing facilities. Customers are also offered access to the products and expertise of other businesses in the Group, particularly Barclays Capital, Barclaycard and Barclays Wealth.
Barclaycard
Barclaycard is a multi-brand credit card and consumer lending business which also processes card payments for retailers and merchants and issues credit and charge cards to corporate customers and the UK Government. It is one of Europes leading credit card businesses and has an increasing presence in the United States and South Africa.
In the UK, Barclaycard comprises Barclaycard UK Cards, Barclaycard Partnerships, Barclays Partner Finance and FirstPlus.
Outside the UK, Barclaycard provides credit cards in the United States, Germany, South Africa (through management of the Absa credit card portfolio) and in the Scandinavian region, where Barclaycard operates through Entercard, a joint venture with Swedbank.
Barclaycard works closely with other parts of the Group, including UK Retail Banking, Barclays Commercial Bank and GRCB Western Europe and GRCB Emerging Markets, to leverage their distribution capabilities.
Global Retail and Commercial Banking Western Europe
GRCB Western Europe encompasses Barclays Global Retail and Commercial Banking, as well as Barclaycard operations, in Spain, Italy, Portugal, France and Russia. GRCB Western Europe serves customers through a variety of distribution channels. GRCB Western Europe provides a variety of products including retail mortgages, current and deposit accounts, commercial lending, unsecured lending, credit cards, investments, and insurance serving the needs of Barclays retail, mass affluent, and corporate customers.
Global Retail and Commercial Banking Emerging Markets
GRCB Emerging Markets serves retail and commercial banking customers in Botswana, Egypt, Ghana, India, Kenya, Mauritius, Pakistan, Seychelles, Tanzania, Uganda, the UAE, Zambia, Indonesia and Zimbabwe. Through a network of more than 683 distribution points and 1,023 ATMs, we provide 3.7 million customers and clients with a full range of products and services. This includes current accounts, savings, investments, mortgages and secured and unsecured lending.
Global Retail and Commercial Banking Absa
GRCB Absa represents Barclays consolidation of Absa, excluding Absa Capital and Absa Card and Absa Wealth which is included as part of Barclays Capital, Barclaycard and Barclays Wealth respectively. Absa Group Limited is a South African financial services organisation serving personal, commercial and corporate customers predominantly in South Africa. GRCB Absa serves retail customers through a variety of distribution channels and offers a full range of banking services, including current and deposit accounts, mortgages, instalment finance, credit cards, bancassurance products and wealth management services. It also offers customised business solutions for commercial and large corporate customers.
Barclays Capital
Barclays Capital is the investment banking division of Barclays that provides large corporate, institutional and government clients with solutions to their financing and risk management needs.
Barclays Capital services a wide variety of client needs, covering strategic advisory and M&A; equity and fixed income capital raising and corporate lending; and risk management across foreign exchange, interest rates, equities and commodities.
Activities are organised into three principal areas: Global Markets, which includes commodities, credit products, equities, foreign exchange, interest rate products; Investment Banking, which includes corporate advisory, Mergers and Acquisitions, equity and fixed-income capital raising and corporate lending; and Private Equity and Principal Investments. Barclays Capital includes Absa Capital, the investment banking business of Absa. Barclays Capital works closely with all other parts of the Group to leverage synergies from client relationships and product capabilities.
Barclays Global Investors
The majority of the BGI business, which was previously reported as a separate business segment, was sold on 1st December 2009 to BlackRock, Inc. and represents the Groups discontinued operations. The continuing operations of BGI disclosed in the segmental analysis represent residual obligations under the cash support arrangements and associated liquidity support charges and, from 1st December 2009, include the Groups 19.9% ongoing economic interest in BlackRock, Inc. This investment is accounted for as an available for sale equity investment, with no dividends being received during 2009.
Barclays Wealth
Barclays Wealth focuses on private and intermediary clients worldwide providing international and private banking, fiduciary services, investment management, and brokerage.
Barclays Wealth works closely with all other parts of the Group to leverage synergies from client relationships and product capabilities.
Head Office Functions and Other Operations
Head Office Functions and Other Operations comprises head office and central support functions, businesses in transition and inter-segment adjustments.
Head office and central support functions comprises the following areas: Executive Management, Finance, Treasury, Corporate Affairs, Human Resources, Strategy and Planning, Internal Audit, Legal, Corporate Secretariat, Property, Tax, Compliance and Risk. Costs incurred wholly on behalf of the businesses are recharged to them.
Businesses in transition principally relate to certain lending portfolios that are centrally managed with the objective of maximising recovery from the assets.
Business segment reorganisation
In November 2009 we regrouped our activities to form:
| Global Retail Banking (GRB), comprising UK Retail Banking, Barclaycard and the former Western Europe and Emerging Markets businesses, led by Antony Jenkins. |
| Corporate and Investment Banking (CIB), comprising Barclays Capital and Barclays Commercial Bank (now called Barclays Corporate); Jerry del Missier and Rich Ricci and Co-Chief Executives of Corporate and Investment Banking. |
GRB focuses on mass consumers, mass affluent consumers and small business customers. We have significantly changed the footprint here over the past three years, and we intend to push that forward, increasing, through time, the ratio of non-UK to UK business whilst strengthening our UK franchises. We will place particular emphasis on creating appropriate scale in the markets in which we have a presence. As we do that, our objectives will be four-fold: profit growth; an improved loan-to-deposit ratio; further international diversification through deepening existing presences; and the generation of net equity.
Barclays Corporate, as part of CIB, focuses on the high end of what we used to call Barclays Commercial, particularly financial institutions, public sector entries and corporate clients. We brought this business alongside Barclays Capital within CIB because we see significant synergy in sharing relationship management and sector expertise across the two. Realisation of the synergy is enabled by the increasing fungibility of client requirements between traditional corporate banking and investment banking product needs within our client base. This is a global opportunity with significant income growth potential for CIB in the years ahead. Our early work has only reinforced that strongly held belief.
In the area of wealth management, the competitive landscape in the global industry has gone through a sea change over the course of the last three years. That creates opportunity, and we intend to seize that by investing to change the scale of this business over the next five years.
For management reporting purposes these changes have taken effect from 1st January 2010 and therefore have not been reflected in the analysis provided in this document.
30 |
Analysis of results by business
UK Retail Banking £m |
Barclays Commercial Bank £m |
Barclaycard £m |
GRCB Western Europe £m |
GRCB Emerging Markets £m |
GRCB Absa £m |
Barclays Capital £m |
Barclays Global Investors a £m |
Barclays Wealth £m |
Head Office Functions and Other Operations £m |
|||||||||||||||||||||
Net interest income |
2,624 | 1,741 | 2,723 | 1,182 | 743 | 1,300 | 1,598 | 43 | 504 | (507 | ) | |||||||||||||||||||
Net fee and commission income |
1,225 | 926 | 1,271 | 438 | 232 | 943 | 3,001 | 1,757 | 802 | (418 | ) | |||||||||||||||||||
Principal transactions |
| (26 | ) | 22 | 123 | 68 | 123 | 7,021 | 98 | 20 | (325 | ) | ||||||||||||||||||
Net premiums from insurance contracts |
198 | | 44 | 544 | | 294 | 5 | | | 92 | ||||||||||||||||||||
Other income |
6 | 112 | 2 | 8 | 2 | 60 | | 5 | 7 | 1,186 | ||||||||||||||||||||
Total income |
4,053 | 2,753 | 4,062 | 2,295 | 1,045 | 2,720 | 11,625 | 1,903 | 1,333 | 28 | ||||||||||||||||||||
Net claims and benefits incurred on insurance contracts |
(68 | ) | | (20 | ) | (572 | ) | | (171 | ) | | | | | ||||||||||||||||
Total income, net of insurance claims |
3,985 | 2,753 | 4,042 | 1,723 | 1,045 | 2,549 | 11,625 | 1,903 | 1,333 | 28 | ||||||||||||||||||||
Impairment charges and other credit provisions |
(936 | ) | (974 | ) | (1,798 | ) | (667 | ) | (471 | ) | (567 | ) | (2,591 | ) | | (51 | ) | (16 | ) | |||||||||||
Net income |
3,049 | 1,779 | 2,244 | 1,056 | 574 | 1,982 | 9,034 | 1,903 | 1,282 | 12 | ||||||||||||||||||||
Operating expenses |
(2,440 | ) | (1,030 | ) | (1,494 | ) | (1,113 | ) | (852 | ) | (1,469 | ) | (6,592 | ) | (1,154 | ) | (1,138 | ) | (570 | ) | ||||||||||
Share of post-tax results of associates and joint ventures |
3 | | 8 | 4 | | (4 | ) | 22 | | | 1 | |||||||||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
| | 3 | 157 | 24 | (3 | ) | | (1 | ) | 1 | 7 | ||||||||||||||||||
Profit on disposal of discontinued operations |
| | | | | | | 6,331 | | | ||||||||||||||||||||
Gain on acquisitions |
| | | 26 | | | | | | | ||||||||||||||||||||
Profit before tax |
612 | 749 | 761 | 130 | (254 | ) | 506 | 2,464 | 7,079 | 145 | (550 | ) | ||||||||||||||||||
As at 31st December 2009 |
||||||||||||||||||||||||||||||
Total assets |
105,228 | 75,547 | 30,220 | 64,185 | 11,874 | 45,824 | 1,019,120 | 5,406 | 15,095 | 6,430 | ||||||||||||||||||||
Total liabilities |
102,934 | 68,108 | 5,543 | 48,049 | 9,836 | 25,769 | 951,192 | 416 | 41,648 | 66,848 |
Note
a | Continuing and discontinued operations including profit on disposal. For a break-down of the continuing operations and discontinued operations in respect of BGI, including a reconciliation of the results of the continuing operations to the results of the total BGI result shown above, see page 46. |
31 |
Financial review
Analysis of results by business
continued
32 |
UK Retail Banking |
2009 |
2008 £m |
2007 £m |
|||||||||
Income statement information |
||||||||||||
Net interest income |
2,624 | 2,996 | 2,858 | |||||||||
Net fee and commission income |
1,225 | 1,299 | 1,183 | |||||||||
Net premiums from insurance contracts |
198 | 205 | 252 | |||||||||
Other income |
6 | 17 | 47 | |||||||||
Total income |
4,053 | 4,517 | 4,340 | |||||||||
Net claims and benefits on insurance contracts |
(68 | ) | (35 | ) | (43 | ) | ||||||
Total income net of insurance claims |
3,985 | 4,482 | 4,297 | |||||||||
Impairment charges |
(936 | ) | (602 | ) | (559 | ) | ||||||
Net income |
3,049 | 3,880 | 3,738 | |||||||||
Operating expenses excluding amortisation of intangible assets |
(2,400 | ) | (2,499 | ) | (2,461 | ) | ||||||
Amortisation of intangible assets |
(40 | ) | (20 | ) | (9 | ) | ||||||
Operating expenses |
(2,440 | ) | (2,519 | ) | (2,470 | ) | ||||||
Share of post-tax results of associates and joint ventures |
3 | 8 | 7 | |||||||||
Profit before tax |
612 | 1,369 | 1,275 | |||||||||
Balance sheet information |
||||||||||||
Loans and advances to customers |
£ | 99.1bn | £ | 94.4bn | £ | 82.0bn | ||||||
Customer accounts |
£ | 92.5bn | £ | 89.6bn | £ | 87.1bn | ||||||
Total assets |
£ | 105.2bn | £ | 101.4bn | £ | 88.5bn | ||||||
Risk weighted assets b |
£ | 32.2bn | £ | 30.5bn | £ | 31.5bn | ||||||
Performance ratios |
||||||||||||
Cost:income ratio |
61% | 56% | 57% | |||||||||
Cost:net income ratio |
80% | 65% | 66% |
Notes
a | Excludes Housing Associations. |
b | Risk weighted assets for 2009 and 2008 are calculated under Basel II. 2007 is calculated under Basel I. |
33 |
Financial review
Analysis of results by business
continued
34 |
Barclays Commercial Bank | 2009 £m |
2008 £m |
2007 £m |
|||||||||
Income statement information |
||||||||||||
Net interest income |
1,741 | 1,757 | 1,747 | |||||||||
Net fee and commission income |
926 | 861 | 750 | |||||||||
Net trading income |
25 | 3 | 9 | |||||||||
Net investment income |
(51 | ) | 19 | 47 | ||||||||
Principal transactions |
(26 | ) | 22 | 56 | ||||||||
Other income |
112 | 105 | 11 | |||||||||
Total income |
2,753 | 2,745 | 2,564 | |||||||||
Impairment charges and other credit provisions |
(974 | ) | (414 | ) | (292 | ) | ||||||
Net income |
1,779 | 2,331 | 2,272 | |||||||||
Operating expenses excluding amortisation of intangible assets |
(1,009 | ) | (1,048 | ) | (924 | ) | ||||||
Amortisation of intangible assets |
(21 | ) | (15 | ) | (5 | ) | ||||||
Operating expenses |
(1,030 | ) | (1,063 | ) | (929 | ) | ||||||
Share of post-tax results of associates and joint ventures |
| (2 | ) | | ||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
| | 14 | |||||||||
Profit before tax |
749 | 1,266 | 1,357 | |||||||||
Balance sheet information |
||||||||||||
Loans and advances to customers |
£ | 59.6bn | £ | 67.5bn | £ | 63.7bn | ||||||
Loans and advances to customers including those designated at fair value |
£ | 72.7bn | £ | 80.5bn | £ | 70.7bn | ||||||
Customer accounts |
£ | 62.7bn | £ | 60.6bn | £ | 60.8bn | ||||||
Total assets |
£ | 75.5bn | £ | 84.0bn | £ | 74.6bn | ||||||
Risk weighted assets |
£ | 60.3bn | £ | 63.1bn | £ | 57.0bn | ||||||
Performance ratios |
||||||||||||
Cost: income ratio |
37% | 39% | 36% | |||||||||
Cost: net income ratio |
58% | 46% | 41% |
35 |
Financial review
Analysis of results by business
continued
Note
a | The number of customers at 31st December 2009 is, after a reduction of 1.5 million, due to the closure of dormant accounts. |
36 |
Barclaycard
|
2009 £m |
2008 |
2007 £m |
|||||||||
Income statement information |
||||||||||||
Net interest income |
2,723 | 1,786 | 1,374 | |||||||||
Net fee and commission income |
1,271 | 1,299 | 1,143 | |||||||||
Net trading income |
(1 | ) | 2 | | ||||||||
Net investment income |
23 | 80 | 11 | |||||||||
Principal transactions |
22 | 82 | 11 | |||||||||
Net premiums from insurance contracts |
44 | 44 | 40 | |||||||||
Other income |
2 | 19 | (25 | ) | ||||||||
Total income |
4,062 | 3,230 | 2,543 | |||||||||
Net claims and benefits incurred on insurance contracts |
(20 | ) | (11 | ) | (13 | ) | ||||||
Total income net of insurance claims |
4,042 | 3,219 | 2,530 | |||||||||
Impairment charges and other credit provisions |
(1,798 | ) | (1,097 | ) | (827 | ) | ||||||
Net income |
2,244 | 2,122 | 1,703 | |||||||||
Operating expenses excluding amortisation of intangible assets |
(1,412 | ) | (1,361 | ) | (1,057 | ) | ||||||
Amortisation of intangible assets |
(82 | ) | (61 | ) | (36 | ) | ||||||
Operating expenses |
(1,494 | ) | (1,422 | ) | (1,093 | ) | ||||||
Profit on disposal of subsidiaries, associates and joint ventures |
8 | (3 | ) | (7 | ) | |||||||
Share of post-tax results of associates and joint ventures |
3 | | | |||||||||
Gain on acquisition |
| 92 | | |||||||||
Profit before tax |
761 | 789 | 603 | |||||||||
Balance sheet information |
||||||||||||
Loans and advances to customers |
£ | 26.5bn | £ | 27.4bn | £ | 19.7bn | ||||||
Total assets |
£ | 30.2bn | £ | 30.9bn | £ | 22.1bn | ||||||
Risk weighted assets |
£ | 30.6bn | £ | 27.3bn | £ | 20.2bn | ||||||
Performance ratios |
||||||||||||
Cost: income ratio |
37% | 44% | 43% | |||||||||
Cost: net income ratio |
67% | 67% | 64% |
37 |
Financial review
Analysis of results by business
continued
38 |
GRCB Western Europe
2009 £m |
2008 a £m |
2007 a £m |
||||||||||
Income statement information |
||||||||||||
Net interest income |
1,182 | 875 | 527 | |||||||||
Net fee and commission income |
438 | 389 | 322 | |||||||||
Net trading income |
| (7 | ) | 13 | ||||||||
Net investment income |
123 | 161 | 93 | |||||||||
Principal transactions |
123 | 154 | 106 | |||||||||
Net premiums from insurance contracts |
544 | 352 | 145 | |||||||||
Other income |
8 | 50 | 7 | |||||||||
Total income |
2,295 | 1,820 | 1,107 | |||||||||
Net claims and benefits incurred under insurance contracts |
(572 | ) | (365 | ) | (170 | ) | ||||||
Total income net of insurance claims |
1,723 | 1,455 | 937 | |||||||||
Impairment charges |
(667 | ) | (297 | ) | (76 | ) | ||||||
Net income |
1,056 | 1,158 | 861 | |||||||||
Operating expenses excluding amortisation of intangible assets |
(1,075 | ) | (941 | ) | (665 | ) | ||||||
Amortisation of intangible assets |
(38 | ) | (19 | ) | (8 | ) | ||||||
Operating expenses |
(1,113 | ) | (960 | ) | (673 | ) | ||||||
Share of post-tax results of associates and joint ventures |
4 | | | |||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
157 | | 8 | |||||||||
Gain on acquisition |
26 | 52 | | |||||||||
Profit before tax |
130 | 250 | 196 | |||||||||
Balance sheet information |
||||||||||||
Loans and advances to customers |
£ | 52.7bn | £ | 53.9bn | £ | 35.0bn | ||||||
Customer accounts |
£ | 23.4bn | £ | 15.6bn | £ | 9.4bn | ||||||
Total assets |
£ | 64.2bn | £ | 65.5bn | £ | 43.7bn | ||||||
Risk weighted assets |
£ | 32.4bn | £ | 37.0bn | £ | 25.0bn | ||||||
Performance ratios |
||||||||||||
Cost: income ratio |
65% | 66% | 72% | |||||||||
Cost: net income ratio |
105% | 83% | 78% |
Note
a | Figures have been restated to include Barclays Russia, which was transferred from GRCB Emerging Markets to GRCB Western Europe during 2009. |
39 |
Financial review
Analysis of results by business
continued
40 |
GRCB Emerging Markets
2009 £m |
2008 a £m |
2007 a £m |
||||||||||
Income statement information |
||||||||||||
Net interest income |
743 | 597 | 319 | |||||||||
Net fee and commission income |
232 | 217 | 140 | |||||||||
Net trading income |
61 | 88 | 56 | |||||||||
Net investment income |
7 | 91 | 16 | |||||||||
Principal transactions |
68 | 179 | 72 | |||||||||
Other income |
2 | 1 | 2 | |||||||||
Total income |
1,045 | 994 | 533 | |||||||||
Impairment charges |
(471 | ) | (165 | ) | (39 | ) | ||||||
Net income |
574 | 829 | 494 | |||||||||
Operating expenses excluding amortisation of intangible assets |
(846 | ) | (685 | ) | (391 | ) | ||||||
Amortisation of intangible assets |
(6 | ) | (3 | ) | (4 | ) | ||||||
Operating expenses |
(852 | ) | (688 | ) | (395 | ) | ||||||
Share of post-tax results of associates and joint ventures |
| | 1 | |||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
24 | | | |||||||||
Profit before tax |
(254 | ) | 141 | 100 | ||||||||
Balance sheet information |
||||||||||||
Loans and advances to customers |
£ | 7.3bn | £ | 9.7bn | £ | 5.1bn | ||||||
Customer accounts |
£ | 8.5bn | £ | 9.3bn | £ | 6.2bn | ||||||
Total assets |
£ | 11.9bn | £ | 13.9bn | £ | 9.2bn | ||||||
Risk weighted assets |
£ | 12.4bn | £ | 14.6bn | £ | 10.5bn | ||||||
Performance ratios |
||||||||||||
Cost: income ratio |
82% | 69% | 74% | |||||||||
Cost: net income ratio |
148% | 83% | 80% |
Note
a | Figures have been restated to exclude Barclays Russia, which was transferred from GRCB Emerging Markets to GRCB Western Europe during 2009. |
41 |
Financial review
Analysis of results by business
continued
42 |
GRCB Absa | |||||||||
2009 £m |
2008 £m |
2007 £m | |||||||
Income statement information |
|||||||||
Net interest income |
1,300 | 1,104 | 1,055 | ||||||
Net fee and commission income |
943 | 762 | 684 | ||||||
Net trading income/(expense) |
(5) | 6 | | ||||||
Net investment income |
128 | 105 | 70 | ||||||
Principal transactions |
123 | 111 | 70 | ||||||
Net premiums from insurance contracts |
294 | 234 | 227 | ||||||
Other income |
60 | 113 | 77 | ||||||
Total income |
2,720 | 2,324 | 2,113 | ||||||
Net claims and benefits incurred under insurance contracts |
(171) | (126) | (114) | ||||||
Total income net of insurance claims |
2,549 | 2,198 | 1,999 | ||||||
Impairment charges |
(567) | (347) | (146) | ||||||
Net income |
1,982 | 1,851 | 1,853 | ||||||
Operating expenses excluding amortisation of intangible assets |
(1,418) | (1,255) | (1,212) | ||||||
Amortisation of intangible assets |
(51) | (50) | (55) | ||||||
Operating expenses |
(1,469) | (1,305) | (1,267) | ||||||
Share of post-tax results of associates and joint ventures |
(4) | 5 | 6 | ||||||
Profit on disposal of subsidiaries, associates and joint ventures |
(3) | 1 | 5 | ||||||
Profit before tax |
506 | 552 | 597 | ||||||
Balance sheet information |
|||||||||
Loans and advances to customers |
£ | 36.4bn | £ | 32.7bn | £ | 29.9bn | |||
Customer accounts |
£ | 19.7bn | £ | 17.0bn | £ | 13.0bn | |||
Total assets |
£ | 45.8bn | £ | 40.4bn | £ | 36.4bn | |||
Risk weighted assets |
£ | 21.4bn | £ | 18.8bn | £ | 17.8bn | |||
Performance ratios |
|||||||||
Cost:income ratio |
58% | 59% | 63% | ||||||
Cost:net income ratio |
74% | 71% | 68% |
43 |
Financial review
Analysis of results by business
continued
Note
a | Top-line income is a non-IFRS measure that represents income before own credit gains/losses and credit market write-downs. This measure has been presented as it provides for a consistent basis for comparing the business performance between financial periods. For a reconciliation of top-line income to total income for Barclays Capital, see the Analysis of Total Income table on this page. |
44 |
Barclays Capital
2009 £m |
2008 £m |
2007 £m |
||||||||||
Income statement information |
||||||||||||
Net interest income |
1,598 | 1,724 | 1,179 | |||||||||
Net fee and commission income |
3,001 | 1,429 | 1,235 | |||||||||
Net trading income |
7,185 | 1,506 | 3,739 | |||||||||
Net investment (loss)/income |
(164 | ) | 559 | 953 | ||||||||
Principal transactions |
7,021 | 2,065 | 4,692 | |||||||||
Other income |
5 | 13 | 13 | |||||||||
Total income |
11,625 | 5,231 | 7,119 | |||||||||
Impairment charges and other credit provisions |
(2,591 | ) | (2,423 | ) | (846 | ) | ||||||
Net income |
9,034 | 2,808 | 6,273 | |||||||||
Operating expenses excluding amortisation of intangible assets |
(6,406 | ) | (3,682 | ) | (3,919 | ) | ||||||
Amortisation of intangible assets |
(186 | ) | (92 | ) | (54 | ) | ||||||
Operating expenses |
(6,592 | ) | (3,774 | ) | (3,973 | ) | ||||||
Share of post-tax results of associates and joint ventures |
22 | 6 | 35 | |||||||||
Gain on acquisition |
| 2,262 | | |||||||||
Profit before tax |
2,464 | 1,302 | 2,335 | |||||||||
Balance sheet information |
||||||||||||
Loans and advances to banks and customers at amortised cost |
£ | 162.6bn | £ | 206.8bn | £ | 135.6bn | ||||||
Total assets |
£ | 1,019.1bn | £ | 1,629.1bn | £ | 839.9bn | ||||||
Risk weighted assets |
£ | 181.1bn | £ | 227.4bn | £ | 178.2bn | ||||||
Performance ratios |
||||||||||||
Cost: income ratio |
57% | 72% | 56% | |||||||||
Cost: net income ratio |
73% | 134% | 63% | |||||||||
Compensation:income ratio |
38% | 44% | 42% | |||||||||
Average total income per employee (000) |
£ | 515 | £ | 281 | £ | 465 | ||||||
Other financial measures |
||||||||||||
Average DVaR (95%) a |
£ | 77.0m | £ | 53.4m | £ | 32.5m |
Note
a | Average DVaR for 2008 and 2007 are calculated with a 98% confidence level. |
45 |
Financial review
Analysis of results by business
continued
Profit on disposal information | As at 1st December 2009 £m | |
Consideration including hedging gains |
||
Cash |
4,207 | |
BlackRock shares |
5,294 | |
Total consideration |
9,501 | |
Net assets disposed |
(2,051) | |
CVC fee |
(106) | |
Transaction costs |
(433) | |
Amounts relating to non-controlling interests |
(580) | |
Profit on disposal before tax |
6,331 |
Note
a | Certain BGI total information may be considered non-IFRS measures because they present BGI results that combine continuing operations and discontinuing operations. See Certain non-IFRS Measures on page i for more information with respect to including BGI results within Group totals. For a reconciliation of the results of the continuing operations in respect of BGI to total BGI results which include both discontinued and continuing operations, see table on page 46. |
46 |
2009 | 2008 | 2007 | |||||||||||||||||||||||||||||||||
Continuing operations £m |
Discontinued operations £m |
Total £m |
Continuing operations £m |
Discontinued operations £m |
Total £m | Continuing operations £m |
Discontinued operations £m |
Total £m | |||||||||||||||||||||||||||
Income statement information |
|||||||||||||||||||||||||||||||||||
Net interest income/(expense) |
10 | 33 | 43 | (38 | ) | | (38 | ) | (20 | ) | 12 | (8 | ) | ||||||||||||||||||||||
Net fee and commission income |
(2 | ) | 1,759 | 1,757 | 1 | 1,916 | 1,917 | (1 | ) | 1,937 | 1,936 | ||||||||||||||||||||||||
Net trading income/(loss) |
20 | 1 | 21 | (4 | ) | (10 | ) | (14 | ) | | 5 | 5 | |||||||||||||||||||||||
Net investment income/(loss) |
11 | 66 | 77 | (29 | ) | | (29 | ) | (9 | ) | | (9 | ) | ||||||||||||||||||||||
Principal transactions |
31 | 67 | 98 | (33 | ) | (10 | ) | (43 | ) | (9 | ) | 5 | (4 | ) | |||||||||||||||||||||
Other income |
1 | 4 | 5 | (2 | ) | 10 | 8 | | 2 | 2 | |||||||||||||||||||||||||
Total income |
40 | 1,863 | 1,903 | (72 | ) | 1,916 | 1,844 | (30 | ) | 1,956 | 1,926 | ||||||||||||||||||||||||
Operating expenses excluding amortisation of intangible assets |
(17 | ) | (1,123 | ) | (1,140 | ) | (274 | ) | (960 | ) | (1,234 | ) | (89 | ) | (1,095 | ) | (1,184 | ) | |||||||||||||||||
Amortisation of intangible assets |
| (14 | ) | (14 | ) | | (15 | ) | (15 | ) | | (8 | ) | (8 | ) | ||||||||||||||||||||
Operating expenses |
(17 | ) | (1,137 | ) | (1,154 | ) | (274 | ) | (975 | ) | (1,249 | ) | (89 | ) | (1,103 | ) | (1,192 | ) | |||||||||||||||||
Profit on disposal of associates and joint ventures |
(1 | ) | | (1 | ) | | | | | | | ||||||||||||||||||||||||
Profit/(loss) before tax and disposal of discontinued operations |
22 | 726 | 748 | (346 | ) | 941 | 595 | (119 | ) | 853 | 734 | ||||||||||||||||||||||||
Profit on disposal of discontinued operations |
| 6,331 | 6,331 | | | | | | | ||||||||||||||||||||||||||
Profit/(loss) before tax |
22 | 7,057 | 7,079 | (346 | ) | 941 | 595 | (119 | ) | 853 | 734 | ||||||||||||||||||||||||
Balance sheet information |
|||||||||||||||||||||||||||||||||||
Total assets |
£ | 5.4bn | | £ | 5.4bn | £ | 0.7bn | £ | 70.6bn | £ | 71.3bn | £ | 0.5bn | £ | 88.7bn | £ | 89.2bn |
47 |
Financial review
Analysis of results by business
continued
48 |
Barclays Wealth
2009 £m |
2008 £m |
2007 £m |
||||||||||
Income statement information |
||||||||||||
Net interest income |
504 | 486 | 431 | |||||||||
Net fee and commission income |
802 | 720 | 739 | |||||||||
Net trading income |
7 | (11 | ) | 3 | ||||||||
Net investment income |
13 | (333 | ) | 52 | ||||||||
Principal transactions |
20 | (344 | ) | 55 | ||||||||
Net premiums from insurance contracts |
| 136 | 195 | |||||||||
Other income |
7 | 26 | 19 | |||||||||
Total income |
1,333 | 1,024 | 1,439 | |||||||||
Net claims and benefits incurred on insurance contracts |
| 300 | (152 | ) | ||||||||
Total income net of insurance claims |
1,333 | 1,324 | 1,287 | |||||||||
Impairment charges |
(51 | ) | (44 | ) | (7 | ) | ||||||
Net income |
1,282 | 1,280 | 1,280 | |||||||||
Operating expenses excluding amortisation of intangible assets |
(1,114 | ) | (919 | ) | (967 | ) | ||||||
Amortisation of intangible assets |
(24 | ) | (16 | ) | (6 | ) | ||||||
Operating expenses |
(1,138 | ) | (935 | ) | (973 | ) | ||||||
Profit on disposal of associates and joint ventures |
1 | 326 | | |||||||||
Profit before tax |
145 | 671 | 307 | |||||||||
Balance sheet information |
||||||||||||
Loans and advances to customers |
£ | 13.1bn | £ | 11.4bn | £ | 9.0bn | ||||||
Customer accounts |
£ | 38.5bn | £ | 42.4bn | £ | 34.4bn | ||||||
Total assets |
£ | 15.1bn | £ | 13.3bn | £ | 18.2bn | ||||||
Risk weighted assets |
£ | 11.4bn | £ | 10.3bn | £ | 8.2bn | ||||||
Performance ratios |
||||||||||||
Cost:income ratio |
85% | 71% | 76% | |||||||||
Average net income generated per member of staff (000) |
£169 | £176 | £188 |
49 |
Financial review
Analysis of results by business
continued
50 |
Head office functions and other operations
2009 £m |
2008 £m |
2007 £m |
||||||||||
Income statement information |
||||||||||||
Net interest income |
(507 | ) | 182 | 128 | ||||||||
Net fee and commission income |
(418 | ) | (486 | ) | (424 | ) | ||||||
Net trading (loss)/income |
(291 | ) | (245 | ) | (66 | ) | ||||||
Net investment income/(expense) |
(34 | ) | 27 | (17 | ) | |||||||
Principal transactions |
(325 | ) | (218 | ) | (83 | ) | ||||||
Net premiums from insurance contracts |
92 | 119 | 152 | |||||||||
Other income |
1,186 | 26 | 35 | |||||||||
Total income |
28 | (377 | ) | (192 | ) | |||||||
Impairment (charges)/releases |
(16 | ) | (30 | ) | (3 | ) | ||||||
Net income |
12 | (407 | ) | (195 | ) | |||||||
Operating expenses excluding amortisation of intangible assets |
(570 | ) | (451 | ) | (233 | ) | ||||||
Amortisation of intangible assets |
| | (1 | ) | ||||||||
Operating expenses |
(570 | ) | (451 | ) | (234 | ) | ||||||
Share of post-tax results of associates and joint ventures |
1 | | | |||||||||
Profit on disposal of associates and joint ventures |
7 | | 1 | |||||||||
Loss before tax |
(550 | ) | (858 | ) | (428 | ) | ||||||
Balance sheet information |
||||||||||||
Total assets |
£ | 6.4bn | £ | 3.1bn | £ | 5.7bn | ||||||
Risk weighted assets |
£ | 0.9bn | £ | 0.4bn | £ | 1.1bn |
51 |
52 |
Risk management and governance
| ||
54 | Risk management | |
54 | Risk factors | |
59 | Barclays risk management strategy | |
66 | Credit risk management | |
94 | Market risk management | |
99 | Capital risk management | |
102 | Liquidity risk management | |
105 | Operational risk management | |
107 | Statistical information | |
117 | Supervision and regulation | |
119 | Board and Executive Committee | |
122 | Directors report | |
126 | Corporate governance report | |
145 | Remuneration report | |
162 | Accountability and audit |
54 |
55 |
56 |
Risk management
Risk factors
continued
57 |
58 |
Risk management
Risk factors
continued
59 |
Risk management
Barclays risk management strategy
60 |
Risk management
Barclays risk management strategy
continued
Note
The | governance structure will not change following the restructure of the Group announced in November 2009. |
61 |
62 |
Risk management
Barclays risk management strategy
continued
63 |
64 |
Risk management
Barclays risk management strategy
continued
65 |
66 |
Risk management
67 |
68 |
Risk management
Credit risk management
continued
Note
a | Total comprises all limits to cross-border counterparties (non-UK) where limits are greater than £10m. |
69 |
70 |
Risk management
Credit risk management
continued
Note
Loan loss rate for the years prior to 2005 does not reflect the application of IAS 32, IAS 39 and IFRS 4.
71 |
72 |
Risk management
Credit risk management
continued
Total assets and Barclays Capital credit market assets
Analysis of Total Assets | Accounting basis | Analysis of total assets | Sub analysis | |||||||||||||||||
Assets as at 31.12.09 | Total assets £m |
Fair value £m |
Cost based measure £m |
Derivatives £m |
Loans and advances a £m |
Debt securities and other bills b £m |
Reverse repurchase agreements c £m |
Equity securities d £m |
Other £m |
Credit market assets e £m | ||||||||||
Cash and balances at central banks |
81,483 | 81,483 | 81,483 | |||||||||||||||||
Items in the course of collection from other banks |
1,593 | 1,593 | 1,593 | |||||||||||||||||
Treasury and other eligible bills |
9,926 | 9,926 | 9,926 | |||||||||||||||||
Debt securities |
116,594 | 116,594 | 116,594 | 1,186 | ||||||||||||||||
Equity securities |
19,602 | 19,602 | 19,602 | |||||||||||||||||
Traded loans |
2,962 | 2,962 | 2,962 | |||||||||||||||||
Commoditiesf |
2,260 | 2,260 | 2,260 | |||||||||||||||||
Trading portfolio assets |
151,344 | 151,344 | 2,962 | 126,520 | 19,602 | 2,260 | 1,186 | |||||||||||||
Financial assets designated at fair value |
||||||||||||||||||||
Loans and advances |
22,390 | 22,390 | 22,390 | 6,941 | ||||||||||||||||
Debt securities |
4,007 | 4,007 | 4,007 | |||||||||||||||||
Equity securities |
6,256 | 6,256 | 6,256 | |||||||||||||||||
Other financial assetsg |
8,658 | 8,658 | 557 | 7,757 | 344 | |||||||||||||||
Held for own account |
41,311 | 41,311 | 22,947 | 4,007 | 7,757 | 6,256 | 344 | 6,941 | ||||||||||||
Held in respect of linked liabilities to customers under investment contractsh |
1,257 | 1,257 | 1,257 | |||||||||||||||||
Derivative financial instruments |
416,815 | 416,815 | 416,815 | 2,304 | ||||||||||||||||
Loans and advances to banks |
41,135 | 41,135 | 41,135 | |||||||||||||||||
Loans and advances to customers |
420,224 | 420,224 | 420,224 | 15,186 | ||||||||||||||||
Debt securities |
43,888 | 43,888 | 43,888 | 535 | ||||||||||||||||
Equity securities |
6,676 | 6,676 | 6,676 | |||||||||||||||||
Treasury and other eligible bills |
5,919 | 5,919 | 5,919 | |||||||||||||||||
Available for sale financial instruments |
56,483 | 56,483 | 49,807 | 6,676 | 535 | |||||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed |
143,431 | 143,431 | 143,431 | |||||||||||||||||
Other assets |
23,853 | 1,207 | 22,646 | 23,853 | 1,200 | |||||||||||||||
Total assets as at 31.12.09 |
1,378,929 | 668,417 | 710,512 | 416,815 | 487,268 | 180,334 | 151,188 | 32,534 | 110,790 | 27,352 | ||||||||||
Total assets as at 31.12.08 |
2,052,980 | 1,356,614 | 696,366 | 984,802 | 542,118 | 224,692 | 137,637 | 39,173 | 124,558 | 41,208 |
Notes
a | Further analysis of loans and advances is on pages 68 to 79. |
b | Further analysis of debt securities and other bills is on page 91. |
c | Reverse repurchase agreements comprise primarily short-term cash lending with assets pledged by counterparties securing the loan. |
d | Equity securities comprise primarily equity securities determined by available quoted prices in active markets. |
e | Further analysis of Barclays Capital credit market exposures is on pages 81 to 90. Undrawn commitments of £257m (2008: £531m) are off-balance sheet and therefore not included in the table above. This is a change in presentation from 31st December 2008, which reflected certain loan facilities originated post 1st July 2007. |
f | Commodities primarily consists of physical inventory positions. |
g | These instruments consist primarily of loans with embedded derivatives and reverse repurchase agreements designated at fair value. |
h | Financial assets designated at fair value in respect of linked liabilities to customers under investment contracts have not been further analysed as the Group is not exposed to the risks inherent in these assets. |
73 |
Loans and advances at amortised cost
As at 31st December 2009 | Gross loans and advances £m |
Impairment allowance £m |
Loans and advances net of impairment £m |
Credit risk loans £m |
CRLs % of gross loans and advances % |
Impairment charge £m |
Loan loss rates basis points | |||||||
Wholesale customers |
218,110 | 4,604 | 213,506 | 10,990 | 5.0 | 3,430 | 157 | |||||||
Wholesale banks |
41,196 | 61 | 41,135 | 57 | 0.1 | 11 | 3 | |||||||
Total wholesale |
259,306 | 4,665 | 254,641 | 11,047 | 4.3 | 3,441 | 133 | |||||||
Retail customers |
212,849 | 6,131 | 206,718 | 11,341 | 5.3 | 3,917 | 184 | |||||||
Total retail |
212,849 | 6,131 | 206,718 | 11,341 | 5.3 | 3,917 | 184 | |||||||
Total |
472,155 | 10,796 | 461,359 | 22,388 | 4.7 | 7,358 | 156 | |||||||
As at 31st December 2008 |
||||||||||||||
Wholesale customers |
266,750 | 2,784 | 263,966 | 8,144 | 3.1 | 2,540 | 95 | |||||||
Wholesale banks |
47,758 | 51 | 47,707 | 48 | 0.1 | 40 | 8 | |||||||
Total wholesale |
314,508 | 2,835 | 311,673 | 8,192 | 2.6 | 2,580 | 82 | |||||||
Retail customers |
201,588 | 3,739 | 197,849 | 7,508 | 3.7 | 2,333 | 116 | |||||||
Total retail |
201,588 | 3,739 | 197,849 | 7,508 | 3.7 | 2,333 | 116 | |||||||
Total |
516,096 | 6,574 | 509,522 | 15,700 | 3.0 | 4,913 | 95 |
Loans and advances held at fair value | As at 31.12.09 £m |
As at a 31.12.08 £m | ||
Government |
5,024 | 5,143 | ||
Financial Institutions |
3,543 | 7,354 | ||
Transport |
177 | 218 | ||
Postal and Communications |
179 | 37 | ||
Business and other services |
2,793 | 2,882 | ||
Manufacturing |
1,561 | 238 | ||
Wholesale and retail distribution and leisure |
664 | 1,110 | ||
Construction |
237 | 412 | ||
Property |
11,490 | 14,944 | ||
Energy and Water |
241 | 258 | ||
Total |
25,909 | 32,596 |
Note
a | 2008 loans and advances held at fair value have been reanalysed to reflect changes in classification of assets. |
74 |
Risk management
Credit risk management
continued
Impairment Charges and Other Credit Provisions |
Year Ended 31.12.09 £m |
Year Ended | ||
Impairment charges on loans and advances |
7,330 | 4,584 | ||
Charges in respect of undrawn facilities and guarantees |
28 | 329 | ||
Impairment charges on loans and advances |
7,358 | 4,913 | ||
Impairment charges on reverse repurchase agreements |
43 | 124 | ||
Impairment charges on available for sale assets |
670 | 382 | ||
Impairment charges and other credit provisions |
8,071 | 5,419 |
Impairment Charges by Business |
Loans and advances £m |
Available for sale assets £m |
Reverse |
Total £m | ||||
Year Ended 31.12.2009 | ||||||||
Global Retail and Commercial Banking |
5,395 | 18 | | 5,413 | ||||
UK Retail Banking |
936 | | | 936 | ||||
Barclays Commercial Bank |
960 | 14 | | 974 | ||||
Barclaycard |
1,798 | | | 1,798 | ||||
GRCB Western Europe |
663 | 4 | | 667 | ||||
GRCB Emerging Markets |
471 | | | 471 | ||||
GRCB Absa |
567 | | | 567 | ||||
Investment Banking and Investment Management |
1,949 | 650 | 43 | 2,642 | ||||
Barclays Capitala |
1,898 | 650 | 43 | 2,591 | ||||
Barclays Wealth |
51 | | | 51 | ||||
Head Office Functions and Other Operations |
14 | 2 | | 16 | ||||
Total Impairment charges |
7,358 | 670 | 43 | 8,071 | ||||
Year Ended 31.12.2008 |
||||||||
Global Retail and Commercial Banking |
2,922 | | | 2,922 | ||||
UK Retail Banking |
602 | | | 602 | ||||
Barclays Commercial Bank |
414 | | | 414 | ||||
Barclaycard |
1,097 | | | 1,097 | ||||
GRCB Western Europe |
297 | | | 297 | ||||
GRCB Emerging Markets |
165 | | | 165 | ||||
GRCB Absa |
347 | | | 347 | ||||
Investment Banking and Investment Management |
1,980 | 363 | 124 | 2,467 | ||||
Barclays Capitala |
1,936 | 363 | 124 | 2,423 | ||||
Barclays Wealth |
44 | | | 44 | ||||
Head Office Functions and Other Operations |
11 | 19 | | 30 | ||||
Total Impairment charges |
4,913 | 382 | 124 | 5,419 |
Note
a | Credit market related impairment charges within Barclays Capital comprised £1,205m (2008: £1,517m) against loans and advances, £464m (2008: £192m) against available for sale assets and £nil (2008: £54m) against reverse repurchase agreements. |
75 |
Potential Credit Risk Loans and Coverage Ratios
|
CRLs |
PPLs |
PCRLs | |||||||||
31.12.09 £m |
31.12.08 £m |
31.12.09 £m |
31.12.08 £m |
31.12.09 £m |
31.12.08 £m | |||||||
Home Loans |
3,604 | 2,528 | 135 | 267 | 3,739 | 2,795 | ||||||
Unsecured and other |
7,737 | 4,980 | 559 | 230 | 8,296 | 5,210 | ||||||
Retail |
11,341 | 7,508 | 694 | 497 | 12,035 | 8,005 | ||||||
Corporate/Wholesale |
11,047 | 8,192 | 2,674 | 1,959 | 13,721 | 10,151 | ||||||
Group |
22,388 | 15,700 | 3,368 | 2,456 | 25,756 | 18,156 | ||||||
Impairment allowance | CRL coverage | PCRL coverage | ||||||||||
31.12.09 £m |
31.12.08 £m |
31.12.09 % |
31.12.08 % |
31.12.09 % |
31.12.08 % | |||||||
Home Loans |
639 | 321 | 17.7 | 12.7 | 17.1 | 11.5 | ||||||
Unsecured and other |
5,492 | 3,418 | 71.0 | 68.6 | 66.2 | 65.6 | ||||||
Retail |
6,131 | 3,739 | 54.1 | 49.8 | 50.9 | 46.7 | ||||||
Corporate/Wholesale |
4,665 | 2,835 | 42.2 | 34.6 | 34.0 | 27.9 | ||||||
Group |
10,796 | 6,574 | 48.2 | 41.9 | 41.9 | 36.2 |
76 |
Risk management
Credit risk management
continued
Wholesale loans and advances at amortised cost
|
||||||||||||||
As at 31.12.09 | Gross loans and advances £m |
Impairment allowance £m |
Loans and advances net of impairment £m |
Credit risk loans £m |
CRLs % of gross loans and advances loans % |
Impairment charge £m |
Loan rates loss bps | |||||||
BCB |
60,840 | 679 | 60,161 | 1,837 | 3.0 | 960 | 158 | |||||||
Barclaycard |
322 | 4 | 318 | 10 | 3.1 | 17 | 528 | |||||||
GRCB WE |
12,690 | 466 | 12,224 | 1,435 | 11.3 | 328 | 258 | |||||||
GRCB EM |
5,228 | 227 | 5,001 | 358 | 6.8 | 140 | 268 | |||||||
GRCB Absa |
10,077 | 195 | 9,882 | 690 | 6.8 | 67 | 66 | |||||||
Barclays Capital |
165,624 | 3,025 | 162,599 | 6,411 | 3.9 | 1,898 | 115 | |||||||
BGI |
5 | | 5 | | | | | |||||||
Barclays Wealth |
3,495 | 43 | 3,452 | 179 | 5.1 | 17 | 49 | |||||||
Head office |
1,025 | 26 | 999 | 127 | 12.4 | 14 | 137 | |||||||
Total |
259,306 | 4,665 | 254,641 | 11,047 | 4.3 | 3,441 | 133 | |||||||
As at 31.12.08 | ||||||||||||||
BCB | 68,904 | 504 | 68,400 | 1,181 | 1.7 | 414 | 60 | |||||||
Barclaycard | 301 | 2 | 299 | 20 | 6.6 | 11 | 365 | |||||||
GRCB WE | 15,750 | 232 | 15,518 | 579 | 3.7 | 125 | 79 | |||||||
GRCB EM | 7,233 | 122 | 7,111 | 190 | 2.6 | 36 | 50 | |||||||
GRCB Absa | 8,648 | 140 | 8,508 | 304 | 3.5 | 19 | 22 | |||||||
Barclays Capital | 208,596 | 1,796 | 206,800 | 5,743 | 2.8 | 1,936 | 93 | |||||||
BGI | 834 | | 834 | | | | | |||||||
Barclays Wealth | 3,282 | 28 | 3,254 | 174 | 5.3 | 28 | 85 | |||||||
Head office | 960 | 11 | 949 | 1 | 0.1 | 11 | 115 | |||||||
Total | 314,508 | 2,835 | 311,673 | 8,192 | 2.6 | 2,580 | 82 |
Analysis of wholesale loans and advances at amortised cost net of impairment allowances
|
||||||||||||||||||||
Corporate | Government | Settlement balances & cash collateral |
Other wholesale | Total wholesale | ||||||||||||||||
Wholesale | 31.12.09 £m |
31.12.08 £m |
31.12.09 £m |
31.12.08 £m |
31.12.09 £m |
31.12.08 £m |
31.12.09 £m |
31.12.08 £m |
31.12.09 £m |
31.12.08 £m | ||||||||||
BCB |
59,979 | 67,741 | 182 | 659 | | | | | 60,161 | 68,400 | ||||||||||
Barclaycard |
318 | 299 | | | | | | | 318 | 299 | ||||||||||
GRCB WE |
12,184 | 15,226 | 14 | 32 | | | 26 | 260 | 12,224 | 15,518 | ||||||||||
GRCB EM |
4,044 | 5,074 | 170 | 1,709 | | | 787 | 328 | 5,001 | 7,111 | ||||||||||
GRCB Absa |
8,695 | 8,480 | 263 | 28 | | | 924 | | 9,882 | 8,508 | ||||||||||
Barclays Capital |
49,849 | 72,796 | 3,456 | 3,760 | 55,672 | 79,418 | 53,622 | 50,826 | 162,599 | 206,800 | ||||||||||
BGI |
5 | 834 | | | | | | | 5 | 834 | ||||||||||
Barclays Wealtha |
2,818 | 2,691 | 162 | 105 | | | 472 | 458 | 3,452 | 3,254 | ||||||||||
Head office |
999 | 949 | | | | | | | 999 | 949 | ||||||||||
Total |
138,891 | 174,090 | 4,247 | 6,293 | 55,672 | 79,418 | 55,831 | 51,872 | 254,641 | 311,673 |
Note
a | 2008 Barclays Wealth analysis of Wholesale loans and advances has been reanalysed to reflect changes in the reclassification of assets. |
77 |
Analysis of Barclays capital wholesale loans and advances at amortised cost
| ||||||||||||||
As at 31.12.09 | Gross loans and advances £m |
Impairment allowance £m |
Loans and advances net of impairment £m |
Credit risk Loans £m |
CRLs % of gross loans and advance % |
Impairment Charge £m |
Loan loss rates basis points | |||||||
Loans and advances to banks |
||||||||||||||
Cash collateral and settlement balances |
15,893 | | 15,893 | | | | | |||||||
Interbank lending |
21,722 | 61 | 21,661 | 57 | 0.3 | 14 | 6 | |||||||
Loans and advances to customers |
||||||||||||||
Corporate and Government lending |
54,342 | 1,037 | 53,305 | 2,198 | 4.0 | 1,115 | 205 | |||||||
ABS CDO Super Senior |
3,541 | 1,610 | 1,931 | 3,541 | 100.0 | 714 | 2,016 | |||||||
Other wholesale lending |
30,347 | 317 | 30,030 | 615 | 2.0 | 55 | 18 | |||||||
Cash collateral and settlement balances |
39,779 | | 39,779 | | | | | |||||||
Total |
165,624 | 3,025 | 162,599 | 6,411 | 3.9 | 1,898 | 115 | |||||||
As at 31.12.08 |
||||||||||||||
Cash collateral and settlement balances |
19,264 | | 19,264 | | | | | |||||||
Interbank lending |
24,086 | 51 | 24,035 | 48 | 0.2 | 40 | 17 | |||||||
Loans and advances to customers |
||||||||||||||
Corporate and Government lending |
77,042 | 486 | 76,556 | 1,100 | 1.4 | 305 | 40 | |||||||
ABS CDO Super Senior |
4,117 | 1,013 | 3,104 | 4,117 | 100.0 | 1,383 | 3,359 | |||||||
Other wholesale lending |
23,933 | 246 | 23,687 | 478 | 2.0 | 208 | 87 | |||||||
Cash collateral and settlement balances |
60,154 | | 60,154 | | | | | |||||||
Total |
208,596 | 1,796 | 206,800 | 5,743 | 2.8 | 1,936 | 93 |
78 |
Risk management
Credit risk management
continued
Retail loans and advances to customers at amortised cost |
||||||||||||||
As at 31.12.09 | Gross loans & advances £m |
Impairment allowance £m |
Loans & advances net of impairment £m |
Credit risk loans £m |
CRLs % of gross loans & advances % |
Impairment charge £m |
Loan loss rates bp | |||||||
UKRB |
101,064 | 1,587 | 99,477 | 3,108 | 3.1 | 936 | 93 | |||||||
Barclaycard |
29,460 | 2,670 | 26,790 | 3,392 | 11.5 | 1,781 | 605 | |||||||
GRCB WE |
41,514 | 689 | 40,825 | 1,411 | 3.4 | 335 | 81 | |||||||
GRCB EM |
3,521 | 474 | 3,047 | 551 | 15.6 | 331 | 940 | |||||||
GRCB Absa |
27,288 | 655 | 26,633 | 2,573 | 9.4 | 500 | 183 | |||||||
Barclays Wealth |
10,002 | 56 | 9,946 | 306 | 3.1 | 34 | 34 | |||||||
Total |
212,849 | 6,131 | 206,718 | 11,341 | 5.3 | 3,917 | 184 | |||||||
As at 31.12.08 | ||||||||||||||
UKRB | 96,083 | 1,134 | 94,949 | 2,403 | 2.5 | 602 | 63 | |||||||
Barclaycard | 29,390 | 1,677 | 27,713 | 2,566 | 8.7 | 1,086 | 370 | |||||||
GRCB WE | 38,997 | 306 | 38,691 | 798 | 2.0 | 172 | 44 | |||||||
GRCB EM | 4,004 | 187 | 3,817 | 175 | 4.4 | 129 | 322 | |||||||
GRCB Absa | 24,677 | 411 | 24,266 | 1,518 | 6.2 | 328 | 133 | |||||||
Barclays Wealth | 8,437 | 24 | 8,413 | 48 | 0.6 | 16 | 19 | |||||||
Total | 201,588 | 3,739 | 197,849 | 7,508 | 3.7 | 2,333 | 116 |
Home loans | Cards and unsecured loans | Other retail | Total retail | |||||||||||||
31.12.09 £m |
31.12.08 £m |
31.12.09 £m |
31.12.08 £m |
31.12.09 £m |
31.12.08 £m |
31.12.09 £m |
31.12.08 £m | |||||||||
UK Retail Banking |
87,943 | 82,303 | 7,329 | 8,294 | 4,205 | 4,352 | 99,477 | 94,949 | ||||||||
Barclaycard |
| | 21,564 | 23,224 | 5,226 | 4,489 | 26,790 | 27,713 | ||||||||
GRCB Western Europe |
34,592 | 33,807 | 3,513 | 4,423 | 2,720 | 461 | 40,825 | 38,691 | ||||||||
GRCB Emerging Markets |
452 | 556 | 2,502 | 2,872 | 93 | 389 | 3,047 | 3,817 | ||||||||
GRCB Absa |
20,492 | 18,411 | 1,003 | 43 | 5,138 | 5,812 | 26,633 | 24,266 | ||||||||
Barclays Wealth a |
5,620 | 4,768 | 1,822 | 1,581 | 2,504 | 2,064 | 9,946 | 8,413 | ||||||||
Total |
149,099 | 139,845 | 37,733 | 40,437 | 19,886 | 17,567 | 206,718 | 197,849 |
Note
a | 2008 Barclays Wealth analysis of retail loans and advances to customers has been reanalysed to reflect changes in the classification of assets. |
79 |
Number of Repossessions in UK Home Finance
As at 31.12.09 |
As at 31.12.08 | |||
Residential and buy-to-let mortgage portfolios |
196 | 156 |
Home loans distribution of balances by loan to value (current valuations)a
UK | Spainb | South Africac | ||||||||||
31.12.09 % |
31.12.08 % |
31.12.09 % |
31.12.08 % |
31.12.09 % |
31.12.08 % | |||||||
<= 75% |
74.5 | 78.3 | 83.2 | 86.7 | 57.8 | 60.5 | ||||||
> 75% and <= 80% |
6.3 | 6.1 | 5.6 | 4.8 | 7.1 | 7.5 | ||||||
> 80% and <= 85% |
5.4 | 5.5 | 4.4 | 3.7 | 7.7 | 7.2 | ||||||
> 85% and <= 90% |
4.6 | 4.5 | 3.2 | 1.6 | 7.6 | 7.6 | ||||||
> 90% and <= 95% |
3.4 | 2.5 | 1.7 | 1.3 | 7.8 | 6.7 | ||||||
> 95% |
5.8 | 3.1 | 1.9 | 1.9 | 12.0 | 10.5 | ||||||
Mark to market LTV % |
43 | 40 | 51 | 48 | 42 | 41 | ||||||
Average LTV on new mortgages |
48 | 47 | 55 | 63 | 53 | 58 |
80 |
Risk management
Credit risk management
continued
Total EL on IRB portfolios | ||||
As at 31.12.09 £m |
As at 31.12.08 £m | |||
UK Retail Banking |
1,703 | 1,258 | ||
Barclays Commercial Bank |
776 | 819 | ||
Barclaycard |
1,261 | 910 | ||
GRCB Western Europe |
243 | | ||
GRCB Emerging Marketsa |
| | ||
GRCB Absa |
1,158 | 692 | ||
Barclays Capital |
2,467 | 1,557 | ||
Barclays Wealth |
23 | | ||
Head Office Functions & Other Operations |
11 | 1 | ||
Total EL on IRB portfolios |
7,642 | 5,237 | ||
Total regulatory impairment allowance on IRB portfolios |
7,592 | 4,672 | ||
Total regulatory impairment allowance on standardised portfolios |
4,693 | 2,560 |
Note
a | Not currently on the IRB approach. |
81 |
Barclays Capital credit market exposuresa | As at 31st December | Year ended 31.12.09 | ||||||||||||||
US Residential Mortgages | Notes | 2009 $m |
2008 $m |
2009 £m |
2008 £m |
Fair value losses £m |
Impairment charge £m |
Gross losses £m | ||||||||
ABS CDO Super Senior |
A1 | 3,127 | 4,526 | 1,931 | 3,104 | | 714 | 714 | ||||||||
Other US sub-prime & Alt-A |
A2 | 2,254 | 11,269 | 1,392 | 7,729 | 531 | 555 | 1,086 | ||||||||
Monoline wrapped US RMBS |
A3 | 9 | 2,389 | 6 | 1,639 | 282 | | 282 | ||||||||
Commercial Mortgages |
||||||||||||||||
Commercial real estate loans and properties |
B1 | 12,525 | 16,882 | 7,734 | 11,578 | 2,466 | | 2,466 | ||||||||
Commercial mortgage-backed securities |
B1 | 762 | 1,072 | 471 | 735 | 44 | | 44 | ||||||||
Monoline wrapped CMBS |
B2 | 49 | 2,703 | 30 | 1,854 | 497 | | 497 | ||||||||
Other Credit Market |
||||||||||||||||
Leveraged Financeb |
C1 | 8,919 | 13,193 | 5,507 | 9,048 | | 396 | 396 | ||||||||
SIVs, SIV-Lites and CDPCs |
C2 | 896 | 1,622 | 553 | 1,113 | 69 | 4 | 73 | ||||||||
Monoline wrapped CLO and other |
C3 | 3,443 | 7,202 | 2,126 | 4,939 | 528 | | 528 | ||||||||
Total exposures |
31,984 | 60,858 | 19,750 | 41,739 | ||||||||||||
Total gross writedowns |
4,417 | 1,669 | 6,086 | |||||||||||||
Loan to Protium |
D | 12,727 | | 7,859 | |
Notes
a | As the majority of positions are denominated in US Dollars, the positions above are shown in both US Dollars and Sterling. |
b | Includes undrawn commitments of £257m (2008: £531m). |
82 |
Risk management
Credit risk management
continued
Analysis of Barclays Capital credit market assets by asset class
| |||||||||||||||||
Trading portfolio assets debt securities £m |
Financial assets designated at fair value loans and advances £m |
Derivative financial instruments £m |
Loans and advances to customers £m |
Available for sale debt securities £m |
Other assets £m |
Total as at 31.12.09 £m |
Total as at 31.12.08 £m | ||||||||||
ABS CDO Super Senior |
1,931 | 1,931 | 3,104 | ||||||||||||||
Other US sub-prime |
3 | 52 | 244 | 24 | 209 | 532 | 3,441 | ||||||||||
Alt-A |
323 | 211 | 326 | 860 | 4,288 | ||||||||||||
RMBS monoline wrapped US RMBS |
6 | 6 | 1,639 | ||||||||||||||
Commercial real estate loans |
6,534 | 6,534 | 11,578 | ||||||||||||||
Commercial real estate properties |
1,200 | 1,200 | | ||||||||||||||
Commercial mortgage backed securities |
860 | (389 | ) | 471 | 735 | ||||||||||||
Monoline wrapped CMBS |
30 | 30 | 1,854 | ||||||||||||||
Leveraged financea |
5,250 | 5,250 | 8,517 | ||||||||||||||
SIVs and SIV-lites |
355 | 53 | 122 | 530 | 963 | ||||||||||||
CDPCs |
23 | 23 | 150 | ||||||||||||||
Monoline wrapped CLO and other |
2,126 | 2,126 | 4,939 | ||||||||||||||
Loan to Protium |
7,859 | 7,859 | | ||||||||||||||
Total |
1,186 | 6,941 | 2,304 | 15,186 | 535 | 1,200 | 27,352 | 41,208 |
Note
a | Further analysis of Barclays Capital credit market exposures is on pages 81 and 82. Undrawn commitments of £257m (2008: £531m) are off-balance sheet and therefore not included in the table above. This is a change in presentation from 31st December 2008, which reflected certain loan facilities originated post 1st July 2007. |
83 |
A. US Residential Mortgages
A1. ABS CDO Super Senior
As at 31.12.09 Total £m |
As at 31.12.08 Total £ m |
As at 31.12.09 Marksa % |
As at 31.12.08 Marksa % | |||||||
2005 and earlier |
1,048 | 1,226 | 77 | 90 | ||||||
2006 |
422 | 471 | 7 | 37 | ||||||
2007 and 2008 |
22 | 25 | 34 | 69 | ||||||
Sub-prime |
1,492 | 1,722 | 57 | 75 | ||||||
2005 and earlier |
761 | 891 | 43 | 77 | ||||||
2006 |
230 | 269 | 59 | 75 | ||||||
2007 and 2008 |
55 | 62 | 14 | 37 | ||||||
Alt-A |
1,046 | 1,222 | 45 | 74 | ||||||
Prime |
421 | 520 | 83 | 100 | ||||||
RMBS CDO |
351 | 402 | 6 | | ||||||
Sub-prime second lien |
110 | 127 | | | ||||||
Total US RMBS |
3,420 | 3,993 | 49 | 68 | ||||||
CMBS |
37 | 44 | 89 | 100 | ||||||
Non-RMBS CDO |
400 | 453 | 35 | 56 | ||||||
CLOs |
32 | 35 | 100 | 100 | ||||||
Other ABS |
37 | 51 | 100 | 100 | ||||||
Total Other ABS |
506 | 583 | 48 | 66 | ||||||
Total notional collateral |
3,926 | 4,576 | ||||||||
Subordination |
(385 | ) | (459 | ) | ||||||
Gross exposure pre-impairment |
3,541 | 4,117 | ||||||||
Impairment allowances |
(1,610 | ) | (1,013 | ) | ||||||
Total |
1,931 | 3,104 | 49 | 68 |
ABS CDO Super Senior positions at 31st December 2009 comprised five high grade liquidity facilities which were fully drawn and classified within loans and receivables (31st December 2008: five facilities).
During the year, ABS CDO Super Senior positions reduced by £1,173m to £1,931m (31st December 2008: £3,104m). Positions are stated after writedowns and charges of £714m incurred in 2009 (2008: £1,461m). There was a decline of £290m resulting from depreciation in the value of the US Dollar against Sterling and amortisation of £169m in the year.
Note
a | Marks above reflect the gross positions after impairment and subordination. |
84 |
Risk management
Credit risk management
continued
A2. Other US Sub-Prime and Alt-A
Other US Sub-prime | As at 31.12.09 £m |
As at 31.12.08 £m |
Marks at 31.12.09 % |
Marks at 31.12.08 % | ||||
Whole loans |
| 1,565 | | 72 | ||||
Sub-prime securities (net of hedges) |
212 | 929 | 38 | 25 | ||||
Other positions with underlying sub-prime collateral: |
||||||||
Derivatives |
244 | 643 | 96 | 87 | ||||
Loans |
76 | 195 | 22 | 70 | ||||
Real Estate |
| 109 | | 46 | ||||
Total Other US Sub-Prime |
532 | 3,441 | ||||||
Alt-A |
||||||||
Whole Loans |
| 776 | | 67 | ||||
Alt-A Securities |
649 | 3,112 | 40 | 16 | ||||
Residuals |
| 2 | | 6 | ||||
Derivative positions with underlying Alt-A collateral |
211 | 398 | 99 | 100 | ||||
Total |
860 | 4,288 | ||||||
Total Other US Sub-Prime and Alt-A |
1,392 | 7,729 |
The majority of Other US sub-prime and Alt-A positions are measured at fair value through profit and loss. The balance reduced by £6,337m to £1,392m (31st December 2008: £7,729m), driven by the Protium sale of £2,319m, other net sales, paydowns and other movements of £2,398m and gross losses of £1,086m. Depreciation of the US Dollar against Sterling resulted in a decline of £534m.
Counterparty derivative positions relating to vehicles which hold sub-prime collateral was £455m (31st December 2008: £1,041m). These positions largely comprise the most senior obligation of the vehicles.
A3. US Residential Mortgage Backed Securities Wrapped by Monoline Insurers
The table below shows RMBS assets where Barclays Capital held protection from monoline insurers at 31st December 2009. These are measured at fair value through profit or loss.
By rating of the monoline | |||||||||||
As at 31.12.09 | |||||||||||
Notional £m |
Fair Value of Underlying Asset £m |
Fair Value Exposure £m |
Credit Valuation Adjustment £m |
Net Exposure £m | |||||||
Non-investment grade |
56 | 6 | 50 | (44 | ) | 6 | |||||
Total |
56 | 6 | 50 | (44 | ) | 6 | |||||
As at 31.12.08 | |||||||||||
A/BBB |
2,567 | 492 | 2,075 | (473 | ) | 1,602 | |||||
Non-investment grade |
74 | 8 | 66 | (29 | ) | 37 | |||||
Total |
2,641 | 500 | 2,141 | (502 | ) | 1,639 |
85 |
A3. US Residential Mortgage Backed Securities Wrapped by Monoline Insurers continued
The balance reduced by £1,633m to £6m (31st December 2008: £1,639m), reflecting the Protium sale of £1,164m, a credit valuation adjustment of £282m, and currency and other movements of £187m.
Barclays would review claims in the event of default of the underlying assets. There have been no claims under the monoline insurance contracts as none of the underlying assets defaulted in the year.
The notional value of the assets split by the rating of the underlying asset is shown below.
As at 31.12.09 | As at 31.12.08 | |||||||||||||
By rating of underlying asset | A/BBB £m |
Non- investment Grade £ m |
Total £m |
AAA/AA £m |
A/BBB £m |
Non- investment Grade £m |
Total £m | |||||||
2005 and earlier |
| | | 143 | | | 143 | |||||||
2006 |
| | | | | 1,240 | 1,240 | |||||||
2007 and 2008 |
| | | | | 510 | 510 | |||||||
High Grade |
| | | 143 | | 1,750 | 1,893 | |||||||
Mezzanine 2005 and earlier |
| 56 | 56 | 31 | 330 | 338 | 699 | |||||||
CDO2 2005 and earlier |
| | | | | 49 | 49 | |||||||
US RMBS |
| 56 | 56 | 174 | 330 | 2,137 | 2,641 |
B. Commercial Mortgages
B1. Commercial Real Estate and Mortgage-Backed Securities
Commercial mortgages held at fair value include commercial real estate loans of £6,534m (31st December 2008: £11,578m), commercial real estate properties of £1,200m (31st December 2008: £nil), and commercial mortgage-backed securities of £471m (31st December 2008: £735m).
Commercial Real Estate Loans and Properties
In the year ended 31st December 2009, the commercial real estate loans and properties balance reduced by £3,844m to £7,734m (31st December 2008: £11,578m). There were gross losses of £2,466m, of which £1,541m related to the US, £843m to UK and Europe, and £82m to Asia. There were gross sales and paydowns of £661m comprising £345m in the UK and Europe, £307m in the US, and £9m in Asia, and currency and other movements of £717m.
The commercial real estate loan balances comprised 51% UK and Europe, 44% US and 5% Asia.
One large transaction comprises 25% of the total US commercial real estate loan balance. The remaining 75% of the US balance comprises 64 transactions. The remaining weighted average number of years to initial maturity of the US portfolio is 1.2 years (31st December 2008: 1.4 years).
The UK and Europe portfolio is well diversified with 56 transactions at 31st December 2009. In Europe protection is provided by loan covenants and periodic LTV retests, which cover 83% of the portfolio. 50% of the German balance relates to one transaction secured on residential assets.
Commercial Real Estate Loans by Region | As at 31.12.09 £m |
As at 31.12.08 £m |
Marks at 31.12.09 % |
Marks at 31.12.08 % | ||||
US |
2,852 | 6,329 | 62 | 88 | ||||
Germany |
1,959 | 2,467 | 84 | 95 | ||||
Sweden |
201 | 265 | 81 | 96 | ||||
France |
189 | 270 | 70 | 94 | ||||
Switzerland |
141 | 176 | 85 | 97 | ||||
Spain |
72 | 106 | 56 | 92 | ||||
Other Europe |
370 | 677 | 57 | 90 | ||||
UK |
429 | 831 | 61 | 89 | ||||
Asia |
321 | 457 | 77 | 97 | ||||
Total |
6,534 | 11,578 |
86 |
Risk management
Credit risk management
continued
B1. Commercial Real Estate and Mortgage-Backed Securities continued
Commercial Real Estate Loans by Industry | As at 31.12.09 |
As at 31.12.08 | ||||||||||||
US £m |
Germany £m |
Other Europe £m |
UK £m |
Asia £m |
Total £m |
Total £m | ||||||||
Residential |
1,132 | 1,053 | | 152 | 102 | 2,439 | 3,582 | |||||||
Office |
372 | 251 | 557 | 79 | 79 | 1,338 | 3,656 | |||||||
Hotels |
614 | | 223 | 8 | 1 | 846 | 1,633 | |||||||
Retail |
54 | 507 | 73 | 30 | 73 | 737 | 957 | |||||||
Industrial |
383 | 105 | 103 | 20 | 11 | 622 | 887 | |||||||
Leisure |
| | | 140 | | 140 | 233 | |||||||
Land |
128 | | | | | 128 | 232 | |||||||
Mixed/Others |
169 | 43 | 17 | | 55 | 284 | 398 | |||||||
Total |
2,852 | 1,959 | 973 | 429 | 321 | 6,534 | 11,578 | |||||||
Commercial Real Estate Properties by Industry | As at 31.12.09 £m |
As at 31.12.08 £m | ||||||||||||
Residential |
56 | | ||||||||||||
Office |
927 | | ||||||||||||
Hotels |
126 | | ||||||||||||
Industrial |
25 | | ||||||||||||
Leisure |
33 | | ||||||||||||
Land |
31 | | ||||||||||||
Mixed/Others |
2 | | ||||||||||||
Total |
1,200 | |
Included within the commercial real estate properties balance are properties held by Crescent Real Estate Holdings LLC (Crescent) with a carrying value of £1,001m. On 19th November 2009, Barclays Capital assumed ownership of Crescent following the completion of a debt restructuring transaction.
Commercial Mortgage Backed Securities | As at 31.12.09 £m |
As at 31.12.08 £m |
Marks ata 31.12.09 % |
Marks ata 31.12.08 % | ||||
Commercial Mortgage Backed Securities (Net of Hedges) |
471 | 735 | 20 | 21 |
Note
a | Marks are based on gross collateral. |
87 |
B2. CMBS Wrapped by Monoline Insurers
The table below shows commercial mortgage backed security assets where Barclays Capital held protection from monoline insurers at 31st December 2009. These are measured at fair value through profit and loss.
By rating of the monoline | As at 31.12.09 | ||||||||||
Notional £m |
Fair value of underlying asset £m |
Fair value exposure £m |
Credit valuation adjustment £m |
Net exposure £m | |||||||
AAA/AA |
54 | 21 | 33 | (3 | ) | 30 | |||||
Non-investment grade |
383 | 160 | 223 | (223 | ) | | |||||
Total |
437 | 181 | 256 | (226 | ) | 30 | |||||
As at 31.12.08 | |||||||||||
AAA/AA |
69 | 27 | 42 | (4 | ) | 38 | |||||
A/BBB |
3,258 | 1,301 | 1,957 | (320 | ) | 1,637 | |||||
Non-investment grade |
425 | 181 | 244 | (65 | ) | 179 | |||||
Total |
3,752 | 1,509 | 2,243 | (389 | ) | 1,854 |
The balance reduced by £1,824m to £30m (31st December 2008: £1,854m), reflecting the Protium sale of £1,208m, a credit valuation adjustment of £497m, and currency and other movements of £119m.
Claims would become due in the event of default of the underlying assets. There have been no claims under the monoline insurance contracts as none of the underlying assets defaulted in the year.
The notional value of the assets split by the current rating of the underlying asset is shown below.
By rating of the underlying asset | As at 31.12.09 | As at 31.12.08 | ||||||||
AAA/AA £m |
A/BBB £m |
Total £m |
AAA/ AA £m |
Total £m | ||||||
2005 and earlier |
| | | 437 | 437 | |||||
2006 |
54 | | 54 | 613 | 613 | |||||
2007 and 2008 |
| 383 | 383 | 2,702 | 2,702 | |||||
CMBS |
54 | 383 | 437 | 3,752 | 3,752 |
88 |
Risk management
Credit risk management
continued
C. Other Credit Market
C1. Leveraged Finance
Leveraged Finance Loans by Region | ||||||
As at 31.12.09 £m |
As at 31.12.08 £m |
|||||
UK |
4,530 | 4,519 | ||||
Europe |
1,051 | 1,291 | ||||
Asia |
165 | 140 | ||||
US |
35 | 3,213 | ||||
Total lending and commitments |
5,781 | 9,163 | ||||
Impairment |
(274 | ) | (115 | ) | ||
Net lending and commitments at period enda |
5,507 | 9,048 |
Leveraged finance loans are classified within loans and advances and are stated at amortised cost less impairment. The table above includes certain loan facilities originated prior to 1st July 2007, the start of the dislocation in the credit marketb.
At 31st December 2009, net lending and commitments reduced £3,541m to £5,507m (31st December 2008: £9,048m), following a repayment of £3,056m at par in January 2009, impairment of £396m, and other movements of £89m.
The overall credit performance of the assets remained satisfactory with the majority of the portfolio performing to plan or in line with original stress tolerances. There were a small number of deteriorating positions on which higher impairment was charged.
C2. SIVs, SIV-Lites and CDPCs
SIV and SIV-lite positions comprise liquidity facilities and derivatives. At 31st December 2009 SIVs and SIV-Lites positions reduced by £433m to £530m (31st December 2008: £963m) with a reduced number of counterparties. There were £72m of gross writedowns in the year.
Credit Derivative Product Companies (CDPCs) positions at 31st December 2009 reduced by £127m to £23m (31st December 2008: £150m).
C3. CLO and Other Assets Wrapped by Monoline Insurers
The table below shows Collateralised Loan Obligations (CLOs) and other assets where we held protection from monoline insurers at 31st December 2009.
By Rating of the Monoline | |||||||||||
As at 31.12.09 | |||||||||||
Notional £m |
Fair value of underlying asset £m |
Fair value exposure £m |
Credit valuation adjustment £m |
Net exposure £m | |||||||
AAA/AA |
7,336 | 5,731 | 1,605 | (91 | ) | 1,514 | |||||
A/BBB |
| | | | | ||||||
Non-investment grade: |
|||||||||||
Fair value through profit and loss |
1,052 | 824 | 228 | (175 | ) | 53 | |||||
Loans and receivables |
9,116 | 7,994 | 1,122 | (563 | ) | 559 | |||||
Total |
17,504 | 14,549 | 2,955 | (829 | ) | 2,126 | |||||
As at 31.12.08 | |||||||||||
AAA/AA |
8,281 | 5,854 | 2,427 | (55 | ) | 2,372 | |||||
A/BBB |
6,446 | 4,808 | 1,638 | (204 | ) | 1,434 | |||||
Non-investment grade |
6,148 | 4,441 | 1,707 | (574 | ) | 1,133 | |||||
Total |
20,875 | 15,103 | 5,772 | (833 | ) | 4,939 |
The balance reduced by £2,813m to £2,126m (31st December 2008: £4,939m), reflecting increases in the fair value of the underlying assets of £1,321m, credit valuation adjustments of £528m, the Protium sale of £396m, and currency and other movements of £568m.
Claims would become due in the event of default of the underlying assets. There have been no claims under the monoline insurance contracts as none of the underlying assets defaulted in the year.
On 25th November 2009, £8,027m of the CLO assets wrapped by non-investment grade rated monolines were reclassified to loans and receivables (as discussed in Note 51). At 31st December 2009, the fair value of the transferred assets was £7,994m and the net exposure to monoline insurers was £559m. The remaining non-investment grade exposure continues to be measured at fair value through profit and loss.
Notes
a | Includes undrawn commitments of £257m (2008: £531m). |
b | This is a change of presentation from 31st December 2008, which reflected certain loan facilities originated post 1st July 2007. |
89 |
The notional value of the assets split by the current rating of the underlying asset is shown below.
By rating of underlying asset | As at 31.12.09 | As at 31.12.08 | ||||||||||||||||
AAA/AA | A/BBB | Non- investment grade fair value £m |
Total £m |
AAA/AA Fair value £m |
A/BBB Fair value £m |
Total £m | ||||||||||||
Fair value £m |
Loans and receivables £m |
Fair value £m |
Loans and receivables £m |
|||||||||||||||
2005 and earlier |
1,518 | 2,209 | 294 | 815 | | 4,836 | 6,037 | | 6,037 | |||||||||
2006 |
1,972 | 2,952 | | 458 | | 5,382 | 5,894 | | 5,894 | |||||||||
2007 and 2008 |
2,452 | 2,199 | 548 | 483 | | 5,682 | 6,295 | | 6,295 | |||||||||
CLOs |
5,942 | 7,360 | 842 | 1,756 | | 15,900 | 18,226 | | 18,226 | |||||||||
2005 and earlier |
| | 55 | | 55 | 110 | 862 | | 862 | |||||||||
2006 |
118 | | 90 | | 125 | 333 | 535 | | 535 | |||||||||
2007 and 2008 |
441 | | | | 720 | 1,161 | 785 | 467 | 1,252 | |||||||||
Other |
559 | | 145 | | 900 | 1,604 | 2,182 | 467 | 2,649 | |||||||||
Total |
6,501 | 7,360 | 987 | 1,756 | 900 | 17,504 | 20,408 | 467 | 20,875 |
D. Protium
On 16th September 2009, Barclays Capital sold assets of £7,454m, including £5,087m in credit market assets, to Protium Finance LP (Protium), a newly established fund. The impact of the sale on each class of credit market asset is detailed in each relevant category in sections A to C.
As part of the transaction, Barclays extended a £7,669m 10-year loan to Protium, which will be repaid during the term from cash generated by the fund. The principal terms of the loan are as follows:
The loan has a final maturity of ten years, with a rate of return fixed at USD LIBOR plus 2.75%.
Protium is obliged to pay principal and interest equal to the amount of available cash generated by the fund after payment of fund expenses and certain payments to the funds partners.
The loan is secured by a charge over the assets of Protium.
The loan is classified as loans and receivables. The difference between the size of the loan and assets sold relates to cash and US Treasuries held by Protium. The increase in the loan balance between 16th September 2009 and 31st December 2009 reflects accrued interest which was received from Protium in January 2010.
The fair value of assets sold to Protium is set out below. The balances at 31st December 2009 include cash realised from subsequent sales and paydowns.
Protium assets | As at 31.12.09 $m |
As at 16.09.09 $m |
As at 30.06.09 $m |
As at 31.12.09 £m |
As at 16.09.09 £m |
As at 30.06.09 £m | ||||||
US Residential Mortgages |
||||||||||||
Other US sub-prime whole loans and real estate |
1,038 | 1,124 | 1,256 | 641 | 682 | 764 | ||||||
Other US sub-prime securities |
578 | 513 | 508 | 357 | 311 | 309 | ||||||
Total other US sub-prime |
1,616 | 1,637 | 1,764 | 998 | 993 | 1,073 | ||||||
Alt-A |
2,112 | 2,185 | 2,342 | 1,304 | 1,326 | 1,424 | ||||||
Monoline wrapped US RMBS |
1,447 | 1,919 | 2,081 | 893 | 1,164 | 1,266 | ||||||
Commercial Mortgages |
||||||||||||
Monoline wrapped CMBS |
1,378 | 1,991 | 2,450 | 851 | 1,208 | 1,490 | ||||||
Other Credit market |
||||||||||||
Monoline wrapped CLO and other |
475 | 652 | 752 | 294 | 396 | 457 | ||||||
Credit market related exposure |
7,028 | 8,384 | 9,389 | 4,340 | 5,087 | 5,710 | ||||||
Fair value of underlying assets wrapped by monoline insurers |
4,095 | 3,592 | 2,728 | 2,529 | 2,179 | 1,659 | ||||||
Other assets |
1,230 | 309 | 285 | 759 | 188 | 173 | ||||||
Total |
12,353 | 12,285 | 12,402 | 7,628 | 7,454 | 7,542 | ||||||
Loan to Protium |
12,727 | 12,641 | | 7,859 | 7,669 | |
90 |
Risk management
Credit risk management
continued
DBRS Inc. (DBRS), a nationally recognised statistical rating organisation, was engaged to provide a private, point-in-time rating reflecting the specific terms and conditions of the Protium loan as a whole. In addition point-in-time ratings with respect to gross cumulative cash flows due to Barclays under the loan to Protium, considered in sequential instalments, were also sought (Tranched Ratings).
On the transaction date, the loan fair value was assessed as equal to its notional amount. Subsequently, the obtained ratings were incorporated into an updated transaction date valuation. This valuation discounted the cash flows at appropriate discount rates determined by Barclays based on the Tranched Ratings. The calculation produced a value of £7,651m ($12,611m). The difference to the original valuation was £18m ($30m), which has been recorded as a loss on sale in the period. The Tranched Ratings and loan valuation are summarised in the table below:
Tranched Rating | Cash flows £m |
Weighted average life (years) |
Spread to LIBOR (bps) |
Net present value £m | ||||
AAA |
2,092 | 3.8 | 52 | 2,015 | ||||
AA+ |
1,464 | 4.3 | 80 | 1,385 | ||||
AA/AA- |
354 | 4.3 | 108/128 | 330 | ||||
A |
642 | 2.6 | 169 | 606 | ||||
BBB/BBB- |
1,098 | 4.7 | 260/355 | 955 | ||||
BB+/BB |
1,021 | 2.1 | 451/546 | 915 | ||||
B/B-/CCC |
1,886 | 3.4 | 700/785/870 | 1,445 | ||||
Total |
8,557 | 282 | 7,651 |
The loan valuation was performed by Barclays and, of the information disclosed above, only the Tranched Ratings were provided by DBRS. The Tranched Ratings are as of 15th September 2009 and are based on a scenario in which the portfolio of assets sold to Protium is static, with no subsequent sales or additional purchases.
A single rating of CCC (low), being the Tranched Rating for the lowest rated cash flows, has been assigned to the loan as a whole by DBRS. This rating addresses the ultimate payment of cumulative principal and interest under the terms and conditions of the Protium loan and it being advanced as a single loan, as opposed to being structurally tranched. The single rating of CCC (low) is also as of 15th September 2009 and is based on a scenario in which the portfolio of assets sold to Protium is static, with no subsequent sales or additional purchases.
The loan to Protium was assessed for impairment by the Group as at 31st December 2009 in line with its impairment policy. This analysis found that there was no impairment as at 31st December 2009.
91 |
Debt securities and other bills
The following table presents an analysis of the credit quality of debt and similar securities, other than loans held within the Group. Securities rated as investment grade amounted to 91.8% of the portfolio (2008: 91.6%).
As at 31.12.09 |
Treasury |
Debt securities £m |
Total £m |
% | ||||
AAA to BBB- (investment grade) |
13,950 | 151,621 | 165,571 | 91.8 | ||||
BB+ to B |
1,895 | 10,297 | 12,192 | 6.8 | ||||
B- or lower |
| 2,571 | 2,571 | 1.4 | ||||
Total |
15,845 | 164,489 | 180,334 | 100.0 | ||||
Of which issued by: |
||||||||
governments and other public bodies |
15,845 | 72,238 | 88,083 | 48.8 | ||||
US agency |
| 23,924 | 23,924 | 13.3 | ||||
mortgage and asset-backed securities |
| 17,826 | 17,826 | 9.9 | ||||
corporate and other issuers |
| 41,641 | 41,641 | 23.1 | ||||
bank and building society certificates of deposit |
| 8,860 | 8,860 | 4.9 | ||||
Total |
15,845 | 164,489 | 180,334 | 100.0 | ||||
Of which classified as: |
||||||||
trading portfolio assets |
9,926 | 116,594 | 126,520 | 70.2 | ||||
financial instruments designated at fair value |
| 4,007 | 4,007 | 2.2 | ||||
available for sale securities |
5,919 | 43,888 | 49,807 | 27.6 | ||||
Total |
15,845 | 164,489 | 180,334 | 100.0 | ||||
As at 31.12.08 | ||||||||
AAA to BBB- (investment grade) |
7,314 | 198,493 | 205,807 | 91.6 | ||||
BB+ to B |
1,233 | 15,309 | 16,542 | 7.4 | ||||
B- or lower |
| 2,343 | 2,343 | 1.0 | ||||
Total |
8,547 | 216,145 | 224,692 | 100.0 | ||||
Of which issued by: |
||||||||
governments and other public bodies |
8,547 | 73,881 | 82,428 | 36.7 | ||||
US agency |
| 34,180 | 34,180 | 15.2 | ||||
mortgage and asset-backed securities |
| 34,844 | 34,844 | 15.5 | ||||
corporate and other issuers |
| 55,244 | 55,244 | 24.6 | ||||
bank and building society certificates of deposit |
| 17,996 | 17,996 | 8.0 | ||||
Total |
8,547 | 216,145 | 224,692 | 100.0 | ||||
Of which classified as: |
||||||||
trading portfolio assets |
4,544 | 148,686 | 153,230 | 68.2 | ||||
financial instruments designated at fair value |
| 8,628 | 8,628 | 3.8 | ||||
available for sale securities |
4,003 | 58,831 | 62,834 | 28.0 | ||||
Total |
8,547 | 216,145 | 224,692 | 100.0 |
92 |
Risk management
Credit risk management
continued
93 |
The tables below set out the fair values of the derivative assets together with the value of those assets subject to enforceable counterparty netting arrangements for which the Group holds offsetting liabilities and eligible collateral.
Derivative assets | Gross assets £m |
Counterparty netting £m |
Net | |||
As at 31.12.09 |
||||||
Foreign exchange |
51,775 | 45,391 | 6,384 | |||
Interest rate |
261,211 | 213,446 | 47,765 | |||
Credit derivatives |
56,295 | 48,774 | 7,521 | |||
Equity and stock index |
17,784 | 13,330 | 4,454 | |||
Commodity derivatives |
29,750 | 21,687 | 8,063 | |||
416,815 | 342,628 | 74,187 | ||||
Total collateral held |
31,471 | |||||
Net exposure less collateral |
42,716 | |||||
As at 31.12.08 |
||||||
Foreign exchange |
107,730 | 91,572 | 16,158 | |||
Interest rate |
615,321 | 558,985 | 56,336 | |||
Credit derivatives |
184,072 | 155,599 | 28,473 | |||
Equity and stock index |
28,684 | 20,110 | 8,574 | |||
Commodity derivatives |
48,995 | 35,903 | 13,092 | |||
984,802 | 862,169 | 122,633 | ||||
Total collateral held |
54,905 | |||||
Net exposure less collateral |
67,728 |
Gross derivative assets of £417bn (2008: £985bn) cannot be netted down under IFRS. Derivative assets would be £374bn (2008: £917bn) lower than reported under IFRS if counterparty or collateral netting were allowed.
Exposure relating to derivatives, repurchase agreements, reverse repurchase agreements, stock borrowing and loan transactions is calculated using internal, FSA approved models. These are used as the basis to assess both regulatory capital and capital appetite and are managed on a daily basis. The methodology encompasses all relevant factors to enable the current value to be calculated and the future value to be estimated, for example: current market rates, market volatility and legal documentation (including collateral rights).
94 |
Risk management
95 |
96 |
Risk management
continued
The daily average, maximum and minimum values of DVaR, Expected Shortfall and 3W were calculated as below:
DVaR (95%) | ||||||||||||||
Year ended 31st December 2009 | Year ended 31st December 2008 | |||||||||||||
Average £m |
High £m |
Low £m |
Average £m |
High £m |
Low £m | |||||||||
Interest rate risk |
44 | 83 | 23 | 29 | 48 | 15 | ||||||||
Credit Spread risk |
58 | 102 | 35 | 31 | 72 | 15 | ||||||||
Commodity risk |
14 | 20 | 11 | 18 | 25 | 13 | ||||||||
Equity risk |
13 | 27 | 5 | 9 | 21 | 5 | ||||||||
Foreign exchange risk |
8 | 15 | 3 | 6 | 13 | 2 | ||||||||
Diversification effect |
(60 | ) | (40 | ) | ||||||||||
Total DVaR |
77 | 119 | 50 | 53 | 95 | 36 | ||||||||
Expected Shortfall |
121 | 188 | 88 | 70 | 146 | 41 | ||||||||
3W |
209 | 301 | 148 | 116 | 282 | 61 |
97 |
98 |
Risk management
Market risk management
continued
99 |
Risk management
100 |
Risk management
Capital risk management
continued
101 |
2009 £m |
|
2008 £m |
| |||
The average supply of capital to support the economic capital framework a | ||||||
Shareholders equity excluding non-controlling interests less goodwill b |
28,000 | 17,650 | ||||
Retirement benefits liability |
800 | 1,050 | ||||
Cash flow hedging reserve |
(300 | ) | 100 | |||
Available for sale reserve |
600 | 400 | ||||
Cumulative gains on own credit |
(1,150 | ) | (1,250 | ) | ||
Preference shares |
5,850 | 5,500 | ||||
Available funds for economic capital excluding goodwill |
33,800 | 23,450 | ||||
Average historic goodwill and intangible assets b |
11,000 | 9,450 | ||||
Available funds for economic capital including goodwill c |
44,800 | 32,900 |
102 |
Risk management
Composition of the Group liquidity pool | ||||||||||
Cash and £bn |
Government £bn |
Government £bn |
Other £bn |
Total £bn | ||||||
As at 31st December 2009 a |
81 | 3 | 31 | 12 | 127 | |||||
As at 31st December 2008 a |
30 | | 2 | 11 | 43 |
103 |
Wholesale depositor split by counterparty type Barclays Capital | ||||||||||||
Banks % |
Corporates % |
Governments % |
Other central banks % |
Other financial institutions % |
Total % | |||||||
As at 31st December 2009 |
36 | 15 | 2 | 16 | 31 | 100 | ||||||
As at 31st December 2008 |
32 | 15 | 11 | 9 | 33 | 100 |
Wholesale depositor split by geography Barclays Capital | ||||||||||||||
US % |
UK % |
Other EU % |
Japan % |
Africa % |
Rest of World % |
Total % | ||||||||
As at 31st December 2009 |
9 | 25 | 23 | 3 | 16 | 24 | 100 | |||||||
As at 31st December 2008 |
13 | 22 | 16 | 9 | 17 | 23 | 100 |
GRCB, Barclays Wealth and Head Office a Behavioural maturity profile of assets and liabilities |
Cash inflow/(outflow) | |||||||||||||||
Funding surplus £bn |
Not more than 1 year £bn |
Over 1 year but not more than 2 years £bn |
Over 2 years but not more than 3 years £bn |
Over 3 years but not more than 4 years £bn |
Over 4 years but not more than 5 years £bn |
Over 5 years £bn |
||||||||||
As at 31st December 2009 |
94.5 | (10.2 | ) | 17.8 | 21.2 | 7.8 | 1.8 | (132.9 | ) |
Note
a | Prior year figures have not been provided as these measures have not previously been reported on a comparable basis. |
104 |
Risk management
Liquidity risk management
continued
Secured funding by asset class | Government | Agency | MBS | ABS | Corporate | Equity | Other | |||||||
% | % | % | % | % | % | % | ||||||||
As at 31st December 2009 |
59 | 7 | 7 | 6 | 10 | 8 | 3 | |||||||
As at 31st December 2008 |
49 | 9 | 11 | 9 | 15 | 4 | 3 | |||||||
Contractual maturity of unsecured liabilities b (Net of assets available from the Group Liquidity pool) |
Not more than 1 month |
Not more than 2 months |
Not more than 3 months |
Not more than 6 months |
Not more than 1 year |
Over 1 year | ||||||||
% | % | % | % | % | % | |||||||||
As at 31st December 2009 |
| | | | 19 | 81 |
Notes
a | The 31st December 2008 average unsecured liability term has been restated to at least 14 months to reflect refinements in the underlying calculation. |
b | Prior years figures have not been provided as these measures have not previously been reported on a comparable basis. |
105 |
Risk management
106 |
Risk management
Operational risk management
continued
107 |
Risk management
Statistical and other risk information
This section of the report contains supplementary information that is more detailed or contains longer histories than the data presented in the discussion. For commentary on this information, please refer to the preceding text (pages 66 to 93).
Credit risk management
Table 1: Maturity analysis of loans and advances to banks | ||||||||||||||||||
At 31st December 2009 | On demand £m |
Not more than three months £m |
Over three months but not more than six months £m |
Over six £m |
Over one but not |
Over three but not |
Over five but not |
Over ten years |
Total £m | |||||||||
United Kingdom |
403 | 3,234 | 64 | 625 | 405 | | | 398 | 5,129 | |||||||||
Other European Union |
1,262 | 10,803 | 44 | 394 | 184 | 8 | 2 | | 12,697 | |||||||||
United States |
1,257 | 10,926 | 77 | 619 | 157 | | 38 | 63 | 13,137 | |||||||||
Africa |
565 | 465 | 221 | 98 | 974 | 6 | 41 | 18 | 2,388 | |||||||||
Rest of the World |
1,275 | 5,111 | 88 | 98 | 708 | 530 | 17 | 18 | 7,845 | |||||||||
4,762 | 30,539 | 494 | 1,834 | 2,428 | 544 | 98 | 497 | 41,196 | ||||||||||
At 31st December 2008 |
||||||||||||||||||
United Kingdom |
127 | 6,474 | 193 | 163 | 232 | | | 343 | 7,532 | |||||||||
Other European Union |
1,210 | 10,458 | 54 | 415 | 407 | 50 | 5 | 1 | 12,600 | |||||||||
United States |
1,310 | 11,215 | 7 | 676 | 324 | | | 84 | 13,616 | |||||||||
Africa |
584 | 595 | 51 | 1 | 51 | 861 | 8 | 38 | 2,189 | |||||||||
Rest of the World |
1,652 | 6,957 | 201 | 666 | 884 | 943 | 39 | 479 | 11,821 | |||||||||
Loans and advances to banks |
4,883 | 35,699 | 506 | 1,921 | 1,898 | 1,854 | 52 | 945 | 47,758 |
Table 2: Interest rate sensitivity of loans and advances | ||||||||||||
2009 | 2008 | |||||||||||
At 31st December | Fixed rate £m |
Variable £m |
Total £m |
Fixed £m |
Variable £m |
Total £m | ||||||
Banks |
15,898 | 25,298 | 41,196 | 12,101 | 35,657 | 47,758 | ||||||
Customers |
94,470 | 336,489 | 430,959 | 98,404 | 369,934 | 468,338 |
108 |
Risk management
Statistical information
continued
Table 3: Loans and advances to customers by industry
At 31st December |
||||||||||
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | ||||||
Financial services |
95,839 | 114,069 | 71,160 | 45,954 | 43,102 | |||||
Agriculture, forestry and fishing |
4,321 | 3,281 | 3,319 | 3,997 | 3,785 | |||||
Manufacturing |
18,855 | 26,374 | 16,974 | 15,451 | 13,779 | |||||
Construction |
6,303 | 8,239 | 5,423 | 4,056 | 5,020 | |||||
Property |
23,468 | 22,155 | 17,018 | 16,528 | 16,325 | |||||
Government |
4,801 | 5,301 | 2,036 | 2,426 | 1,718 | |||||
Energy and water |
10,735 | 14,101 | 8,632 | 6,810 | 6,891 | |||||
Wholesale and retail, distribution and leisure |
19,746 | 20,208 | 18,216 | 15,490 | 17,760 | |||||
Transport |
7,284 | 8,612 | 6,258 | 5,586 | 5,960 | |||||
Postal and communication |
3,427 | 7,268 | 5,404 | 2,180 | 1,313 | |||||
Business and other services |
30,277 | 37,373 | 30,363 | 26,999 | 22,529 | |||||
Home loans |
149,738 | 140,166 | 106,751 | 92,477 | 85,206 | |||||
Other personal |
44,971 | 48,305 | 46,423 | 37,535 | 39,866 | |||||
Finance lease receivables |
11,194 | 12,886 | 11,190 | 10,142 | 9,088 | |||||
Loans and advances to customers |
430,959 | 468,338 | 349,167 | 285,631 | 272,342 |
Table 4: Loans and advances to customers in the UK
At 31st December |
||||||||||
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | ||||||
Financial services |
21,975 | 26,091 | 21,131 | 14,011 | 11,958 | |||||
Agriculture, forestry and fishing |
2,192 | 2,245 | 2,220 | 2,307 | 2,409 | |||||
Manufacturing |
8,549 | 11,340 | 9,388 | 9,047 | 8,469 | |||||
Construction |
3,544 | 4,278 | 3,542 | 2,761 | 3,090 | |||||
Property |
13,514 | 12,091 | 10,203 | 10,010 | 10,547 | |||||
Government |
496 | 20 | 201 | 6 | 6 | |||||
Energy and water |
2,447 | 3,040 | 2,203 | 2,360 | 2,701 | |||||
Wholesale and retail distribution and leisure |
12,792 | 14,421 | 13,800 | 12,951 | 12,747 | |||||
Transport |
2,784 | 3,467 | 3,185 | 2,745 | 2,797 | |||||
Postal and communication |
1,098 | 1,491 | 1,416 | 899 | 455 | |||||
Business and other services |
16,577 | 19,589 | 20,485 | 19,260 | 15,397 | |||||
Home loans |
90,903 | 85,672 | 69,874 | 62,621 | 57,382 | |||||
Other personal |
27,687 | 28,362 | 28,691 | 27,617 | 30,598 | |||||
Finance lease receivables |
3,021 | 3,911 | 4,008 | 3,923 | 5,203 | |||||
Loans and advances to customers in the UK |
207,579 | 216,018 | 190,347 | 170,518 | 163,759 |
Loans and advances included in the above table for the year 2008 have been reanalysed between Home loans and Other personal to reflect changes in classification of assets.
The industry classifications in Tables 3-7 have been prepared at the level of the borrowing entity. This means that a loan to the subsidiary of a major corporation is classified by the industry in which the subsidiary operates, even though the Parents predominant business may be in a different industry.
109 |
Table 5: Loans and advances to customers in other European Union countries
At 31st December |
||||||||||
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | ||||||
Financial services |
14,475 | 14,218 | 7,585 | 5,629 | 3,982 | |||||
Agriculture, forestry and fishing |
187 | 216 | 141 | 786 | 155 | |||||
Manufacturing |
5,754 | 8,700 | 4,175 | 3,147 | 2,254 | |||||
Construction |
1,610 | 1,786 | 1,159 | 639 | 803 | |||||
Property |
4,224 | 4,814 | 2,510 | 2,162 | 3,299 | |||||
Government |
575 | 1,089 | | 6 | | |||||
Energy and water |
3,882 | 5,313 | 2,425 | 2,050 | 1,490 | |||||
Wholesale and retail distribution and leisure |
2,428 | 2,653 | 1,719 | 776 | 952 | |||||
Transport |
1,905 | 2,603 | 1,933 | 1,465 | 1,695 | |||||
Postal and communication |
649 | 962 | 662 | 580 | 432 | |||||
Business and other services |
4,878 | 5,490 | 3,801 | 2,343 | 3,594 | |||||
Home loans |
35,752 | 34,451 | 21,405 | 18,202 | 16,114 | |||||
Other personal |
7,403 | 6,440 | 6,615 | 4,086 | 2,283 | |||||
Finance lease receivables |
2,636 | 3,328 | 2,403 | 1,559 | 1,870 | |||||
Loans and advances to customers in other European Union countries |
86,358 | 92,063 | 56,533 | 43,430 | 38,923 |
Table 6: Loans and advances to customers in the United States
At 31st December |
||||||||||
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | ||||||
Financial services |
46,132 | 56,006 | 29,342 | 17,516 | 16,229 | |||||
Agriculture, forestry and fishing |
1 | | 2 | 2 | 1 | |||||
Manufacturing |
797 | 2,171 | 818 | 519 | 937 | |||||
Construction |
7 | 21 | 18 | 13 | 32 | |||||
Property |
428 | 549 | 568 | 1,714 | 329 | |||||
Government |
303 | 336 | 221 | 153 | 300 | |||||
Energy and water |
2,336 | 3,085 | 1,279 | 1,078 | 1,261 | |||||
Wholesale and retail distribution and leisure |
720 | 1,165 | 846 | 403 | 794 | |||||
Transport |
383 | 415 | 137 | 128 | 148 | |||||
Postal and communication |
355 | 3,343 | 2,446 | 36 | 236 | |||||
Business and other services |
1,721 | 2,279 | 1,053 | 1,432 | 885 | |||||
Home loans |
19 | 28 | 10 | 349 | 2 | |||||
Other personal |
7,410 | 7,691 | 3,256 | 2,022 | 1,443 | |||||
Finance lease receivables |
318 | 298 | 304 | 312 | 328 | |||||
Loans and advances to customers in the United States |
60,930 | 77,387 | 40,300 | 25,677 | 22,925 |
Table 7: Loans and advances to customers in Africa
At 31st December |
||||||||||
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | ||||||
Financial services |
3,600 | 1,956 | 3,472 | 2,821 | 4,350 | |||||
Agriculture, forestry and fishing |
1,936 | 817 | 956 | 889 | 1,193 | |||||
Manufacturing |
1,419 | 1,082 | 1,351 | 1,747 | 1,501 | |||||
Construction |
903 | 2,053 | 637 | 591 | 1,068 | |||||
Property |
4,154 | 3,485 | 2,433 | 1,987 | 1,673 | |||||
Government |
1,449 | 1,741 | 967 | 785 | 625 | |||||
Energy and water |
158 | 118 | 356 | 156 | 193 | |||||
Wholesale and retail distribution and leisure |
1,789 | 1,012 | 1,326 | 1,050 | 2,774 | |||||
Transport |
368 | 739 | 116 | 354 | 394 | |||||
Postal and communication |
715 | 293 | 231 | 241 | 27 | |||||
Business and other services |
4,319 | 4,699 | 1,285 | 2,631 | 1,258 | |||||
Home loans |
22,057 | 19,036 | 15,393 | 11,223 | 11,630 | |||||
Other personal |
964 | 3,069 | 6,287 | 2,976 | 4,955 | |||||
Finance lease receivables |
5,018 | 5,130 | 4,357 | 4,240 | 1,580 | |||||
Loans and advances to customers in Africa |
48,849 | 45,230 | 39,167 | 31,691 | 33,221 |
110 |
Risk management
Statistical information
continued
Table 8: Loans and advances to customers in the Rest of the World
At 31st December |
||||||||||
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | ||||||
Loans and advances |
27,042 | 37,421 | 22,702 | 14,207 | 13,407 | |||||
Finance lease receivables |
201 | 219 | 118 | 108 | 107 | |||||
Loans and advances to customers in the Rest of the World |
27,243 | 37,640 | 22,820 | 14,315 | 13,514 |
Table 9: Maturity analysis of loans and advances to customers | ||||||||||||||||||
At 31st December 2009 | On demand £m |
Not more than three months £m |
Over three months but not more than six months £m |
Over six months but not more than one year £m |
Over one but not £m |
Over three but not |
Over five years but not more than ten years £m |
Over ten |
Total £m | |||||||||
United Kingdom |
||||||||||||||||||
Corporate lending |
21,369 | 14,941 | 1,568 | 2,856 | 13,057 | 10,071 | 9,759 | 14,626 | 88,247 | |||||||||
Other lending to customers in the United Kingdom |
5,862 | 3,802 | 2,092 | 3,809 | 15,201 | 10,404 | 23,302 | 54,860 | 119,332 | |||||||||
Total United Kingdom |
27,231 | 18,743 | 3,660 | 6,665 | 28,258 | 20,475 | 33,061 | 69,486 | 207,579 | |||||||||
Other European Union |
4,094 | 16,113 | 1,976 | 3,278 | 11,088 | 9,247 | 10,137 | 30,425 | 86,358 | |||||||||
United States |
4,887 | 25,296 | 2,265 | 3,637 | 4,876 | 1,251 | 11,485 | 7,233 | 60,930 | |||||||||
Africa |
11,248 | 2,457 | 1,052 | 1,322 | 4,307 | 3,091 | 6,162 | 19,210 | 48,849 | |||||||||
Rest of the World |
1,967 | 6,616 | 1,189 | 3,758 | 4,367 | 4,485 | 3,154 | 1,707 | 27,243 | |||||||||
Total |
49,427 | 69,225 | 10,142 | 18,660 | 52,896 | 38,549 | 63,999 | 128,061 | 430,959 | |||||||||
At 31st December 2008 |
||||||||||||||||||
United Kingdom |
||||||||||||||||||
Corporate lending |
24,790 | 14,715 | 1,574 | 3,259 | 10,585 | 12,372 | 10,495 | 15,876 | 93,666 | |||||||||
Other lending to customers in the United Kingdom |
4,560 | 6,264 | 2,495 | 4,477 | 16,604 | 10,541 | 21,913 | 55,498 | 122,352 | |||||||||
Total United Kingdom |
29,350 | 20,979 | 4,069 | 7,736 | 27,189 | 22,913 | 32,408 | 71,374 | 216,018 | |||||||||
Other European Union |
5,254 | 17,618 | 2,707 | 5,681 | 11,808 | 10,272 | 10,138 | 28,585 | 92,063 | |||||||||
United States |
6,298 | 39,754 | 2,737 | 5,413 | 8,767 | 3,447 | 4,238 | 6,733 | 77,387 | |||||||||
Africa |
8,428 | 2,247 | 1,143 | 1,852 | 4,560 | 4,557 | 5,674 | 16,769 | 45,230 | |||||||||
Rest of the World |
3,832 | 8,150 | 2,167 | 1,545 | 9,267 | 4,008 | 5,666 | 3,005 | 37,640 | |||||||||
Total |
53,162 | 88,748 | 12,823 | 22,227 | 61,591 | 45,197 | 58,124 | 126,466 | 468,338 |
Table 10: Foreign outstandings in currencies other than the local currency of the borrower for countries where this exceeds 1% of total Group assets | ||||||||||
At 31st December 2009 | As % of assets |
Total £m |
Banks and other financial institutions £m |
Governments and official institutions £m |
Commercial £m | |||||
United States |
1.2 | 16,907 | 4,622 | | 12,285 | |||||
At 31st December 2008 |
||||||||||
United States |
3.1 | 63,614 | 16,724 | 2 | 46,888 | |||||
Cayman Islands |
1.2 | 23,765 | 271 | | 23,494 | |||||
At 31st December 2007 |
||||||||||
United States |
2.1 | 26,249 | 7,151 | 6 | 19,092 |
At 31st December 2009, 2008 and 2007, there were no countries where Barclays had cross-currency loans to borrowers between 0.75% and 1% of total Group assets.
111 |
Table 11: Off-balance sheet and other credit exposures as at 31st December | 2009 £m |
2008 £m |
2007 £m | |||
Off-balance sheet exposures |
||||||
Contingent liabilities |
52,774 | 66,310 | 45,774 | |||
Commitments |
207,275 | 260,816 | 192,639 | |||
On-balance sheet exposures |
||||||
Trading portfolio assets |
151,344 | 185,637 | 193,691 | |||
Financial assets designated at fair value held on own account |
41,311 | 54,542 | 56,629 | |||
Derivative financial instruments |
416,815 | 984,802 | 248,088 | |||
Available for sale financial investments |
56,483 | 64,976 | 43,072 |
Table 12: Notional principal amounts of credit derivatives as at 31st December | 2009 £m |
2008 £m |
2007 £m | |||
Credit derivatives held or issued for trading purposes a |
2,016,796 | 4,129,244 | 2,472,249 |
Table 13: Credit risk loans summary At 31st December |
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | |||||
Impaired loans |
16,240 | 12,264 | 8,574 | 4,444 | 4,550 | |||||
Accruing loans which are contractually overdue 90 days or more as to principal or interest |
5,317 | 2,953 | 794 | 598 | 609 | |||||
Impaired and restructured loans |
831 | 483 | 273 | 46 | 51 | |||||
Credit risk loans |
22,388 | 15,700 | 9,641 | 5,088 | 5,210 |
Table 14: Credit risk loans At 31st December |
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | |||||
Impaired loans: |
||||||||||
United Kingdom |
4,519 | 3,793 | 3,605 | 3,340 | 2,965 | |||||
Other European Union |
4,004 | 1,713 | 472 | 410 | 345 | |||||
United States |
4,612 | 4,397 | 3,703 | 129 | 230 | |||||
Africa |
2,170 | 1,996 | 757 | 535 | 831 | |||||
Rest of the World |
935 | 365 | 37 | 30 | 179 | |||||
Total |
16,240 | 12,264 | 8,574 | 4,444 | 4,550 | |||||
Accruing loans which are contractually overdue 90 days or more as to principal or interest: |
||||||||||
United Kingdom |
2,312 | 1,656 | 676 | 516 | 539 | |||||
Other European Union |
951 | 562 | 79 | 58 | 53 | |||||
United States |
232 | 433 | 10 | 3 | | |||||
Africa |
1,739 | 172 | 29 | 21 | 17 | |||||
Rest of the World |
83 | 130 | | | | |||||
Total |
5,317 | 2,953 | 794 | 598 | 609 | |||||
Impaired and restructured loans: |
||||||||||
United Kingdom |
582 | 367 | 179 | | 5 | |||||
Other European Union |
41 | 29 | 14 | 10 | 7 | |||||
United States |
180 | 82 | 38 | 22 | 16 | |||||
Africa |
22 | | 42 | 14 | 23 | |||||
Rest of the World |
6 | 5 | | | | |||||
Total |
831 | 483 | 273 | 46 | 51 | |||||
Total credit risk loans: |
||||||||||
United Kingdom |
7,413 | 5,816 | 4,460 | 3,856 | 3,509 | |||||
Other European Union |
4,996 | 2,304 | 565 | 478 | 405 | |||||
United States |
5,024 | 4,912 | 3,751 | 154 | 246 | |||||
Africa |
3,931 | 2,168 | 828 | 570 | 871 | |||||
Rest of the World |
1,024 | 500 | 37 | 30 | 179 | |||||
Credit risk loans |
22,388 | 15,700 | 9,641 | 5,088 | 5,210 |
Note
a | Includes credit derivatives held as economic hedges which are not designated as hedges for accounting purposes. |
112 |
Risk management
Statistical information
continued
Table 15: Potential problem loans | ||||||||||
At 31st December | 2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | |||||
United Kingdom |
858 | 883 | 419 | 465 | 640 | |||||
Other European Union |
790 | 963 | 59 | 32 | 26 | |||||
United States |
553 | 431 | 964 | 21 | 12 | |||||
Africa |
488 | 140 | 355 | 240 | 248 | |||||
Rest of the World |
679 | 39 | | 3 | 3 | |||||
Potential problem loans |
3,368 | 2,456 | 1,797 | 761 | 929 |
Table 16: Interest foregone on credit risk loans | ||||||
2009 £m |
2008 £m |
2007 £m | ||||
Interest income that would have been recognised under the original contractual terms |
||||||
United Kingdom |
392 | 244 | 340 | |||
Rest of the World |
736 | 235 | 91 | |||
Total |
1,128 | 479 | 431 |
Interest income of approximately £413m (2008: £195m, 2007: £48m) from such loans was included in profit, of which £137m (2008: £72m, 2007: £26m) related to domestic lending and the remainder related to foreign lending.
In addition, a further £185m (2008: £135m, 2007: £113m) was recognised arising from impaired loans. Following impairment, interest income is recognised using the original effective rate of interest which was used to discount the expected future cash flows for the purpose of measuring the impairment loss. £52m (2008: £42m, 2007: £93m) of this related to domestic impaired loans and the remainder related to foreign impaired loans.
Table 17: Analysis of impairment/provision charges | ||||||||||||
At 31st December | 2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m |
|||||||
Impairment charge/net specific provisions charge |
||||||||||||
United Kingdom |
2,744 | 1,817 | 1,593 | 1,880 | 1,382 | |||||||
Other European Union |
1,408 | 587 | 123 | 92 | 75 | |||||||
United States |
1,525 | 1,519 | 374 | 12 | 76 | |||||||
Africa |
814 | 454 | 214 | 143 | 37 | |||||||
Rest of the World |
839 | 207 | 2 | (53 | ) | 4 | ||||||
Impairment on loans and advances |
7,330 | 4,584 | 2,306 | 2,074 | 1,574 | |||||||
Impairment on available for sale assets |
670 | 382 | 13 | 86 | 4 | |||||||
Impairment on reverse repurchase agreements |
43 | 124 | | | | |||||||
Impairment charge |
8,043 | 5,090 | 2,319 | 2,160 | 1,578 | |||||||
Other credit provisions charge/(release) |
28 | 329 | 476 | (6 | ) | (7 | ) | |||||
Impairment/provision charges |
8,071 | 5,419 | 2,795 | 2,154 | 1,571 |
Table 18: Impairment/provisions charges ratios (Loan loss ratios) | ||||||||||
2009 % |
2008 % |
2007 % |
2006 % |
2005 % | ||||||
Impairment/provisions charges as a percentage of average loans and advances for the year: |
||||||||||
Impairment charge |
1.64 | 1.01 | 0.64 | 0.66 | 0.58 | |||||
Total |
1.64 | 1.01 | 0.64 | 0.66 | 0.58 | |||||
Amounts written off (net of recoveries) |
0.72 | 0.61 | 0.49 | 0.61 | 0.50 |
113 |
Table 19: Analysis of allowance for impairment/provision for bad and doubtful debts | 2009 | 2008 | 2007 | 2006 | 2005 | |||||
£m | £m | £m | £m | £m | ||||||
Impairment allowance/specific provisions |
||||||||||
United Kingdom |
4,083 | 2,947 | 2,526 | 2,477 | 2,266 | |||||
Other European Union |
2,014 | 963 | 344 | 311 | 284 | |||||
United States |
2,518 | 1,561 | 356 | 100 | 130 | |||||
Africa |
1,349 | 857 | 514 | 417 | 647 | |||||
Rest of the World |
832 | 246 | 32 | 30 | 123 | |||||
Allowance for impairment provision balances |
10,796 | 6,574 | 3,772 | 3,335 | 3,450 | |||||
Average loans and advances for the year |
447,569 | 453,413 | 357,853 | 313,614 | 271,421 |
Table 20: Allowance for impairment/provision balance ratios | 2009 | 2008 | 2007 | 2006 | 2005 | |||||
% | % | % | % | % | ||||||
Allowance for impairment/provision balance at end of year as a percentage of loans and advances at end of year: |
||||||||||
Impairment balance |
2.29 | 1.27 | 0.97 | 1.05 | 1.14 | |||||
Total |
2.29 | 1.27 | 0.97 | 1.05 | 1.14 |
Table 21: Movements in allowance for impairment/provisions charge for bad and doubtful debts a |
2009 | 2008 | 2007 | 2006 | 2005 | ||||||||||
£m | £m | £m | £m | £m | |||||||||||
Allowance for impairment/provision balance at beginning of year |
6,574 | 3,772 | 3,335 | 3,450 | 2,637 | ||||||||||
Acquisitions and disposals |
434 | 307 | (73 | ) | (23 | ) | 555 | ||||||||
Unwind of discount |
(185 | ) | (135 | ) | (113 | ) | (98 | ) | (76 | ) | |||||
Exchange and other adjustments |
(127 | ) | 791 | 53 | (153 | ) | 125 | ||||||||
Amounts written off |
(3,380 | ) | (2,919 | ) | (1,963 | ) | (2,174 | ) | (1,587 | ) | |||||
Recoveries |
150 | 174 | 227 | 259 | 222 | ||||||||||
Impairment/provision charged against profit |
7,330 | 4,584 | 2,306 | 2,074 | 1,574 | ||||||||||
Allowance for impairment/provision balance at end of year |
10,796 | 6,574 | 3,772 | 3,335 | 3,450 |
Table 22: Amounts written off | 2009 | 2008 | 2007 | 2006 | 2005 | ||||||||||
£m | £m | £m | £m | £m | |||||||||||
United Kingdom |
(1,569 | ) | (1,514 | ) | (1,530 | ) | (1,746 | ) | (1,302 | ) | |||||
Other European Union |
(453 | ) | (162 | ) | (143 | ) | (74 | ) | (56 | ) | |||||
United States |
(669 | ) | (1,044 | ) | (145 | ) | (46 | ) | (143 | ) | |||||
Africa |
(438 | ) | (187 | ) | (145 | ) | (264 | ) | (81 | ) | |||||
Rest of the World |
(251 | ) | (12 | ) | | (44 | ) | (5 | ) | ||||||
Amounts written off |
(3,380 | ) | (2,919 | ) | (1,963 | ) | (2,174 | ) | (1,587 | ) |
114 |
Risk management
Statistical information
continued
Table 23: Recoveries | 2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m |
||||||||||
United Kingdom |
48 | 131 | 154 | 178 | 160 | ||||||||||
Other European Union |
12 | 4 | 32 | 18 | 13 | ||||||||||
United States |
6 | 1 | 7 | 22 | 15 | ||||||||||
Africa |
80 | 36 | 34 | 33 | 16 | ||||||||||
Rest of the World |
4 | 2 | | 8 | 18 | ||||||||||
Recoveries |
150 | 174 | 227 | 259 | 222 | ||||||||||
Table 24: Impairment allowances/provision charged against profit a | 2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m |
||||||||||
New and increased impairment allowance/specific provision charge: |
|||||||||||||||
United Kingdom |
3,123 | 2,160 | 1,960 | 2,253 | 1,763 | ||||||||||
Other European Union |
1,625 | 659 | 192 | 182 | 113 | ||||||||||
United States |
1,535 | 1,529 | 431 | 60 | 105 | ||||||||||
Africa |
932 | 526 | 268 | 209 | 109 | ||||||||||
Rest of the World |
896 | 242 | 20 | 18 | 39 | ||||||||||
8,111 | 5,116 | 2,871 | 2,722 | 2,129 | |||||||||||
Reversals of impairment allowance/specific provision charge: |
|||||||||||||||
United Kingdom |
(331 | ) | (212 | ) | (213 | ) | (195 | ) | (221 | ) | |||||
Other European Union |
(205 | ) | (68 | ) | (37 | ) | (72 | ) | (25 | ) | |||||
United States |
(4 | ) | (9 | ) | (50 | ) | (26 | ) | (14 | ) | |||||
Africa |
(38 | ) | (36 | ) | (20 | ) | (33 | ) | (56 | ) | |||||
Rest of the World |
(53 | ) | (33 | ) | (18 | ) | (63 | ) | (17 | ) | |||||
(631 | ) | (358 | ) | (338 | ) | (389 | ) | (333 | ) | ||||||
Recoveries |
(150 | ) | (174 | ) | (227 | ) | (259 | ) | (222 | ) | |||||
Net charge to profit |
7,330 | 4,584 | 2,306 | 2,074 | 1,574 | ||||||||||
Table 25: Total impairment/specific provision charges for bad and doubtful debts by industry |
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m |
||||||||||
United Kingdom: |
|||||||||||||||
Financial services |
485 | 76 | 32 | 64 | 22 | ||||||||||
Agriculture, forestry and fishing |
2 | 4 | | 5 | 9 | ||||||||||
Manufacturing |
112 | 118 | 72 | 1 | 120 | ||||||||||
Construction |
54 | 15 | 14 | 17 | 14 | ||||||||||
Property |
113 | 80 | 36 | 15 | 18 | ||||||||||
Energy and water |
| 1 | 1 | (7 | ) | 1 | |||||||||
Wholesale and retail distribution and leisure |
314 | 59 | 118 | 88 | 39 | ||||||||||
Transport |
13 | 3 | 3 | 19 | (27 | ) | |||||||||
Postal and communication |
17 | | 15 | 15 | 3 | ||||||||||
Business and other services |
175 | 234 | 81 | 133 | 45 | ||||||||||
Home loans |
33 | 28 | 1 | 4 | (7 | ) | |||||||||
Other personal |
1,376 | 1,178 | 1,187 | 1,526 | 1,142 | ||||||||||
Finance lease receivables |
50 | 21 | 33 | | 3 | ||||||||||
2,744 | 1,817 | 1,593 | 1,880 | 1,382 | |||||||||||
Overseas |
4,586 | 2,767 | 713 | 194 | 192 | ||||||||||
Impairment/specific provision charges |
7,330 | 4,584 | 2,306 | 2,074 | 1,574 |
The category Other personal includes credit cards, personal loans, second liens and personal overdrafts.
The industry classifications in Tables 25, 26 and 27 have been prepared at the level of the borrowing entity. This means that a loan to the subsidiary of a major corporation is classified by the industry in which the subsidiary operates, even though the Parents predominant business may be in a different industry.
Note
a | Does not reflect the impairment of available for sale assets, reverse repurchase agreements or other credit risk provisions. |
115 |
Table 26: Allowance for impairment/specific provision for bad and doubtful debts by industry | ||||||||||||||||||||
2009 | 2008 | 2007 | 2006 | 2005 | ||||||||||||||||
£m | % | £m | % | £m | % | £m | % | £m | % | |||||||||||
United Kingdom: |
||||||||||||||||||||
Financial services |
493 | 4.6 | 81 | 1.2 | 103 | 2.7 | 67 | 2.0 | 26 | 0.8 | ||||||||||
Agriculture, forestry and fishing |
| | 1 | 0.0 | 5 | 0.1 | 17 | 0.5 | 12 | 0.3 | ||||||||||
Manufacturing |
142 | 1.3 | 185 | 2.8 | 65 | 1.7 | 85 | 2.5 | 181 | 5.2 | ||||||||||
Construction |
41 | 0.4 | 18 | 0.3 | 16 | 0.4 | 16 | 0.5 | 13 | 0.4 | ||||||||||
Property |
90 | 0.8 | 114 | 1.7 | 54 | 1.4 | 26 | 0.8 | 24 | 0.7 | ||||||||||
Energy and water |
| | 1 | 0.0 | 1 | | | | 18 | 0.5 | ||||||||||
Wholesale and retail distribution and leisure |
182 | 1.7 | 43 | 0.7 | 102 | 2.7 | 81 | 2.4 | 99 | 2.9 | ||||||||||
Transport |
| 0.0 | | 0.0 | 11 | 0.3 | 24 | 0.7 | 32 | 0.9 | ||||||||||
Postal and communication |
27 | 0.3 | 33 | 0.5 | 25 | 0.7 | 12 | 0.4 | 2 | 0.1 | ||||||||||
Business and other services |
218 | 2.0 | 236 | 3.6 | 158 | 4.2 | 186 | 5.6 | 102 | 3.0 | ||||||||||
Home loans |
63 | 0.6 | 46 | 0.7 | 15 | 0.4 | 10 | 0.3 | 50 | 1.4 | ||||||||||
Other personal |
2,762 | 25.5 | 2,160 | 32.9 | 1,915 | 50.8 | 1,953 | 58.6 | 1,696 | 49.2 | ||||||||||
Finance lease receivables |
65 | 0.6 | 29 | 0.4 | 56 | 1.5 | | | 11 | 0.3 | ||||||||||
4,083 | 37.8 | 2,947 | 44.8 | 2,526 | 67.0 | 2,477 | 74.3 | 2,266 | 65.7 | |||||||||||
Overseas |
6,713 | 62.2 | 3,627 | 55.2 | 1,246 | 33.0 | 858 | 25.7 | 1,184 | 34.3 | ||||||||||
Total |
10,796 | 100 | 6,574 | 100.0 | 3,772 | 100.0 | 3,335 | 100.0 | 3,450 | 100.0 |
Table 27: Analysis of amounts written off and recovered by industry | ||||||||||||||||||||
Amounts written off for the year |
Recoveries of amounts previously written off | |||||||||||||||||||
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m |
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m | |||||||||||
United Kingdom: |
||||||||||||||||||||
Financial services |
72 | 88 | 6 | 13 | 2 | 3 | 4 | 1 | | 1 | ||||||||||
Agriculture, forestry and fishing |
2 | 6 | 5 | 8 | 3 | | | 2 | 1 | | ||||||||||
Manufacturing |
162 | 53 | 83 | 73 | 47 | 4 | 8 | 7 | 21 | 11 | ||||||||||
Construction |
34 | 19 | 23 | 17 | 15 | 3 | 2 | 3 | 2 | 1 | ||||||||||
Property |
141 | 27 | 16 | 23 | 4 | 3 | 2 | 10 | 6 | 1 | ||||||||||
Energy and water |
2 | 1 | | 1 | 22 | 4 | | | 2 | | ||||||||||
Wholesale and retail distribution and leisure |
182 | 137 | 109 | 120 | 85 | 8 | 7 | 12 | 14 | 25 | ||||||||||
Transport |
14 | 10 | 13 | 11 | 29 | 1 | 1 | 1 | 10 | |||||||||||
Postal and communication |
23 | 3 | 3 | 5 | 15 | | | | | | ||||||||||
Business and other services |
197 | 153 | 83 | 124 | 83 | 5 | 10 | 22 | 17 | 14 | ||||||||||
Home loans |
16 | 4 | 1 | | 2 | | 1 | 1 | 7 | 4 | ||||||||||
Other personal |
705 | 960 | 1,164 | 1,351 | 992 | 13 | 88 | 96 | 107 | 92 | ||||||||||
Finance lease receivables |
19 | 53 | 24 | | 3 | 4 | 8 | | | 1 | ||||||||||
1,569 | 1,514 | 1,530 | 1,746 | 1,302 | 48 | 131 | 154 | 178 | 160 | |||||||||||
Overseas |
1,811 | 1,405 | 433 | 428 | 285 | 102 | 43 | 73 | 81 | 62 | ||||||||||
Total |
3,380 | 2,919 | 1,963 | 2,174 | 1,587 | 150 | 174 | 227 | 259 | 222 |
116 |
Risk management
Statistical information
continued
Table 28: Total impairment allowance/(provision) coverage of credit risk loans | ||||||||||
2009 % |
2008 % |
2007 % |
2006 % |
2005 % | ||||||
United Kingdom |
55.1 | 50.7 | 56.6 | 64.2 | 64.6 | |||||
Other European Union |
40.3 | 41.8 | 60.9 | 65.1 | 70.1 | |||||
United States |
50.1 | 31.8 | 9.5 | 64.9 | 52.8 | |||||
Africa |
34.3 | 39.5 | 62.1 | 73.2 | 74.3 | |||||
Rest of the World |
81.3 | 49.2 | 86.5 | 100.0 | 68.7 | |||||
Total coverage of credit risk loans |
48.2 | 41.9 | 39.1 | 65.6 | 66.2 |
Table 29: Total impairment allowance/(provision) coverage of potential credit risk lending (CRLs and PPLs) | ||||||||||
2009 % |
2008 % |
2007 % |
2006 % |
2005 % | ||||||
United Kingdom |
49.4 | 44.0 | 51.8 | 57.3 | 54.6 | |||||
Other European Union |
34.8 | 29.5 | 55.1 | 61.0 | 65.9 | |||||
United States |
45.1 | 29.2 | 7.6 | 57.1 | 50.4 | |||||
Africa |
30.5 | 37.1 | 43.4 | 51.5 | 57.8 | |||||
Rest of the World |
48.9 | 45.5 | 86.5 | 91.0 | 67.6 | |||||
Total coverage of potential credit risk lending |
41.9 | 36.2 | 33.0 | 57.0 | 56.2 |
117 |
Risk management
118 |
Risk management
Supervision and regulation
continued
119 |
120 |
Board and executive committee
continued
121 |
122 |
123 |
Warrants
Notes
a | The percentages of voting rights detailed above have been calculated without including the new shares to be issued when the warrants are exercised. This results in the percentage figures being artificially high. |
b | The number of Barclays shares includes 8,003,236 contracts for difference to which voting rights are attached. |
c | The number of Barclays shares includes 192,860,970 Total Return Swap shares to which voting rights are attached. |
124 |
Directors report
continued
125 |
126 |
127 |
128 |
Corporate governance
Corporate governance report
continued
129 |
130 |
Corporate governance
Corporate governance report
continued
Board and Committee Attendance
Independent | Scheduled Board |
Additional Board a |
Board Audit Committee |
Board HR & Remuneration Committee |
Board Corporate Governance & Nominations Committee |
Board Risk Committee |
AGM | |||||||||
Number of meetings held |
8 | 19 | 11 | 14 | 4 | 5 | 1 | |||||||||
Group Chairman |
||||||||||||||||
Marcus Agius |
OA | 8 | 19 | | 14 | 4 | | 1 | ||||||||
Executive Directors |
||||||||||||||||
John Varley (Group Chief Executive) |
ED | 8 | 19 | | | | | 1 | ||||||||
Bob Diamond |
ED | 8 | 17 | | | | | 1 | ||||||||
Chris Lucas |
ED | 8 | 19 | | | | | 1 | ||||||||
Frits Seegers (to 3rd November) |
ED | 6 | 19 | | | | | 1 | ||||||||
Non-executive Directors |
||||||||||||||||
David Booth |
I | 8 | 16 | | | | 5 | 1 | ||||||||
Sir Richard Broadbent |
||||||||||||||||
(Deputy Chairman & Senior Independent Director) |
I | 8 | 18 | | 14 | 4 | 5 | 1 | ||||||||
Leigh Clifford |
I | 8 | 7 | | 11 | | | 1 | ||||||||
Fulvio Conti |
I | 8 | 15 | 10 | | | | 1 | ||||||||
Professor Dame Sandra Dawson (to 23rd April) |
I | 3 | 11 | 5 | | | | 1 | ||||||||
Simon Fraser (from 10th March) b |
I | 7 | 15 | 5 | 7 | | | | ||||||||
Reuben Jeffery III (from 16th July) |
I | 4 | 2 | | | | | | ||||||||
Sir Andrew Likierman |
I | 8 | 17 | 11 | | | 5 | 1 | ||||||||
Sir Michael Rake |
I | 8 | 17 | 11 | | 2 | 3 | 1 | ||||||||
Sir Nigel Rudd (Deputy Chairman to 23rd April) |
I | 3 | 11 | | | 1 | | 1 | ||||||||
Stephen Russell (to 31st October) |
I | 6 | 12 | 7 | | 2 | 3 | 1 | ||||||||
Sir John Sunderland |
I | 8 | 17 | | 14 | 4 | | 1 | ||||||||
Patience Wheatcroft (to 16th June) |
I | 3 | 14 | | | | | 1 |
131 |
Corporate governance
Corporate governance report
Note
a | Individual directors may fall into one or more categories. |
132 |
Corporate governance
Corporate governance report
continued
133 |
Corporate governance Corporate governance report |
Current membership of the Board Committees
Board Audit Committee |
Board Corporate Governance & Nominations Committee |
Board HR & Remuneration Committee |
Board Risk Committee | |||||
Marcus Agius |
| C | M | | ||||
David Booth |
| M | | C | ||||
Sir Richard Broadbent |
| M | C | M | ||||
Leigh Clifford |
| | M | | ||||
Fulvio Conti |
M | | | | ||||
Simon Fraser |
M | | M | | ||||
Reuben Jeffery III |
| | | M | ||||
Sir Andrew Likierman |
M | | | M | ||||
Sir Michael Rake |
C | M | | M | ||||
Sir John Sunderland |
| M | M | |
Key
C Chairman
M Member
134 |
Corporate governance
Corporate governance report
continued
135 |
136 |
Corporate governance
Corporate governance report
continued
137 |
Note
a | Included in Board and Committee Composition for 2008. |
138 |
Corporate governance
Corporate governance report
continued
139 |
140 |
Corporate governance
Corporate governance report
continued
141 |
Board Risk Committee Chairmans Statement
142 |
Corporate governance
Corporate governance report
continued
143 |
144 |
Corporate governance
Corporate governance report
continued
145 |
Corporate governance
146 |
Corporate governance
Remuneration report
continued
147 |
148 |
Corporate governance
Remuneration report
continued
149 |
Table 1a: Executive Directors annual remuneration | ||||||||
Element | Purpose | Delivery | Programme summary | When normally received/ awarded | ||||
Base salary |
To reflect the market value of the individual and their role | Cash Monthly Pensionable |
Reviewed annually, with any increases typically effective on 1st April |
Paid in year | ||||
Annual performance bonus (cash) | To incentivise the delivery of annual goals at the Group, business division and individual levels | A proportion of annual performance bonus paid in cash Non-pensionable |
Based on annual performance of the Group as a whole, business unit performance where relevant and individual performance |
Normally paid in the following financial year | ||||
Total cash |
Sub-total of the above | |||||||
Deferred share award (ESAS) | To align annual performance with shareholder value and increase retention | A proportion of annual performance bonus recommended as a deferred share award under ESAS Non-pensionable |
Discretionary award of shares to be deferred for three to five years. No performance condition on release, as a deferred share award 20% bonus shares releasable after three years, a further 10% after five years Dividends normally accumulated during deferral period |
Normally awarded in the following financial year | ||||
Long-term incentive award 2010-2012 (PSP) | To reward the creation of sustained growth in shareholder value | Award of shares that vests after three years, subject to performance conditions Non-pensionable |
Discretionary awards Participation reviewed annually Barclays performance over three years determines the performance shares eligible for release to each individual Dividends normally accumulated during deferral period |
Normally awarded in the following financial year | ||||
Pension (or cash allowance) | To provide a market competitive post-retirement benefit | Deferred cash or cash allowance Monthly |
Non-contributory, defined benefit scheme and/or defined contribution scheme, or cash allowance in lieu of pension contributions |
Paid or accrued during year | ||||
Other benefits |
To provide market competitive benefits | Benefit in kind, or cash allowance Non-pensionable |
Benefits include private medical insurance, life and disability cover, accommodation overseas when required for business purposes, use of company-owned vehicle or cash equivalent and tax advice |
Received during year | ||||
Sub-total in accordance with Schedule 8 of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 | Total of base salary, annual performance bonus (cash), pension cash allowance and other benefits |
150 |
Corporate governance
Remuneration report
continued
Table 1b: Executive Directors annual remuneration | John Varley | Robert E Diamond Jr | Chris Lucas | |||||||||
2009 £000 |
2008 £000 |
2009 £000 |
2008 £000 |
2009 £000 |
2008 £000 | |||||||
Base salary |
1,100 | 1,075 | 250 | 250 | 650 | 638 | ||||||
Annual performance bonus (cash) |
0 | 0 | 0 | 0 | 0 | 0 | ||||||
Total cash |
1,100 | 1,075 | 250 | 250 | 650 | 638 | ||||||
Deferred share award |
||||||||||||
(ESAS) |
0 | 0 | 0 | 0 | 1,500 | 0 | ||||||
Long term incentive award 2010-2012 (PSP) |
0 | 0 | 6,000 | 0 | 1,000 | 800 | ||||||
Pension (or cash allowance) | Member of pension scheme See page 153 |
Member of pension scheme See page 153 |
Member of pension scheme See page 153 |
Member of pension scheme See page 153 |
163 | 159 | ||||||
Other benefits |
23 | 23 | 134 | 66 | 19 | 18 | ||||||
Sub-total in accordance with Schedule 8 of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 |
1,123 | 1,098 | 384 | 316 | 832 | 815 |
151 |
Table 3: Long-term plans and deferred share plans | |||||||||||||
Number of shares under award/option at 1st January 2009 (maximum) |
Awarded in year (maximum) |
Market price on award date |
Weighted average exercise price |
Number released/ exercised |
|||||||||
John Varley |
|||||||||||||
PSP 2006-2008 |
473,604 | | £ | 6.75 | | | |||||||
PSP 2007-2009 |
504,294 | | £ | 7.08 | | | |||||||
PSP 2008-2010 |
812,412 | | £ | 4.25 | | | |||||||
ISOP |
944,655 | | | £ | 4.29 | | |||||||
Sharesave |
3,735 | | | £ | 4.70 | | |||||||
ESAS |
469,467 | | | | (38,498 | ) | |||||||
Robert E. Diamond Jr |
|||||||||||||
PSP 2006-2008 |
2,368,014 | | £ | 6.75 | | | |||||||
PSP 2007-2009 |
2,878,686 | | £ | 7.08 | | | |||||||
PSP 2008-2010 |
2,031,030 | | £ | 4.25 | | | |||||||
ISOP |
575,008 | | | £ | 4.42 | | |||||||
BGI EOP |
100,000 | | | £ | 20.11 | (100,000 | ) | ||||||
ESAS |
7,048,112 | | | | (3,682,230 | ) | |||||||
Chris Lucas |
|||||||||||||
PSP 2007-2009 |
255,396 | | £ | 7.08 | | | |||||||
PSP 2008-2010 |
541,608 | | £ | 4.25 | | | |||||||
PSP 2009-2011 |
| 1,598,046 | £ | 2.34 | | | |||||||
Sharesave |
3,735 | | | £ | 4.70 | | |||||||
ESAS |
79,477 | | | | (35,471 | ) |
Table 4: Performance conditions attaching to the share plans in which the executive Directors participate | ||||||
Scheme | Performance period |
Performance measure | Target | |||
PSP |
2009 -2011 | 50% of award calibrated against TSR | 33% of maximum award released for above median performance (6th place) with 100% released in 1st place and a scaled basis in between | |||
50% average RoRWA | 17% of maximum award released for 0.83% scaled to a maximum award at 1.34% | |||||
2008-2010 | 50% of award calibrated against TSR | As above | ||||
50% of award calibrated against Cumulative EP over the three-year performance period | 33% of maximum award released for £6,921m scaled to 100% of maximum award at £8,350m | |||||
2007-2009 | 50% of award calibrated against TSR | As above | ||||
50% of award calibrated against Cumulative EP over the three-year performance period | 33% of maximum award released for £7,618m scaled to 100% of maximum award at £8,668m |
152 |
Corporate governance
Remuneration report
continued
Market price on release/ exercise date |
Number lapsed in 2009 |
Number of shares under award/option at 31st December 2009 (maximum) |
Vested number of shares under option |
Value of release/ exercise |
End of three- year PSP performance period, or first exercise/ scheduled release date |
Last exercise/ scheduled release date | ||||||
| (240,749) | 232,855 | | | 31/12/08 | 30/03/11 | ||||||
| | 504,294 | | | 31/12/09 | 22/03/10 | ||||||
| | 812,412 | | | 31/12/10 | 20/03/11 | ||||||
| | 944,655 | 944,655 | | 18/05/03 | 22/03/14 | ||||||
| | 3,735 | | | 01/11/14 | 30/04/15 | ||||||
£2.08 | | 430,969 | | £0.08m | 12/03/08 | 20/03/13 | ||||||
| (1,203,741) | 1,164,273 | | | 31/12/08 | 30/03/11 | ||||||
| | 2,878,686 | | | 31/12/09 | 22/03/10 | ||||||
| | 2,031,030 | | | 31/12/10 | 20/03/11 | ||||||
| | 575,008 | 575,008 | | 12/03/04 | 22/03/14 | ||||||
£109.45 | | | | £8.93m | 26/03/07 | 15/12/09 | ||||||
£2.08 | | 3,365,882 | | £7.67m | 07/03/10 | 20/03/13 | ||||||
| | 255,396 | | | 31/12/09 | 22/03/10 | ||||||
| | 541,608 | | | 31/12/10 | 20/03/11 | ||||||
| | 1,598,046 | | | 31/12/11 | 27/04/12 | ||||||
| | 3,735 | | | 01/11/14 | 30/04/15 | ||||||
£2.08 | | 44,006 | | £0.07m | 20/03/11 | 20/03/13 |
TSR peer group constituents | ||||||||
UK | Mainland Europe | US | Underpin | Actual performance | ||||
HSBC, Lloyds Banking Group, Royal Bank of Scotland |
Banco Santander, BBVA, BNP Paribas, Deutsche Bank, UBS, Unicredit | Citigroup, JP Morgan Chase |
Committee must be satisfied with the underlying financial health of the Group after considering Economic Profit (EP) and Profit Before Tax (PBT) on a cumulative basis over the three-year period | To be determined at vesting in March 2012 | ||||
HBOS, HSBC, Lloyds TSB, Royal Bank of Scotland |
As above | As above | Cumulative EP over performance period must exceed cumulative EP over previous three years | To be determined at vesting in March 2011 | ||||
As above |
As above | As above | As above | Performance condition partially met |
153 |
Table 5: Pension provision | ||||||||||||||||||||
Age at 31st December 2009 |
Completed years of service |
Accrued at 31st |
Pension accrued during 2009 (including increase for inflation) £000 |
Pension accrued during 2009 (excluding inflation) £000 |
Accrued £000 |
Transfer value of |
Transfer value of £000 |
Increase in transfer value during the year £000 |
Annual cash in lieu of pension £000 | |||||||||||
John Varley |
53 | 27 | 572 | 47 | 56 | 619 | 12,328 | 17,015 | 4,687 | | ||||||||||
Robert E Diamond Jr |
58 | 13 | 45 | 13 | 14 | 58 | 280 | 383 | 103 | | ||||||||||
Chris Lucas |
49 | 2 | | | | | | | | 163 |
154 |
Corporate governance
Remuneration report
continued
Table 9: Contract terms | Effective date of contract |
Notice period from the Company |
Potential compensation for loss of office | |||
Executive Directors | ||||||
John Varley |
1st September 2004 | 12 months | 12 months base salary, bonus equivalent to the average of the previous three years and continuation of medical and pension benefits whilst an employee | |||
Robert E Diamond Jr |
1st June 2005 | 12 months | 12 months base salary, bonus equivalent to the average of the previous three years and continuation of medical and pension benefits whilst an employee | |||
Chris Lucas |
1st April 2007 | 12 months | 12 months base salary, bonus equivalent to the average of the previous three years up to 100% of base salary and continuation of medical and pension benefits whilst an employee |
Table 10: Fees for external appointments held by executive Directors Director |
2009 | 2008 | ||||||||
Organisation |
Fees | Fees retained |
Fees | Fees retained | ||||||
John Varley |
British Grolux Investments Limited | £8,061 | £8,061 | £7,788 | £7,788 | |||||
AstraZeneca PLC | £95,000 | £95,000 | £83,333 | £83,333 |
Any other positions held by the executive Directors do not attract fees.
155 |
Table 11: 2009 fees | ||||||||||||||||||||
Chairman £000 |
Deputy Chairman £000 |
Board Member £000 |
Board Audit Committee £000 |
Board HR and Remuneration Committee £000 |
Board Corporate Governance and Nominations Committee £000 |
Board Risk Committee £000 |
Benefits £000 |
Total 2009 £000 |
Total 2008 £000 | |||||||||||
Fees (at 31st Dec 09) |
||||||||||||||||||||
Full-year fee |
750 | 200 | 70 | | | | | | | | ||||||||||
Committee Chair |
| | | 60 | 40 | | 40 | | | | ||||||||||
Committee Member |
| | | 25 | 15 | 15 | 15 | | | | ||||||||||
Fees to 31st December 2009 Group Chairman |
||||||||||||||||||||
Marcus Agius |
750 | | | | M. | Ch. | | 1 | 751 | 751 | ||||||||||
Non-executive Directors |
||||||||||||||||||||
David Booth |
| | M. | | | | M. | | 85 | 83 | ||||||||||
Sir Richard Broadbent |
| DCh. | M. | | Ch. | M. | Ch. | | 197 | 188 | ||||||||||
Leigh Clifford AO |
| | M. | | M. | | | | 123 | 115 | ||||||||||
Fulvio Conti |
| | M. | M. | | | | | 95 | 90 | ||||||||||
Simon Fraser |
| | M. | M. | M. | | | | 83 | | ||||||||||
Reuben Jeffery III |
| | M. | | | | | | 32 | | ||||||||||
Sir Andrew Likierman |
| | M. | M. | | | M. | | 110 | 105 | ||||||||||
Sir Michael Rake |
| | M. | Ch. | | M. | M. | | 141 | 90 | ||||||||||
Sir John Sunderland |
| | M. | | M. | M. | | | 108 | 98 |
Leigh Clifford was also a member of the Asia Pacific Advisory Committee and received fees of US$60,000 (2008: US$60,000). These fees are included in those shown above. As Deputy Chairman, Sir Richard Broadbent receives a fee of £200,000 per annum. From 16th July 2009, the date from which he was appointed as Deputy Chairman, Sir Richard Broadbent did not receive any additional fees for serving on Board Committees or as Senior Independent Director.
Sir John Sunderland was appointed as a member of the Group Brand and Reputation Committee (for which the full-year fee is £15,000) with effect from 1st July 2009 and received fees of £7,500. These fees are included in those shown above.
156 |
Corporate governance
Remuneration report
continued
Letters of appointment
The Group Chairman, Deputy Chairman and non-executive Directors have individual letters of appointment. Each non-executive Director appointment is for an initial six-year term, renewable for a single term of three years thereafter.
Details of non-executive Directors standing for re-election at the 2010 AGM are set out on page 123.
Former Directors
Frits Seegers, Sir Nigel Rudd, Professor Dame Sandra Dawson, Stephen Russell and Patience Wheatcroft ceased to be Directors during the year.
Frits Seegers ceased to be a Director with effect from 3rd November 2009 and continued as an employee in order to effect a successful handover. Professor Dame Sandra Dawson and Sir Nigel Rudd did not put themselves forward for re-election at the 2009 AGM and received no termination payments. Patience Wheatcroft resigned as a non-executive Director with effect from 16th June 2009 and received no termination payment. Stephen Russell resigned as a non-executive Director with effect from 31st October 2009 and received no termination payment. Their remuneration for 2009 was as follows:
Table 14: Annual remuneration | Received for 2009 | |||||||||||||||
Salary and fees £000 |
Annual cash bonus £000 |
Deferred share award (ESAS) £000 |
Long term incentive (PSP) £000 |
Benefits £000 |
Cash allowance £000 |
Total 2009 £000 |
Total 2008 £000 | |||||||||
Frits Seegers |
700 | 467 | 933 | 0 | 110 | 175 | 2,385 | 2,502 | ||||||||
Professor Dame Sandra Dawson |
30 | | | | | | 30 | 90 | ||||||||
Sir Nigel Rudd DL |
63 | | | | | | 63 | 200 | ||||||||
Stephen Russell |
113 | | | | | | 113 | 153 | ||||||||
Patience Wheatcroft |
41 | | | | | | 41 | 78 |
In respect of the deferred share award (ESAS), a recommendation was made to the ESAS trustee that a provisional allocation of shares is made to Mr Seegers, scheduled to vest over a three-year period (31.5% scheduled to vest at first and second anniversary of grant and 37% scheduled to vest at third anniversary of grant. The third portion alone will include 20% bonus shares). The ESAS amount shown in Table 14 shows the basic allocation, but does not include bonus shares. Including the maximum potential bonus shares, the ESAS award will have an initial value of £1,002,042 for Mr Seegers.
During Mr Seegers notice period, which will expire on 31st December 2010 at the latest, monthly payments of £161,150 constituting base salary, instalments in respect of bonus for 2010 and other benefits are payable in line with his contract. In the event of an earlier cessation of employment by mutual agreement, monthly payments in respect of salary, cash allowance in lieu of pension and other benefits will cease to be made.
Sir Nigel Rudd was appointed as Chairman of the Advisory Committee UK & Ireland Private Bank with effect from 1st December 2009. As Chairman of the Advisory Committee, Sir Nigel will receive a fee of £150,000 p.a. and in 2009 received £12,500. These fees are not included in those shown above.
Patience Wheatcroft was a member of the Group Brand and Reputation Committee (for which the full-year fee is £15,000) until her resignation as a non-executive Director with effect from 16th June 2009 and received fees of £6,917. These fees are included in those shown above.
Table 15: Terms of contract or letter of appointment |
Effective date | Notice period from the Company |
Potential compensation for loss of office | |||
Frits Seegers |
7th June 2006 | 12 months | 12 months base salary, bonus equivalent to the average of the previous three years and continuation of medical and pension benefits whilst an employee | |||
Professor Dame Sandra Dawson |
1st March 2003 | 6 months | 6 months fees | |||
Sir Nigel Rudd DL |
1st February 1996 | 6 months | 6 months fees | |||
Stephen Russell |
25th October 2000 | 6 months | 6 months fees | |||
Patience Wheatcroft |
1st January 2008 | 6 months | 6 months fees |
Table 16: Other directorships held by Frits Seegers | 2009 | 2008 | ||||||||||
Director | Organisation | Fees | Fees retained |
Fees | Fees retained | |||||||
Frits Seegers |
Absa Group Limited and Absa Bank Limited |
£ | 7,598 | £0 | £ | 26,807 | £0 |
Frits Seegers held this position until 11th February 2009.
157 |
Former Directors continued
Table 17: Executive Share Award Scheme (ESAS) | |||||||||||||||||||||
Scheme | Number at 1st January 2009 (maximum) |
Awarded in year (maximum) |
Market price on award date |
Number released |
Market price on release date |
Number lapsed in 2009 |
Number at 3rd November 2009 (maximum) |
Value of release |
First date |
Last release date | |||||||||||
Frits Seegers |
|||||||||||||||||||||
ESAS |
285,712 | | | (84,521 | ) | £2.83 | | 201,191 | £0.24m | 21/03/10 | 20/03/11 |
Mr Seegers received 53,817 dividend shares from the ESAS released during the year (share price on release date was £2.86).
Table 18: Performance Share Plan (PSP) | |||||||||||||||||||||
Scheme | Number of shares at 1st January 2009 (maximum) |
Awarded in year (maximum) |
Market price on award date |
Number released |
Market price on release date |
Number lapsed in 2009 |
Number of shares at 3rd November 2009 (maximum) |
Value of release |
End of three- year PSP performance period |
Scheduled release date | |||||||||||
Frits Seegers |
|||||||||||||||||||||
PSP 2006-2008 |
485,868 | | £6.30 | | | (246,983 | ) | 238,885 | | 31/12/08 | 31/08/11 | ||||||||||
PSP 2007-2009 |
420,246 | | £7.08 | | | | 420,246 | | 31/12/09 | 22/03/10 | |||||||||||
PSP 2008-2010 |
1,083,216 | | £4.25 | | | | 1,083,216 | | 31/12/10 | 20/03/11 | |||||||||||
PSP 2009-2011 |
| 3,196,095 | £2.34 | | | | 3,196,095 | | 31/12/11 | 27/04/12 |
In respect of Mr Seegers 2006 PSP award (scheduled to vest in 2009), vesting was deferred for a further two-year period at his request, subject to the satisfaction of further performance conditions. The maximum number of shares that may be released is as set out in the table. There is no opportunity to receive shares in excess of this number (save for any dividend shares that may be awarded by the PSP trustee). Following his cessation as a Director, a recommendation has been made for the award to vest in March 2010. The Committee determined that the further performance conditions (as requested in 2009) had been met.
50% of Mr Seegers 2009 PSP award was subject to the Return on Risk-Weighted Assets condition measured at GRCB level. The Committee determined that following the reorganisation of GRCB, performance would be measured for the 2009 financial year only, to reflect his contribution whilst in service (and is subject to the auditors final confirmation). Performance shares under this portion of the award (if any) will not vest until the third anniversary of grant. The TSR portion of the award will continue to be measured for the full three-year period, with shares (if any) scheduled to vest on or after the third anniversary of grant.
Table 19: Sharesave | ||||||||||||||||||||||||
Scheme | Number at 1st January 2009 (maximum) |
Awarded in year (maximum) |
Weighted average exercise price |
Number vested in year |
Number exercised |
Market price on exercise date |
Number lapsed in 2009 |
Number at 3rd November 2009 (maximum) |
Vested number of share options |
Value of exercise |
First exercise date |
Last exercise date | ||||||||||||
Frits Seegers |
||||||||||||||||||||||||
Sharesave |
3,480 | | £4.70 | | | | 3,480 | | | 01/11/12 | 01/05/13 |
Gary Hoffman, a former Director, is a Director of Barclays Pension Fund Trustees Limited and received fees of £55,254.
158 |
Corporate governance
Remuneration report
continued
Share and long-term incentive plans
Barclays operates a number of Group-wide plans. Summaries of the principal plans are set out below. Barclays has a number of employee benefit trusts which operate with these plans. In some cases, the trustees grant awards and purchase shares in the market to satisfy awards as required, in others, new issue or treasury shares may be used to satisfy awards where the appropriate shareholder approval has been obtained. The number of shares held by the trustees is set out in Note 44 on pages 238 and 239. The limits on the issue of new shares comply with the guidelines issued by the Association of British Insurers.
Table 20: Plans under which awards made in 2009 | ||||
Plan name |
Executive Directors eligible? | Description | ||
Performance Share Plan (PSP) | Yes | PSP is a performance related share plan under which awards of Barclays PLC shares may be made to selected employees (including executive Directors), subject to trustee discretion. | ||
The PSP trustee may select any employee of the Group to participate in the plan. | ||||
Awards are granted by the PSP trustee, in consultation with the Remuneration Committee and are communicated as provisional allocations to participants. No right to the shares arises until the PSP trustee releases the shares. | ||||
Participants do not pay for a grant or release of an award. | ||||
Awards are normally releasable on or after the third anniversary of grant, to the extent that applicable performance conditions are satisfied, subject to trustee discretion. | ||||
Any awards released may also include an additional number of shares equivalent to any dividends that would have been paid on the shares between the date of grant and release. | ||||
Normally, the maximum expected value of an award made to an employee at the date of grant is the higher of 150% of base salary, or 75% of base salary and target bonus. Maximum awards reflect the relevant market for each executive Director. Awards are communicated on grant as an expected value. This is a single value for the award at grant, which takes into account the sum of the various possible performance and vesting outcomes. | ||||
On cessation of employment, eligible leavers (as defined) normally receive an award pro rated for time and performance subject to trustee discretion. For other leavers, awards will normally lapse. | ||||
On a change of control awards may vest at the PSP trustees discretion and may be pro rated for time and performance to the date of change of control. | ||||
PSP is not an HMRC approved plan. | ||||
The plan was approved for a ten year period by shareholders in April 2005.
| ||||
Executive Share Award Scheme (ESAS) |
Yes |
ESAS is a deferred share award plan operated in conjunction with various Group bonus plans for selected employees (including executive Directors), subject to trustee discretion. | ||
Awards are granted by the ESAS trustee having first consulted with the Remuneration Committee. | ||||
For certain eligible employees a proportion of discretionary annual bonus is delivered in cash and a proportion is as a recommended mandatory provisional allocation of Barclays PLC shares under ESAS. | ||||
The mandatory provisional allocation will normally include bonus shares equal to 30% of the value of the deferred bonus amount awarded in shares. | ||||
Under mandatory ESAS awards, nil cost options are typically granted three years from award, subject to the discretion of the ESAS trustee. Participants may then call for the shares plus two thirds of the bonus shares and any associated dividend shares. If the nil cost option is not exercised by the end of the two year period, the ESAS trustee may release all shares, bonus shares and any dividend shares to the participant. | ||||
In addition to mandatory ESAS, participants may also request to waive any bonus (or part of a bonus) to which they may become entitled and request that a voluntary ESAS award be made to them in the form of a nil cost option. Voluntary ESAS awards are typically fully exercisable after five years, and include bonus shares equal to 30% of the waived bonus amount. Dividend shares may be awarded, as per mandatory ESAS awards. | ||||
On cessation of employment, a participant may forfeit an award depending on the reason for leaving. Special provisions apply on a change of control. | ||||
ESAS is also used to make certain awards to facilitate the retention and recruitment of new joiners to the Group who have forfeited share awards on leaving previous employment. Typically bonus shares are not awarded, though dividend shares may be awarded, as per mandatory ESAS awards. | ||||
ESAS is not an HMRC approved plan.
| ||||
Incentive shares |
No |
Incentive shares are discretionary share awards that may be made to selected employees (excluding executive Directors), subject to trustee discretion. | ||
Shares are normally released after three years, subject to continued employment and the discretion of the trustee. Dividends received are normally awarded as additional shares and released at the same time. | ||||
On cessation of employment eligible leavers (as defined) normally receive an award pro rated for time in employment, subject to the discretion of the trustee; for other leavers, awards will normally lapse. | ||||
On a change of control awards may vest, pro rated for time to the date of change of control, subject to the discretion of the trustee. | ||||
Incentive shares is not an HMRC approved plan.
|
159 |
Share and long-term incentive plans continued
Table 20: Plans under which awards made in 2009 continued
| ||||
Plan name | Executive Directors eligible? |
Description | ||
Long Term Cash Plan (LTCP) | No | The LTCP is a forward-looking plan introduced for 2009, under which conditional awards of cash are made to eligible employees (excluding executive Directors). Awards are released in portions over a period of time (two years for 2009 awards), subject to continued employment. At the time of the final release, for 2009 awards, a service credit (10% of the initial value of the award) is added. Participants must normally be in employment at the time of release in order to receive each portion of the payment. Participants who leave employment before the release date of any portion of the award will normally forfeit any outstanding amounts. For categories of eligible leavers an award will vest, pro rated for time in service. On a change of control awards may vest at the discretion of the Committee.
| ||
Sharesave | Yes | Sharesave was approved for a ten-year period in 2000 and is due to expire at the end of 2010. Shareholder approval will be sought at the AGM to establish a replacement scheme on substantially the same terms. Sharesave is a share option plan under which all eligible employees in the UK, Ireland and Spain (including executive Directors) are invited to participate. It is HMRC approved in the UK and approved by the Revenue Commissioners in Ireland. Participants are granted options over Barclays PLC shares which may be at a discount to the market value at the date of award (currently 20%). At the expiry of a fixed term (three, five or seven years) participants may use savings to acquire the shares by exercising their option within 6 months of the date of vesting. Participants may save up to £250 per month (¤500 in Ireland, ¤135 in Spain) for this purpose. On cessation of employment eligible leavers (as defined) may exercise their option to acquire shares to the extent of their savings for a period of 6 months. On a change of control, participants may be able to exercise their options to acquire shares to the extent of their savings for a period of 6 months (or a shorter period in certain circumstances).
| ||
Sharepurchase | Yes | Sharepurchase is an HMRC approved share incentive plan under which all employees in the UK (including executive Directors) are invited to participate. Participants may purchase up to £1,500 of shares each tax year. To encourage employee share ownership, Barclays matches the first £600 of shares purchased by participants on a one-for-one basis. Dividends are also earned in the form of additional shares. Purchased shares may be withdrawn from the plan at any time. Matching and dividend shares must be held in trust for three years before release, but may be kept in trust for five years. On cessation of employment participants must withdraw all shares and depending on the reason for and timing of cessation, the matching shares may be forfeited. On a change of control, participants are able to instruct the Sharepurchase trustee how to act or vote on their behalf. The plan was approved by shareholders in April 2000.
| ||
Global Sharepurchase | Yes | Global Sharepurchase is an extension of the Sharepurchase plan that is offered to employees in the UK. When the Sharepurchase plan was approved by shareholders in April 2000, the approval included the option of extending the plan to other jurisdictions. Employees in certain jurisdictions are invited under the terms of the Global Sharepurchase plan to purchase shares in Barclays PLC, which attract a matching share award awarded by Barclays (up to a cap) and associated dividend shares. Global Sharepurchase operates in substantially the same way as Sharepurchase.
|
160 |
Corporate governance
Remuneration report
continued
Share and long-term incentive plans continued
Table 21: New plans under which awards to be made in 2010 | ||||
Plan name | Executive Directors eligible? |
Description | ||
Share Value Plan (SVP) | No | The SVP is a new share incentive plan to be introduced for 2010. Share awards in 2010 will be discretionary awards that may be made to selected employees (excluding executive Directors), subject to trustee discretion. Awards vest in three annual instalments over three years, subject to continued employment and the discretion of the trustee. Dividends received are normally awarded as additional shares and released at the same time. Vesting of the awards may be reduced (to nil if appropriate) on occurrence of certain events (e.g. where the Companys accounts have been materially restated at any time during the vesting period). Participants who leave employment voluntarily or are dismissed for gross misconduct before the release date of any instalment will normally forfeit any outstanding awards. For categories of eligible leavers awards will vest. On a change of control awards may vest subject to the discretion of the Committee and the trustee. The SVP is not an HMRC approved plan. | ||
Cash Value Plan (CVP) | No | The CVP is a new cash incentive plan to be introduced for 2010. Discretionary awards of cash are made to eligible employees (excluding executive Directors). The CVP operates in substantially the same way as the SVP with the intention that 2010 awards are paid in three annual instalments over a three-year period, at the discretion of the Companys Cash Plans Committee. In addition to cash awards, participants may be awarded a service credit (10% of the initial value of the award) to be paid at the same time as the final instalment of their award, subject to continued employment in the Group. Similar leaver and change of control provisions apply under the CVP as for the SVP. |
161 |
Share and long-term incentive plans continued
Table 22: Plans under which awards not made in 2009 | ||||
Plan name | Executive Directors eligible? |
Description | ||
ISOP (Incentive Share Option Plan) | Yes | The Incentive Share Option Plan is a share option plan under which share options were granted to selected employees (including executive Directors). No options have been granted since 2004. ISOP contains HMRC approved and unapproved parts. Options were awarded at the market price at the date of grant calculated in accordance with the rules of the plan. Options granted had an EP threshold and a TSR performance condition associated with them. Options were normally exercisable between three and ten years of the grant date. All options granted which met these performance criteria have now vested and are exercisable. On cessation of employment eligible leavers (as defined) normally are able to exercise their options; for other leavers, options normally lapse. On a change of control options would remain exercisable for a specified period. The plan was approved for a ten year period by shareholders in April 2000.
| ||
ESOS (Executive Share Option Scheme) | n/a | The Executive Share Option Scheme is a share option plan under which share options were granted to selected employees (including executive Directors). No options have been granted since 2000. Options were awarded at the market price at the date of grant calculated in accordance with the rules of the plan. Options were normally exercisable between three and ten years of the grant date. All options are now vested. On cessation of employment eligible leavers (as defined) normally are able to exercise their option pro-rated for performance; for other leavers, options normally lapse. On a change of control options remain exercisable for a specified period. The plan was adopted for a ten year period by shareholders in 1990.
| ||
BGI EOP (BGI Equity Ownership Plan) |
No | The BGI Equity Ownership Plan (BGI EOP) was approved by shareholders at Barclays 2000 AGM to provide the employee share incentive arrangements required to recruit and retain senior management. Under the terms of the BGI EOP, options were granted at fair value to key BGI employees over shares in Barclays Global Investors UK Holdings Limited (BGI Holdings) within an overall cap of 20% of the issued ordinary share capital of BGI Holdings. Employees who were executive Directors of Barclays PLC at the date of grant were not eligible to receive options under the BGI EOP. Following completion of the sale of BGI on 1st December 2009, the BGI EOP was terminated on 16th December 2009, in accordance with the rules of the plan. Under the terms of EOP participants were able to exercise their outstanding options in full. Participants were then able to sell their newly acquired and existing BGI Holdings shares to Barclays Bank PLC. In accordance with the terms of EOP, the price per BGI Holdings share was determined to be £109.45. As part of the termination of EOP, participants exercised outstanding options to purchase 6.4 million shares and the Group repurchased all participants holdings totalling 10.2 million shares for a net consideration of £542m, after deducting aggregate option exercise costs of £571m.
BGI EOP Accounting and disclosure The BGI EOP is accounted for as an equity settled share-based payment in accordance with IFRS 2 Share-based Payment. The fair value of the services received from the employees is measured by reference to the fair value of the share options granted on the date of the grant. The cost of the employee services received in respect of the share options granted is recognised in the income statement over the period that the services are received. In accordance with IFRS 2, details of share options granted and exercised, together with weighted average fair values at grant date and weighted average exercise prices are set out in Note 44 to the accounts. In accordance with IAS 33 Earnings per Share, unexercised options are taken into account in the calculation of diluted earnings per share as set out in Note 11 to the accounts. For Group reporting, participants shareholdings are treated as non controlling interests and goodwill has been previously recognised as a result of the purchase of shares offered for sale by employees. The related goodwill and non-controlling interests relating to the scheme are included in Notes 21 and 33 to the accounts respectively. Following completion of the sale of BGI, the BGI EOP was terminated. The cost of terminating the plan has been included as a cost of disposal in Note 38 to the accounts.
| ||
BGI Equity Participation Plan | No | The BGI Equity Participation Plan was a share plan linked to the value of BGI shares intended for selected BGI employees (in the form of stock appreciation rights settled in shares of restricted share awards). No awards have been or will be made under the plan as BGI has now been sold from the Group.
|
162 |
Corporate governance
163 |
165 |
166 |
Independent Registered Public Accounting Firms report
167 |
Consolidated accounts Barclays PLC
168 |
Consolidated accounts Barclays PLC
Accounting policies
continued
169 |
170 |
Consolidated accounts Barclays PLC
Accounting policies
continued
171 |
172 |
Consolidated accounts Barclays PLC
Accounting policies
continued
173 |
174 |
Consolidated accounts Barclays PLC
Accounting policies
continued
175 |
176 |
Consolidated accounts Barclays PLC
Accounting policies
continued
177 |
Consolidated accounts Barclays PLC
Accounting developments
178 |
Consolidated accounts Barclays PLC
Consolidated income statement
For the year ended 31st December
Notes | 2009 £m |
2008 £m |
2007 £m |
||||||||
Continuing operations |
|||||||||||
Interest income |
2 | 21,236 | 28,010 | 25,296 | |||||||
Interest expense |
2 | (9,318 | ) | (16,541 | ) | (15,698 | ) | ||||
Net interest income |
11,918 | 11,469 | 9,598 | ||||||||
Fee and commission income |
3 | 9,946 | 7,573 | 6,741 | |||||||
Fee and commission expense |
3 | (1,528 | ) | (1,082 | ) | (970 | ) | ||||
Net fee and commission income |
8,418 | 6,491 | 5,771 | ||||||||
Net trading income |
4 | 7,001 | 1,339 | 3,754 | |||||||
Net investment income |
4 | 56 | 680 | 1,216 | |||||||
Principal transactions |
7,057 | 2,019 | 4,970 | ||||||||
Net premiums from insurance contracts |
5 | 1,172 | 1,090 | 1,011 | |||||||
Other income |
6 | 1,389 | 367 | 186 | |||||||
Total income |
29,954 | 21,436 | 21,536 | ||||||||
Net claims and benefits incurred on insurance contracts |
5 | (831 | ) | (237 | ) | (492 | ) | ||||
Total income net of insurance claims |
29,123 | 21,199 | 21,044 | ||||||||
Impairment charges and other credit provisions |
7 | (8,071 | ) | (5,419 | ) | (2,795 | ) | ||||
Net income |
21,052 | 15,780 | 18,249 | ||||||||
Staff costs |
8 | (9,948 | ) | (7,204 | ) | (7,611 | ) | ||||
Administration and general expenses |
9 | (5,561 | ) | (5,305 | ) | (3,854 | ) | ||||
Depreciation of property, plant and equipment |
23 | (759 | ) | (606 | ) | (453 | ) | ||||
Amortisation of intangible assets |
22 | (447 | ) | (276 | ) | (178 | ) | ||||
Operating expenses |
(16,715 | ) | (13,391 | ) | (12,096 | ) | |||||
Share of post-tax results of associates and joint ventures |
20 | 34 | 14 | 42 | |||||||
Profit on disposal of subsidiaries, associates and joint ventures |
38 | 188 | 327 | 28 | |||||||
Gains on acquisitions |
40 | 26 | 2,406 | | |||||||
Profit before tax |
4,585 | 5,136 | 6,223 | ||||||||
Tax |
10 | (1,074 | ) | (453 | ) | (1,699 | ) | ||||
Profit after tax from continuing operations |
3,511 | 4,683 | 4,524 | ||||||||
Discontinued operations |
|||||||||||
Profit after tax for the year from discontinued operations, including gain on disposal |
39 | 6,777 | 604 | 571 | |||||||
Net profit for the year |
10,288 | 5,287 | 5,095 | ||||||||
Profit attributable to equity holders of the Parent from: |
|||||||||||
Continuing operations |
2,628 | 3,795 | 3,886 | ||||||||
Discontinued operations |
6,765 | 587 | 531 | ||||||||
Total |
9,393 | 4,382 | 4,417 | ||||||||
Profit attributable to non-controlling interests |
33 | 895 | 905 | 678 | |||||||
10,288 | 5,287 | 5,095 | |||||||||
p | p | p | |||||||||
Earnings per share |
|||||||||||
Basic earnings per share |
11 | 86.2 | 59.3 | 68.9 | |||||||
Basic earnings per share continuing operations |
24.1 | 51.4 | 60.6 | ||||||||
Basic earnings per share discontinued operations |
62.1 | 7.9 | 8.3 | ||||||||
Diluted earnings per share |
11 | 81.6 | 57.5 | 66.9 | |||||||
Diluted earnings per share continuing operations |
22.7 | 49.8 | 58.8 | ||||||||
Diluted earnings per share discontinued operations |
58.9 | 7.7 | 8.1 | ||||||||
Interim dividend per ordinary share |
1.0 | 11.5 | 11.50 | ||||||||
Final dividend per ordinary share |
1 | 1.5 | | 22.50 | |||||||
£m | £m | £m | |||||||||
Interim dividend paid |
113 | 906 | 768 | ||||||||
Final dividend |
1 | 176 | | 1,485 |
The Board of Directors approved the accounts set out on pages 167 to 282 on 9th March 2010.
The accompanying notes form an integral part of the Consolidated accounts.
179 |
Consolidated accounts Barclays PLC
Consolidated statement of comprehensive income
For the year ended 31st December
2009 £m |
2008 £m |
2007 £m | ||||||
Net profit for the year |
10,288 | 5,287 | 5,095 | |||||
Other comprehensive income: |
||||||||
Continuing operations |
||||||||
Currency translation differences |
(861 | ) | 2,274 | 43 | ||||
Available for sale financial assets |
1,236 | (1,561 | ) | 1 | ||||
Cash flow hedges |
165 | 376 | 359 | |||||
Other |
| (5 | ) | 22 | ||||
Tax relating to components of other comprehensive income |
(26 | ) | 851 | 40 | ||||
Other comprehensive income for the year, net of tax, from continuing operations |
514 | 1,935 | 465 | |||||
Other comprehensive income for the year, net of tax, from discontinued operations |
(58 | ) | 114 | 26 | ||||
Total comprehensive income for the year |
10,744 | 7,336 | 5,586 | |||||
Attributable to: |
||||||||
Equity holders of the Parent |
9,556 | 6,213 | 4,854 | |||||
Non-controlling interests |
1,188 | 1,123 | 732 | |||||
10,744 | 7,336 | 5,586 |
Income tax relating to each component of other comprehensive income is disclosed in Note 10.
180 |
Consolidated accounts Barclays PLC
Consolidated balance sheet
As at 31st December
Notes | 2009 £m |
2008 £m |
||||||
Assets |
||||||||
Cash and balances at central banks |
81,483 | 30,019 | ||||||
Items in the course of collection from other banks |
1,593 | 1,695 | ||||||
Trading portfolio assets |
12 | 151,344 | 185,637 | |||||
Financial assets designated at fair value: |
||||||||
held on own account |
13 | 41,311 | 54,542 | |||||
held in respect of linked liabilities to customers under investment contracts |
13 | 1,257 | 66,657 | |||||
Derivative financial instruments |
14 | 416,815 | 984,802 | |||||
Loans and advances to banks |
15 | 41,135 | 47,707 | |||||
Loans and advances to customers |
15 | 420,224 | 461,815 | |||||
Available for sale financial investments |
16 | 56,483 | 64,976 | |||||
Reverse repurchase agreements and cash collateral on securities borrowed |
17 | 143,431 | 130,354 | |||||
Other assets |
18 | 6,358 | 6,302 | |||||
Current tax assets |
349 | 389 | ||||||
Investments in associates and joint ventures |
20 | 422 | 341 | |||||
Goodwill |
21 | 6,232 | 7,625 | |||||
Intangible assets |
22 | 2,563 | 2,777 | |||||
Property, plant and equipment |
23 | 5,626 | 4,674 | |||||
Deferred tax assets |
19 | 2,303 | 2,668 | |||||
Total assets |
1,378,929 | 2,052,980 | ||||||
Liabilities |
||||||||
Deposits from banks |
76,446 | 114,910 | ||||||
Items in the course of collection due to other banks |
1,466 | 1,635 | ||||||
Customer accounts |
322,429 | 335,505 | ||||||
Trading portfolio liabilities |
12 | 51,252 | 59,474 | |||||
Financial liabilities designated at fair value |
24 | 86,202 | 76,892 | |||||
Liabilities to customers under investment contracts |
13 | 1,679 | 69,183 | |||||
Derivative financial instruments |
14 | 403,416 | 968,072 | |||||
Debt securities in issue |
135,902 | 149,567 | ||||||
Repurchase agreements and cash collateral on securities lent |
17 | 198,781 | 182,285 | |||||
Other liabilities |
25 | 12,101 | 12,640 | |||||
Current tax liabilities |
992 | 1,216 | ||||||
Insurance contract liabilities, including unit-linked liabilities |
26 | 2,140 | 2,152 | |||||
Subordinated liabilities |
27 | 25,816 | 29,842 | |||||
Deferred tax liabilities |
19 | 470 | 304 | |||||
Provisions |
28 | 590 | 535 | |||||
Retirement benefit liabilities |
30 | 769 | 1,357 | |||||
Total liabilities |
1,320,451 | 2,005,569 | ||||||
Shareholders equity |
||||||||
Called up share capital |
31 | 2,853 | 2,093 | |||||
Share premium account |
31 | 7,951 | 4,045 | |||||
Other equity |
31 | | 3,652 | |||||
Other reserves |
32 | 2,768 | 2,793 | |||||
Retained earnings |
32 | 33,845 | 24,208 | |||||
Less: treasury shares |
32 | (140 | ) | (173 | ) | |||
Shareholders equity excluding non-controlling interests |
47,277 | 36,618 | ||||||
Non-controlling interests |
33 | 11,201 | 10,793 | |||||
Total shareholders equity |
58,478 | 47,411 | ||||||
Total liabilities and shareholders equity |
1,378,929 | 2,052,980 |
The accompanying notes form an integral part of the Consolidated accounts.
Marcus Agius
Group Chairman
John Varley
Group Chief Executive
Chris Lucas
Group Finance Director
181 |
Consolidated accounts Barclays PLC
Consolidated statement of changes in equity
Notes |
Share capital and share premium a £m |
Other Reserves b £m |
Retained earnings c £m |
Total £m |
Non- controlling interests d £m |
Total equity £m |
||||||||||||||
Balance at 1st January 2009 |
6,138 | 6,272 | 24,208 | 36,618 | 10,793 | 47,411 | ||||||||||||||
Net profit for the year |
| | 9,393 | 9,393 | 895 | 10,288 | ||||||||||||||
Other comprehensive income: |
||||||||||||||||||||
Currency translation differences |
| (1,138 | ) | | (1,138 | ) | 277 | (861 | ) | |||||||||||
Available for sale financial assets |
| 1,250 | | 1,250 | (14 | ) | 1,236 | |||||||||||||
Cash flow hedges |
| 194 | | 194 | (29 | ) | 165 | |||||||||||||
Tax relating to components of other comprehensive income |
| (256 | ) | 171 | (85 | ) | 59 | (26 | ) | |||||||||||
Other comprehensive income net of tax from discontinued operations |
| (75 | ) | 17 | (58 | ) | | (58 | ) | |||||||||||
Total comprehensive income |
| (25 | ) | 9,581 | 9,556 | 1,188 | 10,744 | |||||||||||||
Issue of new ordinary shares |
749 | | | 749 | | 749 | ||||||||||||||
Issue of shares under employee share schemes |
35 | | 298 | 333 | | 333 | ||||||||||||||
Net purchase of treasury shares |
| (47 | ) | | (47 | ) | | (47 | ) | |||||||||||
Transfers |
| 80 | (80 | ) | | | | |||||||||||||
Dividends |
1 | | | (113 | ) | (113 | ) | (767 | ) | (880 | ) | |||||||||
Net decrease in non-controlling interest arising on acquisitions, disposals and capital issuances |
| | | | (82 | ) | (82 | ) | ||||||||||||
Conversion of Mandatorily Convertible Notes |
3,882 | (3,652 | ) | (230 | ) | | | | ||||||||||||
Other |
| | 181 | 181 | 69 | 250 | ||||||||||||||
Balance at 31st December 2009 |
10,804 | 2,628 | 33,845 | 47,277 | 11,201 | 58,478 | ||||||||||||||
Balance at 1st January 2008 |
1,707 | 614 | 20,970 | 23,291 | 9,185 | 32,476 | ||||||||||||||
Net profit for the year |
| | 4,382 | 4,382 | 905 | 5,287 | ||||||||||||||
Other comprehensive income: |
||||||||||||||||||||
Currency translation differences |
| 2,174 | | 2,174 | 100 | 2,274 | ||||||||||||||
Available for sale financial assets |
| (1,559 | ) | | (1,559 | ) | (2 | ) | (1,561 | ) | ||||||||||
Cash flow hedges |
| 271 | | 271 | 105 | 376 | ||||||||||||||
Tax relating to components of other comprehensive income |
| 882 | (46 | ) | 836 | 15 | 851 | |||||||||||||
Other |
| | (5 | ) | (5 | ) | | (5 | ) | |||||||||||
Other comprehensive income net of tax from discontinued operations |
| 124 | (10 | ) | 114 | | 114 | |||||||||||||
Total comprehensive income |
| 1,892 | 4,321 | 6,213 | 1,123 | 7,336 | ||||||||||||||
Issue of new ordinary shares |
4,422 | | | 4,422 | | 4,422 | ||||||||||||||
Issue of shares under employee share schemes |
19 | | 463 | 482 | | 482 | ||||||||||||||
Issue of shares and warrants |
| | 1,410 | 1,410 | | 1,410 | ||||||||||||||
Repurchase of shares |
(10 | ) | 10 | (173 | ) | (173 | ) | | (173 | ) | ||||||||||
Net purchase of treasury shares |
| (350 | ) | | (350 | ) | | (350 | ) | |||||||||||
Transfers |
| 437 | (437 | ) | | | | |||||||||||||
Dividends |
| | (2,344 | ) | (2,344 | ) | (703 | ) | (3,047 | ) | ||||||||||
Net increase in non-controlling interest arising on acquisitions, disposals and capital issuances |
| | | | 1,338 | 1,338 | ||||||||||||||
Issue of Mandatorily Convertible Notes |
| 3,652 | | 3,652 | | 3,652 | ||||||||||||||
Other |
| 17 | (2 | ) | 15 | (150 | ) | (135 | ) | |||||||||||
Balance at 31st December 2008 |
6,138 | 6,272 | 24,208 | 36,618 | 10,793 | 47,411 |
Notes
a | Details of share capital and share premium are shown in Note 31. |
b | Details of other reserves are shown in Note 32. Other reserves above includes treasury shares. |
c | Details of retained earnings and treasury shares are shown in Note 32. |
d | Details of non-controlling interests are shown in Note 33. |
182 |
Consolidated accounts Barclays PLC
Consolidated cash flow statement
For the year ended 31st December
2009 £m |
2008 £m |
2007 £m |
|||||||||||
Continuing operations |
|||||||||||||
Reconciliation of profit before tax to net cash flows from operating activities: |
|||||||||||||
Profit before tax |
4,585 | 5,136 | 6,223 | ||||||||||
Adjustment for non-cash items: |
|||||||||||||
Allowance for impairment |
8,071 | 5,419 | 2,795 | ||||||||||
Depreciation, amortisation and impairment of property, plant, equipment and intangibles |
1,196 | 885 | 651 | ||||||||||
Other provisions, including pensions |
428 | 804 | 753 | ||||||||||
Net profit from associates and joint ventures |
(34 | ) | (14 | ) | (42 | ) | |||||||
Net profit on disposal of investments and property, plant and equipment |
(383 | ) | (371 | ) | (862 | ) | |||||||
Net profit from disposal of associates and joint ventures |
3 | | (26 | ) | |||||||||
Net profit from disposal of subsidiaries |
(191 | ) | (327 | ) | (2 | ) | |||||||
Net gains on acquisitions |
(26 | ) | (2,406 | ) | | ||||||||
Other non-cash movements a |
4,573 | 960 | (1,181 | ) | |||||||||
Changes in operating assets and liabilities: |
|||||||||||||
Net decrease/(increase) in loans and advances to banks and customers |
25,482 | (58,431 | ) | (77,987 | ) | ||||||||
Net (decrease)/increase in deposits and debt securities in issue |
(49,203 | ) | 77,743 | 90,589 | |||||||||
Net decrease/(increase) in derivative financial instruments |
3,321 | (17,529 | ) | (2,144 | ) | ||||||||
Net decrease/(increase) in trading assets |
34,334 | 26,919 | (18,227 | ) | |||||||||
Net decrease in trading liabilities |
(8,222 | ) | (5,928 | ) | (6,472 | ) | |||||||
Net increase/(decrease) in financial investments |
20,459 | 5,229 | (4,379 | ) | |||||||||
Net (increase)/decrease in other assets |
(465 | ) | (3,016 | ) | 1,116 | ||||||||
Net decrease in other liabilities |
(907 | ) | (477 | ) | (1,071 | ) | |||||||
Tax paid |
(1,177 | ) | (1,404 | ) | (1,254 | ) | |||||||
Net cash from operating activities |
41,844 | 33,192 | (11,520 | ) | |||||||||
Purchase of available for sale investments |
(78,420 | ) | (57,756 | ) | (26,899 | ) | |||||||
Proceeds from sale or redemption of available for sale investments |
88,559 | 51,429 | 38,423 | ||||||||||
Net addition of intangible assets |
(226 | ) | (666 | ) | (227 | ) | |||||||
Purchase of property, plant and equipment |
(1,150 | ) | (1,643 | ) | (1,182 | ) | |||||||
Proceeds from sale of property, plant and equipment |
372 | 799 | 617 | ||||||||||
Acquisitions of subsidiaries, net of cash acquired |
(28 | ) | (961 | ) | (270 | ) | |||||||
Disposal of subsidiaries, net of cash disposed |
339 | 238 | 383 | ||||||||||
Disposal of discontinued operation, net of cash disposed |
2,469 | | | ||||||||||
Increase in investment in subsidiaries |
| (157 | ) | (668 | ) | ||||||||
Decrease in investment in subsidiaries |
| 19 | 57 | ||||||||||
Acquisition of associates and joint ventures |
(81 | ) | (96 | ) | (220 | ) | |||||||
Disposal of associates and joint ventures |
69 | 137 | 145 | ||||||||||
Other cash flows associated with investing activities |
(15 | ) | (5 | ) | 153 | ||||||||
Net cash from investing activities |
11,888 | (8,662 | ) | 10,312 | |||||||||
Dividends paid |
(633 | ) | (2,697 | ) | (2,151 | ) | |||||||
Proceeds of borrowings and issuance of debt securities |
3,549 | 5,763 | 4,646 | ||||||||||
Repayments of borrowings and redemption of debt securities |
(4,383 | ) | (1,207 | ) | (683 | ) | |||||||
Net issue of shares and other equity instruments |
773 | 9,505 | 2,494 | ||||||||||
Repurchase of shares and other equity instruments |
| (173 | ) | (1,802 | ) | ||||||||
Net disposal/(purchase) of treasury shares |
33 | 87 | (48 | ) | |||||||||
Net issue of shares to non-controlling interests |
| 1,356 | 1,331 | ||||||||||
Net cash from financing activities |
(661 | ) | 12,634 | 3,787 | |||||||||
Effect of exchange rates on cash and cash equivalents |
(2,864 | ) | (6,018 | ) | (537 | ) | |||||||
Net cash from discontinued operations |
(376 | ) | 286 | 83 | |||||||||
Net increase in cash and cash equivalents |
49,831 | 31,432 | 2,125 | ||||||||||
Cash and cash equivalents at beginning of year |
64,509 | 33,077 | 30,952 | ||||||||||
Cash and cash equivalents at end of year |
114, 340 | 64,509 | 33,077 | ||||||||||
Cash and cash equivalents comprise: |
|||||||||||||
Cash and balances at central banks |
81,483 | 30,019 | 5,801 | ||||||||||
Loans and advances to banks |
41,135 | 47,707 | 40,120 | ||||||||||
Less: non-cash and amounts with original maturity greater than three months |
(10,674 | ) | (15,428 | ) | (19,377 | ) | |||||||
30,461 | 32,279 | 20,743 | |||||||||||
Available for sale treasury and other eligible bills |
56,483 | 64,976 | 43,072 | ||||||||||
Less: non-cash and amounts with original maturity greater than three months |
(54,239 | ) | (62,876 | ) | (41,688 | ) | |||||||
2,244 | 2,100 | 1,384 | |||||||||||
Trading portfolio assets |
151,344 | 185,637 | 193,691 | ||||||||||
Less: non-cash and amounts with original maturity greater than three months |
(151,192 | ) | (185,526 | ) | (188,556 | ) | |||||||
152 | 111 | 5,135 | |||||||||||
Other |
| | 14 | ||||||||||
114,340 | 64,509 | 33,077 |
Interest received in 2009 was £32,437m (2008: £41,017m, 2007: £49,441m) and interest paid in 2009 was £20,889m (2008: £38,975m, 2007: £37,821m). The Group is required to maintain balances with central banks and other regulatory authorities and these amounted to £2,470m at 31st December 2009 (2008: £1,050m).
Note
a | Other non-cash movements principally comprise movements in exchange rates and the fair value of available for sale investments less subordinated debt hedging. |
183 |
Parent company accounts
Income statement For the year ended 31st December
|
2009 £m |
2008 £m |
2007 £m |
||||||
Dividends received from subsidiary |
103 | 1,173 | 3,287 | ||||||
Interest income |
53 | 7 | 4 | ||||||
Trading gain/(loss) |
| 18 | (13 | ) | |||||
Other income |
| | 15 | ||||||
Management charge from subsidiary |
(4 | ) | (4 | ) | (4 | ) | |||
Profit before tax |
152 | 1,194 | 3,289 | ||||||
Tax |
(27 | ) | (1 | ) | | ||||
Profit after tax |
125 | 1,193 | 3,289 |
The Company had no staff during the year (2008: nil, 2007: nil).
Profit after tax and total comprehensive income for the year was £125m (2008: £1,193m, 2007: £3,289m). There were no other components of total comprehensive income other than the net profit for the year.
Balance sheet As at 31st December
|
Notes | 2009 £m |
2008 £m | |||
Assets |
||||||
Non-current assets |
||||||
Investment in subsidiaries |
41 | 20,215 | 15,340 | |||
Current assets |
||||||
Cash and balances at central banks |
1 | | ||||
Other assets |
26 | 3,851 | ||||
Total assets |
20,242 | 19,191 | ||||
Liabilities |
||||||
Current liabilities |
||||||
Amounts payable within one year |
28 | 1 | ||||
Shareholders equity |
||||||
Called up share capital |
31 | 2,853 | 2,093 | |||
Share premium account |
31 | 7,951 | 4,045 | |||
Other equity |
31 | | 3,652 | |||
Capital redemption reserve |
32 | 394 | 394 | |||
Retained earnings |
32 | 9,016 | 9,006 | |||
Total shareholders equity |
20,214 | 19,190 | ||||
Total liabilities and shareholders equity |
20,242 | 19,191 |
The accompanying notes form an integral part of the accounts.
Marcus Agius
Group Chairman
John Varley
Group Chief Executive
Chris Lucas
Group Finance Director
184 |
Accounts of Barclays PLC
Parent company accounts
continued
Statement of changes in equity | Notes | Share capital and share premium a £m |
Other reserves b £m |
Retained earnings c £m |
Total equity £m |
|||||||||
Balance at 1st January 2009 |
6,138 | 4,046 | 9,006 | 19,190 | ||||||||||
Total comprehensive income: |
||||||||||||||
Net profit for the year and total comprehensive income |
| | 125 | 125 | ||||||||||
Issue of new ordinary shares |
749 | | | 749 | ||||||||||
Issue of shares under employee share schemes |
35 | | | 35 | ||||||||||
Issue of warrants |
| | | | ||||||||||
Mandatorily Convertible Notes issued |
3,882 | (3,652 | ) | (230 | ) | | ||||||||
Repurchase of shares |
| | | | ||||||||||
Dividends |
1 | | | (113 | ) | (113 | ) | |||||||
Other |
| | 228 | 228 | ||||||||||
Balance at 31st December 2009 |
10,804 | 394 | 9,016 | 20,214 | ||||||||||
Balance at 1st January 2008 |
1,707 | 384 | 8,990 | 11,081 | ||||||||||
Total comprehensive income: |
||||||||||||||
Net profit for the year and total comprehensive income |
| | 1,193 | 1,193 | ||||||||||
Issue of new ordinary shares |
4,422 | | 634 | 5,056 | ||||||||||
Issue of shares under employee share schemes |
19 | | | 19 | ||||||||||
Issue of warrants |
| | 776 | 776 | ||||||||||
Mandatorily Convertible Notes issued |
| 3,652 | | 3,652 | ||||||||||
Repurchase of shares |
(10 | ) | 10 | (173 | ) | (173 | ) | |||||||
Dividends |
| | (2,414 | ) | (2,414 | ) | ||||||||
Other |
| | | | ||||||||||
Balance at 31st December 2008 |
6,138 | 4,046 | 9,006 | 19,190 |
In 2009 and 2008 there were no other components of total comprehensive income other than the net profit for the year.
Notes
a | Details of share capital and share premium are shown in Note 31. |
b | Details of other reserves are shown in Note 32. |
c | Details of retained earnings are shown in Note 32. |
185 |
Cash flow statement For the year ended 31st December
|
2009 £m |
2008 £m |
2007 £m |
||||||
Reconciliation of profit before tax to net cash flows from operating activities: |
|||||||||
Profit before tax |
152 | 1,194 | 3,289 | ||||||
Changes in operating assets and liabilities: |
|||||||||
Net decrease/(increase) in other assets |
2 | (16 | ) | (3 | ) | ||||
Net increase/(decrease) in other liabilities |
1 | | (3 | ) | |||||
Net cash from operating activities |
155 | 1,178 | 3,283 | ||||||
Capital contribution to subsidiaries |
(800 | ) | (4,362 | ) | (1,434 | ) | |||
Purchase of shares in subsidiaries |
(25 | ) | (16 | ) | (316 | ) | |||
Liquidation of subsidiary |
| 205 | | ||||||
Net cash used in investing activities |
(825 | ) | (4,173 | ) | (1,750 | ) | |||
Issue of shares and other equity instruments |
784 | 4,911 | 2,494 | ||||||
Dividends paid |
(113 | ) | (2,414 | ) | (2,129 | ) | |||
Repurchase of ordinary shares |
| (173 | ) | (1,802 | ) | ||||
Net cash from financing activities |
671 | 2,324 | (1,437 | ) | |||||
Net increase/(decrease) in cash and cash equivalents |
1 | (671 | ) | 96 | |||||
Cash and cash equivalents at beginning of year |
| 671 | 575 | ||||||
Cash and cash equivalents at end of year |
1 | | 671 | ||||||
Cash and cash equivalents comprise: |
|||||||||
Cash and balances at central banks |
1 | | 671 | ||||||
Net cash from operating activities includes: |
|||||||||
Dividends received |
103 | 1,173 | 3,287 | ||||||
Interest received |
53 | 7 | 4 |
The Parent Companys principal activity is to hold the investment in its wholly-owned subsidiary, Barclays Bank PLC. Dividends received are treated as operating income.
The Company was not exposed at 31st December 2009 or 2008 to significant risks arising from the financial instruments it holds; which comprised cash, balances with central banks and other assets which had no credit or market risk.
Non-cash transactions
During 2008 Barclays Bank PLC issued £4,050m of Mandatorily Convertible Notes (MCNs), which had mandatorily converted into ordinary shares of Barclays PLC by 30th June 2009. Barclays PLCs right to receive the MCNs was included in other assets in 2008, with a corresponding increase, net of issue costs, in other equity. In 2009, Barclays PLC waived its rights over the MCNs, which have been added to its cost of investment in its subsidiary.
The accompanying notes form an integral part of the accounts.
186 |
For the year ended 31st December 2009
1 Dividends per share
The Directors have recommended the final dividend in respect of 2009 of 1.5p per ordinary share of 25p each, amounting to a total of £176m, which will be paid on 19th March 2010. The financial statements for the year ended 31st December 2009 do not reflect these dividends, which will be accounted for in shareholders equity as an appropriation of retained profits in the year ending 31st December 2010. The financial statements to 31st December 2009 include the 2009 interim dividend of £113m.
2 Net interest income
Interest arising from: | 2009 £m |
2008 £m |
2007 £m |
||||||
Cash and balances with central banks |
131 | 174 | 145 | ||||||
Available for sale investments |
1,937 | 2,355 | 2,580 | ||||||
Loans and advances to banks |
513 | 1,267 | 1,416 | ||||||
Loans and advances to customers |
18,456 | 23,754 | 19,559 | ||||||
Other interest income |
199 | 460 | 1,596 | ||||||
Interest income |
21,236 | 28,010 | 25,296 | ||||||
Deposits from banks |
(634 | ) | (2,189 | ) | (2,720 | ) | |||
Customer accounts |
(2,716 | ) | (6,697 | ) | (4,110 | ) | |||
Debt securities in issue |
(3,889 | ) | (5,910 | ) | (6,651 | ) | |||
Subordinated liabilities |
(1,718 | ) | (1,349 | ) | (878 | ) | |||
Other interest expense |
(361 | ) | (396 | ) | (1,339 | ) | |||
Interest expense |
(9,318 | ) | (16,541 | ) | (15,698 | ) | |||
Net interest income |
11,918 | 11,469 | 9,598 |
Interest income includes £185m (2008: £135m, 2007: £113m) arising from impaired loans.
Other interest income principally includes interest income relating to reverse repurchase agreements. Similarly, other interest expense principally includes interest expense relating to repurchase agreements and hedging activity.
Included in net interest income is hedge ineffectiveness as detailed in Note 14.
3 Net fee and commission income
2009 £m |
2008 £m |
2007 £m |
|||||||
Fee and commission income |
|||||||||
Brokerage fees |
88 | 56 | 78 | ||||||
Investment management fees |
133 | 120 | 122 | ||||||
Banking and credit related fees and commissions |
9,578 | 7,208 | 6,363 | ||||||
Foreign exchange commissions |
147 | 189 | 178 | ||||||
Fee and commission income |
9,946 | 7,573 | 6,741 | ||||||
Fee and commission expense |
(1,528 | ) | (1,082 | ) | (970 | ) | |||
Net fee and commission income |
8,418 | 6,491 | 5,771 |
187 |
4 Principal transactions
2009 £m |
2008 £m |
2007 £m | |||||
Net trading income |
7,001 | 1,339 | 3,754 | ||||
Net gain from disposal of available for sale assets |
349 | 212 | 560 | ||||
Dividend income |
6 | 196 | 26 | ||||
Net (loss)/gain from financial instruments designated at fair value |
(208 | ) | 33 | 293 | |||
Other investment (losses)/income |
(91 | ) | 239 | 337 | |||
Net investment income |
56 | 680 | 1,216 | ||||
Principal transactions |
7,057 | 2,019 | 4,970 |
Net trading income includes the profits and losses arising both on the purchase and sale of trading instruments and from the revaluation to fair value, together with the interest income earned from these instruments and the related funding cost.
Net trading income included a £682m gain (2008: £1,272m, 2007: £640m) related to foreign exchange dealings.
The net loss on financial assets designated at fair value included within principal transactions was £2,557m (2008: £6,602m loss, 2007: £78m gain) of which losses of £2,349m (2008: £6,635m loss, 2007: £215m loss) were included in net trading income and losses of £208m (2008: £33m gain, 2007: £293m gain) were included within net investment income.
The net loss on financial liabilities designated at fair value included within principal transactions was £3,158m (2008: £3,328m gain, 2007: £231m loss) all of which was included within net trading income.
Net trading income includes the net loss from tightening credit spreads relating to Barclays Capital issued structured notes held at fair value of £1,820m (2008: £1,663m gain, 2007: £658m gain).
5 Insurance premiums and insurance claims and benefits
2009 £m |
2008 £m |
2007 £m |
|||||||
Gross premiums from insurance contracts |
1,224 | 1,138 | 1,062 | ||||||
Premiums ceded to reinsurers |
(52 | ) | (48 | ) | (51 | ) | |||
Net premiums from insurance contracts |
1,172 | 1,090 | 1,011 |
2009 £m |
2008 £m |
2007 £m |
|||||||
Gross claims and benefits incurred on insurance contracts |
858 | 263 | 520 | ||||||
Reinsurers share of claims incurred |
(27 | ) | (26 | ) | (28 | ) | |||
Net claims and benefits incurred on insurance contracts |
831 | 237 | 492 |
6 Other income
2009 £m |
2008 £m |
2007 £m |
|||||||
Increase/(decrease) in fair value of assets held in respect of linked liabilities to customers under investment contracts |
102 | (1,219 | ) | 23 | |||||
(Increase)/decrease in liabilities to customers under investment contracts |
(102 | ) | 1,219 | (23 | ) | ||||
Property rentals |
64 | 73 | 53 | ||||||
Gains on debt buy backs and extinguishments |
1,255 | 24 | | ||||||
Other |
70 | 270 | 133 | ||||||
Other income |
1,389 | 367 | 186 |
188 |
Notes to the accounts
For the year ended 31st December 2009
continued
7 Impairment charges and other credit provisions
2009 £m |
2008 £m |
2007 £m |
|||||||
Impairment charges on loans and advances |
|||||||||
New and increased impairment allowances |
8,111 | 5,116 | 2,871 | ||||||
Releases |
(631 | ) | (358 | ) | (338 | ) | |||
Recoveries |
(150 | ) | (174 | ) | (227 | ) | |||
Impairment charges on loans and advances |
7,330 | 4,584 | 2,306 | ||||||
Charge in respect of provision for undrawn contractually committed facilities and guarantees provided |
28 | 329 | 476 | ||||||
Impairment charges on loans and advances and other credit provisions |
7,358 | 4,913 | 2,782 | ||||||
Impairment charges on reverse repurchase agreements |
43 | 124 | | ||||||
Impairment on available for sale assets |
670 | 382 | 13 | ||||||
Impairment charges and other credit provisions |
8,071 | 5,419 | 2,795 |
An analysis of the impairment charges by class of financial instrument is included in Note 47.
8 Staff costs
2009 £m |
2008 £m |
2007 £m | |||||
Salaries and accrued incentive payments |
8,081 | 5,787 | 6,322 | ||||
Social security costs |
606 | 444 | 480 | ||||
Pension costs defined contribution plans |
224 | 221 | 119 | ||||
Pension costs defined benefit plans (Note 30) |
(33 | ) | 89 | 150 | |||
Other post-retirement benefits (Note 30) |
16 | 1 | 9 | ||||
Other |
1,054 | 662 | 531 | ||||
Staff costs |
9,948 | 7,204 | 7,611 |
Included in salaries and incentive payments is £290m (2008: £257m, 2007: £551m) arising from equity settled share-based payments, of which £56m (2008: £23m, 2007: £60m) is a charge related to option-based schemes and of which £12m (2008: £35m, 2007: £74m) relates to discontinued operations. Also included is £8m (2008: £3m, 2007: £8m) arising from cash settled share-based payments.
In December 2009, the UK government announced that the Finance Bill 2010 will introduce a bank payroll tax of 50% applicable to discretionary bonuses over £25,000 awarded to UK bank employees between 9th December 2009 and 5th April 2010. Draft legislation and further guidance on its application has been published. Based on this, and in accordance with IAS 19 Employee benefits, the Group has accrued for the estimated tax payable in respect of employee services provided during the period. For 2009, £190m has been included within Other Staff Costs in respect of 2009 cash awards. A further provision of £35m has also been included in Other Staff Costs in respect of certain prior year awards being distributed during the tax window, which may fall within the proposed legislation.
Staff costs above relate to continuing operations only. Total staff costs for the Group (including both continuing and discontinued operations) was
£10,683m (2008: £7,779m, 2007: £8,405m) comprising salaries and accrued incentive payments of £8,595m (2008: £6,273m, 2007: £6,993m), social security costs of £621m (2008: £464m, 2007: £508m), pension costs of £217m (2008: £326m, 2007: £291m), other post-retirement benefits of £19m (2008: £1m, 2007: £10m) and other staff costs of £1,231m (2008: £715m, 2007: £603m).
The total average number of persons employed by the Group (including both continuing and discontinued operations) during the year was 153,800 (2008: 151,500).
9 Administration and general expenses
2009 £m |
2008 £m |
2007 £m |
|||||||
Administrative expenses |
4,889 | 4,791 | 3,691 | ||||||
Impairment charges/(releases) |
|||||||||
property and equipment (Note 23) |
34 | 33 | 2 | ||||||
intangible assets (Note 22) |
27 | (3 | ) | 14 | |||||
goodwill (Note 21) |
1 | 112 | | ||||||
Operating lease rentals |
639 | 520 | 414 | ||||||
Gain on property disposals |
(29 | ) | (148 | ) | (267 | ) | |||
Administration and general expenses |
5,561 | 5,305 | 3,854 |
189 |
9 Administration and general expenses continued
Auditors remuneration
Notes | Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||||
2009 |
|||||||||||||
Audit of the Groups annual accounts |
12 | | | | 12 | ||||||||
Other services: |
|||||||||||||
Fees payable for the audit of the Companys associates pursuant to legislation |
a | ) | 23 | | | | 23 | ||||||
Other services supplied pursuant to such legislation |
b | ) | | 2 | | | 2 | ||||||
Other services relating to taxation |
c | ) | | | 7 | | 7 | ||||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Company or any of its associates |
d | ) | | | | 3 | 3 | ||||||
Other |
| 4 | | 1 | 5 | ||||||||
Total auditors remuneration |
35 | 6 | 7 | 4 | 52 | ||||||||
2008 |
|||||||||||||
Audit of the Groups annual accounts |
12 | | | | 12 | ||||||||
Other services: |
|||||||||||||
Fees payable for the audit of the Companys associates pursuant to legislation |
a | ) | 19 | | | | 19 | ||||||
Other services supplied pursuant to such legislation |
b | ) | | 2 | | | 2 | ||||||
Other services relating to taxation |
c | ) | | | 9 | | 9 | ||||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Company or any of its associates |
d | ) | | | | 2 | 2 | ||||||
Other |
| 4 | | 1 | 5 | ||||||||
Total auditors remuneration |
31 | 6 | 9 | 3 | 49 | ||||||||
2007 |
|||||||||||||
Audit of the Groups annual accounts |
7 | | | | 7 | ||||||||
Other services: |
|||||||||||||
Fees payable for the audit of the Companys associates pursuant to legislation |
a | ) | 11 | | | | 11 | ||||||
Other services supplied pursuant to such legislation |
b | ) | 6 | 2 | | | 8 | ||||||
Other services relating to taxation |
c | ) | | | 3 | | 3 | ||||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Company or any of its associates |
d | ) | | | | 5 | 5 | ||||||
Other |
| 1 | | 1 | 2 | ||||||||
Total auditors remuneration |
24 | 3 | 3 | 6 | 36 |
The figures shown in the above table relate to fees paid to PricewaterhouseCoopers LLP and its associates for continuing operations of business. Fees paid to other auditors not associated with PricewaterhouseCoopers LLP in respect of the audit of the Companys subsidiaries were £3m (2008: £3m, 2007: £2m).
a) | Fees payable for the audit of the Companys associates pursuant to legislation comprise the fees for the statutory audit of the subsidiaries and associated pension schemes both inside and outside Great Britain and fees for the work performed by the associates of PricewaterhouseCoopers LLP in respect of the consolidated financial statements of the Company. The fees relating to the audit of the associated pension schemes were £0.5m (2008: £0.2m, 2007: £0.3m). |
b) | Other services supplied pursuant to such legislation comprise services in relation to statutory and regulatory filings. These include audit services for the review of the interim financial information under the Listing Rules of the UK listing authority and fees paid for reporting under Section 404 of the US Sarbanes-Oxley Act (Section 404). In 2009 and 2008 fees paid for reporting under Section 404 are not separately identifiable from the fees of the audit of the Groups annual accounts and the Companys associates. |
c) | Other services relating to taxation include compliance services such as tax return preparation and advisory services such as consultation on tax matters, tax advice relating to transactions and other tax planning and advice. |
d) | Services relating to corporate finance transactions comprise due diligence related to transactions and other work in connection with such transactions. |
Excluded from the total auditors remuneration above are fees paid to PricewaterhouseCoopers LLP and associates relating to BGI (discontinued operations) of £4m (2008: £3m, 2007: £8m).
190 |
Notes to the accounts
For the year ended 31st December 2009
continued
10 Tax
The charge for tax is based upon the UK corporation tax rate of 28% (2008: 28.5%, 2007: 30%) and comprises:
2009 £m |
2008 £m |
2007 £m |
|||||||
Current tax charge/(credit) |
|||||||||
Current year |
1,249 | 1,201 | 2,013 | ||||||
Adjustment for prior years |
(118 | ) | 98 | 10 | |||||
1,131 | 1,299 | 2,023 | |||||||
Deferred tax charge/(credit) |
|||||||||
Current year |
45 | (577 | ) | (297 | ) | ||||
Adjustment for prior years |
(102 | ) | (269 | ) | (27 | ) | |||
(57 | ) | (846 | ) | (324 | ) | ||||
Total charge |
1,074 | 453 | 1,699 |
The effective tax rate for the years 2009, 2008 and 2007 is lower than the standard rate of corporation tax in the UK of 28% (2008: 28.5%, 2007: 30%). The differences are set out below:
2009 £m |
2008 £m |
2007 £m |
|||||||
Profit before tax |
4,585 | 5,136 | 6,223 | ||||||
Tax charge at standard UK corporation tax rate of 28% (2008: 28.5%, 2007: 30%) |
1,284 | 1,464 | 1,867 | ||||||
Adjustment for prior years |
(220 | ) | (171 | ) | (17 | ) | |||
Effect of overseas tax rates different from UK standard tax rate |
(27 | ) | 175 | (82 | ) | ||||
Non-taxable gains and income (including amounts offset by unrecognised tax losses) |
(112 | ) | (859 | ) | (136 | ) | |||
Share-based payments |
(38 | ) | 201 | 71 | |||||
Deferred tax assets not recognised/(previously not recognised) |
27 | (504 | ) | (159 | ) | ||||
Change in tax rates |
(12 | ) | (1 | ) | 24 | ||||
Other non-allowable expenses |
172 | 148 | 131 | ||||||
Overall tax charge |
1,074 | 453 | 1,699 | ||||||
Effective tax rate |
23 | % | 9 | % | 27 | % |
The effective tax rate for 2009, based on profit before tax on continuing operations was 23.4% (2008: 8.8%). The effective tax rate differs from the UK tax rate of 28% (2008: 28.5%) because of non-taxable gains and income, different tax rates applied to taxable profits and losses outside the UK, disallowed expenditure and adjustments in respect of prior years. The low effective tax rate of 8.8% on continuing operations in 2008 mainly resulted from the Lehman Brothers North American business acquisition.
Tax effects relating to each component of other comprehensive income
For the year ended 31st December | 2009 | 2008 | 2007 | ||||||||||||||||||||||
Before tax amount £m |
Tax (expense)/ benefit £m |
Net of tax amount £m |
Before tax amount £m |
Tax (expense)/ benefit £m |
Net of tax amount £m |
Before tax amount £m |
Tax (expense)/ benefit £m |
Net of tax amount £m | |||||||||||||||||
Continuing operations |
|||||||||||||||||||||||||
Currency translation differences |
(861 | ) | (2 | ) | (863 | ) | 2,274 | 840 | 3,114 | 43 | 102 | 145 | |||||||||||||
Available for sale |
1,236 | (177 | ) | 1,059 | (1,561 | ) | 207 | (1,354 | ) | 1 | (1 | ) | | ||||||||||||
Cash flow hedge |
165 | (65 | ) | 100 | 376 | (194 | ) | 182 | 359 | (119 | ) | 240 | |||||||||||||
Other |
| 218 | 218 | (5 | ) | (2 | ) | (7 | ) | 22 | 58 | 80 | |||||||||||||
Other comprehensive income |
540 | (26 | ) | 514 | 1,084 | 851 | 1,935 | 425 | 40 | 465 |
191 |
11 Earnings per share
2009 £m |
2008 £m |
2007 £m |
|||||||
Continuing operations |
|||||||||
Profit attributable to equity holders of Parent |
2,628 | 3,795 | 3,886 | ||||||
Dilutive impact of convertible options |
(17 | ) | (19 | ) | (15 | ) | |||
Profit attributable to equity holders of Parent including dilutive impact of convertible options |
2,611 | 3,776 | 3,871 | ||||||
Discontinued operations |
6,765 | 587 | 531 | ||||||
2009 million |
2008 million |
2007 million |
|||||||
Basic weighted average number of shares in issue |
10,890 | 7,389 | 6,410 | ||||||
Number of potential ordinary shares |
594 | 188 | 177 | ||||||
Diluted weighted average number of shares |
11,484 | 7,577 | 6,587 | ||||||
p | p | p | |||||||
Basic earnings per share |
86.2 | 59.3 | 68.9 | ||||||
Continuing operations |
24.1 | 51.4 | 60.6 | ||||||
Discontinued operations |
62.1 | 7.9 | 8.3 | ||||||
Diluted earnings per share |
81.6 | 57.5 | 66.9 | ||||||
Continuing operations |
22.7 | 49.8 | 58.8 | ||||||
Discontinued operations |
58.9 | 7.7 | 8.1 |
The calculation of basic earnings per share is based on the profit attributable to equity holders of the Parent and the number of basic weighted average number of shares excluding own shares held in employee benefits trusts and shares held for trading.
The basic weighted average number of shares in issue in the year ended 31st December 2009 reflects the full year impact of the 1,803 million shares issued during 2008, the 2,642 million shares that were issued during the first six months of 2009 following conversion in full of the Mandatorily Convertible Notes, and the weighted average impact of the 379 million warrants exercised during 2009. The increase in the number of potential ordinary shares is primarily driven by the warrants issued in 2008 becoming dilutive in 2009 as the average share price exceeded the warrants exercise price.
When calculating the diluted earnings per share, the profit attributable to equity holders of the Parent is adjusted for the dilutive impact of the potential conversion of outstanding options held in respect of Absa Group Limited that would increase the Groups non-controlling interests on exercise. In addition, the weighted average number of shares in issue is adjusted for the effects of all dilutive potential ordinary shares held in respect of Barclays PLC, totalling 594 million (2008: 188 million, 2007: 177 million).
Of the total number of employee share options and share awards at 31st December 2009, 97 million were anti-dilutive (2008: 64 million, 2007: nil).
Subsequent to the balance sheet date, the Group continued to make on-market purchases of treasury shares for the purposes of satisfying its various employee share schemes. No adjustment has been made to earnings per share in respect of these purchases.
12 Trading portfolio
2009 £m |
2008 £m |
|||||
Trading portfolio assets |
||||||
Treasury and other eligible bills |
9,926 | 4,544 | ||||
Debt securities |
116,594 | 148,686 | ||||
Equity securities |
19,602 | 30,535 | ||||
Traded loans |
2,962 | 1,070 | ||||
Commodities |
2,260 | 802 | ||||
Trading portfolio assets |
151,344 | 185,637 | ||||
Trading portfolio liabilities |
||||||
Treasury and other eligible bills |
(381 | ) | (79 | ) | ||
Debt securities |
(44,327 | ) | (44,309 | ) | ||
Equity securities |
(6,468 | ) | (14,919 | ) | ||
Commodities |
(76 | ) | (167 | ) | ||
Trading portfolio liabilities |
(51,252 | ) | (59,474 | ) |
As disclosed in Note 51, £8,027m of collateralised loan obligations were reclassified from the trading portfolio to loans and receivables during the year.
192 |
Notes to the accounts
For the year ended 31st December 2009
continued
13 Financial assets designated at fair value
Held on own account
2009 £m |
2008 £m | |||
Loans and advances |
22,390 | 30,187 | ||
Debt securities |
4,007 | 8,628 | ||
Equity securities |
6,256 | 6,496 | ||
Other financial assets |
8,658 | 9,231 | ||
Financial assets designated at fair value held on own account |
41,311 | 54,542 |
The maximum exposure to credit risk on loans and advances designated at fair value at 31st December 2009 was £22,390m (2008: £30,187m). The amount by which related credit derivatives and similar instruments mitigate the exposure to credit risk at 31st December 2009 was £1,416m (2008: £2,084m).
The net loss attributable to changes in credit risk for loans and advances designated at fair value was £2,370m in 2009 (2008: £2,550m). The gains on related credit derivatives was £229m for the year (2008: £519m).
The cumulative net loss attributable to changes in credit risk for loans and advances designated at fair value since initial recognition is £5,321m at 31st December 2009 (2008: £2,951m). The cumulative change in fair value of related credit derivatives at 31st December 2009 is £744m (2008: £515m).
Held in respect of linked liabilities to customers under investment contracts/liabilities arising from investment contracts
2009 £m |
2008 £m |
|||||
Financial assets designated at fair value held in respect of linked liabilities to customers under investment contracts |
1,257 | 66,657 | ||||
Cash and bank balances within the portfolio |
422 | 2,526 | ||||
Assets held in respect of linked liabilities to customers under investment contracts |
1,679 | 69,183 | ||||
Liabilities to customers under investment contracts |
(1,679 | ) | (69,183 | ) |
A portion of the Groups fund management business in 2008, mostly relating to BGI, takes the legal form of investment contracts, under which legal title to the underlying investment is held by the Group, but the inherent risks and rewards in the investments are borne by the investors. In the normal course of business, the Groups financial interest in such investments is restricted to fees for investment management services.
Due to the nature of these contracts, the carrying value of the assets is always the same as the value of the liabilities and any change in the value of the assets results in an equal but opposite change in the value of the amounts due to the policyholders.
The Group is therefore not exposed to the financial risks market risk, credit risk and liquidity risk inherent in the investments and they are omitted from the disclosures on financial risks in Notes 47 to 49.
On the balance sheet, the assets are included as Financial assets designated at fair value held in respect of linked liabilities to customers under investment contracts. Balances within the portfolio have been included in the Groups cash balances. The associated obligation to deliver the value of the investments to customers at their fair value on-balance sheet date is included as Liabilities to customers under investment contracts.
The increase/decrease in fair value arising from the return on the investments and the corresponding increase/decrease in linked liabilities to customers is disclosed in Note 6.
193 |
14 Derivative financial instruments
The Groups objectives and policies on managing the risks that arise in connection with derivatives, including the policies for hedging, are included in Notes 46 to 49.
The fair values and notional amounts of derivative instruments held for trading are set out in the following table:
2009 | 2008 | |||||||||||||
Notional |
Fair value | Notional |
Fair value | |||||||||||
Year ended 31st December Derivatives held for trading |
Assets £m |
Liabilities £m |
Assets £m |
Liabilities £m |
||||||||||
Foreign exchange derivatives |
||||||||||||||
Forward foreign exchange |
1,457,271 | 18,148 | (18,019 | ) | 1,374,108 | 44,631 | (46,371 | ) | ||||||
Currency swaps |
810,666 | 26,008 | (32,357 | ) | 828,983 | 47,077 | (53,116 | ) | ||||||
OTC options bought and sold |
539,976 | 7,332 | (7,321 | ) | 426,739 | 15,405 | (14,331 | ) | ||||||
OTC derivatives |
2,807,913 | 51,488 | (57,697 | ) | 2,629,830 | 107,113 | (113,818 | ) | ||||||
Exchange traded futures bought and sold |
2,035 | | | 8,008 | | | ||||||||
Exchange traded options bought and sold |
28,220 | | | 1,295 | | | ||||||||
Foreign exchange derivatives |
2,838,168 | 51,488 | (57,697 | ) | 2,639,133 | 107,113 | (113,818 | ) | ||||||
Interest rate derivatives |
||||||||||||||
Interest rate swaps |
9,408,811 | 193,133 | (179,744 | ) | 17,624,591 | 498,661 | (496,292 | ) | ||||||
Forward rate agreements |
4,436,628 | 3,595 | (3,289 | ) | 4,377,619 | 8,853 | (8,224 | ) | ||||||
OTC options bought and sold |
5,113,613 | 63,647 | (61,304 | ) | 5,598,960 | 105,743 | (101,005 | ) | ||||||
OTC derivatives |
18,959,052 | 260,375 | (244,337 | ) | 27,601,170 | 613,257 | (605,521 | ) | ||||||
Exchange traded futures bought and sold |
547,685 | | | 586,312 | | | ||||||||
Exchange traded options bought and sold |
272,960 | | | 276,752 | | | ||||||||
Exchange traded swaps |
13,424,261 | | | 9,411,001 | | | ||||||||
Interest rate derivatives |
33,203,958 | 260,375 | (244,337 | ) | 37,875,235 | 613,257 | (605,521 | ) | ||||||
Credit derivatives |
||||||||||||||
Swaps |
2,016,796 | 56,295 | (51,780 | ) | 4,129,244 | 184,072 | (170,011 | ) | ||||||
Equity and stock index derivatives |
||||||||||||||
OTC options bought and sold |
124,944 | 13,042 | (15,681 | ) | 180,157 | 19,576 | (19,998 | ) | ||||||
Equity swaps and forwards |
45,922 | 2,057 | (1,718 | ) | 51,267 | 3,432 | (2,819 | ) | ||||||
OTC derivatives |
170,866 | 15,099 | (17,399 | ) | 231,424 | 23,008 | (22,817 | ) | ||||||
Exchange traded futures bought and sold |
57,565 | | | 38,340 | | | ||||||||
Exchange traded options bought and sold |
130,885 | 2,631 | (2,371 | ) | 121,712 | 5,551 | (3,109 | ) | ||||||
Equity and stock index derivatives |
359,316 | 17,730 | (19,770 | ) | 391,476 | 28,559 | (25,926 | ) | ||||||
Commodity derivatives |
||||||||||||||
OTC options bought and sold |
92,508 | 4,262 | (4,215 | ) | 78,680 | 6,565 | (10,261 | ) | ||||||
Commodity swaps and forwards |
252,621 | 22,872 | (22,012 | ) | 407,015 | 38,316 | (35,556 | ) | ||||||
OTC derivatives |
345,129 | 27,134 | (26,227 | ) | 485,695 | 44,881 | (45,817 | ) | ||||||
Exchange traded futures bought and sold |
312,883 | 2,436 | (2,008 | ) | 165,564 | 3,953 | (2,745 | ) | ||||||
Exchange traded options bought and sold |
55,729 | 180 | (200 | ) | 54,435 | 161 | (233 | ) | ||||||
Commodity derivatives |
713,741 | 29,750 | (28,435 | ) | 705,694 | 48,995 | (48,795 | ) | ||||||
Derivative assets/(liabilities) held for trading |
39,131,979 | 415,638 | (402,019 | ) | 45,740,782 | 981,996 | (964,071 | ) |
194 |
Notes to the accounts
For the year ended 31st December 2009
continued
14 Derivative financial instruments continued
The fair values and notional amounts of derivative instruments held for risk management are set out in the following table:
2009 | 2008 | |||||||||||||
Notional contract amount £m |
Fair value | Notional contract amount £m |
Fair value | |||||||||||
Year ended 31st December Derivatives held for trading |
Assets £m |
Liabilities £m |
Assets £m |
Liabilities £m |
||||||||||
Derivatives designated as cash flow hedges |
||||||||||||||
Currency swaps |
| | | 586 | | (271 | ) | |||||||
Interest rate swaps |
79,241 | 478 | (494 | ) | 60,669 | 1,013 | (1,011 | ) | ||||||
Equity options |
| | | 400 | | (154 | ) | |||||||
OTC options bought and sold |
673 | 2 | | | | | ||||||||
Forward foreign exchange |
2,224 | 237 | (51 | ) | 1,871 | 309 | (354 | ) | ||||||
Exchange traded interest rate swaps |
33,534 | | | 20,028 | | | ||||||||
Derivatives designated as cash flow hedges |
115,672 | 717 | (545 | ) | 83,554 | 1,322 | (1,790 | ) | ||||||
Derivatives designated as fair value hedges |
||||||||||||||
Currency swaps |
502 | 10 | | 2,666 | 283 | (105 | ) | |||||||
Interest rate swaps |
12,199 | 357 | (459 | ) | 14,010 | 1,052 | (357 | ) | ||||||
Equity options |
7,710 | 53 | (56 | ) | 259 | 124 | (110 | ) | ||||||
Forward foreign exchange |
5,386 | 18 | (103 | ) | | | | |||||||
Exchange traded interest rate swaps |
32,257 | | | 18,767 | | | ||||||||
Derivatives designated as fair value hedges |
58,054 | 438 | (618 | ) | 35,702 | 1,459 | (572 | ) | ||||||
Derivatives designated as hedges of net investments |
||||||||||||||
Forward foreign exchange |
5,321 | 22 | (97 | ) | 2,019 | 4 | (76 | ) | ||||||
Currency swaps |
971 | | (137 | ) | 3,675 | 21 | (1,563 | ) | ||||||
Derivatives designated as hedges of net investment |
6,292 | 22 | (234 | ) | 5,694 | 25 | (1,639 | ) | ||||||
Derivative assets/(liabilities) held for risk management |
180,018 | 1,177 | (1,397 | ) | 124,950 | 2,806 | (4,001 | ) |
Interest rate derivatives, designated as cash flow hedges, primarily hedge the exposure to cash flow variability from interest rates of variable rate loans to banks and customers, variable rate debt securities held and highly probable forecast financing transactions and reinvestments.
Interest rate derivatives designated as fair value hedges primarily hedge the interest rate risk of fixed rate borrowings in issue, fixed rate loans to banks and customers and investments in fixed rate debt securities held.
Currency derivatives are primarily designated as hedges of the foreign currency risk of net investments in foreign operations.
The Groups total derivative asset and liability position as reported on the balance sheet is as follows:
2009 | 2008 | |||||||||||||
Notional contract amount £m |
Fair value | Notional |
Fair value | |||||||||||
Year ended 31st December | Assets £m |
Liabilities £m |
Assets £m |
Liabilities £m |
||||||||||
Total derivative assets/(liabilities) held for trading |
39,131,979 | 415,638 | (402,019 | ) | 45,740,782 | 981,996 | (964,071 | ) | ||||||
Total derivative assets/(liabilities) held for risk management |
180,018 | 1,177 | (1,397 | ) | 124,950 | 2,806 | (4,001 | ) | ||||||
Derivative assets/(liabilities) |
39,311,997 | 416,815 | (403,416 | ) | 45,865,732 | 984,802 | (968,072 | ) |
Derivative assets and liabilities subject to counterparty netting agreements amounted to £343bn (2008: £862bn). Additionally, the Group held £31bn (2008: £55bn) of collateral against the net derivative assets exposure.
195 |
14 Derivative financial instruments continued
The Group has hedged the following forecast cash flows, which primarily vary with interest rates. These cash flows are expected to impact the income statement in the following periods, excluding any hedge adjustments that may be applied:
Total £m |
Up to one year £m |
Between one to two years £m |
Between two to three years £m |
Between three to four years £m |
Between four to five years £m |
More than five years £m | ||||||||
2009 |
||||||||||||||
Forecast receivable cash flows |
3,304 | 467 | 838 | 837 | 700 | 370 | 92 | |||||||
Forecast payable cash flows |
558 | 51 | 96 | 122 | 145 | 116 | 28 | |||||||
2008 |
||||||||||||||
Forecast receivable cash flows |
2,569 | 875 | 586 | 596 | 347 | 127 | 38 | |||||||
Forecast payable cash flows |
974 | 275 | 166 | 175 | 145 | 123 | 90 |
The maximum length of time over which the Group hedges exposure to the variability in future cash flows for forecast transactions, excluding those forecast transactions related to the payment of variable interest on existing financial instruments, is nine years (2008: seven years).
All gains or losses on hedging derivatives relating to forecast transactions, which are no longer expected to occur, have been recycled to the income statement.
A loss of £1,478m on hedging instruments was recognised in relation to fair value hedges in net interest income (2008: £2,439m gain). A gain of £1,604m on the hedged items was recognised in relation to fair value hedges in net interest income (2008: £2,423m loss).
Ineffectiveness recognised in relation to cash flow hedges in net interest income was a gain of £21m (2008: £14m gain). Ineffectiveness recognised in relation to hedges of net investment was a loss of £5m (2008: £2m gain).
15 Loans and advances to banks and customers
2009 £m |
2008 £m |
|||||
Gross loans and advances to banks |
41,196 | 47,758 | ||||
Less: Allowance for impairment |
(61 | ) | (51 | ) | ||
Loans and advances to banks |
41,135 | 47,707 | ||||
Gross loans and advances to customers |
430,959 | 468,338 | ||||
Less: Allowance for impairment |
(10,735 | ) | (6,523 | ) | ||
Loans and advances to customers |
420,224 | 461,815 |
196 |
Notes to the accounts
For the year ended 31st December 2009
continued
16 Available for sale financial investments
2009 £m |
2008 £m |
|||||
Debt securities |
43,888 | 58,831 | ||||
Treasury bills and other eligible bills |
5,919 | 4,003 | ||||
Equity securities |
6,676 | 2,142 | ||||
Available for sale financial investments |
56,483 | 64,976 | ||||
Movement in available for sale financial investments |
||||||
At beginning of year |
64,976 | 43,072 | ||||
Exchange and other adjustments |
(4,399 | ) | 14,275 | |||
Acquisitions and transfers |
83,915 | 59,703 | ||||
Disposals (through sale and redemption) |
(88,854 | ) | (50,501 | ) | ||
Gains/(losses) from changes in fair value recognised in equity |
1,576 | (1,174 | ) | |||
Impairment charge |
(670 | ) | (382 | ) | ||
Amortisation charge |
(6 | ) | (17 | ) | ||
Business disposals/discontinued operations |
(55 | ) | | |||
At end of year |
56,483 | 64,976 |
17 Securities borrowing, securities lending, repurchase and reverse repurchase agreements
Amounts included in the balance sheet and reported on a net basis where the Group has the intention and the legal ability to settle net or realise simultaneously were as follows:
a) Reverse repurchase agreements and cash collateral on securities borrowed
Amounts advanced to counterparties under reverse repurchase agreements and cash collateral provided under stock borrowing agreements are treated as collateralised loans receivable. The related securities purchased or borrowed subject to an agreement with the counterparty to repurchase them are not recognised on-balance sheet where the risks and rewards of ownership remain with the counterparty.
2009 £m |
2008 £m | |||
Banks |
67,872 | 55,471 | ||
Customers |
75,559 | 74,883 | ||
Reverse repurchase agreements and cash collateral held on securities borrowed |
143,431 | 130,354 |
b) Repurchase agreements and cash collateral on securities lent
Securities that are not recorded on the balance sheet (for example, securities that have been obtained as a result of reverse repurchase and stock borrowing transactions) may also be lent or sold subject to a commitment to repurchase such securities remain off-balance sheet. In both instances, amounts received from counterparty are treated as liabilities, which at 31st December were as follows:
2009 £m |
2008 £m | |||
Banks |
93,692 | 87,403 | ||
Customers |
105,089 | 94,882 | ||
Repurchase agreements and cash collateral on securities lent |
198,781 | 182,285 |
18 Other assets
2009 £m |
2008 £m | |||
Sundry debtors |
4,909 | 4,814 | ||
Prepayments |
1,010 | 882 | ||
Accrued income |
347 | 483 | ||
Reinsurance assets |
92 | 123 | ||
Other assets |
6,358 | 6,302 |
Included in the above are balances of £4,978m (2008: £4,704m) expected to be recovered within no more than 12 months after the balance sheet date and balances of £1,380m (2008: £1,598m) expected to be recovered more than 12 months after the balance sheet date.
Other assets include £3,476m (2008: £3,096m) of receivables which meet the definition of financial assets.
197 |
19 Deferred tax
The components of deferred taxes disclosed on the balance sheet are as follows:
2009 £m |
2008 £m |
|||||
Deferred tax liability |
(470 | ) | (304 | ) | ||
Deferred tax asset |
2,303 | 2,668 | ||||
Net deferred tax |
1,833 | 2,364 |
Deferred taxes are calculated on all temporary differences under the liability method. Movements on deferred tax assets and liabilities were as follows:
Fixed asset timing differences £m |
Available for sale investments £m |
Cash flow hedges £m |
Pensions and other retirement benefits £m |
Allowance for impairment on loans £m |
Other provisions £m |
Tax losses carried forward £m |
Share based payments £m |
Other £m |
Total £m |
|||||||||||||||||||||
Liabilities |
(945 | ) | (46 | ) | (368 | ) | | | | | | (1,075 | ) | (2,434 | ) | |||||||||||||||
Assets |
87 | 57 | 246 | 403 | 356 | 532 | 1,659 | 342 | 1,116 | 4,798 | ||||||||||||||||||||
At 1st January 2009 |
(858 | ) | 11 | (122 | ) | 403 | 356 | 532 | 1,659 | 342 | 41 | 2,364 | ||||||||||||||||||
Income statement |
340 | (8 | ) | 44 | (189 | ) | 39 | 15 | (785 | ) | 50 | 293 | (201 | ) | ||||||||||||||||
Equity |
| (21 | ) | (59 | ) | | | | | 156 | 24 | 100 | ||||||||||||||||||
Acquisitions and disposals |
1 | | | (5 | ) | (1 | ) | (8 | ) | 4 | (41 | ) | (98 | ) | (148 | ) | ||||||||||||||
Exchange and other adjustments |
(26 | ) | (8 | ) | (2 | ) | 10 | (15 | ) | (245 | ) | 160 | (171 | ) | 15 | (282 | ) | |||||||||||||
(543 | ) | (26 | ) | (139 | ) | 219 | 379 | 294 | 1,038 | 336 | 275 | 1,833 | ||||||||||||||||||
Liabilities |
(660 | ) | (54 | ) | (278 | ) | | | | | | (197 | ) | (1,189 | ) | |||||||||||||||
Assets |
117 | 28 | 139 | 219 | 379 | 294 | 1,038 | 336 | 472 | 3,022 | ||||||||||||||||||||
At 31st December 2009 |
(543 | ) | (26 | ) | (139 | ) | 219 | 379 | 294 | 1,038 | 336 | 275 | 1,833 | |||||||||||||||||
Liabilities |
(803 | ) | (101 | ) | (51 | ) | | | | | | (771 | ) | (1,726 | ) | |||||||||||||||
Assets |
| | 44 | 491 | 108 | 377 | 215 | 428 | 671 | 2,334 | ||||||||||||||||||||
At 1st January 2008 |
(803 | ) | (101 | ) | (7 | ) | 491 | 108 | 377 | 215 | 428 | (100 | ) | 608 | ||||||||||||||||
Income statement |
124 | 8 | 5 | (90 | ) | 223 | (10 | ) | 598 | (215 | ) | 227 | 870 | |||||||||||||||||
Equity |
| 103 | (161 | ) | | | | 750 | (33 | ) | (13 | ) | 646 | |||||||||||||||||
Acquisitions and disposals |
(195 | ) | | | | | 56 | | 75 | (211 | ) | (275 | ) | |||||||||||||||||
Exchange and other adjustments |
16 | 1 | 41 | 2 | 25 | 109 | 96 | 87 | 138 | 515 | ||||||||||||||||||||
(858 | ) | 11 | (122 | ) | 403 | 356 | 532 | 1,659 | 342 | 41 | 2,364 | |||||||||||||||||||
Liabilities |
(945 | ) | (46 | ) | (368 | ) | | | | | | (1,075 | ) | (2,434 | ) | |||||||||||||||
Assets |
87 | 57 | 246 | 403 | 356 | 532 | 1,659 | 342 | 1,116 | 4,798 | ||||||||||||||||||||
At 31st December 2008 |
(858 | ) | 11 | (122 | ) | 403 | 356 | 532 | 1,659 | 342 | 41 | 2,364 |
The amount of deferred tax liability expected to be settled after more than 12 months is £955m (2008: £1,949m).
The amount of deferred tax asset expected to be recovered after more than 12 months is £2,446m (2008: £4,593m).
The deferred tax assets balance includes £197m (2008: £2,139m) which is the excess deferred tax assets over deferred tax liabilities in entities which have suffered a loss in either the current or prior year. This is based on management assessment that it is probable that the relevant entities will have taxable profits against which the temporary differences can be utilised.
Deferred tax assets have not been recognised in respect of deductible temporary differences (gross) of £4m (2008: £9m), unused tax losses (gross) of £8,542m (2008: £4,083m loss) and unused tax credits of £nil (2008: £46m). Tax losses of £8,516m expire in 2029. The other tax losses, tax credits and temporary differences do not expire under current tax legislation. Deferred tax assets have not been recognised in respect of these items because it is not probable that future taxable profit will be available against which the Group can utilise benefits. The unused tax losses include amounts relating to non-UK branches of Barclays Bank PLC where the future tax benefit might be restricted to the amount in excess of the UK rate.
The amount of temporary differences associated with investments in subsidiaries, branches, associates and joint ventures for which deferred tax liabilities have not been recognised is £738m (2008: £8,429m).
198 |
Notes to the accounts
For the year ended 31st December 2009
continued
20 Investments in associates and joint ventures
Share of net assets
Associates | Joint ventures | Total | ||||||||||||||||
. | 2009 £m |
2008 £m |
2009 £m |
2008 £m |
2009 £m |
2008 £m |
||||||||||||
At beginning of year |
175 | 90 | 166 | 287 | 341 | 377 | ||||||||||||
Share of results before tax |
21 | 25 | 21 | (6 | ) | 42 | 19 | |||||||||||
Share of tax |
(2 | ) | (3 | ) | (6 | ) | (2 | ) | (8 | ) | (5 | ) | ||||||
Share of post-tax results |
19 | 22 | 15 | (8 | ) | 34 | 14 | |||||||||||
Dividends paid |
| | (1 | ) | | (1 | ) | | ||||||||||
New investments |
198 | 6 | 1 | 27 | 199 | 33 | ||||||||||||
Acquisitions |
38 | 62 | 3 | 1 | 41 | 63 | ||||||||||||
Disposals |
(58 | ) | (20 | ) | (14 | ) | (117 | ) | (72 | ) | (137 | ) | ||||||
Exchange and other adjustments |
(122 | ) | 15 | 2 | (24 | ) | (120 | ) | (9 | ) | ||||||||
At end of year |
250 | 175 | 172 | 166 | 422 | 341 |
Goodwill included above:
Associates | Joint ventures | Total | |||||||||||||
. | 2009 £m |
2008 £m |
2009 £m |
2008 £m |
2009 £m |
2008 £m | |||||||||
Cost |
|||||||||||||||
At beginning of year |
| | 31 | 27 | 31 | 27 | |||||||||
Acquisitions |
19 | | | | 19 | | |||||||||
Exchange and other adjustments |
(1 | ) | | (1 | ) | 4 | (2 | ) | 4 | ||||||
At end of year |
18 | | 30 | 31 | 48 | 31 |
The Group holds investments in associates listed on the Johannesburg Stock Exchange: Pinnacle Point Group Limited, Blue Financial Services Limited (acquired during 2009) and Sekunjalo Investments Limited (acquired during 2009). The fair value of the Groups investment in these associates is £15m (2008: £60m). Ambit Properties Limited was disposed during 2009 (2008: fair value of £51m).
Aggregate cash consideration paid for additional investments in associates and joint ventures was £82m (2008: £96m), which also included New China Trust. Additional investments for non-cash consideration, include Barclays Vida y Pensiones Compañía de Seguros (£69m) and associates held by Crescent Real Estate Holdings LLC (£89m).
Summarised financial information for the Groups associates and joint ventures is set out below:
2009 | 2008 | |||||||||||
. | Associates £m |
Joint ventures £m |
Associates £m |
Joint ventures £m |
||||||||
Property, plant and equipment |
1,174 | 98 | 788 | 104 | ||||||||
Financial investments |
772 | 6 | 124 | | ||||||||
Trading portfolio assets |
426 | | | | ||||||||
Loans to banks and customers |
712 | 3,124 | 271 | 2,883 | ||||||||
Other assets |
1,855 | 293 | 1,343 | 418 | ||||||||
Total assets |
4,939 | 3,521 | 2,526 | 3,405 | ||||||||
Deposits from banks and customers |
2,200 | 2,751 | 1,376 | 2,207 | ||||||||
Trading portfolio liabilities |
370 | 107 | | | ||||||||
Other liabilities |
1,666 | 380 | 985 | 890 | ||||||||
Shareholders equity |
703 | 283 | 165 | 308 | ||||||||
Total liabilities and shareholders equity |
4,939 | 3,521 | 2,526 | 3,405 | ||||||||
Net income |
1,022 | 391 | 859 | 357 | ||||||||
Operating expenses |
(1,045 | ) | (342 | ) | (732 | ) | (364 | ) | ||||
(Loss)/profit before tax |
(23 | ) | 49 | 127 | (7 | ) | ||||||
(Loss)/profit after tax |
(96 | ) | 30 | 52 | (11 | ) |
The amounts included above, which include the entire assets, liabilities and net income of the investees, not just the Groups share, are based on accounts made up to 31st December 2009 with the exception of certain undertakings for which the amounts are based on accounts made up to dates not earlier than three months before the balance sheet date.
The Groups share of commitments and contingencies of its associates and joint ventures is £5m (2008: £nil).
199 |
21 Goodwill
2009 £m |
2008 £m |
|||||
Net book value |
||||||
At beginning of year |
7,625 | 7,014 | ||||
Acquisitions |
63 | 400 | ||||
Business disposals/discontinued operations |
(1,503 | ) | (10 | ) | ||
Impairment charge |
(1 | ) | (112 | ) | ||
Exchange and other adjustments |
48 | 333 | ||||
At end of year |
6,232 | 7,625 |
Goodwill is allocated to business operations according to business segments identified by the Group under IFRS 8, as follows:
2009 £m |
2008 a £m | |||
UK Retail Banking |
3,146 | 3,139 | ||
Barclays Commercial Bank |
22 | 10 | ||
Barclaycard |
525 | 413 | ||
GRCB Western Europe |
886 | 948 | ||
GRCB Emerging Markets |
39 | 49 | ||
GRCB Absa |
1,116 | 1,084 | ||
Barclays Capital |
107 | 95 | ||
Barclays Global Investors |
| 1,496 | ||
Barclays Wealth |
391 | 391 | ||
Goodwill |
6,232 | 7,625 |
The goodwill disposal relates to Barclays Global Investors. During 2009, the allocation of balances has been updated to reflect certain changes in the business structure.
Goodwill is reviewed annually for impairment, or more frequently when there are indicators that impairment may have occurred, by comparing the carrying value to its recoverable amount.
Impairment testing of goodwill
The recoverable amount of each operations goodwill is based on value-in-use or fair value less costs to sell calculations. The calculations are based upon discounting expected pre-tax cash flows at a risk-adjusted interest rate appropriate to the cash generating unit, the determination of both of which requires the exercise of judgement. The estimation of pre-tax cash flows is sensitive to the periods for which forecasts are available and to assumptions regarding the long-term sustainable cash flows. While forecasts are compared with actual performance and external economic data, expected cash flows naturally reflect managements view of future performance.
At 31st December 2009, the goodwill allocated to UK Retail Banking was £3,146m (2008: £3,139m) including £3,130m (2008: £3,130m) relating to Woolwich, the goodwill allocated to GRCB Absa was £1,116m (2008: £1,084m) and the goodwill allocated to Barclays Global Investors was £nil (2008: £1,496m). The remaining aggregate of goodwill of £1,986m (2008: £1,915m) consists of balances relating to multiple business operations which are not considered individually significant.
Key assumptions used in impairment testing for significant goodwill
UK Retail Banking
The recoverable amount of UK Retail Banking has been determined based on a value in use calculation. The calculation uses cash flow predictions based on financial budgets approved by management covering a three-year period, with a terminal growth rate of 3% applied thereafter. The forecast cash flows have been discounted at a rate of 14%. The recoverable amount exceeded the carrying amount including goodwill by £1.2bn. A one percentage point change in the discount rate or the terminal growth rate would reduce the recoverable amount by £0.7bn and £0.5bn respectively. A reduction in the forecast cash flows of 5% per annum would reduce the recoverable amount by £0.4bn.
Global Retail and Commercial Banking Absa
The recoverable amount of GRCB Absa has been determined based on a value in use calculation. The calculation uses cash flow predictions based on financial budgets approved by management covering a three year period, with a terminal growth rate of 6% applied thereafter. The forecast cash flows have been discounted at a rate of 14%. The result of the impairment test is not sensitive to reasonably possible changes in key assumptions.
Barclays Global Investors
All of the goodwill in Barclays Global Investors has been disposed of following the sale of this business to BlackRock, Inc on 1st December 2009. The value of the goodwill was recovered in full as a result of the transaction.
Note
a | Figures have been restated for the transfer of Barclays Russia from GRCB Emerging Markets to GRCB Western Europe. |
200 |
Notes to the accounts
For the year ended 31st December 2009
continued
22 Intangible assets
Internally generated software £m |
Other software £m |
Core deposit intangibles £m |
Brands £m |
Customer £m |
Mortgage £m |
Licences £m |
Total £m |
|||||||||||||||||
2009 |
||||||||||||||||||||||||
Cost |
||||||||||||||||||||||||
At 1st January 2009 |
721 | 328 | 261 | 155 | 1,565 | 173 | 426 | 3,629 | ||||||||||||||||
Acquisitions and disposals of subsidiaries |
| | | | 1 | | 109 | 110 | ||||||||||||||||
Disposal of discontinued operations |
(66 | ) | | | (2 | ) | | | (32 | ) | (100 | ) | ||||||||||||
Additions/disposals |
264 | (36 | ) | | | | | 11 | 239 | |||||||||||||||
Exchange and other adjustments |
44 | (55 | ) | 40 | 22 | (45 | ) | (9 | ) | (52 | ) | (55 | ) | |||||||||||
At 31st December 2009 |
963 | 237 | 301 | 175 | 1,521 | 164 | 462 | 3,823 | ||||||||||||||||
Accumulated amortisation and impairment |
||||||||||||||||||||||||
At 1st January 2009 |
(284 | ) | (69 | ) | (52 | ) | (55 | ) | (172 | ) | (116 | ) | (104 | ) | (852 | ) | ||||||||
Disposal of discontinued operations |
25 | | | 2 | | | 8 | 35 | ||||||||||||||||
Disposals |
12 | 4 | | | | | | 16 | ||||||||||||||||
Amortisation charge |
(190 | ) | (29 | ) | (22 | ) | (17 | ) | (136 | ) | (13 | ) | (54 | ) | (461 | ) | ||||||||
Impairment charge |
(11 | ) | | | (6 | ) | | | (10 | ) | (27 | ) | ||||||||||||
Exchange and other adjustments |
(17 | ) | 36 | (8 | ) | (8 | ) | (10 | ) | 12 | 24 | 29 | ||||||||||||
At 31st December 2009 |
(465 | ) | (58 | ) | (82 | ) | (84 | ) | (318 | ) | (117 | ) | (136 | ) | (1,260 | ) | ||||||||
Net book value |
498 | 179 | 219 | 91 | 1,203 | 47 | 326 | 2,563 | ||||||||||||||||
2008 |
||||||||||||||||||||||||
Cost |
||||||||||||||||||||||||
At 1st January 2008 |
388 | 188 | 244 | 149 | 524 | 126 | 161 | 1,780 | ||||||||||||||||
Acquisitions and disposals of subsidiaries |
| 127 | 17 | 6 | 992 | | 210 | 1,352 | ||||||||||||||||
Additions/disposals |
274 | 5 | | | | | 3 | 282 | ||||||||||||||||
Exchange and other adjustments |
59 | 8 | | | 49 | 47 | 52 | 215 | ||||||||||||||||
At 31st December 2008 |
721 | 328 | 261 | 155 | 1,565 | 173 | 426 | 3,629 | ||||||||||||||||
Accumulated amortisation and impairment |
||||||||||||||||||||||||
At 1st January 2008 |
(163 | ) | (57 | ) | (37 | ) | (38 | ) | (101 | ) | (64 | ) | (38 | ) | (498 | ) | ||||||||
Disposals |
11 | 7 | | | | | | 18 | ||||||||||||||||
Amortisation charge |
(86 | ) | (33 | ) | (14 | ) | (15 | ) | (62 | ) | (22 | ) | (59 | ) | (291 | ) | ||||||||
Impairment release |
3 | | | | | | | 3 | ||||||||||||||||
Exchange and other adjustments |
(49 | ) | 14 | (1 | ) | (2 | ) | (9 | ) | (30 | ) | (7 | ) | (84 | ) | |||||||||
At 31st December 2008 |
(284 | ) | (69 | ) | (52 | ) | (55 | ) | (172 | ) | (116 | ) | (104 | ) | (852 | ) | ||||||||
Net book value |
437 | 259 | 209 | 100 | 1,393 | 57 | 322 | 2,777 |
Of the amortisation charge for the year, £447m (2008: £276m) relates to continuing operations.
The impairment release detailed above has been included within other operating expenses.
201 |
23 Property, plant and equipment
Investment property £m |
Property £m |
Equipment £m |
Leased assets £m |
Total £m |
||||||||||
2009 |
||||||||||||||
Cost |
||||||||||||||
At 1st January 2009 |
| 3,624 | 3,944 | 304 | 7,872 | |||||||||
Acquisitions and disposals of subsidiaries |
978 | 171 | 5 | | 1,154 | |||||||||
Disposal of discontinued operations |
| (120 | ) | (99 | ) | | (219 | ) | ||||||
Additions/disposals |
137 | 233 | 387 | (37 | ) | 720 | ||||||||
Change in fair value of investment properties |
6 | | | | 6 | |||||||||
Fully depreciated assets written off |
| (6 | ) | (17 | ) | | (23 | ) | ||||||
Exchange and other adjustments |
86 | (72 | ) | (23 | ) | (201 | ) | (210 | ) | |||||
At 31st December 2009 |
1,207 | 3,830 | 4,197 | 66 | 9,300 | |||||||||
Accumulated depreciation and impairment |
||||||||||||||
At 1st January 2009 |
| (1,011 | ) | (2,144 | ) | (43 | ) | (3,198 | ) | |||||
Acquisitions and disposals of subsidiaries |
| | 2 | | 2 | |||||||||
Disposal of discontinued operations |
| 33 | 64 | | 97 | |||||||||
Depreciation charge |
| (201 | ) | (565 | ) | (20 | ) | (786 | ) | |||||
Impairment charge |
| (32 | ) | (2 | ) | | (34 | ) | ||||||
Disposals |
| 46 | 97 | 1 | 144 | |||||||||
Fully depreciated assets written off |
| 6 | 17 | | 23 | |||||||||
Exchange and other adjustments |
| 31 | 2 | 45 | 78 | |||||||||
At 31st December 2009 |
| (1,128 | ) | (2,529 | ) | (17 | ) | (3,674 | ) | |||||
Net book value |
1,207 | 2,702 | 1,668 | 49 | 5,626 | |||||||||
2008 |
||||||||||||||
Cost |
||||||||||||||
At 1st January 2008 |
| 2,451 | 2,995 | 413 | 5,859 | |||||||||
Acquisitions and disposals of subsidiaries |
| 992 | 218 | | 1,210 | |||||||||
Additions/disposals |
| 8 | 570 | (109 | ) | 469 | ||||||||
Fully depreciated assets written off |
| (15 | ) | (7 | ) | | (22 | ) | ||||||
Exchange and other adjustments |
| 188 | 168 | | 356 | |||||||||
At 31st December 2008 |
| 3,624 | 3,944 | 304 | 7,872 | |||||||||
Accumulated depreciation and impairment |
||||||||||||||
At 1st January 2008 |
| (1,044 | ) | (1,804 | ) | (15 | ) | (2,863 | ) | |||||
Acquisitions and disposals of subsidiaries |
| (8 | ) | (12 | ) | | (20 | ) | ||||||
Depreciation charge |
| (124 | ) | (475 | ) | (31 | ) | (630 | ) | |||||
Impairment charge |
| | (33 | ) | | (33 | ) | |||||||
Disposals |
| 168 | 185 | 3 | 356 | |||||||||
Fully depreciated assets written off |
| 15 | 7 | | 22 | |||||||||
Exchange and other adjustments |
| (18 | ) | (12 | ) | | (30 | ) | ||||||
At 31st December 2008 |
| (1,011 | ) | (2,144 | ) | (43 | ) | (3,198 | ) | |||||
Net book value |
| 2,613 | 1,800 | 261 | 4,674 |
Of the depreciation charge for the year £759m (2008: £606m) relates to continuing operations.
The fair value of Barclays investment property is based on valuations supported by appropriately qualified independent valuers.
Leased assets represent assets leased to customers under operating leases.
Certain of the Groups equipment is held on finance leases, see Note 37.
202 |
Notes to the accounts
For the year ended 31st December 2009
continued
24 Financial liabilities designated at fair value
2009 | 2008 | |||||||
Fair value £m |
Contractual amount due on maturity £m |
Fair value £m |
Contractual amount due on maturity £m | |||||
Debt securities |
72,191 | 77,636 | 61,297 | 69,197 | ||||
Deposits |
6,275 | 6,544 | 10,518 | 10,109 | ||||
Other |
7,736 | 8,811 | 5,077 | 6,761 | ||||
Financial liabilities designated at fair value |
86,202 | 92,991 | 76,892 | 86,067 |
At 31st December 2009, the own credit adjustment arose from the fair valuation of £61.5bn of Barclays Capital structured notes (2008: £54.5bn). The movement in Barclays credit spreads in the year affected the fair value of these notes and as a result revaluation losses of £1,820m were recognised in trading income (2008: £1,663m gains).
The cumulative own credit net gain that has been recognised on issued notes is £501m at 31st December 2009 (2008: £2,321m).
25 Other liabilities
2009 £m |
2008 £m | |||
Accruals and deferred income |
6,007 | 6,495 | ||
Sundry creditors |
5,972 | 6,049 | ||
Obligations under finance leases (Note 37) |
122 | 96 | ||
Other liabilities |
12,101 | 12,640 |
Included in the above are balances of £10,966m (2008: £11,068m) expected to be settled within no more than 12 months after the balance sheet date; and balances of £1,135m (2008: £1,572m) expected to be settled more than 12 months after the balance sheet date.
Accruals and deferred income includes £108m (2008: £101m) for the Groups estimated share of levies that will be raised by the Financial Services Compensation Scheme (FSCS). The provision is based on estimates of the Groups market participation in the relevant charging periods and the interest FSCS will pay on the facilities provided by HM Treasury in support of its obligations to depositors of banks declared in default. The total of these facilities is understood to be some £20bn.
While it is anticipated that the substantial majority of these facilities will be repaid wholly from recoveries from the institutions concerned, there is the risk of shortfall, such that the FSCS may place additional levies on FSCS participants. It is not currently possible to estimate the amount of potential additional levies, or the Groups share, which is expected to be based on a future level of market participation, or the effect that such levies may have upon operating results in any particular financial period.
26 Insurance assets and liabilities
Insurance assets
Reinsurance assets are £92m (2008: £123m) and relate principally to the Groups long-term business. Reinsurers share of provisions relating to the Groups short-term business are £7m (2008: £32m). The reinsurance assets expected to be recovered after more than one year are £85m (2008: £91m).
Insurance contract liabilities including unit-linked liabilities
Insurance liabilities comprise the following:
2009 £m |
2008 £m | |||
Insurance contract liabilities: |
||||
linked liabilities |
139 | 125 | ||
non-linked liabilities |
1,886 | 1,908 | ||
Provision for claims |
115 | 119 | ||
Insurance contract liabilities including unit-linked liabilities |
2,140 | 2,152 |
Insurance contract liabilities relate principally to the Groups long-term business. Insurance contract liabilities associated with the Groups short-term non-life business are £132m (2008: £73m).
203 |
26 Insurance assets and liabilities continued
Movements in insurance liabilities and reinsurance assets
Movements in insurance assets and insurance contract liabilities were as follows:
2009 | 2008 | ||||||||||||||||
Gross £m |
Reinsurance £m |
Net £m |
Gross £m |
Reinsurance £m |
Net £m |
||||||||||||
At beginning of year |
2,152 | (123 | ) | 2,029 | 3,903 | (157 | ) | 3,746 | |||||||||
Change in year |
(12 | ) | 31 | 19 | (1,751 | ) | 34 | (1,717 | ) | ||||||||
At end of year |
2,140 | (92 | ) | 2,048 | 2,152 | (123 | ) | 2,029 |
Assumptions used to measure insurance liabilities
The assumptions that have the greatest effect on the measurement of the amounts recognised above, and the processes used to determine them were as follows:
Long-term business linked and non-linked
Mortality mortality estimates are based on standard industry and national mortality tables, adjusted where appropriate to reflect the Groups own experience. A margin is added to ensure prudence for example, future mortality improvements for annuity business.
Renewal expenses level and inflation expense reserves are a small part of overall insurance liabilities, however, increases in expenses caused by unanticipated inflation or other unforeseen factors could lead to expense reserve increases. Expenses are therefore set using prudent assumptions. Initial renewal expense levels are set by considering expense forecasts for the business and, where appropriate, building in a margin to allow for the increasing burden of fixed costs on the UK closed life book of business. The inflation assumption is set by adding a margin to the market rate of inflation implied by index-linked gilt yields.
Short-term business
Short-term business for single premium policies the proportion of unearned premiums is calculated based on estimates of the frequency and severity of incidents.
Changes in assumptions
There have been no changes in assumptions in 2009 that have had a material effect on the financial statements.
Uncertainties associated with cash flows related to insurance contracts and risk management activities
The assumptions used to determine uncertainties in cash flows and the processes used to manage risk were as follows:
Long-term insurance contracts (linked and non-linked)
For long-term insurance contracts where death is the insured risk, the most significant factors that could affect the frequency and severity of claims are the incidence of disease, such as AIDS, or general changes in lifestyle, such as in eating, exercise and smoking. Where survival is the insured risk, advances in medical care and social conditions are the key factors that increase longevity.
The Group manages its exposure to risk by operating in part as a unit-linked business, prudent product design, applying strict underwriting criteria, transferring risk to reinsurers, managing claims and establishing prudent reserves.
Short-term insurance contracts
For payment protection contracts where inability to make payments under a loan contract is the insured risk, the most significant factors are the health of the policyholder and the possibility of unemployment which depends upon, among other things, long-term and short-term economic factors. The Group manages its exposure to such risks through prudent product design, efficient claims management, prudent reserving methodologies and bases, regular product, economic and market reviews and regular adequacy tests on the size of the reserves.
Absa insures property and motor vehicles, for which the most significant factors that could affect the frequency and severity of claims are climatic change and crime. Absa manages its exposure to risk by diversifying insurance risks accepted and transferring risk to reinsurers.
Sensitivity analysis
The following table presents the sensitivity of the level of insurance contract liabilities disclosed in this note to movements in the actuarial assumptions used to calculate them. The percentage change in variable is applied to a range of existing actuarial modelling assumptions to derive the possible impact on net profit after tax. The disclosure is not intended to explain the impact of a percentage change in the insurance assets and liabilities disclosed above.
2009 | 2008 | |||||||
Change in variable % |
Net profit after tax impact £m |
Change in variable % |
Net profit after tax impact £m | |||||
Long-term insurance contracts: |
||||||||
Improving mortality (annuitants only) |
10 | | 10 | 1 | ||||
Worsening of mortality (assured lives only) |
10 | 14 | 10 | 20 | ||||
Worsening of base renewal expense level |
20 | 11 | 20 | 19 | ||||
Worsening of expense inflation rate |
10 | 3 | 10 | 1 | ||||
Short-term insurance contracts: |
||||||||
Worsening of claim expense assumptions |
10 | 5 | 10 | 3 |
Any change in net profit after tax would result in a corresponding increase or decrease in shareholders equity.
The above analyses are based on a change in a single assumption while holding all other assumptions constant. In practice this is unlikely to occur.
204 |
Notes to the accounts
For the year ended 31st December 2009
continued
26 Insurance assets and liabilities continued
Options and guarantees
The Groups insurance contracts do not contain options or guarantees that give rise to material risk.
Concentration of insurance risk
The Group considers that the concentration of insurance risk that is most relevant to the Group financial statements is according to the type of cover offered and the location of insured risk. The following table shows the maximum amounts payable under all of the Groups insurance products. It ignores the probability of insured events occurring and the contribution from investments backing the insurance policies. The table shows the broad product types and the location of the insured risk, before and after the impact of reinsurance that represents the risk that is passed to other insurers.
2009 | 2008 | |||||||||||||
Before Reinsurance £m |
Reinsurance £m |
After Reinsurance £m |
Before Reinsurance £m |
Reinsurance £m |
After Reinsurance £m | |||||||||
Total benefits insured by product type |
||||||||||||||
Long-term insurance contracts |
13,405 | (1,547 | ) | 11,858 | 19,193 | (3,591 | ) | 15,602 | ||||||
Short-term insurance contracts |
49,359 | (4,145 | ) | 45,214 | 36,228 | (2,735 | ) | 33,493 | ||||||
Total benefits insured |
62,764 | (5,692 | ) | 57,072 | 55,421 | (6,326 | ) | 49,095 | ||||||
Total benefits insured by geographic location |
||||||||||||||
United Kingdom |
5,727 | (363 | ) | 5,364 | 8,120 | (525 | ) | 7,595 | ||||||
Other European Union |
1,724 | (20 | ) | 1,704 | 6,519 | (2,305 | ) | 4,214 | ||||||
Africa |
55,313 | (5,309 | ) | 50,004 | 40,782 | (3,496 | ) | 37,286 | ||||||
Total benefits insured |
62,764 | (5,692 | ) | 57,072 | 55,421 | (6,326 | ) | 49,095 |
Reinsurer credit risk
For the long-term business, reinsurance programmes are in place to restrict the amount of cover on any single life. The reinsurance cover is spread across highly rated companies to diversify the risk of reinsurer solvency. Net insurance reserves include a margin to reflect reinsurer credit risk.
27 Subordinated liabilities
Subordinated liabilities, which are all issued by Barclays Bank PLC (The Bank) or other subsidiaries of the Group, include accrued interest and comprise dated and undated loan capital as follows:
2009 £m |
2008 £m | |||||
Undated loan capital |
8,148 | 13,673 | ||||
Dated loan capital |
17,668 | 16,169 | ||||
25,816 | 29,842 | |||||
Undated loan capital
|
||||||
Notes | 2009 £m |
2008 £m | ||||
Non-convertible |
||||||
Barclays Bank PLC |
||||||
6% Callable Perpetual Core Tier One Notes |
a,p | 424 | 487 | |||
6.86% Callable Perpetual Core Tier One Notes (US$1,000m) |
a,p | 784 | 1,118 | |||
5.3304% Step-up Callable Perpetual Reserve Capital Instruments |
b,q | 560 | 652 | |||
5.926% Step-up Callable Perpetual Reserve Capital Instruments (US$1,350m) |
c,r | 928 | 1,109 | |||
6.3688% Step-up Callable Perpetual Reserve Capital Instruments |
m,ac | 567 | 600 | |||
7.434% Step-up Callable Perpetual Reserve Capital Instruments (US$1,250m) |
n,ad | 866 | 1,055 | |||
14% Step-up Callable Perpetual Reserve Capital Instruments |
e,s | 2,608 | 2,514 | |||
Junior Undated Floating Rate Notes (US$121m) |
d,t | 75 | 83 | |||
7.7% Undated Subordinated Notes (US$99m, 2008: US$2,000m) |
o,af | 65 | 1,644 | |||
Undated Floating Rate Primary Capital Notes Series 3 |
d,u | 145 | 147 | |||
9.25% Perpetual Subordinated Bonds (ex-Woolwich plc) |
f,v | 95 | 232 | |||
9% Permanent Interest Bearing Capital Bonds |
g,w | 43 | 120 | |||
8.25% Undated Subordinated Notes |
o,ae | 152 | 1,092 | |||
7.125% Undated Subordinated Notes |
h,x | 180 | 620 | |||
6.875% Undated Subordinated Notes |
i,y | 151 | 729 | |||
6.375% Undated Subordinated Notes |
j,z | 147 | 526 | |||
6.125% Undated Subordinated Notes |
k,aa | 220 | 666 | |||
6.5% Undated Subordinated Notes (FFr 1,000m) |
| 151 | ||||
5.03% Reverse Dual Currency Undated Subordinated Loan (Yen 8,000m) |
l,ab | 55 | 51 | |||
5% Reverse Dual Currency Undated Subordinated Loan (Yen 12,000m) |
l,ab | 83 | 77 | |||
Undated loan capital non-convertible |
8,148 | 13,673 |
205 |
27 Subordinated liabilities continued
Security and subordination
None of the undated loan capital is secured.
The Junior Undated Floating Rate Notes (the Junior Notes) rank behind the claims against the Bank of depositors and other unsecured unsubordinated creditors and holders of dated loan capital.
All other issues of undated loan capital rank pari passu with each other and behind the claims of the holders of the Junior Notes, except for the 6% and 6.86% Callable Perpetual Core Tier One Notes (the TONs) and the 5.3304%, 5.926%, 6.3688%, 7.434% and 14% Step-up Callable Perpetual Reserve Capital Instruments (the RCIs) (such issues, excluding the TONs and the RCIs, being the Undated Notes and Loans).
The TONs and the RCIs rank pari passu with each other and behind the claims of the holders of the Undated Notes and Loans.
Interest
Notes
a) | These TONs bear a fixed rate of interest until 2032. After that date, in the event that the TONs are not redeemed, the TONs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
b) | These RCIs bear a fixed rate of interest until 2036. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
c) | These RCIs bear a fixed rate of interest until 2016. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
d) | These Notes bear interest at rates fixed periodically in advance, based on London interbank rates. |
e) | These RCIs bear a fixed rate of interest until 2019. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
f) | These Bonds bear a fixed rate of interest until 2021. After that date, in the event that the Bonds are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
g) | The interest rate on these Bonds is fixed for the life of this issue. |
h) | These Notes bear a fixed rate of interest until 2020. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
i) | These Notes bear a fixed rate of interest until 2015. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
j) | These Notes bear a fixed rate of interest until 2017. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
k) | These Notes bear a fixed rate of interest until 2027. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
l) | These Loans bear a fixed rate of interest until 2028 based on a US Dollar principal amount, but the interest payments have been swapped, resulting in a Yen interest rate payable, which is fixed periodically in advance based on London interbank rates. After that date, in the event that the Loans are not redeemed, the Loans will bear Yen interest rates fixed periodically in advance, based on London interbank rates. |
m) | These RCIs bear a fixed rate of interest until 2019. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
n) | These RCIs bear a fixed rate of interest until 2017. After that date, in the event that the RCIs are not redeemed, the RCIs will bear interest at rates fixed periodically in advance, based on London interbank rates. |
o) | These Notes bear a fixed rate of interest until 2018. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance, based on London interbank rates. |
206 |
Notes to the accounts
For the year ended 31st December 2009
continued
27 Subordinated liabilities continued
Barclays Bank PLC is not obliged to make a payment of interest on its Undated Notes and Loans excluding the 9.25% Perpetual Subordinated Bonds, 7.7% Undated Subordinated Notes and 8.25% Undated Subordinated Notes if, in the preceding six months, a dividend has not been declared or paid on any class of shares of Barclays PLC or, in certain cases, any class of preference shares of the Bank. The Bank is not obliged to make a payment of interest on its 9.25% Perpetual Subordinated Bonds if, in the immediately preceding 12 months interest period, a dividend has not been paid on any class of its share capital. Interest not so paid becomes payable in each case if such a dividend is subsequently paid or in certain other circumstances. During the year, the Bank declared and paid dividends on its ordinary shares and on all classes of preference shares.
No payment of principal or any interest may be made unless the Bank satisfies a specified solvency test.
The Bank may elect to defer any payment of interest on the 7.7% Undated Subordinated Notes and 8.25% Undated Subordinated Notes. Until such time as any deferred interest has been paid in full, neither the Bank nor Barclays PLC may declare or pay a dividend, subject to certain exceptions, on any of its ordinary shares, preference shares, or other share capital or satisfy any payments of interest or coupons on certain other junior obligations.
The Bank may elect to defer any payment of interest on the RCIs (b, c, e, m and n above). Any such deferred payment of interest must be paid on the earlier of (i) the date of redemption of the RCIs, (ii) the coupon payment date falling on or nearest to the tenth anniversary of the date of deferral of such payment, and (iii) in respect of e above only, substitution. Whilst such deferral is continuing, neither the Bank nor Barclays PLC may declare or pay a dividend, subject to certain exceptions, on any of its ordinary shares or preference shares.
The Bank may elect to defer any payment of interest on the TONs if it determines that it is, or such payment would result in it being, in non-compliance with capital adequacy requirements and policies of the FSA. Any such deferred payment of interest will only be payable on a redemption of the TONs. Until such time as the Bank next makes a payment of interest on the TONs, neither the Bank nor Barclays PLC may (i) declare or pay a dividend, subject to certain exceptions, on any of their respective ordinary shares or Preference Shares, or make payments of interest in respect of the Banks Reserve Capital Instruments and (ii) certain restrictions on the redemption, purchase or reduction of their respective share capital and certain other securities also apply.
Repayment
Notes
p) | These TONs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after June 2032. |
q) | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after December 2036. |
r) | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after December 2016. |
s) | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after June 2019. |
t) | These Notes are repayable, at the option of the Bank, in whole or in part on any interest payment date. |
u) | These Notes are repayable, at the option of the Bank, in whole on any interest payment date. |
v) | These Bonds are repayable, at the option of the Bank, in whole in 2021, or on any fifth anniversary thereafter. |
w) | These Bonds are repayable, at the option of the Bank, in whole at any time. |
x) | These Notes are repayable, at the option of the Bank, in whole in 2020, or on any fifth anniversary thereafter. |
y) | These Notes are repayable, at the option of the Bank, in whole in 2015, or on any fifth anniversary thereafter. |
z) | These Notes are repayable, at the option of the Bank, in whole in 2017, or on any fifth anniversary thereafter. |
aa) | These Notes are repayable, at the option of the Bank, in whole in 2027, or on any fifth anniversary thereafter. |
ab) | These Loans are repayable, at the option of the Bank, in whole in 2028, or on any fifth anniversary thereafter. |
ac) | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after December 2019. |
ad) | These RCIs are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after December 2017. |
ae) | These Notes are repayable, at the option of the Bank, in whole on any interest payment date falling in or after December 2018. |
af) | These Notes are repayable, at the option of the Bank, in whole on any interest payment date falling in or after April 2018. |
In addition, each issue of undated loan capital is repayable, at the option of the Bank, in whole for certain tax reasons, either at any time, or on an interest payment date. There are no events of default except non-payment of principal or mandatory interest.
Any repayments require the prior notification to the FSA.
All issues of undated loan capital have been made in the eurocurrency market and/or under Rule 144A, and no issues have been registered under the US Securities Act of 1933.
207 |
27 Subordinated liabilities continued
Dated loan capital
Dated loan capital is issued by the Bank for the development and expansion of the Groups business and to strengthen its capital base by Barclays Bank Spain SA (Barclays Spain), Barclays Bank of Botswana Ltd (BBB), Barclays Bank Zambia PLC (Barclays Zambia) and Barclays Bank of Kenya (Barclays Kenya) to enhance their respective capital bases and by Absa and Barclays Bank of Ghana Ltd (BBG) for general corporate purposes. It comprises:
Notes | 2009 £m |
2008 £m | ||||
Non-convertible |
||||||
Barclays Bank PLC |
||||||
7.4% Subordinated Notes 2009 (US$400m) |
| 275 | ||||
Subordinated Fixed to CMS-Linked Notes 2009 (31m) |
| 31 | ||||
12% Unsecured Capital Loan Stock 2010 |
a | 27 | 27 | |||
5.75% Subordinated Notes 2011 (1,000m) |
a | 853 | 943 | |||
5.25% Subordinated Notes 2011 (250m) (ex-Woolwich plc) |
a | 246 | 260 | |||
5.015% Subordinated Notes 2013 (US$150m) |
a | 99 | 112 | |||
4.875% Subordinated Notes 2013 (750m) |
a | 693 | 750 | |||
Callable Floating Rate Subordinated Notes 2015 (US$1,500m) |
b,j | 927 | 1,031 | |||
4.38% Fixed Rate Subordinated Notes 2015 (US$75m) |
a | 51 | 88 | |||
4.75% Fixed Rate Subordinated Notes 2015 (US$150m) |
a | 103 | 81 | |||
Floating Rate Subordinated Step-up Callable Notes 2016 (US$750m) |
b,j | 463 | 514 | |||
Callable Floating Rate Subordinated Notes 2016 ( 1,250m) |
b,j | 1,115 | 1,211 | |||
Callable Floating Rate Subordinated Notes 2017 (US$500m) |
b,j | 309 | 343 | |||
10.125% Subordinated Notes 2017 (ex-Woolwich plc) |
g,j | 107 | 109 | |||
Floating Rate Subordinated Step-up Callable Notes 2017 (US$1,500m) |
b,j | 926 | 1,029 | |||
Floating Rate Subordinated Step-up Callable Notes 2017 (1,500m) |
b,j | 1,337 | 1,444 | |||
6.05% Fixed Rate Subordinated Notes 2017 (US$2,250m) |
a | 1,505 | 1,856 | |||
Floating Rate Subordinated Notes 2018 (40m) |
b | 36 | 38 | |||
6% Fixed Rate Subordinated Notes due 2018 (1,750m) |
a | 1,641 | 1,767 | |||
CMS-Linked Subordinated Notes due 2018 (100m) |
b | 92 | 100 | |||
CMS-Linked Subordinated Notes due 2018 (135m) |
b | 124 | 135 | |||
Floating Rate Subordinated Notes 2019 (50m) |
b | 43 | 47 | |||
Callable Fixed/Floating Rate Subordinated Notes 2019 (1,000m) |
h | 915 | 984 | |||
9.5% Subordinated Bonds 2021(ex-Woolwich plc) |
a | 276 | 298 | |||
Subordinated Floating Rate Notes 2021 (100m) |
b | 87 | 94 | |||
10% Fixed Rate Subordinated Notes 2021 |
a | 2,022 | | |||
10.179% Fixed Rate Subordinated Notes 2021 (US$ 1,521m) |
a | 942 | | |||
Subordinated Floating Rate Notes 2022 (50m) |
b | 45 | 49 | |||
Subordinated Floating Rate Notes 2023 (50m) |
b | 45 | 48 | |||
Fixed/Floating Rate Subordinated Callable Notes 2023 |
m,j | 568 | 571 | |||
5.75% Fixed Rate Subordinated Notes 2026 |
a | 631 | 690 | |||
5.4% Reverse Dual Currency Subordinated Loan 2027 (Yen 15,000m) |
i | 105 | 128 | |||
6.33% Subordinated Notes 2032 |
a | 52 | 53 | |||
Subordinated Floating Rate Notes 2040 (100m) |
b | 89 | 96 | |||
Barclays Bank SA, Spain (Barclays Spain) |
||||||
Subordinated Floating Rate Capital Notes 2011 ( 11m) |
b | 4 | 11 | |||
Absa |
||||||
14.25% Subordinated Callable Notes 2014 (ZAR 3,100m) |
| 240 | ||||
10.75% Subordinated Callable Notes 2015 (ZAR 1,100m) |
c,j | 95 | 85 | |||
Subordinated Callable Notes 2015 (ZAR 400m) |
d,j | 36 | 30 | |||
8.75% Subordinated Callable Notes 2017 (ZAR 1,500m) |
e,j | 129 | 115 | |||
Subordinated Callable Notes 2018 (ZAR 1,886m) |
d,j | 173 | 144 | |||
8.8% Subordinated Fixed Rate Callable Notes 2019 (ZAR 1,725m) |
n,j | 143 | 146 | |||
Subordinated Callable Notes 2019 (ZAR 3,000m) |
d,j | 268 | | |||
8.1% Subordinated Callable Notes 2020 (ZAR 2,000m) |
f,j | 160 | 130 | |||
Subordinated Callable Notes 2028 (ZAR 1,500m) |
d,j | 127 | | |||
Barclays Bank of Ghana Ltd (BBG) |
||||||
14% Fixed Rate BBG Subordinated Callable Notes 2016 (GHC 10m) |
a,j | 4 | 5 | |||
Barclays Bank of Kenya (Barclays Kenya) |
||||||
Floating Rate Subordinated Notes 2014 (KES 968m) |
o | 8 | 8 | |||
Floating Rate Subordinated Notes 2015 (KES 740m) |
o | 6 | 6 | |||
Fixed Rate Subordinated Notes 2015 (KES 1,260m) |
a | 10 | 12 | |||
Barclays Bank Zambia PLC (Barclays Zambia) |
||||||
Subordinated Unsecured Floating Rate Capital Notes 2016 (ZMK 49,232m) |
p | 6 | | |||
Dated loan capital non-convertible |
17,643 | 16,134 |
208 |
Notes to the accounts
For the year ended 31st December 2009
continued
27 Subordinated liabilities continued
Notes | 2009 £m |
2008 £m | |||||
Convertible |
|||||||
Barclays Bank of Botswana (BBB) |
|||||||
Subordinated Unsecured Fixed Rate Capital Notes 2014 (BWP 190m) |
j,k | ) | 18 | 17 | |||
Barclays Bank Zambia PLC (Barclays Zambia) |
|||||||
Subordinated Unsecured Floating Rate Capital Notes 2015 (ZMK 49,086m) |
j,l | ) | 7 | 7 | |||
Absa |
|||||||
Redeemable cumulative option-holding preference shares (ZAR 147m) |
| 11 | |||||
Dated loan capital convertible |
25 | 35 | |||||
Total dated loan capital |
17,668 | 16,169 |
None of the Groups dated loan capital is secured. The debt obligations of the Bank, Barclays Spain, BBG, BBB, Barclays Zambia, Barclays Kenya and Absa rank ahead of the interests of holders of their equity and the dated loan capital has been issued on the basis that the claims thereunder are subordinated to the respective claims of their depositors and other unsecured unsubordinated creditors.
Interest
Notes
a) | The interest rates on these Notes are fixed for the life of those issues. |
b) | These Notes bear interest at rates fixed periodically in advance based on London or European interbank rates. |
c) | These Notes bear a fixed rate of interest until 2010. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
d) | These Notes bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
e) | These Notes bear a fixed rate of interest until 2012. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
f) | These Notes bear a fixed rate of interest until 2015. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
g) | These Notes bear a fixed rate of interest until 2012. After that date, in the event that the Notes are not redeemed, the coupon will be reset to a fixed margin over a reference gilt rate for a further period of five years. |
h) | These Notes bear a fixed rate of interest until 2014. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on European interbank rates. |
i) | This Loan bears a fixed rate of interest based on a US Dollar principal amount, but the interest payments have been swapped, resulting in a Yen interest rate payable which is fixed periodically in advance based on London interbank rates. |
j) | Repayable at the option of the issuer, prior to maturity, on conditions governing the respective debt obligations, some in whole or in part, and some only in whole. |
k) | These Notes bear interest at rates fixed periodically in advance based on the Bank of Botswana Certificate Rate. All of these Notes will be compulsorily converted to Preference Shares of BBB, having a total par value equal in sum to the principal amount of Notes outstanding at the time of conversion, should BBB experience pre-tax losses in excess of its retained earnings and other capital surplus accounts. |
l) | These Notes bear interest at rates fixed periodically in advance based on the Bank of Zambia Treasury Bill rate. All of these Notes will be compulsorily converted to Preference Shares of Barclays Zambia, having a total par value equal in sum to the principal amount of Notes outstanding at the time of conversion, should Barclays Zambia experience pre-tax losses in excess of its retained earnings and other capital surplus accounts. |
m) | These Notes bear a fixed rate of interest until 2018. After that date in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on London interbank rates. |
n) | These Notes bear a fixed rate of interest until 2014. After that date, in the event that the Notes are not redeemed, the Notes will bear interest at rates fixed periodically in advance based on Johannesburg interbank acceptance rates. |
o) | These Notes bear interest at rates fixed periodically in advance based on the Central Bank of Kenya Treasury Bill rates. |
p) | These Notes bear interest at rates fixed periodically in advance based on the Central Bank of Zambia Treasury Bill rates. |
209 |
27 Subordinated liabilities continued
The 7.4% Subordinated Notes 2009 (the 7.4% Notes) issued by the Bank were registered under the US Securities Act of 1933. All other issues of dated loan capital by the Bank, Barclays Spain, BBG, BBB, Barclays Zambia, Barclays Kenya and Absa, which were made in non-US markets, have not been so registered.
Repayment terms
Unless otherwise indicated, the Groups dated loan capital outstanding at 31st December 2009 is redeemable only on maturity, subject in particular cases, to provisions allowing an early redemption in the event of certain changes in tax law or, in the case of BBB and Barclays Zambia, to certain changes in legislation or regulations.
Any repayments prior to maturity require, in the case of the Bank, the prior notification to the FSA, in the case of BBB, the prior approval of the Bank of Botswana, in the case of Barclays Zambia, the prior approval of the Bank of Zambia, and in the case of Absa, the prior approval of the South African Registrar of Banks.
There are no committed facilities in existence at the balance sheet date which permit the refinancing of debt beyond the date of maturity.
28 Provisions
Onerous contracts £m |
Redundancy and restructuring £m |
Undrawn £m |
Sundry provisions £m |
Total £m |
|||||||||||
At 1st January 2009 |
50 | 118 | 109 | 258 | 535 | ||||||||||
Acquisitions and disposals of subsidiaries |
| (2 | ) | 1 | (6 | ) | (7 | ) | |||||||
Exchange and other adjustments |
| 4 | 2 | | 6 | ||||||||||
Additions |
51 | 269 | 119 | 125 | 564 | ||||||||||
Amounts used |
(27 | ) | (201 | ) | (21 | ) | (142 | ) | (391 | ) | |||||
Unused amounts reversed |
(8 | ) | (26 | ) | (48 | ) | (37 | ) | (119 | ) | |||||
Amortisation of discount |
2 | | | | 2 | ||||||||||
At 31st December 2009 |
68 | 162 | 162 | 198 | 590 | ||||||||||
At 1st January 2008 |
64 | 82 | 475 | 209 | 830 | ||||||||||
Acquisitions and disposals of subsidiaries |
9 | (9 | ) | | (1 | ) | (1 | ) | |||||||
Exchange and other adjustments |
2 | | 63 | 15 | 80 | ||||||||||
Additions |
12 | 269 | 461 | 102 | 844 | ||||||||||
Amounts used |
(41 | ) | (213 | ) | (794 | ) | (42 | ) | (1,090 | ) | |||||
Unused amounts reversed |
| (11 | ) | (96 | ) | (25 | ) | (132 | ) | ||||||
Amortisation of discount |
4 | | | | 4 | ||||||||||
At 31st December 2008 |
50 | 118 | 109 | 258 | 535 |
Provisions expected to be recovered or settled within no more than 12 months after 31st December 2009 were £466m (2008: £333m).
Sundry provisions are made with respect to commission clawbacks, warranties and litigation claims.
29 Securitisations
The Group was party to securitisation transactions involving its residential mortgage loans, business loans and credit card balances. In addition, the Group acts as a conduit for commercial paper, whereby it acquires static pools of residential mortgage loans from other lending institutions for securitisation transactions.
In these transactions, the assets, or interests in the assets, or beneficial interests in the cash flows arising from the assets, are transferred to a special purpose entity, or to a trust which then transfers its beneficial interests to a special purpose entity, which then issues floating rate debt securities to third-party investors.
Securitisations may, depending on the individual arrangement, result in continued recognition of the securitised assets and the recognition of the debt securities issued in the transaction; lead to partial continued recognition of the assets to the extent of the Groups continuing involvement in those assets or to derecognition of the assets and the separate recognition, as assets or liabilities, of any rights and obligations created or retained in the transfer. Full derecognition only occurs when the Group transfers both its contractual right to receive cash flows from the financial assets, or retains the contractual rights to receive the cash flows, but assumes a contractual obligation to pay the cash flows to another party without material delay or reinvestment, and also transfers substantially all the risks and rewards of ownership, including credit risk, prepayment risk and interest rate risk.
210 |
Notes to the accounts
For the year ended 31st December 2009
continued
29 Securitisations continued
The following table shows the carrying amount of securitised assets, stated at the amount of the Groups continuing involvement where appropriate, together with the associated liabilities, for each category of asset on the balance sheet:
2009 | 2008 | |||||||||
Carrying £m |
Associated liabilities £m |
Carrying amount of assets £m |
Associated liabilities £m |
|||||||
Loans and advances to customers |
||||||||||
Residential mortgage loans |
10,374 | (10,738 | ) | 12,754 | (13,172 | ) | ||||
Credit card receivables |
1,288 | (1,288 | ) | 1,888 | (2,109 | ) | ||||
Other personal lending |
94 | (124 | ) | 212 | (256 | ) | ||||
Wholesale and corporate loans and advances |
4,835 | (5,999 | ) | 7,702 | (8,937 | ) | ||||
Total |
16,591 | (18,149 | ) | 22,556 | (24,474 | ) | ||||
Assets designated at fair value through profit or loss |
||||||||||
Retained interest in residential mortgage loans |
26 | 316 |
Balances included within loans and advances to customers represent securitisations where substantially all the risks and rewards of the asset have been retained by the Group.
The excess of total associated liabilities over the carrying amount of assets primarily reflects timing differences in the receipt and payment of cash flows, and foreign exchange movements where the assets and associated liabilities are denominated in different currencies.
Retained interests in residential mortgage loans are securities which represent a continuing exposure to the prepayment and credit risk in the underlying securitised assets. The total amount of the loans was £14,795m (2008: £31,734m). The retained interest is initially recorded as an allocation of the original carrying amount based on the relative fair values of the portion derecognised and the portion retained.
30 Retirement benefit obligations
Pension schemes
The UK Retirement Fund (UKRF), which is the main scheme of the Group, amounting to 93% of all the Groups schemes in terms of benefit obligations, comprises ten sections.
The 1964 Pension Scheme
Most employees recruited before July 1997 are members of this non-contributory defined benefit scheme. Pensions are calculated by reference to service and pensionable salary and are normally subject to a deduction from State pension age.
The Retirement Investment Scheme (RIS)
A defined contribution plan for most joiners between July 1997 and 1st October 2003. This was closed to new entrants on 1st October 2003 and the large majority of existing members of the RIS transferred to Afterwork in respect of future benefit accrual with effect from 1st January 2004. There are no longer any active members of the RIS.
The Pension Investment Plan (PIP)
A defined contribution plan created from 1st July 2001 to provide benefits for employees of Barclays Capital.
Afterwork
Combines a contributory cash balance element with a voluntary defined contribution element. The majority of new employees outside of Barclays Capital since 1st October 2003 are eligible to join Afterwork. In addition, the large majority of active members of the RIS (now closed) were transferred to Afterwork in respect of future benefit accrual after 1st January 2004.
Career Average Section
The Career Average Section was established in the UKRF with effect from 1st May 2004 following the transfer of members from the Woolwich Pension Fund. The Career Average Section is a non-contributory career average scheme and was closed to new entrants on 1st December 2006.
1951 Fund Section, AP89 Section, BCPS Section, CCS Section and Mercantile Section
Five new sections were established in the UKRF with effect from 31st March 2007 following the merger of the UKRF with five smaller schemes sponsored from within the Group. All five sections are closed to new members.
The 1951 Fund Section, AP89 Section and Mercantile Section provide final salary benefits calculated by reference to service and pensionable salary.
The BCPS and CCS Sections provide defined contribution benefits. The benefits built up in these sections in relation to service before 6th April 1997 are subject to a defined benefit minimum.
In addition, the costs of ill-health retirements and death in service benefits are generally borne by the UKRF for each of the ten sections. From November 2008, members were given the option to contribute by way of salary sacrifice to the UKRF.
On 10th September 2009, the Trust Deed was amended such that with effect from 1st April 2010 the following sections of the UKRF will close to the accrual of future pension benefits: 1964 Pension Scheme; AP89 Section; 1951 Fund Section; Mercantile Section; Career Average Section; and CCS Section. Members of these sections will be eligible to accrue future service pension benefits in either Afterwork or PIP from 1st April 2010. This gave rise to the recognition of a curtailment gain during the year of £487m, the recognition of actuarial losses of £79m and an additional cost of £37m included in other staff costs.
211 |
30 Retirement benefit obligations continued
Governance
The UKRF operates under trust law and is managed and administered on behalf of the members in accordance with the terms of the Trust Deed and all relevant legislations. The Corporate Trustee is Barclays Pension Funds Trustees Limited (BPFTL), a private limited company incorporated on 20th December 1990 and is a wholly owned subsidiary of Barclays Bank PLC. The Trustee is the legal owner of the assets of the UKRF which are held separately from the assets of the Group.
The Trustee Board comprises six Management Directors selected by Barclays, of whom three are independent Directors with no relationship with Barclays or the UKRF, and three are Member Nominated Directors. In addition there are three Alternate Management Directors and three Alternate Member Nominated Directors. Member Nominated Directors are selected from those eligible active staff and pensioner members who apply to be considered for the role.
The Pensions Act 2004 (the Act) requires corporate trustees to take responsibility for making arrangements for the nomination and selection of Member Nominated Directors (MNDs). A formal procedure has been in place since 1st September 2007, which is fully compliant with the legal requirements and reflects best practice. Eligibility for nomination and selection is open to all members of the UKRF but excludes those in receipt of solely spouses, civil partners, dependants or ex-spouse participants pensions, deferred pensioners and members with eligibility for death benefits only.
Under the Act, the Bank and the Trustee must agree on the funding rate, including a recovery plan to fund any deficit against the scheme specific statutory funding objective. The first ongoing funding valuation to be completed under this legislation was carried out as at 30th September 2007.
There are other pension schemes (both defined benefit and defined contribution) in the UK and overseas. The same principles of pension governance applies to UK based schemes, although different legislation covers overseas schemes where, in most cases, the Bank has the power to determine the funding rate.
The following tables present an analysis of defined benefit obligation and fair value of plan assets for all the Groups pension schemes and post-retirement benefits (the latter are unfunded) and present the amounts recognised in the income statement including those related to post-retirement health care.
2009 | 2008 | 2007 | |||||||||||||||||||||||
Pensions £m |
Other post- retirement benefits £m |
Total £m |
Pensions £m |
Other post- retirement benefits £m |
Total £m |
Pensions £m |
Other post- retirement benefits £m |
Total £m |
|||||||||||||||||
Income statement charge |
|||||||||||||||||||||||||
Current service cost |
281 | 10 | 291 | 299 | 2 | 301 | 332 | 2 | 334 | ||||||||||||||||
Interest cost |
992 | 9 | 1,001 | 991 | 8 | 999 | 905 | 8 | 913 | ||||||||||||||||
Expected return on scheme assets |
(935 | ) | | (935 | ) | (1,175 | ) | | (1,175 | ) | (1,074 | ) | | (1,074 | ) | ||||||||||
Recognised actuarial (gain)/loss |
96 | | 96 | (23 | ) | (1 | ) | (24 | ) | (1 | ) | | (1 | ) | |||||||||||
Past service cost |
6 | | 6 | 2 | (8 | ) | (6 | ) | 20 | | 20 | ||||||||||||||
Curtailment or settlements |
(473 | ) | | (473 | ) | (5 | ) | | (5 | ) | (32 | ) | | (32 | ) | ||||||||||
Total included in staff costs |
(33 | ) | 19 | (14 | ) | 89 | 1 | 90 | 150 | 10 | 160 |
Staff costs are included in other operating expenses. Of the other post retirement benefit costs £16m relate to continuing operations (2008: £1m, 2007: £9m).
2009 | 2008 | |||||||||||||||||||||||||||||
Pensions | Post-retirement benefits |
Total | Pensions | Post-retirement benefits |
Total | |||||||||||||||||||||||||
UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | |||||||||||||||||||||
Benefit obligation at beginning of the year |
(14,395 | ) | (1,220 | ) | (43 | ) | (125 | ) | (15,783 | ) | (16,563 | ) | (913 | ) | (60 | ) | (98 | ) | (17,634 | ) | ||||||||||
Current service cost |
(254 | ) | (27 | ) | (1 | ) | (9 | ) | (291 | ) | (276 | ) | (23 | ) | | (2 | ) | (301 | ) | |||||||||||
Interest cost |
(941 | ) | (51 | ) | (3 | ) | (6 | ) | (1,001 | ) | (946 | ) | (45 | ) | (3 | ) | (5 | ) | (999 | ) | ||||||||||
Past service cost |
(1 | ) | | | | (1 | ) | (2 | ) | (11 | ) | 7 | | (6 | ) | |||||||||||||||
Curtailments or settlements |
482 | (7 | ) | | 1 | 476 | 7 | 2 | | | 9 | |||||||||||||||||||
Actuarial (loss)/gain |
(4,757 | ) | (33 | ) | (3 | ) | 7 | (4,786 | ) | 2,807 | | 11 | (5 | ) | 2,813 | |||||||||||||||
Contributions by plan participants |
(2 | ) | (5 | ) | | | (7 | ) | (20 | ) | (3 | ) | | | (23 | ) | ||||||||||||||
Benefits paid |
659 | 58 | 1 | 6 | 724 | 598 | 42 | 2 | 9 | 651 | ||||||||||||||||||||
Business disposals |
| 9 | | 6 | 15 | | | | | | ||||||||||||||||||||
Exchange and other adjustments |
| (1 | ) | (16 | ) | 25 | 8 | | (269 | ) | | (24 | ) | (293 | ) | |||||||||||||||
Benefit obligation at end of the year |
(19,209 | ) | (1,277 | ) | (65 | ) | (95 | ) | (20,646 | ) | (14,395 | ) | (1,220 | ) | (43 | ) | (125 | ) | (15,783 | ) |
212 |
Notes to the accounts
For the year ended 31st December 2009
continued
30 Retirement benefit obligations continued
The benefit obligation arises from plans that are wholly unfunded and wholly or partly funded as follows:
2009 £m |
2008 £m |
|||||
Unfunded obligations |
(288 | ) | (297 | ) | ||
Wholly or partly funded obligations |
(20,358 | ) | (15,486 | ) | ||
Total |
(20,646 | ) | (15,783 | ) |
Change in plan assets
2009 | 2008 | |||||||||||||||||||||||||||||
Pensions |
Post-retirement benefits |
Total | Pensions |
Post-retirement benefits |
Total | |||||||||||||||||||||||||
UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | |||||||||||||||||||||
Fair value of plan assets at beginning of the year |
13,537 | 959 | | | 14,496 | 17,231 | 796 | | | 18,027 | ||||||||||||||||||||
Expected return on plan assets |
904 | 31 | | | 935 | 1,134 | 41 | | | 1,175 | ||||||||||||||||||||
Employer contribution |
525 | 76 | 1 | 6 | 608 | 336 | 71 | 2 | 9 | 418 | ||||||||||||||||||||
Settlements |
| (2 | ) | | | (2 | ) | | (2 | ) | | | (2 | ) | ||||||||||||||||
Contributions by plan participants |
2 | 5 | | | 7 | 20 | 3 | | | 23 | ||||||||||||||||||||
Actuarial gain/(loss) |
1,424 | (8 | ) | | | 1,416 | (4,534 | ) | (121 | ) | | | (4,655 | ) | ||||||||||||||||
Benefits paid |
(659 | ) | (58 | ) | (1 | ) | (6 | ) | (724 | ) | (598 | ) | (42 | ) | (2 | ) | (9 | ) | (651 | ) | ||||||||||
Business disposals |
| (6 | ) | | | (6 | ) | | | | | | ||||||||||||||||||
Exchange and other adjustments |
(58 | ) | 28 | | | (30 | ) | (52 | ) | 213 | | | 161 | |||||||||||||||||
Fair value of plan assets at the end of the year |
15,675 | 1,025 | | | 16,700 | 13,537 | 959 | | | 14,496 |
Amounts recognised on-balance sheet
The pension and post-retirement benefit assets and liabilities recognised on the balance sheet are as follows:
2009 | 2008 | |||||||||||||||||||||||||||||
Pensions |
Post-retirement benefits |
Total | Pensions |
Post-retirement benefits |
Total | |||||||||||||||||||||||||
UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | UK £m |
Overseas £m |
UK £m |
Overseas £m |
£m | |||||||||||||||||||||
Benefit obligation at end of period |
(19,209 | ) | (1,277 | ) | (65 | ) | (95 | ) | (20,646 | ) | (14,395 | ) | (1,220 | ) | (43 | ) | (125 | ) | (15,783 | ) | ||||||||||
Fair value of plan assets at end of period |
15,675 | 1,025 | | | 16,700 | 13,537 | 959 | | | 14,496 | ||||||||||||||||||||
Net deficit |
(3,534 | ) | (252 | ) | (65 | ) | (95 | ) | (3,946 | ) | (858 | ) | (261 | ) | (43 | ) | (125 | ) | (1,287 | ) | ||||||||||
Unrecognised actuarial losses/(gains) |
3,087 | 158 | (7 | ) | 10 | 3,248 | (167 | ) | 150 | (11 | ) | 23 | (5 | ) | ||||||||||||||||
Net recognised liability |
(447 | ) | (94 | ) | (72 | ) | (85 | ) | (698 | ) | (1,025 | ) | (111 | ) | (54 | ) | (102 | ) | (1,292 | ) | ||||||||||
Recognised assets a |
| 71 | | | 71 | | 65 | | | 65 | ||||||||||||||||||||
Recognised liability |
(447 | ) | (165 | ) | (72 | ) | (85 | ) | (769 | ) | (1,025 | ) | (176 | ) | (54 | ) | (102 | ) | (1,357 | ) | ||||||||||
Net recognised liability |
(447 | ) | (94 | ) | (72 | ) | (85 | ) | (698 | ) | (1,025 | ) | (111 | ) | (54 | ) | (102 | ) | (1,292 | ) |
The UKRF funded status, as measured using the IAS 19 assumptions detailed below, has decreased from a deficit of £0.9bn at 31st December 2008 to a deficit of £3.5bn at 31st December 2009. The most significant reasons for this change were the decrease in AA corporate bond yields which resulted in a lower discount rate of 5.61% (31st December 2008: 6.75%) and an increase in the long-term inflation assumption to 3.76% (31st December 2008: 3.16%). The impact of the change in assumptions was partially offset by a one-off curtailment credit resulting from the closure of the UK final salary pension schemes to existing members, better than expected asset performance, and contributions paid in excess of the pension expense.
Note
a | Included within other assets. |
213 |
30 Retirement benefit obligations continued
Assumptions
Obligations arising under defined benefit schemes are actuarially valued using the projected unit credit method. Under this method, where a defined benefit scheme is closed to new members, such as in the case of the 1964 Pension Scheme, the current service cost expressed as a percentage of salary is expected to increase in the future, although this higher rate will be applied to a decreasing payroll. The latest actuarial IFRS valuations were carried out as at 31st December using the following assumptions:
UK schemes | Overseas schemes | |||||||
2009 % p.a. |
2008 % p.a. |
2009 % p.a. |
2008 % p.a. | |||||
Discount rate |
5.61 | 6.75 | 7.53 | 7.09 | ||||
Rate of increase in salaries |
4.26 | 3.66 | 5.49 | 5.93 | ||||
Inflation rate |
3.76 | 3.16 | 3.78 | 3.98 | ||||
Rate of increase for pensions in payment |
3.56 | 3.06 | 3.27 | 3.17 | ||||
Rate of increase for pensions in deferment |
3.76 | 3.16 | 2.81 | 4.37 | ||||
Initial health care inflation |
7.00 | 8.00 | 8.50 | 9.00 | ||||
Long-term health care inflation |
5.00 | 5.00 | 5.00 | 5.01 | ||||
Expected return on plan assets |
6.70 | 6.80 | 7.44 | 7.95 |
The expected return on plan assets assumption is weighted on the basis of the fair value of these assets. Health care inflation assumptions are weighted on the basis of the health care cost for the period. All other assumptions are weighted on the basis of the defined benefit obligation at the end of the period.
The UK Schemes discount rate assumption is based on a liability-weighted rate derived from an AA corporate bond yield curve.
The overseas health care inflation assumptions relate to the US.
Mortality assumptions
The post-retirement mortality assumptions used in valuing the liabilities of the UKRF were based on the standard 2000 series tables as published by the Institute and Faculty of Actuaries. These tables are considered to be most relevant to the population of the UKRF based on their mortality history. These were then adjusted in line with the actual experience of the UKRFs own pensioners relative to the standard table. An allowance has been made for future mortality improvements based on the medium cohort projections published by the Continuous Mortality Investigation Bureau subject to a floor of 1% pa on future improvements. On this basis the post-retirement mortality assumptions for the UKRF includes:
2009 | 2008 | 2007 | 2006 | 2005 | ||||||
Longevity at 60 for current pensioners (years) |
||||||||||
Males |
27.5 | 27.4 | 26.7 | 25.8 | 25.8 | |||||
Females |
28.7 | 28.5 | 27.9 | 29.5 | 29.5 | |||||
Longevity at 60 for future pensioners currently aged 40 (years) |
||||||||||
Males |
29.6 | 29.5 | 28.0 | 27.1 | 27.1 | |||||
Females |
30.6 | 30.5 | 29.1 | 30.7 | 30.6 |
Sensitivity analysis
Sensitivity analysis for each of the principal assumptions used to measure the benefit obligation of the UKRF are as follows:
Impact on UKRF benefit obligation | ||||||
(Decrease)/ % |
(Decrease)/ £bn |
|||||
0.5% increase to: |
||||||
Discount rate |
(8.5 | ) | (1.6 | ) | ||
Rate of inflation |
7.7 | 1.5 | ||||
1 year increase to longevity at 60 |
2.5 | 0.5 |
Following the amendment to the UKRF Trust Deed on 10th September 2009, the UKRF benefit obligation is not sensitive to future salary growth.
214 |
Notes to the accounts
For the year ended 31st December 2009
continued
30 Retirement benefit obligations continued
Post-retirement health care
A one percentage point change in assumed health care trend rates, assuming all other assumptions remain constant would have the following effects for 2009:
1% increase £m |
1% decrease £m |
||||
Effect on total of service and interest cost components |
1 | (1 | ) | ||
Effect on post-retirement benefit obligation |
13 | (11 | ) |
Assets
A long-term strategy has been set for the asset allocation of the UKRF which comprises a mixture of equities, bonds, property and other appropriate assets. This recognises that different asset classes are likely to produce different long-term returns and some asset classes may be more volatile than others.
The long-term strategy ensures that investments are adequately diversified. Asset managers are permitted some flexibility to vary the asset allocation from the long-term strategy within control ranges agreed with the Trustees from time to time.
The UKRF also employs derivative instruments, where appropriate, to achieve a desired exposure or return, or to match assets more closely to liabilities. The value of assets shown reflects the actual physical assets held by the scheme, with any derivative holdings reflected on a mark to market basis. The expected return on asset assumptions overall have been based on the portfolio of assets created after allowing for the net impact of the derivatives on the risk and return profile of the holdings.
During the second half of 2009, an investment de-risking programme was agreed for the UKRF between the Bank and the Trustee in order to achieve a better matching between assets and liabilities and to reduce the investment risk profile of the plan. This involved a partial sale of physical equities and purchase of index-linked gilts.
The value of the assets of the schemes, their percentage in relation to total scheme assets, and their expected rate of return at 31st December 2009 and 31st December 2008 were as follows:
UK schemes | Overseas schemes | Total | ||||||||||||||||||||
Value £m |
% of total fair value of scheme assets |
Expected of return % |
Value £m |
% of total fair value of scheme assets |
Expected of return % |
Value £m |
% of total fair value of scheme assets |
Expected of return % | ||||||||||||||
2009 |
||||||||||||||||||||||
Equities |
4,236 | 27 | 8.6 | 400 | 39 | 7.8 | 4,636 | 28 | 8.5 | |||||||||||||
Bonds |
8,787 | 56 | 4.9 | 387 | 38 | 6.0 | 9,174 | 55 | 4.9 | |||||||||||||
Property |
1,186 | 8 | 7.0 | 20 | 2 | 12.6 | 1,206 | 7 | 7.1 | |||||||||||||
Derivatives |
(37 | ) | | | | | | (37 | ) | | | |||||||||||
Cash |
1,157 | 7 | 0.5 | 139 | 14 | 3.2 | 1,296 | 8 | 0.8 | |||||||||||||
Other |
346 | 2 | 5.0 | 79 | 7 | 8.1 | 425 | 2 | 5.6 | |||||||||||||
Fair value of plan assets a |
15,675 | 100 | 6.7 | 1,025 | 100 | 6.6 | 16,700 | 100 | 6.7 | |||||||||||||
2008 |
||||||||||||||||||||||
Equities |
5,813 | 43 | 8.5 | 217 | 23 | 9.3 | 6,030 | 42 | 8.5 | |||||||||||||
Bonds |
6,360 | 47 | 5.3 | 166 | 17 | 6.2 | 6,526 | 45 | 5.3 | |||||||||||||
Property |
1,214 | 9 | 7.2 | 16 | 2 | 13.4 | 1,230 | 8 | 7.3 | |||||||||||||
Derivatives |
(420 | ) | (3 | ) | | | | | (420 | ) | (3 | ) | | |||||||||
Cash |
(131 | ) | (1 | ) | 2.0 | 415 | 43 | 7.6 | 284 | 2 | 3.9 | |||||||||||
Other |
701 | 5 | 7.4 | 145 | 15 | 6.4 | 846 | 6 | 7.2 | |||||||||||||
Fair value of plan assets a |
13,537 | 100 | 6.8 | 959 | 100 | 8.0 | 14,496 | 100 | 6.9 |
Note
a | Excludes £890m (2008: £675m) representing the money purchase assets of the UKRF. |
215 |
30 Retirement benefit obligations continued
The UKRF plan assets include £58m relating to UK private equity investments (2008: £27m) and £921m relating to overseas private equity investments (2008: £735m). These are disclosed within Equities.
Amounts included in the fair value of plan assets include £4m (2008: £5m) relating to shares in Barclays Group, £5m (2008: £11m) relating to bonds issued by the Barclays Group, £nil (2008: £nil) relating to other investments in the Barclays Group, and £10m (2008: £17m) relating to property occupied by Group companies.
The expected return on assets is determined by calculating a total return estimate based on weighted average estimated returns for each asset class. Asset class returns are estimated using current and projected economic and market factors such as inflation, credit spreads and equity risk premiums.
The Group actual return on plan assets was an increase of £2,351m (2008: £3,480m decrease).
Actuarial gains and losses
The actuarial gains and losses arising on plan liabilities and plan assets are as follows:
2009 £m |
2008 £m |
2007 £m |
2006 £m |
2005 £m |
|||||||||||
UK schemes |
|||||||||||||||
Present value of obligations |
(19,274 | ) | (14,438 | ) | (16,623 | ) | (17,353 | ) | (18,252 | ) | |||||
Fair value of plan assets |
15,675 | 13,537 | 17,231 | 16,761 | 15,571 | ||||||||||
Net (deficit)/surplus in the plans |
(3,599 | ) | (901 | ) | 608 | (592 | ) | (2,681 | ) | ||||||
Experience gains and (losses) on plan liabilities |
|||||||||||||||
amount |
107 | (81 | ) | (297 | ) | 48 | (2 | ) | |||||||
as percentage of plan liabilities |
1% | (1% | ) | (2% | ) | | | ||||||||
Difference between actual and expected return on plan assets |
|||||||||||||||
amount |
1,424 | (4,534 | ) | (332 | ) | 423 | 1,599 | ||||||||
as percentage of plan assets |
9% | (33% | ) | (2% | ) | 3% | 10% | ||||||||
Overseas schemes |
|||||||||||||||
Present value of obligations |
(1,372 | ) | (1,345 | ) | (1,011 | ) | (970 | ) | (1,017 | ) | |||||
Fair value of plan assets |
1,025 | 959 | 796 | 745 | 819 | ||||||||||
Net deficit in the plans |
(347 | ) | (386 | ) | (215 | ) | (225 | ) | (198 | ) | |||||
Experience losses on plan liabilities |
|||||||||||||||
amount |
(45 | ) | (96 | ) | (79 | ) | (54 | ) | (2 | ) | |||||
as percentage of plan liabilities |
(3% | ) | (7% | ) | (8% | ) | (6% | ) | | ||||||
Difference between actual and expected return on plan assets |
|||||||||||||||
amount |
(8 | ) | (121 | ) | (11 | ) | 25 | 2 | |||||||
as percentage of plan assets |
(1% | ) | (13% | ) | | 3% | | ||||||||
Total UK and Overseas schemes |
|||||||||||||||
Present value of obligations |
(20,646 | ) | (15,783 | ) | (17,634 | ) | (18,323 | ) | (19,269 | ) | |||||
Fair value of plan assets |
16,700 | 14,496 | 18,027 | 17,506 | 16,390 | ||||||||||
Net (deficit)/surplus in the plans |
(3,946 | ) | (1,287 | ) | 393 | (817 | ) | (2,879 | ) | ||||||
Experience gains and (losses) on plan liabilities |
|||||||||||||||
amount |
62 | (177 | ) | (376 | ) | (6 | ) | (4 | ) | ||||||
as percentage of plan liabilities |
0% | (1% | ) | (2% | ) | | | ||||||||
Difference between actual and expected return on plan assets |
|||||||||||||||
amount |
1,416 | (4,655 | ) | (343 | ) | 448 | 1,601 | ||||||||
as percentage of plan assets |
8% | (32% | ) | (2% | ) | 3% | 10 | % |
216 |
Notes to the accounts
For the year ended 31st December 2009
continued
30 Retirement benefit obligations continued
Funding
The most recent triennial funding valuation of the UK Retirement Fund (UKRF) was performed with an effective date of 30th September 2007. In compliance with the Pensions Act 2004, the Bank and Trustee have agreed a scheme-specific funding target, statement of funding principles, and a schedule of contributions. This agreement forms the basis of the Groups commitment that the fund has sufficient assets to make payments to members in respect of their accrued benefits as and when they fall due. This funding valuation uses a discount rate that reflects a prudent expectation of long-term future investment returns from the current and assumed future investment strategy, and takes into account projected future salary increases when assessing liabilities arising from accrued service.
As at 30th September 2007 the funding valuation showed a surplus of £0.2bn. The Scheme Actuary prepares an annual update of the funding position as at 30th September. The latest annual update was carried out as at 30th September 2009 and showed a deficit of £4.8bn. The next triennial funding valuation will take place with an effective date of 30th September 2010.
The Group has agreed funding contributions which, in aggregate, are no less than those which are sufficient to meet the Groups share of the cost of benefits accruing over each year. The Group has, in the recent past, chosen to make funding contributions in excess of this, more consistent with the IAS 19 service cost; and in 2009 made an additional voluntary contribution of £150m.
Defined benefit contributions paid with respect to the UKRF were as follows:
£m | ||
Contributions paid |
||
2009 |
525 | |
2008 |
336 | |
2007 |
355 |
Excluding the UKRF, the Group is expected to pay contributions of approximately £1m to UK schemes and £59m to overseas schemes in 2010.
The Group is committed to making estimated contributions to UKRF in 2010 of £290m, with potential additional voluntary contributions dependent on the schemes funding level.
31 Ordinary shares, share premium, and other equity
Ordinary shares and share premium
Number of m |
Ordinary shares £m |
Share premium £m |
Total £m |
||||||||
At 1st January 2009 |
8,372 | 2,093 | 4,045 | 6,138 | |||||||
Issued under the Incentive Share Option Plan a |
| | | | |||||||
Issued to staff under the Share Incentive Plan |
19 | 5 | 30 | 35 | |||||||
Issue of new ordinary shares |
379 | 94 | 655 | 749 | |||||||
Conversion of Mandatorily Convertible Notes |
2,642 | 661 | 3,221 | 3,882 | |||||||
At 31st December 2009 |
11,412 | 2,853 | 7,951 | 10,804 | |||||||
At 1st January 2008 |
6,601 | 1,651 | 56 | 1,707 | |||||||
Issued to staff under the Sharesave Share Option Scheme |
3 | 1 | 13 | 14 | |||||||
Issued under the Incentive Share Option Plan a |
1 | | 3 | 3 | |||||||
Issued to staff under the Share Incentive Plan a |
1 | | 2 | 2 | |||||||
Issue of new ordinary shares |
1,803 | 451 | 3,971 | 4,422 | |||||||
Repurchase of shares |
(37 | ) | (10 | ) | | (10 | ) | ||||
At 31st December 2008 |
8,372 | 2,093 | 4,045 | 6,138 |
Note
a | The nominal value of share options issued during 2008 for the Incentive Share Option Plan and Share Incentive Plan was less than £500,000 in each case. |
217 |
31 Ordinary shares, share premium, and other equity continued
The authorised share capital of Barclays PLC is £5,290m, US$77.5m, 40m and Japanese Yen (¥)4,000m (31st December 2008: £3,540m, US$77.5m, 40m and ¥4,000m) comprising 20,996 million (31st December 2008: 13,996 million) ordinary shares of 25p each, 0.4 million (31st December 2008: 0.4 million) Sterling preference shares of £100 each, 0.4 million (31st December 2008: 0.4 million) US Dollar preference shares of $100 each, 150 million (31st December 2008: 150 million) US Dollar preference shares of $0.25 each, 0.4 million (31st December 2008: 0.4 million) Euro preference shares of 100 each, 0.4 million (31st December 2008: 0.4 million) Yen preference shares of ¥10,000 each and 1 million (31st December 2008: 1 million) staff shares of £1 each.
Called up share capital, allotted and fully paid | 2009 £m |
2008 £m |
|||
Ordinary shares: |
|||||
At beginning of year |
2,093 | 1,650 | |||
Issued to staff under the Sharesave Share Option Scheme |
| 1 | |||
Issued to staff under the Share Incentive Plan |
5 | | |||
Issue of new ordinary shares |
94 | 451 | |||
Conversion of Mandatorily Convertible Notes |
661 | | |||
Repurchase of shares |
| (9 | ) | ||
At end of year |
2,853 | 2,093 | |||
Staff shares: |
|||||
At beginning of year |
| 1 | |||
Repurchase of shares |
| (1 | ) | ||
At end of year |
| | |||
Total |
2,853 | 2,093 |
Issue of new ordinary shares
During the year, the following share issues took place:
Conversion of Mandatorily Convertible Notes
The Mandatorily Convertible Notes (MCNs), issued by Barclays Bank PLC on 27th November 2008, were converted into 2,642 million ordinary shares in Barclays PLC by 30th June 2009 at the conversion price of £1.53276. £661m was credited to share capital and the remaining £3,221m (net of issuance costs) was credited to the share premium account.
Warrants
On 31st October 2008 Barclays PLC issued, in conjunction with a simultaneous issue of Reserve Capital Instruments issued by Barclays Bank PLC, warrants to subscribe for up to 1,516.9 million new ordinary shares at a price of £1.97775 to Qatar Holding LLC and HH Sheikh Mansour Bin Zayed Nahyan.
On 28th October 2009, Qatar Holding LLC exercised 379.2 million warrants to subscribe for new Barclays PLC Shares. £94m was credited to share capital and the remaining £655m was credited to the share premium account.
Share repurchase
No share repurchases were made during the year. In 2008, Barclays PLC repurchased shares at a cost of £173m.
At the 2009 AGM on 23rd April 2009, Barclays PLC was authorised to repurchase 837,620,130 of its ordinary shares of 25p. The authorisation is effective until the AGM in 2010.
Shares under option
The Group has four schemes that give employees rights to subscribe for new shares in Barclays PLC. A summary of the key terms of each scheme are included in Note 44.
At 31st December 2009, 91.3 million (2008: 94.1 million) options were outstanding under the terms of the Sharesave Share Option Scheme (Sharesave), no options were outstanding under the terms of the Executive Share Option Scheme (ESOS) (2008: 0.5 million), 0.1 million (2008: 0.4 million) options were outstanding under the terms of the Woolwich Executive Share Option Plan (Woolwich ESOP) and 12.6 million (2008: 20.5 million) options were outstanding under the terms of the Incentive Share Option Plan (ISOP) enabling certain Directors and members of staff to subscribe for ordinary shares between 2009 and 2017 at prices ranging from 144p to 547p.
In addition to the above, the independent trustee of the Barclays Group (ESAS) Employees Benefit Trust (ESAS Trust), established by Barclays Bank PLC in 1996, operates the Executive Share Award Scheme (ESAS). ESAS is a deferred share bonus plan for employees of the Group. The key terms of the ESAS are described in Note 44. The independent trustees of the ESAS Trust make awards of Barclays shares and grant options over Barclays shares to beneficiaries of the ESAS Trust. Beneficiaries of the ESAS Trust include employees and former employees of the Barclays Group.
218 |
Notes to the accounts
For the year ended 31st December 2009
continued
31 Ordinary shares, share premium, and other equity continued
The independent trustee of the Barclays Group (PSP and ESOS) Employees Benefit Trust (PSP Trust), established by Barclays Bank PLC in 1996, operates the Performance Share Plan (PSP) and may satisfy awards under the ESOS. No awards have been made under this trust since 1999. All awards are in the form of options over Barclays shares.
The Sharepurchase scheme which was established in 2002 is open to all eligible UK employees, including executive Directors. The key terms of the Sharepurchase scheme are described in Note 44.
The Global Sharepurchase scheme which was established in 2009 is open to all eligible non UK employees, excluding executive Directors. The key terms of the Global Sharepurchase scheme are described in Note 44.
32 Reserves
Other reserves
Capital £m |
Other capital reserve £m |
Available for sale reserve £m |
Cash flow hedging reserve £m |
Currency translation reserve £m |
Total £m |
|||||||||||
At 1st January 2009 |
394 | 617 | (1,190 | ) | 132 | 2,840 | 2,793 | |||||||||
Net gains from changes in fair value |
| | 1,194 | 287 | | 1,481 | ||||||||||
Net gains transferred to net profit |
| | (415 | ) | (92 | ) | | (507 | ) | |||||||
Currency translation differences |
| | | | (1,223 | ) | (1,223 | ) | ||||||||
Net losses transferred to net profit due to impairment |
| | 670 | | | 670 | ||||||||||
Changes in insurance liabilities |
| | (67 | ) | | | (67 | ) | ||||||||
Net gains transferred to net profit due to fair value hedging |
| | (123 | ) | | | (123 | ) | ||||||||
Tax |
| | (179 | ) | (75 | ) | (2 | ) | (256 | ) | ||||||
At 31st December 2009 |
394 | 617 | (110 | ) | 252 | 1,615 | 2,768 | |||||||||
At 1st January 2008 |
384 | 617 | 154 | 26 | (307 | ) | 874 | |||||||||
Net (losses)/gains from changes in fair value |
| | (1,736 | ) | 252 | | (1,484 | ) | ||||||||
Net (gains)/losses transferred to net profit |
| | (212 | ) | 19 | | (193 | ) | ||||||||
Currency translation differences |
| | | | 2,307 | 2,307 | ||||||||||
Net losses transferred to net profit due to impairment |
| | 382 | | | 382 | ||||||||||
Changes in insurance liabilities |
| | 17 | | | 17 | ||||||||||
Net gains transferred to net profit due to fair value hedging |
| | (2 | ) | | | (2 | ) | ||||||||
Tax |
| | 207 | (165 | ) | 840 | 882 | |||||||||
Repurchase of shares |
10 | | | | | 10 | ||||||||||
At 31st December 2008 |
394 | 617 | (1,190 | ) | 132 | 2,840 | 2,793 |
Available for sale net gains transferred to net profit includes £349m gain (2008: £212m gain) relating to continuing operations and £66m gain (2008: £nil) relating to discontinued operations.
The capital redemption reserve and other capital reserve represent transfers from retained earnings in accordance with relevant legislation. These reserves are not distributable.
The available for sale reserve represents the unrealised change in the fair value of available for sale investments since initial recognition.
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss.
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Groups net investment in foreign operations, net of the effects of hedging.
Transfers from cash flow hedging reserve
Gains and losses transferred from the cash flow hedging reserve were to: interest income: £22m loss (2008: £4m loss), interest expense: £272m gain (2008: £74m loss), net trading income: £165m loss (2008: £119m gain), and administration and general expenses: £7m gain (2008: £60m loss).
219 |
32 Reserves continued
Retained earnings and treasury shares
Retained earnings £m |
Treasury shares £m |
Total £m |
|||||||
At 1st January 2009 |
24,208 | (173 | ) | 24,035 | |||||
Profit attributable to equity holders of the Parent |
9,393 | | 9,393 | ||||||
Equity-settled share schemes |
298 | | 298 | ||||||
Tax on equity-settled share schemes |
156 | | 156 | ||||||
Other taxes |
32 | | 32 | ||||||
Net purchases of treasury shares |
| (47 | ) | (47 | ) | ||||
Transfer |
(80 | ) | 80 | | |||||
Dividends paid |
(113 | ) | | (113 | ) | ||||
Conversion of mandatorily convertible notes |
(230 | ) | | (230 | ) | ||||
Other |
181 | | 181 | ||||||
At 31st December 2009 |
33,845 | (140 | ) | 33,705 | |||||
At 1st January 2008 |
20,970 | (260 | ) | 20,710 | |||||
Profit attributable to equity holders of the Parent |
4,382 | | 4,382 | ||||||
Equity-settled share schemes |
463 | | 463 | ||||||
Tax on equity-settled share schemes |
(4 | ) | | (4 | ) | ||||
Other taxes |
(52 | ) | | (52 | ) | ||||
Net purchases of treasury shares |
| (350 | ) | (350 | ) | ||||
Transfer |
(437 | ) | 437 | | |||||
Dividends paid |
(2,344 | ) | | (2,344 | ) | ||||
Repurchase of shares |
(173 | ) | | (173 | ) | ||||
Arising on share issue |
634 | | 634 | ||||||
Issue of warrants |
776 | | 776 | ||||||
Other |
(7 | ) | | (7 | ) | ||||
At 31st December 2008 |
24,208 | (173 | ) | 24,035 |
The treasury shares primarily relate to Barclays PLC shares held by employee benefit trusts in relation to the Executive Share Award Scheme, Performance Share Plan and Sharepurchase Scheme, to the extent that such shares have not been allocated to employees. These schemes are described in Note 44.
The total number of Barclays shares held in Group employee benefit trusts at 31st December 2009 was 125.1 million (2008: 217.9 million). No dividend rights have been waived on these shares. The total market value of the shares held in trust, based on the year-end share price of £2.75 (2008: £1.53), was £344m (2008: £333m). As at 31st December 2009, options over 15.6 million (2008: 19.1 million) of the total shares held in the trusts were exercisable.
The Group operates in a number of countries subject to regulations under which subsidiaries and other operations have to maintain minimum levels of capital. The current policy of the Group is that the local capital requirements are met, to the greatest possible extent, through the retention of profit. Certain countries also operate exchange control regulations which limit the amount of dividends that can be remitted to non-resident shareholders.
Retained earnings Barclays PLC (Parent Company)
Retained earnings £m |
Capital £m | ||||
At 1st January 2009 |
9,006 | 394 | |||
Profit after tax |
125 | | |||
Dividends paid |
(113 | ) | | ||
Conversion of mandatorily convertible notes |
(230 | ) | | ||
Other |
228 | | |||
At 31st December 2009 |
9,016 | 394 | |||
At 1st January 2008 |
8,990 | 384 | |||
Profit after tax |
1,193 | | |||
Dividends paid |
(2,414 | ) | | ||
Arising on share issue |
634 | | |||
Repurchase of shares |
(173 | ) | 10 | ||
Issue of warrants |
776 | | |||
At 31st December 2008 |
9,006 | 394 |
Details of principal subsidiaries held through Barclays Bank PLC are shown in Note 41.
220 |
Notes to the accounts
For the year ended 31st December 2009
continued
33 Non-controlling interests
2009 £m |
2008 £m |
|||||
At beginning of year |
10,793 | 9,185 | ||||
Share of profit after tax |
895 | 905 | ||||
Dividend and other payments |
(767 | ) | (703 | ) | ||
Equity issued by subsidiaries |
| 1,349 | ||||
Available for sale reserve: net (loss)/gain from changes in fair value |
(12 | ) | (1 | ) | ||
Cash flow hedges: (loss)/gain from changes in fair value |
(19 | ) | 76 | |||
Currency translation differences |
277 | 100 | ||||
Additions |
9 | | ||||
Disposals |
(91 | ) | (11 | ) | ||
Other |
116 | (107 | ) | |||
At end of year |
11,201 | 10,793 |
The non-controlling interests as at 31st December represented holdings in the following:
2009 £m |
2008 £m | |||
Barclays Bank PLC issued Preference shares |
5,933 | 5,927 | ||
Barclays Bank PLC issued Reserve Capital Instruments equity accounted |
1,908 | 1,908 | ||
Barclays Bank PLC issued Upper Tier 2 instruments equity accounted |
586 | 586 | ||
Absa Group Limited issued preference shares and other non-controlling interests |
2,539 | 1,994 | ||
Other |
235 | 378 | ||
Total |
11,201 | 10,793 |
There were no Preference Shares issued by Barclays Bank PLC during the year.
34 Contingent liabilities and commitments
The following table summarises the nominal principal amount of contingent liabilities and commitments with off-balance sheet risk:
2009 £m |
2008 £m | |||
Acceptances and endorsements |
375 | 585 | ||
Guarantees and letters of credit pledged as collateral security |
15,406 | 15,652 | ||
Securities lending arrangements |
27,406 | 38,290 | ||
Other contingent liabilities |
9,587 | 11,783 | ||
Contingent liabilities |
52,774 | 66,310 | ||
Documentary credits and other short-term trade related transactions |
762 | 859 | ||
Undrawn note issuance and revolving underwriting facilities: |
||||
Forward asset purchases and forward deposits placed |
46 | 291 | ||
Standby facilities, credit lines and other |
206,467 | 259,666 | ||
Commitments |
207,275 | 260,816 |
Nature of instruments
In common with other banks, the Group conducts business involving acceptances, performance bonds and indemnities. The majority of these facilities are offset by corresponding obligations of third parties.
An acceptance is an undertaking by a bank to pay a bill of exchange drawn on a customer. The Group expects most acceptances to be presented, but reimbursement by the customer is normally immediate. Endorsements are residual liabilities of the Group in respect of bills of exchange, which have been paid and subsequently rediscounted.
Guarantees and letters of credit are given as security to support the performance of a customer to third parties. As the Group will only be required to meet these obligations in the event of the customers default, the cash requirements of these instruments are expected to be considerably below their nominal amounts.
Until the disposal of BGI on 1st December 2009, the Group facilitated securities lending arrangements for its managed investment funds whereby securities held by funds under management were lent to third parties. Borrowers provided cash or investment grade assets as collateral equal to 100% of the market value of the securities lent plus a margin of 2% 10%. The Group has agreed with BlackRock to continue to provide indemnities to support these arrangements for a further three years. As at 31st December 2009, the value of the collateral held was £28,248m (2008: £39,690m) and that of the stock lent was £27,406m (2008: £38,290m).
Other contingent liabilities include transaction-related customs and performance bonds and are, generally, short-term commitments to third parties which are not directly dependent on the customers creditworthiness.
221 |
34 Contingent liabilities and commitments continued
Commitments to lend are agreements to lend to a customer in the future, subject to certain conditions. Such commitments are either made for a fixed period, or have no specific maturity but are cancellable by the lender subject to notice requirements.
Documentary credits commit the Group to make payments to third parties, on production of documents, which are usually reimbursed immediately by customers.
Capital commitments
At 31st December 2009 the commitments for capital expenditure under contract amounted to £129m (2008: £48m).
Assets pledged
Assets are pledged as collateral to secure liabilities under repurchase agreements, securitisations and stock lending agreements or as security deposits relating to derivatives. The disclosure includes any asset transfers associated with liabilities under repurchase agreements and securities lending transactions.
The following table summarises the nature and carrying amount of the assets pledged as security against these liabilities:
2009 £m |
2008 £m | |||
Trading portfolio assets |
96,176 | 81,186 | ||
Loans and advances |
48,846 | 28,789 | ||
Available for sale investments |
24,264 | 32,321 | ||
Other |
77 | 3,812 | ||
Assets pledged |
169,363 | 146,108 |
Collateral held as security for assets
Under certain transactions, including reverse repurchase agreements and stock borrowing transactions, the Group is allowed to resell or repledge the collateral held. The fair value at the balance sheet date of collateral accepted and repledged to others was as follows:
2009 £m |
2008 £m | |||
Fair value of securities accepted as collateral |
357,159 | 424,819 | ||
Of which fair value of securities repledged/transferred to others |
283,334 | 374,222 |
35 Legal proceedings
On 25th November 2009, the UK Supreme Court decided the test case relating to current account overdraft charges in favour of the banks. The Office of Fair Trading subsequently confirmed that it will not proceed with its investigation into the fairness of these charges following the Supreme Court judgment. Accordingly, we are seeking to have all outstanding claims which were premised on the same legal principles as those at issue in the test case discontinued or dismissed. There remain a small number of residual complaints challenging the charges on a different basis, but these complaints are not expected to have a material effect on Barclays.
Barclays Bank PLC, Barclays PLC and various current and former members of Barclays PLCs Board of Directors have been named as defendants in five proposed securities class actions (which have been consolidated) pending in the United States District Court for the Southern District of New York. The consolidated amended complaint, dated 12th February 2010, alleges that the registration statements relating to American Depositary Shares representing Preferred Stock, Series 2, 3, 4 and 5 (ADS) offered by Barclays Bank PLC at various times between 2006 and 2008 contained misstatements and omissions concerning (amongst other things) Barclays portfolio of mortgage-related (including US subprime-related) securities, Barclays exposure to mortgage and credit market risk and Barclays financial condition. The consolidated amended complaint asserts claims under Sections 11, 12(a)(2) and 15 of the Securities Act of 1933. Barclays considers that these ADS-related claims against it are without merit and is defending them vigorously. It is not possible to estimate any possible loss in relation to these claims or any effect that they might have upon operating results in any particular financial period.
On 15th September 2009 motions were filed in the United States Bankruptcy Court for the Southern District of New York by Lehman Brothers Holdings Inc. (LBHI), the SIPA Trustee for Lehman Brothers Inc. (the Trustee) and the Official Committee of Unsecured Creditors of Lehman Brothers Holdings Inc. (the Committee). All three motions challenge certain aspects of the transaction pursuant to which Barclays Capital Inc. (BCI) and other companies in the Barclays Group acquired most of the assets of Lehman Brothers Inc. (LBI) in September 2008 and the court order approving such sale. The claimants seek an order: voiding the transfer of certain assets to BCI; requiring BCI to return to the LBI estate alleged excess value BCI received; and declaring that BCI is not entitled to certain assets that it claims pursuant to the sale documents and order approving the sale. On 16th November 2009, LBHI, the Trustee and the Committee filed separate complaints in the Bankruptcy Court asserting claims against BCI based on the same underlying allegations as the pending motions and seeking relief similar to that which is requested in the motions. On 29th January 2010, BCI filed its response to the motions. Barclays considers that the motions and claims against BCI are without merit and BCI is vigorously defending its position. On 29th January 2010, BCI also filed a motion seeking delivery of certain assets that LBHI and LBI have failed to deliver as required by the sale documents and the court order approving the sale. It is not possible to estimate any possible loss to Barclays in relation to these matters or any effect that these matters might have upon operating results in any particular financial period.
Barclays is engaged in various other litigation proceedings both in the United Kingdom and a number of overseas jurisdictions, including the United States, involving claims by and against it which arise in the ordinary course of business. Barclays does not expect the ultimate resolution of any of the proceedings to which Barclays is party to have a significant adverse effect on the financial position of the Group and Barclays has not disclosed the contingent liabilities associated with these claims either because they cannot reasonably be estimated or because such disclosure could be prejudicial to the conduct of the claims.
222 |
Notes to the accounts
For the year ended 31st December 2009
continued
36 Competition and regulatory matters
The scale of regulatory change remains challenging and the global financial crisis is resulting in a significant tightening of regulation and changes to regulatory structures globally, especially for banks that are deemed to be of systemic importance. Concurrently, there is continuing political and regulatory scrutiny of the operation of the banking and consumer credit industries in the UK and elsewhere which, in some cases, is leading to increased regulation. For example, the Credit Card Accountability, Responsibility and Disclosure Act of 2009 in the US will restrict many credit card pricing and marketing practices. The nature and impact of future changes in the legal framework, policies and regulatory action cannot currently be fully predicted and are beyond Barclays control but, especially in the area of banking regulation, are likely to have an impact on Barclays businesses and earnings.
The market for payment protection insurance (PPI) has been under scrutiny by the UK competition authorities and financial services regulators. Following a reference from the Office of Fair Trading (OFT), the UK Competition Commission (CC) undertook an in-depth enquiry into the PPI market. The CC published its final report on 29th January 2009 concluding that the businesses which offer PPI alongside credit face little or no competition when selling PPI to their credit customers. In March 2009, Barclays submitted a targeted appeal focused on the prohibition on sale of PPI at the point of sale (POSP) remedy on the basis that it was not based on sound analysis, and is unduly draconian. The Competition Appeals Tribunal (CAT) upheld Barclays appeal on two grounds, meaning that the CC will be required to reconsider the POSP remedy and the basis for it, and made an order to that effect on 26th November 2009.
This remittal process is expected to take until the autumn of 2010, at which time the CC will publish its final Remedies Order.
Separately, in 2006, the FSA published the outcome of its broad industry thematic review of PPI sales practices in which it concluded that some firms fail to treat customers fairly and that the FSA would strengthen its actions against such firms. Tackling poor PPI sales practices remains a priority for the FSA. In September 2009, the FSA issued a Consultation Paper on the assessment and redress of PPI complaints made on or after 14th January 2005. The FSA has announced that it intends to publish a final version of the policy statement in early 2010 and will amend the DISP (Dispute Resolution: Complaints) rules in the FSA Sourcebook. Barclays voluntarily complied with the FSAs request to cease selling single premium PPI by the end of January 2009.
The OFT has carried out investigations into Visa and MasterCard credit card interchange rates. A decision by the OFT in the MasterCard interchange case was set aside by the CAT in 2006. The OFT is progressing its investigations in the Visa interchange case and a second MasterCard interchange case in parallel and both are ongoing. The outcome is not known but these investigations may have an impact on the consumer credit industry in general and therefore on Barclays business in this sector. In 2007, the OFT expanded its investigations into interchange rates to include debit cards.
Notwithstanding the Supreme Court ruling in relation to the test case (see Note 35 on page 221) Barclays continues to be involved in the OFTs work on personal current accounts. The OFT initiated a market study into personal current accounts (PCAs) in the UK in 2007 which also included an examination of other retail banking products, in particular savings accounts, credit cards, personal loans and mortgages in order to take into account the competitive dynamics of UK retail banking. In 2008, the OFT published its market study report, in which it concluded that certain features of the UK PCA market were not working well for consumers. The OFT reached the provisional view that some form of regulatory intervention is necessary in the UK PCA market. The OFT also held a consultation to seek views on the findings and possible measures to address the issues raised in its report. In October 2009, the OFT published a follow-up report containing details of voluntary initiatives in relation to transparency and switching agreed between the OFT and the industry. A further follow-up report is expected in March 2010 to provide details of voluntary initiatives agreed in relation to charging structures. Barclays has participated fully in the market study process and will continue to do so.
US laws and regulations require compliance with US economic sanctions, administered by the Office of Foreign Assets Control, against designated foreign countries, nationals and others. HM Treasury regulations similarly require compliance with sanctions adopted by the UK government. Barclays has been conducting an internal review of its conduct with respect to US Dollar payments involving countries, persons and entities subject to these sanctions and has been reporting to governmental authorities about the results of that review. Barclays received inquiries relating to these sanctions and certain US Dollar payments processed by its New York branch from the New York County District Attorneys Office and the US Department of Justice which, along with other authorities, has been reported to be conducting investigations of sanctions compliance by non-US financial institutions. Barclays has responded to those inquiries and is cooperating with the regulators, the Department of Justice and the District Attorneys Office in connection with their investigations of Barclays conduct with respect to sanctions compliance. Barclays has also received a formal notice of investigation from the FSA, and has been keeping the FSA informed of the progress of the US investigations and Barclays internal review. Barclays review is ongoing. It is currently not possible to predict the ultimate resolution of the issues covered by Barclays review and the investigations, including the timing and potential financial impact of any resolution, which could be substantial.
223 |
37 Leasing
The Group is both lessor and lessee under finance and operating leases, providing asset financing for its customers and leasing assets for its own use. In addition, assets leased by the Group may be sublet to other parties. An analysis of the impact of these transactions on the Group balance sheet and income statement is as follows:
a) As Lessor
Finance lease receivables
The Group specialises in asset-based lending and works with a broad range of international technology, industrial equipment and commercial companies to provide customised finance programmes to assist manufacturers, dealers and distributors of assets.
Finance lease receivables are included within loans and advances to customers. The Groups net investment in finance lease receivables was as follows:
2009 | 2008 | |||||||||||||||||
Gross £m |
Future finance income £m |
Present value of £m |
Unguaranteed £m |
Gross £m |
Future £m |
Present value of £m |
Unguaranteed £m | |||||||||||
Not more than one year |
3,513 | (456 | ) | 3,057 | 55 | 3,929 | (689 | ) | 3,240 | 149 | ||||||||
Over one year but not more than five years |
7,597 | (1,117 | ) | 6,480 | 154 | 8,668 | (1,673 | ) | 6,995 | 355 | ||||||||
Over five years |
2,084 | (427 | ) | 1,657 | 407 | 3,419 | (768 | ) | 2,651 | 25 | ||||||||
Total |
13,194 | (2,000 | ) | 11,194 | 616 | 16,016 | (3,130 | ) | 12,886 | 529 |
The allowance for uncollectable finance lease receivables included in the allowance for impairment amounted to £321m at 31st December 2009 (2008: £189m).
Operating lease receivables
The Group acts as lessor, whereby items of plant and equipment are purchased and then leased to third parties under arrangements qualifying as operating leases. The items purchased to satisfy these leases are included within plant and equipment (see Note 23) and are generally disposed of at the end of the lease term.
The future minimum lease payments expected to be received under non-cancellable operating leases at 31st December 2009 were as follows:
2009 | 2008 | |||
Plant and £m |
Plant and £m | |||
Not more than one year |
10 | 80 | ||
Over one year but not more than two years |
7 | 42 | ||
Over two years but not more than three years |
7 | 36 | ||
Over three years but not more than four years |
6 | 24 | ||
Over four years but not more than five years |
8 | 13 | ||
Over five years |
1 | 39 | ||
Total |
39 | 234 |
224 |
Notes to the accounts
For the year ended 31st December 2009
continued
37 Leasing continued
b) As Lessee
Finance lease commitments
The Group leases items of property, plant and equipment on terms that meet the definition of finance leases. Finance lease commitments are included within other liabilities (see Note 25).
Obligations under finance leases were as follows:
2009 | 2008 | |||
Total future minimum payments £m |
Total future minimum payments £m | |||
Not more than one year |
16 | 35 | ||
Over one year but not more than two years |
7 | 13 | ||
Over two years but not more than three years |
30 | 14 | ||
Over three years but not more than four years |
18 | 17 | ||
Over four years but not more than five years |
17 | 14 | ||
Over five years |
34 | 3 | ||
Net obligations under finance leases |
122 | 96 |
The carrying amount of assets held under finance leases at the balance sheet date was:
2009 £m |
2008 £m |
|||||
Cost |
127 | 87 | ||||
Accumulated depreciation |
(84 | ) | (67 | ) | ||
Net book value |
43 | 20 |
Operating lease commitments
The Group leases various offices, branches and other premises under non-cancellable operating lease arrangements. The leases have various terms, escalation and renewal rights. There are no contingent rents payable. The Group also leases equipment under non-cancellable lease arrangements. Where the Group is the lessee the future minimum lease payment under non-cancellable operating leases are as follows:
2009 | 2008 | |||||||
Property £m |
Equipment £m |
Property £m |
Equipment £m | |||||
Not more than one year |
459 | 9 | 275 | 5 | ||||
Over one year but not more than two years |
424 | 6 | 354 | 1 | ||||
Over two years but not more than three years |
378 | | 334 | 1 | ||||
Over three years but not more than four years |
334 | | 315 | | ||||
Over four years but not more than five years |
341 | | 465 | 5 | ||||
Over five years |
2,933 | 3 | 2,744 | 1 | ||||
Total |
4,869 | 18 | 4,487 | 13 |
The total of future minimum sublease payments to be received under non-cancellable subleases at the balance sheet date is £147m (2008: £158m).
225 |
38 Disposal of subsidiaries
During the year, the Group disposed of Barclays Global Investors (BGI), 50% of Barclays Vida y Pensiones Compañía de Seguros and 7% of the GRCB Emerging Markets Botswana business.
BGI | Other | Total | |||||||
2009 £m |
2009 £m |
2009 £m |
|||||||
Consideration received including hedging gains: |
|||||||||
Cash received a |
4,207 | 158 | 4,365 | ||||||
Non-cash consideration |
5,294 | 118 | 5,412 | ||||||
Total consideration received |
9,501 | 276 | 9,777 | ||||||
Assets and liabilities disposed of: |
|||||||||
Assets |
|||||||||
Cash and balances at central banks |
667 | | 667 | ||||||
Financial assets designated at fair value: |
|||||||||
held on own account |
| 393 | 393 | ||||||
held in respect of linked liabilities to customers under investment contracts |
71,791 | | 71,791 | ||||||
Derivative financial instruments |
| 5 | 5 | ||||||
Loans and advances to customers |
| 4 | 4 | ||||||
Available for sale investments |
55 | 788 | 843 | ||||||
Other assets |
398 | 204 | 602 | ||||||
Goodwill and Intangible assets |
1,586 | | 1,586 | ||||||
Property, plant and equipment |
122 | | 122 | ||||||
Deferred tax assets |
99 | | 99 | ||||||
Total |
74,718 | 1,394 | 76,112 | ||||||
Liabilities |
|||||||||
Customer accounts |
| (368 | ) | (368 | ) | ||||
Liabilities to customers under investment contracts |
(71,791 | ) | (415 | ) | (72,206 | ) | |||
Derivative financial instruments |
| (8 | ) | (8 | ) | ||||
Other liabilities |
(911 | ) | (74 | ) | (985 | ) | |||
Current tax liabilities |
35 | | 35 | ||||||
Insurance contract liabilities, including unit-linked liabilities |
| (354 | ) | (354 | ) | ||||
Deferred tax liabilities |
| (16 | ) | (16 | ) | ||||
Total |
(72,667 | ) | (1,235 | ) | (73,902 | ) | |||
Net assets disposed of |
2,051 | 159 | 2,210 | ||||||
Group share of net assets disposed of |
2,051 | 82 | 2,133 | ||||||
Transaction costs |
(539 | ) | (10 | ) | (549 | ) | |||
Amounts relating to non-controlling interests |
(580 | ) | | (580 | ) | ||||
Gain on sale before tax |
6,331 | 184 | 6,515 | ||||||
Tax |
(43 | ) | (28 | ) | (71 | ) | |||
Gain on sale, net of tax |
6,288 | 156 | 6,444 |
On 1st December 2009 the Group completed the sale of BGI to BlackRock, Inc. (BlackRock) recognising a profit on disposal before tax of £6,331m. The tax charge of £43m reflects the application of UK substantial shareholdings relief in accordance with UK tax law.
The consideration at completion was $15.2bn (£9.5bn), including 37.567 million new BlackRock shares, giving an economic interest of 19.9% of the enlarged BlackRock group. Barclays Group holds 4.9% of the voting rights and under the terms of the transaction may not acquire additional voting rights and will vote in accordance with the recommendations of the BlackRock Board of Directors. John Varley and Robert E Diamond Jr. have been appointed to the BlackRock Board, which comprises 18 Directors. The Group is not deemed to exercise significant influence and the investment has been accounted for as an available for sale equity investment.
The Group has provided BlackRock with customary warranties and indemnities in connection with the sale. Barclays will also continue to indemnify securities lending arrangements until 30th November 2012 (included within contingent liabilities in Note 34) and provide support to certain BGI cash funds until December 2013 in the form of credit derivatives (included within derivative liabilities in Note 14) and financial guarantees (included within provisions in Note 28).
In addition, Barclays, BlackRock and their respective affiliates also enter into agreements and transactions with one another in the ordinary course of their respective businesses and on an arms length commercial basis, subject to applicable regulation and agreements with relevant regulators.
In connection with its financing of its acquisition of BGI, BlackRock entered into a 364-day revolving credit facility with a group of lenders including Barclays, who is also acting as revolving agent. Of the $2bn credit facility, $0.8bn was committed by other lenders and following completion BlackRock had borrowed or notified to be borrowed $1.5bn under the facility. All amounts borrowed under this facility have been fully repaid and the facility was terminated prior to 31st December 2009.
Prior year disposals
In 2008, the Group disposed of Barclays Life Assurance Limited. There were no material disposals in 2007.
Note
a | Net cash consideration received from the sale of BGI, excluding the effect of hedging, cash balances disposed of and transaction costs paid, was £2,469m. |
226 |
Notes to the accounts
For the year ended 31st December 2009
continued
39 Discontinued operations
The disposed BGI business has been treated as a discontinued operation, the results of which are set out below. For the year ended 31st December 2009 the results are for the 11 month period up to the date of disposal.
2009 £m |
2008 £m |
2007 £m |
|||||||
Net interest income |
33 | | 12 | ||||||
Net fee and commission income |
1,759 | 1,916 | 1,937 | ||||||
Net trading income/(loss) |
67 | (10 | ) | 5 | |||||
Other income |
4 | 10 | 2 | ||||||
Total income |
1,863 | 1,916 | 1,956 | ||||||
Operating expenses excluding amortisation of intangible assets |
(1,123 | ) | (960 | ) | (1,095 | ) | |||
Amortisation of intangible assets |
(14 | ) | (15 | ) | (8 | ) | |||
Operating expenses |
(1,137 | ) | (975 | ) | (1,103 | ) | |||
Profit before tax from discontinued operations |
726 | 941 | 853 | ||||||
Tax on discontinued operations |
(237 | ) | (337 | ) | (282 | ) | |||
Profit after tax from discontinued operations |
489 | 604 | 571 | ||||||
Profit on disposal of discontinued operations a |
6,331 | | | ||||||
Tax on disposal |
(43 | ) | | | |||||
Net profit on the disposal of the discontinued operation |
6,288 | | | ||||||
Profit after tax from discontinued operations, including gain on disposal |
6,777 | 604 | 571 |
Other comprehensive income relating to discontinued operations is as follows:
2009 £m |
2008 £m |
2007 £m | ||||||
Available for sale assets |
10 | (9 | ) | 1 | ||||
Currency translation reserve |
(85 | ) | 133 | 11 | ||||
Tax relating to components of other comprehensive income |
17 | (10 | ) | 14 | ||||
Other comprehensive income, net of tax, from discontinued operations |
(58 | ) | 114 | 26 |
The cash flows attributable to the discontinued operations were as follows:
2009 £m |
2008 £m |
2007 £m |
|||||||
Cash flows from discontinued operations |
|||||||||
Net cash flows from operating activities |
333 | 524 | 773 | ||||||
Net cash flows from investing activities |
(25 | ) | (93 | ) | (248 | ) | |||
Net cash flows from financing activities |
(550 | ) | (362 | ) | (429 | ) | |||
Effects of exchange rates on cash and cash equivalents |
(134 | ) | 217 | (13 | ) | ||||
Net cash flows from discontinued operations |
(376 | ) | 286 | 83 |
Notes
a | Details of the profit on disposal are shown in Note 38. |
227 |
40 Acquisition of subsidiaries
a) Crescent Real Estate
On 19th November 2009, Barclays formed Crescent Real Estate Holdings LLC a joint venture with Goff Capital, Inc., to assume 99.7% ownership of Crescent Real Estate Equities Limited partnership (Crescent) following the completion of a debt restructuring transaction. Crescent is a real estate investment company that owns and manages office space, as well as investments in resort residential developments and luxury hotels across the US. These properties are accounted for as investment properties.
The assets and liabilities of Crescent at acquisition were as follows:
Carrying value pre- acquisition £m |
Fair value adjustments £m |
Fair values £m |
|||||||
Assets |
|||||||||
Loans and advances to customers |
85 | | 85 | ||||||
Investment in associates and joint ventures |
132 | (45 | ) | 87 | |||||
Property, plant and equipment |
879 | 69 | 948 | ||||||
Other assets |
154 | (2 | ) | 152 | |||||
Total assets |
1,250 | 22 | 1,272 | ||||||
Liabilities |
|||||||||
Deposits from banks |
(170 | ) | | (170 | ) | ||||
Other liabilities |
(102 | ) | 3 | (99 | ) | ||||
Total liabilities |
(272 | ) | 3 | (269 | ) | ||||
Net assets |
978 | 25 | 1,003 | ||||||
Group share of net assets acquired |
978 | 25 | 1,003 | ||||||
Acquisition cost |
|||||||||
Loans |
1,003 | ||||||||
Total consideration |
1,003 |
No goodwill arose on acquisition.
The results of Crescents operations have been included from 19th November 2009 and did not materially contribute to the consolidated profit before tax. It is impracticable to disclose the revenue and profit or loss of the combined entity as though the acquisition date had been 1st January 2009.
228 |
Notes to the accounts
For the year ended 31st December 2009
continued
40 Acquisition of subsidiaries continued
b) Other acquisitions
Other acquisitions made by the Group during the year included 100% of PT Bank Akita on 1st February 2009 and 100% of the Portuguese credit card business of Citibank International PLC on 1st December 2009.
The Group increased its share in Abseq Properties (Pty) Ltd (previously accounted for as an associate) to 85% on 30th January 2009. On 6th April 2009, the Group acquired 100% of Care Principles as part of a debt restructuring transaction.
None of these acquisitions were individually material.
Details of the net assets acquired and the consideration paid are set out in aggregate below. The results of their operations have been included from the dates acquired and contributed a loss of £17m to the consolidated profit before tax.
Carrying value pre- acquisition £m |
Fair value adjustments £m |
Other adjustments £m |
Fair values £m |
|||||||||
Assets |
||||||||||||
Loans and advances to customers |
598 | (9 | ) | | 589 | |||||||
Investments in associates and joint ventures |
3 | | | 3 | ||||||||
Intangible assets |
| 75 | 16 | 91 | ||||||||
Property, plant and equipment |
201 | 5 | | 206 | ||||||||
Other assets |
38 | | | 38 | ||||||||
Total assets |
840 | 71 | 16 | 927 | ||||||||
Liabilities |
||||||||||||
Deposits from banks |
(806 | ) | 45 | 117 | (644 | ) | ||||||
Customer accounts |
(48 | ) | | | (48 | ) | ||||||
Derivative financial instruments |
| (32 | ) | 19 | (13 | ) | ||||||
Deferred tax liabilities |
(14 | ) | (26 | ) | | (40 | ) | |||||
Other liabilities |
(111 | ) | 18 | (2 | ) | (95 | ) | |||||
Total liabilities |
(979 | ) | 5 | 134 | (840 | ) | ||||||
Net assets acquired |
(139 | ) | 76 | 150 | 87 | |||||||
Group share of net assets acquired |
66 | |||||||||||
Acquisition cost |
||||||||||||
Cash Paid |
24 | |||||||||||
Deferred consideration |
19 | |||||||||||
Attributable costs |
4 | |||||||||||
Total consideration |
47 | |||||||||||
Goodwill |
7 | |||||||||||
Gain on acquisition |
26 |
Cash outflows in respect of acquisitions
The aggregate net outflow of cash from the acquisition of the above Group entities was £28m, representing cash consideration and attributable costs.
Prior year acquisitions
The initial accounting for the 2008 acquisition of the North American businesses of Lehman Brothers was completed on 22nd September 2009. There were no revisions to the initial accounting disclosed in the 2008 financial statements. Approximately £2.3bn of the assets acquired as part of the acquisition had not been received by 31st December 2009, approximately £1.8bn of which were recognised as part of the accounting for the acquisition and are included in the balance sheet as at 31st December 2009. Ongoing legal proceedings related to the acquisition, including in respect of assets not yet received, are discussed in Note 35.
In addition, in 2008 the Group acquired Macquarie Bank Limiteds residential mortgage businesses, Goldfish credit card UK businesses and 100% of the ordinary shares of Expobank.
In 2007, the Group acquired 100% of the ordinary shares of each of Indexchange Investment AG, Equifirst Corporation and Walbrook Group Limited.
229 |
41 Investment in subsidiaries
The investment in Barclays Bank PLC is stated on the balance sheet of Barclays PLC at a cost of £20,215m (2008: £15,340m). The increase of £4,875m (2008: £5,154m) during the year represents the cost of additional shares of £25m (2008: £16m), capital contributions of £800m (2008: £4,362m) and a non-cash capital contribution of £4,050m (2008: £776m).
Principal subsidiaries
Country of registration or incorporation |
Company name | Nature of business | Percentage of equity capital held % |
||||
Botswana |
Barclays Bank of Botswana Limited | Banking | 67.8 | ||||
Egypt |
Barclays Bank Egypt SAE | Banking | 100 | ||||
England |
Barclays Bank PLC | Banking, holding company | 100 | * | |||
England |
Barclays Mercantile Business Finance Limited | Loans and advances including leases to customers | 100 | * | |||
England |
Barclays Bank Trust Company Limited | Banking, securities industries and trust services | 100 | * | |||
England |
Barclays Stockbrokers Limited | Stockbroking | 100 | * | |||
England |
Barclays Capital Securities Limited | Securities dealing | 100 | * | |||
England |
FIRSTPLUS Financial Group PLC | Secured loan provider | 100 | ||||
England |
Gerrard Investment Management Limited | Investment management | 100 | * | |||
Ghana |
Barclays Bank of Ghana Limited | Banking | 100 | ||||
Ireland |
Barclays Insurance (Dublin) Limited | Insurance provider | 100 | * | |||
Ireland |
Barclays Assurance (Dublin) Limited | Insurance provider | 100 | * | |||
Isle of Man |
Barclays Private Clients International Limited | Banking | 100 | ||||
Japan |
Barclays Capital Japan Limited | Securities dealing | 100 | * | |||
Jersey |
Barclays Private Bank & Trust Limited | Banking, trust company | 100 | * | |||
Kenya |
Barclays Bank of Kenya Limited | Banking | 68.5 | ||||
Russia |
Barclays Bank LLC | Banking | 100 | * | |||
South Africa |
Absa Group Limited | Banking | 55.5 | ||||
Spain |
Barclays Bank SA | Banking | 99.7 | ||||
Switzerland |
Barclays Bank (Suisse) S.A. | Banking and trust services | 100 | ||||
USA |
Barclays Capital Inc. | Securities dealing | 100 | * | |||
USA |
Barclays Financial Corporation | Holding company for US credit card issuer | 100 | * | |||
USA |
Barclays Group US Inc. | Holding company | 100 | ||||
Zimbabwe |
Barclays Bank of Zimbabwe Limited | Banking | 67.7 | * |
In accordance with Section 410(2)(a) of the Companies Act 2006, the above information is provided solely in relation to principal subsidiaries.
The country of registration or incorporation is also the principal area of operation of each of the above subsidiaries. Investments in these subsidiaries are held directly by Barclays Bank PLC except where marked*.
Full information of all subsidiaries will be included in the Annual Return to be filed at UK Companies House.
Entities in which the Group holds less than half the voting rights
There are a number of entities in which the Group holds less than half the voting rights which are consolidated when the substance of the relationship between the Group and the entity indicates that the entity is controlled by the Group. Such entities are deemed to be controlled by the Group when relationships with such entities give rise to benefits that are in substance no different from those that would arise were the entity a subsidiary.
The consolidation of such entities may be appropriate in a number of situations, but primarily when:
| the operating and financial policies of the entity are closely defined from the outset (i.e. it operates on an autopilot basis) with such policies being largely determined by the Group; |
| the Group has rights to obtain the majority of the benefits of the entity and/or retains the majority of the residual or ownership risks related to the entity; or |
| the activities of the entity are being conducted largely on behalf of the Group according to its specific business objectives. |
Such entities are created for a variety of purposes including securitisation, structuring, asset realisation, intermediation and management.
Subsidiaries with a different reporting date from that of the Parent of 31st December
Entities may have a different reporting date from that of the Parent of 31st December. Dates may differ for a variety of reasons including local reporting regulations or tax laws. In accordance with our accounting policies, for the purpose of inclusion in the consolidated financial statements of Barclays PLC, entities with different reporting dates are made up until 31st December.
230 |
Notes to the accounts
For the year ended 31st December 2009
continued
41 Investment in subsidiaries continued
Entities where the Groups interest exceeds 50% which are excluded from consolidation
Although the Groups interest in the equity voting rights in certain entities exceeds 50%, or it may have the power to appoint a majority of their Boards of Directors, they are excluded from consolidation because the Group either cannot direct the financial and operating policies of these entities, or on the grounds that another entity has a superior economic interest in them. Consequently, these entities are not deemed to be controlled by Barclays.
The table below includes information in relation to such entities as required by the Companies Act 2006 Section 410(2)(b).
Country of registration or incorporation |
Name | Percentage of % |
Equity share- holders funds £m |
Retained loss for the year £m | ||||
UK |
Fitzroy Finance Limited | 100 | | | ||||
Cayman Islands |
Palomino Limited | 100 | 1 | |
42 Related party transactions and Directors remuneration
a) Related party transactions
Parties are considered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operation decisions, or one other party controls both. The definition includes subsidiaries, associates, joint ventures and the Groups pension schemes, as well as other persons.
Subsidiaries
Transactions between Barclays PLC and subsidiaries also meet the definition of related party transactions. Where these are eliminated on consolidation, they are not disclosed in the Group financial statements. Transactions between Barclays PLC and its subsidiary, Barclays Bank PLC are fully disclosed in its balance sheet and income statement. A list of the Groups principal subsidiaries is shown in Note 41.
Associates, joint ventures and other entities
The Group provides banking services to its associates, joint ventures, the Group pension funds (principally the UK Retirement Fund) and to entities under common directorships, providing loans, overdrafts, interest and non-interest bearing deposits and current accounts to these entities as well as other services. Group companies also provide investment management and custodian services to the Group pension schemes. The Group also provides banking services for unit trusts and investment funds managed by Group companies and are not individually material. All of these transactions are conducted on the same terms as third-party transactions.
Entities under common directorships
The Group enters into normal commercial relationships with entities for which members of the Groups Board also serve as Directors. The amounts included in the Groups financial statements relating to such entities that are not publicly listed are shown in the table opposite under Entities under common directorships.
231 |
42 Related party transactions and Directors remuneration continued
Amounts included in the accounts, in aggregate, by category of related party entity are as follows:
Associates £m |
Joint ventures £m |
Entities under common directorships £m |
Pension £m |
Total £m |
|||||||||
For the year ended and as at 31st December 2009 |
|||||||||||||
Income statement: |
|||||||||||||
Interest received |
3 | 90 | 7 | | 100 | ||||||||
Interest paid |
| (18 | ) | | | (18 | ) | ||||||
Fees received for services rendered (including investment management and custody and commissions) | 10 | 9 | | 6 | 25 | ||||||||
Fees paid for services provided |
(47 | ) | (113 | ) | | | (160 | ) | |||||
Principal transactions |
(11 | ) | (35 | ) | 6 | | (40 | ) | |||||
Impairment |
(2 | ) | (5 | ) | | | (7 | ) | |||||
Assets: |
|||||||||||||
Loans and advances to banks and customers |
144 | 1,145 | 192 | | 1,481 | ||||||||
Derivative transactions |
3 | 8 | 48 | | 59 | ||||||||
Other assets |
76 | 193 | | | 269 | ||||||||
Liabilities: |
|||||||||||||
Deposits from banks |
| 654 | | | 654 | ||||||||
Customer accounts |
54 | 252 | 29 | 23 | 358 | ||||||||
Derivative transactions |
| 3 | 10 | | 13 | ||||||||
Other liabilities |
2 | 22 | | 23 | 47 |
Associates £m |
Joint ventures £m |
Entities under common directorships £m |
Pension £m |
Total £m |
||||||||||
For the year ended and as at 31st December 2008 |
||||||||||||||
Income statement: |
||||||||||||||
Interest received |
| 105 | 3 | | 108 | |||||||||
Interest paid |
| (73 | ) | | | (73 | ) | |||||||
Fees received for services rendered (including investment management and custody and commissions) | | 15 | | 5 | 20 | |||||||||
Fees paid for services provided |
(44 | ) | (146 | ) | | | (190 | ) | ||||||
Principal transactions |
8 | 59 | 60 | (25 | ) | 102 | ||||||||
Assets: |
||||||||||||||
Loans and advances to banks and customers |
110 | 954 | 34 | | 1,098 | |||||||||
Derivative transactions |
| 9 | 311 | 15 | 335 | |||||||||
Other assets |
67 | 276 | | 3 | 346 | |||||||||
Liabilities: |
||||||||||||||
Deposits from banks |
| 592 | | | 592 | |||||||||
Customer accounts |
| 167 | 74 | 10 | 251 | |||||||||
Derivative transactions |
| | 111 | 41 | 152 | |||||||||
Other liabilities |
3 | 18 | | 28 | 49 |
Associates £m |
Joint ventures £m |
Entities under common directorships £m |
Pension £m |
Total £m |
||||||||||
For the year ended and as at 31st December 2007 |
||||||||||||||
Income statement: |
||||||||||||||
Interest received |
5 | 88 | 1 | | 94 | |||||||||
Interest paid |
(1 | ) | (58 | ) | (1 | ) | | (60 | ) | |||||
Fees received for services rendered (including investment management and custody and commissions) | 1 | 34 | | 26 | 61 | |||||||||
Fees paid for services provided |
(52 | ) | (78 | ) | | | (130 | ) | ||||||
Principal transactions |
(27 | ) | 45 | (16 | ) | | 2 | |||||||
Assets: |
||||||||||||||
Loans and advances to banks and customers |
142 | 1,285 | 40 | | 1,467 | |||||||||
Derivative transactions |
| 4 | 36 | | 40 | |||||||||
Other assets |
213 | 106 | | 14 | 333 | |||||||||
Liabilities: |
||||||||||||||
Deposits from banks |
11 | | | | 11 | |||||||||
Customer accounts |
| 61 | 33 | 12 | 106 | |||||||||
Derivative transactions |
| 10 | 50 | | 60 | |||||||||
Other liabilities |
4 | 125 | | | 129 |
232 |
Notes to the accounts
For the year ended 31st December 2009
continued
42 Related party transactions and Directors remuneration continued
No guarantees, pledges or commitments have been given or received in respect of these transactions in 2009, 2008 or 2007.
Derivatives transacted on behalf of the Pensions Funds Unit Trusts and Investment Funds amounted to £192m (2008: £318m, 2007: £22m).
In 2008 Barclays paid £12m (2007: £18m) of its charitable donations through the Charities Aid Foundation, a registered charitable organisation, in which a Director of the Company was a Trustee. In 2009, following personnel changes, Charities Aid Foundation is not a related party.
Key Management Personnel
The Groups Key Management Personnel, and persons connected with them, are also considered to be related parties for disclosure purposes. Key Management Personnel are defined as those persons having authority and responsibility for planning, directing and controlling the activities of Barclays PLC (directly or indirectly) and comprise the Directors of Barclays PLC and the Officers of the Group, certain direct reports of the Group Chief Executive and the heads of major business units.
There were no material related party transactions with Entities under common directorship where a Director or other member of Key Management Personnel (or any connected person) is also a Director or other member of Key Management Personnel (or any connected person) of Barclays.
The Group provides banking services to Directors and other Key Management Personnel and persons connected to them. Transactions during the year and the balances outstanding at 31st December 2009 were as follows:
Directors, other Key Management Personnel and connected persons |
|||||||||
2009 £m |
2008 £m |
2007 £m |
|||||||
Loans outstanding at 1st January |
7.3 | 7.4 | 7.8 | ||||||
Loans issued during the year |
1.9 | 6.9 | 2.7 | ||||||
Loan repayments during the year |
(1.6 | ) | (5.5 | ) | (3.2 | ) | |||
Loans outstanding at 31st December |
7.6 | 8.8 | 7.3 | ||||||
Interest income earned |
0.1 | 0.4 | 0.4 |
No allowances for impairment were recognised in respect of loans to Directors or other members of Key Management Personnel (or any connected person) in 2009, 2008 or 2007.
2009 £m |
2008 £m |
2007 £m |
|||||||
Deposits outstanding at 1st January |
28.7 | 8.9 | 15.0 | ||||||
Deposits received during the year |
160.0 | 235.7 | 114.4 | ||||||
Deposits repaid during the year |
(158.0 | ) | (221.9 | ) | (115.0 | ) | |||
Deposits outstanding at 31st December |
30.7 | 22.7 | 14.4 | ||||||
Interest expense on deposits |
0.1 | 0.5 | 0.6 |
During 2009 the membership of the Group Executive Committee increased. These additional persons became Officers of the Group and as such are included in Key Management Personnel for 2009, but not 2008.
Of the loans outstanding above, £0.1m (2008: £1.6m, 2007: £nil) relates to Directors and other Key Management Personnel (and persons connected to them) that left the Group during the year. Of the deposits outstanding above, £3.7m (2008: £6.1m, 2007: £2.8m) related to Directors and other Key Management Personnel (and persons connected to them) that left the Group during the year. The amounts disclosed as at 1st January includes deposits outstanding for those who became Directors or Key Management Personnel during the year.
All loans to Directors and other Key Management Personnel (and persons connected to them), (a) were made in the ordinary course of business, (b) were made on substantially the same terms, including interest rates and collateral, as those prevailing at the same time for comparable transactions with other persons and (c) did not involve more than a normal risk of collectability or present other unfavourable features; with the exception of £692 provided on an interest free basis.
A loan of £692 provided on an interest free basis was granted to one non-Director member of Barclays Key Management to purchase a commuter rail ticket. The maximum loan outstanding during the year was £692. Commuter rail ticket loans are provided to all Barclays staff members upon request on the same terms.
233 |
42 Related party transactions and Directors remuneration continued
Remuneration of Directors and other Key Management Personnel
Directors, other Key Management Personnel and connected persons | ||||||
2009 £m |
2008 £m |
2007 £m | ||||
Salaries and other short-term benefits |
8.6 | 10.7 | 23.7 | |||
Pension costs |
0.7 | 0.9 | 1.1 | |||
Other long-term benefits |
2.5 | 1.6 | 9.2 | |||
Share-based payments |
15.8 | 11.8 | 31.7 | |||
Employer social security charges on emoluments |
2.9 | 2.7 | 7.8 | |||
30.5 | 27.7 | 73.5 |
b) Disclosure required by the Companies Act 2006
The following information is presented in accordance with the Companies Act 2006:
Directors remuneration
2009 £m |
2008 £m | |||
Aggregate emoluments |
8.8 | 6.0 | ||
Gains made on the exercise of share options |
8.9 | | ||
Amounts paid under long-term incentive schemes |
| 7.4 | ||
17.7 | 13.4 |
Actual pension contributions of £18,786 were paid to money purchase schemes on behalf of one Director (2008: £11,745, one Director). Notional pension contributions to money purchase schemes were £nil (2008: £nil).
As at 31st December 2009, two Directors were accruing retirement benefits under a defined benefit scheme (2008: two Directors).
One Director (Frits Seegers) agreed to waive his fees as non-executive Director of Absa Group Limited and Absa Bank Limited. The fees for 2009 were ZAR 0.1m (£0.01m). The fees for 2008 were ZAR 0.4m (£0.03m). In both 2008 and 2009 the fees were paid to Barclays.
Directors and Officers shareholdings and options
The beneficial ownership of the ordinary share capital of Barclays PLC by all Directors and Officers of Barclays PLC (involving 23 persons) and Barclays Bank PLC (involving 24 persons) at 31st December 2009 amounted 20,000,820 ordinary shares of 25p each (0.18% of the ordinary share capital outstanding) and 20,008,541 ordinary shares of 25p each (0.18% of the ordinary share capital outstanding), respectively.
Directors and Officers of Barclays PLC held in total (involving 12 persons) at 31st December 2009, options to purchase 3,279,642 Barclays PLC ordinary shares of 25p each at prices ranging from 255p to 470p under Sharesave and ranging from 317p to 520p under the Incentive Share Option Plan, respectively.
234 |
Notes to the accounts
For the year ended 31st December 2009
continued
42 Related party transactions and Directors remuneration continued
Advances and credit to Directors and guarantees on behalf of Directors
In accordance with Section 413 of the Companies Act 2006 and in relation to those who served as Directors of the Company at any time in the financial year, the total amount of advances and credits at 31st December 2009 was £1.8m (2008: £0.8m). The total amount of guarantees on behalf of Directors at 31st December 2009 was £nil (2008: £nil).
c) US disclosures
For US disclosure purposes, the aggregate emoluments of all Directors and Officers of Barclays PLC who held office during the year (2009: 28 persons, 2008: 24 persons, 2007: 22 persons) for the year ended 31st December 2009 amounted to £29.8m (2008: £26.8m, 2007: £64.6m). In addition, the aggregate amount set aside for the year ended 31st December 2009, to provide pension benefits for the Directors and Officers amounted to £0.7m (2008: £0.9m, 2007: £1.1m). The aggregate emoluments of all Directors and Officers of Barclays Bank PLC who held office during the year (2009: 29 persons, 2008: 25 persons, 2007: 23 persons) for the year ended 31st December 2009 amounted to £30.1m (2008: £26.9m and 2007: £64.9m). In addition, the aggregate amount set aside by the Bank and its subsidiaries for the year ended 31st December 2009, to provide pension benefits for the Directors and Officers amounted to £0.7m (2008: £0.9m, 2007: £1.1m).
43 Events after the balance sheet date
On 1st January 2010, the Group acquired 100% ownership of Standard Life Bank Plc for a consideration of £227m in cash. The assets acquired include a savings book of approximately £5.8bn, and a mortgage book with outstanding balances of approximately £7.5bn.
As announced on 3rd November 2009, the Group has made changes to its business structure, which will be reflected in the Groups external financial reporting for periods commencing 1st January 2010. The segmental information presented in Note 53 represents the business segments and other operations used for management and reporting purposes during the year ended 31st December 2009.
On 17th February 2010, 626.8 million of the 758.4 million warrants held by PCP Gulf Invest 3 Limited (a subsidiary of Nexus Capital Investing Limited) were exercised for an aggregate exercise price of approximately £1,240m. As a result 626.8 million new ordinary shares were issued representing a 5.2% ownership in the Groups enlarged share capital.
44 Share-based payments
The Group operates share schemes for employees throughout the world. The main current schemes are:
Sharesave
Eligible employees in the UK, Spain and Ireland may participate in the Barclays Sharesave scheme. Under this scheme, employees may enter into contracts to save up to £250 per month (Ireland: ¤500, Spain: ¤135) and, at the expiry of a fixed term of three, five or seven years (Spain: three years), have the option to use these savings to acquire shares in the Company at a discount, calculated in accordance with the rules of the scheme. The discount is currently 20% of the market price at the date the options are granted. Participants in the scheme have six months from the date of vest in which the option can be exercised.
UK Sharepurchase
UK Sharepurchase was introduced in January 2002. It is an HM Revenue & Customs approved all-employee share plan. The plan is open to all eligible UK employees, including executive Directors. Under the plan, participants are able to purchase up to £1,500 worth of Barclays PLC ordinary shares per tax year, which, if kept in trust for five years, can be withdrawn from the plan tax-free. Matching shares were introduced to the scheme during 2005 where the purchase of Barclays shares by the participant are matched equally by the Company up to a value of £600 per tax year. Any shares in the plan will earn dividends in the form of additional shares, which must normally be held by the trustee for three years before being eligible for release.
Global Sharepurchase
Global Sharepurchase was introduced in August 2009. The plan is open to all eligible employees in countries outside the UK, including executive Directors. In 2009, the plan was launched in Germany, Hong Kong, Japan, Singapore and Switzerland. Under the plan, participants are able to purchase up to £1,500 worth of Barclays PLC ordinary shares per calendar year, from post-tax salary. The purchase of Barclays shares by the participant is matched by the Company on a one-for-one basis up to a value of £600 per calendar year. Matching Shares are forfeited if the participant chooses to sell shares purchased from their post-tax salary before the third anniversary of purchase. Any shares in the plan will earn dividends in the form of additional shares, which must normally be held by the trustee for three years before being eligible for release.
Executive Share Award Scheme (ESAS)
For certain employees of the Group an element of their annual bonus is in the form of a deferred award of a provisional allocation of Barclays PLC shares under ESAS. The total value of the bonus made to the employee of which ESAS is an element is dependent upon the business unit, Group and individual employee performance. The ESAS element of the annual bonus must normally be held for at least three years. Additional bonus shares are subsequently awarded to recipients of the provisional allocation and vest upon achieving continued service for three and five years from the date of award. ESAS awards are also made to eligible employees for recruitment purposes. All awards are subject to potential forfeit if the individual resigns and commences work with a competitor business.
Performance Share Plan (PSP)
The Performance Share Plan (PSP) was approved by shareholders at the 2005 AGM to replace the ISOP scheme. Performance shares are free Barclays shares for which no exercise price is payable and which qualify for dividends. Performance share awards are communicated to participants as an initial allocation. Barclays performance over a three-year period determines the final number of shares that may be released to participants.
Incentive Share Plan (Incentive Shares)
The Incentive Share Plan (Incentive Shares) was introduced in March 2008. Incentive Shares are granted to participants in the form of a provisional allocation of Barclays shares which vest upon achieving continued service after three years. Participants do not pay to receive an award or to receive a release of shares. Incentive Shares qualify for dividends.
235 |
44 Share-based payments continued
Options granted under the following schemes are over subsidiaries of Barclays PLC:
Absa Group Limited Share Incentive Trust (AGLSIT)
In terms of the rules of Absa Group Limited Share Incentive Trust, the maximum number of shares which may be issued or transferred and/or in respect of which options may be granted to the participants shall be limited to shares representing 10% of the total number of issued shares from time to time. This is an equity-settled share-based payment arrangement and options are allocated to Absa employees according to the normal human resources talent management processes. The options issued up to August 2005 had no performance criteria linked to them and vested in equal tranches after three, four and five years respectively. No dividends accrue to the option holder over the vesting period. The options expire after a period of ten years from the issuing date. Options issued since August 2005 have performance criteria associated with them, which require headline earnings per share to exceed an agreed benchmark over a three-year period from the grant date for the options to vest. Participants need to be in the employ of Absa at the vesting date in order to be entitled to the options.
Absa Group Limited Executive Share Award Scheme (AGLESAS)
The ESAS is an equity-settled share-based payment arrangement, where the participants notional bonus comprises a number of restricted nil-cost options, based on the allocation price of ordinary shares. Such an initial allocation is held in trust or in the name of the participant. If the participant is in the employ of Absa after the three-year vesting period, the participant will receive 20% matched shares. If the bonus award remains in the ESAS for another two years, the participant receives another 10% matched shares. Dividend shares are paid to participants on the ordinary shares as if the shares were held from inception. The number of dividend shares awarded is therefore calculated on the initial allocation and on the 20% and/or 10% matched shares, over the three- or five-year period. Employees that receive a performance bonus in excess of a predetermined amount were compelled to place a set percentage of their bonus award into the ESAS. Employees also had the option of utilising more of their bonus award for voluntary ESAS options.
Absa Group Limited Performance Share Plan (AGLPSP)
The Performance Share Plan (PSP) was implemented in 2008. Performance shares are free Absa Group Limited shares for which no exercise price is payable and which qualify for dividends. Performance share awards are communicated to participants as an initial allocation. Absa Group Limiteds performance over a three-year period determines the final number of shares that may be released to participants.
Options remain outstanding under the following closed schemes:
Incentive Share Option Plan (ISOP)
The ISOP was open by invitation to the employees and Directors of Barclays PLC. Options were granted at the market price at the date of grant calculated in accordance with the rules of the plan, and are normally exercisable between three and ten years from that date. The final number of shares over which the option may be exercised is determined by reference to set performance criteria. The number of shares under option represents the maximum possible number that may be exercised. No awards were made under ISOP during 2009.
Woolwich Executive Share Option Plan (Woolwich ESOP)
Options originally granted over Woolwich PLC shares at market value were exercised in 2001 or exchanged, in accordance with the proposals made under the offer to acquire the Woolwich, for options over Barclays PLC shares. Under the rules of ESOP, the performance conditions attached to the exercise of options were disapplied on acquisition of Woolwich PLC by Barclays. Options lapse ten years after grant.
In addition, there were no options outstanding at year end under the following closed schemes:
Absa Group Broad-based Black Economic Empowerment transaction (BEE)
The Group entered into a black economic empowerment (BEE) transaction with Batho Bonke Capital (Proprietary) Limited in July 2004. The shares issued in terms of the transaction vested immediately. Due to the shares issued vesting immediately and also as a result of the issue being before 1st January 2005, the provisions of IFRS 2 Share-based payments were not applicable. In the current period 49.9% of the options were repurchased from Batho Bonke (Proprietary) Limited at a discount to their fair value. Batho Bonke utilised the proceeds to exercise 11,970,536 options. The Group provided bridging finance for the remaining 24,678,764 options. The life of these options was effectively extended for three months, effective 1st June 2009. The modification did not result in an increase in the fair value of these options and therefore, in terms of the provisions of IFRS 2, no cost was recognised in the statement of comprehensive income in the current period.
The bridging finance was redeemed on 1st September 2009 and Batho Bonke Capital (Proprietary) Limited exercised the balance of the options outstanding.
Absa Group Limited Share Ownership Administrative Trust (AGLSOT)
AGLSOT enabled all Absa employees to participate in a one-off offer to purchase 200 redeemable cumulative option-holding preference shares. Each redeemable preference share carries the option to acquire one Absa ordinary share. Options vest after three years and lapse after five years from the date of issue. Exercise may occur in lots of 100 only and within a price range varying from R48 to R69 (£3.81 to £5.48) dependent on the 30-day volume weighted trading price on the JSE Limited. Options are redeemed by Absa on the final exercise date.
Executive Share Option Scheme (ESOS)
The ESOS is a long-term incentive scheme and was available by invitation to certain senior executives of the Group with grants usually made annually. Options were issued with an exercise price equivalent to the market price at the date of the grant without any discount, calculated in accordance with the rules of the scheme, and are normally exercisable between three and ten years from that date. No further awards are made under ESOS.
Barclays Global Investors Equity Ownership Plan (BGI EOP)
The EOP was provided to key employees of BGI and was wound up following the disposal of BGI. The exercise price of the options was determined by the Remuneration Committee of Barclays PLC based on the fair value of BGI as determined by an independent appraiser. The options were granted over shares in Barclays Global Investors UK Holdings Limited, a subsidiary of Barclays Bank PLC.
Options were not exercisable until vesting, with a third of the options held generally becoming exercisable at each anniversary of grant. The shareholder had the right to offer to sell the shares to Barclays Bank PLC 355 days following the exercise of the option. The most recently agreed valuation was £109.45, at 30th November 2009. No awards were made under the BGI EOP in 2009.
The scheme rules provided that in the event of a sale of the business, outstanding options vest before the disposal. During the year the Group disposed of Barclays Global Investors. Accordingly, the share-based payment charge has been accelerated in these financial statements.
236 |
Notes to the accounts
For the year ended 31st December 2009
continued
44 Share-based payments continued
At the balance sheet date the following cash-settled schemes operated within the Group:
Absa Group Limited Phantom Performance Share Plan (Phantom PSP)
The Phantom PSP is a cash-settled plan and payments made to participants in respect of their awards are in the form of cash. The Phantom PSP shares (and any associated notional dividend shares) are awarded at no cost to the participants. The amount that is ultimately paid to the participants is equal to the market value of a number of ordinary shares as determined after a three-year vesting period. The vesting of the Phantom PSP awards will be subject to two non-market performance conditions which will be measured over a three-year period, starting on the first day of the financial year in which the award is made. The award will vest after three years to the extent that the performance conditions are satisfied. These awards are forfeited in total if Absa performance fails to meet the minimum criteria.
Absa Group Limited Phantom Executive Share Award Scheme (Phantom ESAS)
The Phantom ESAS is a cash-settled share-based payment arrangement, where the participants notional bonus comprises a number of restricted nil-cost options, based on the allocation price of ordinary shares. If the participant is in the employ of the Group after the three-year vesting period, the participant will receive 20% bonus phantom shares. If the bonus award remains in the Phantom ESAS for another two years, the participant receives an additional 10% bonus phantom shares. Dividend phantom shares are paid to participants on the ordinary phantom shares as if the shares were held from inception. The number of dividend phantom shares awarded is therefore calculated on the initial allocation and on the 20% and 10% bonus phantom shares, over the three- or five-year period. Employees that receive performance bonuses in excess of a predetermined amount are compelled to place a set percentage of the bonus award in the Phantom ESAS. Employees also have the option of utilising more of their bonus award for voluntary ESAS phantom shares.
The weighted average fair value per option granted during the year is as follows:
2009 £ |
2008 £ | |||
Sharesave |
1.43 | 0.92 | ||
PSP |
2.81 | 4.89 | ||
Sharepurchase |
1.82 | 3.38 | ||
ISP |
2.58 | 4.22 | ||
ESAS |
1.08 | 4.09 | ||
AGLPSP |
6.88 | 7.76 | ||
AGLESAS |
6.82 | 7.17 |
Fair values for Sharesave and PSP are calculated at the date of grant using either a Black-Scholes model or Monte Carlo simulation. Sharepurchase, ISP, ESAS, AGLPSP and AGLESAS are nil cost awards on which the performance conditions are substantially completed at the date of grant. Consequently the fair value of these awards is based on the market value at that date.
As described above, the terms of the ESAS scheme require shares to be held for a set number of years from the date of vest. The calculation of the vest date fair value of such awards includes a reduction for this post-vesting restriction. This discount is determined by calculating how much a willing market participant would rationally pay to remove the restriction using a Black-Scholes option pricing model. The total discount required in 2009 is £10m (2008: £10m, 2007: £66m).
The significant weighted average assumptions used to estimate the fair value of the options granted in 2009 are as follows:
2009 | ||||||
Sharesave | PSP | |||||
Weighted average share price |
3.51 | 2.34 | ||||
Weighted average exercise price |
2.70 | 1.77 | ||||
Expected volatility |
45 | % | 45 | % | ||
Expected option life |
4 years | 2 years |
The significant weighted average assumptions used to estimate the fair value of the options granted in 2008 are as follows:
2008 | ||||||
Sharesave | PSP | |||||
Weighted average share price |
3.11 | 5.45 | ||||
Weighted average exercise price |
2.51 | 2.07 | ||||
Expected volatility |
37 | % | 37 | % | ||
Expected option life |
4 years | 3 years |
The significant weighted average assumptions used to estimate the fair value of the options granted in 2007 are as follows:
2007 | ||||||||||||
Sharesave | PSP | BGI EOP | AGLSIT | |||||||||
Weighted average share price |
5.82 | 7.07 | 95.33 | 9.18 | ||||||||
Weighted average exercise price |
4.81 | | 95.33 | 7.62 | ||||||||
Expected volatility |
25 | % | 25 | % | 20 | % | 30 | % | ||||
Expected option life |
4 years | 3 years | 4 years | 5 years |
237 |
44 Share-based payments continued
Expected volatility and dividend yield on the date of grant have been used as inputs into the respective valuation models for Sharesave and PSP.
The yield on UK government bonds with a commensurate life has been used to determine the risk-free discount rate of 3% for Sharesave and PSP. Option life is estimated based upon historical data for the holding period of options between grant and exercise dates.
For the purposes of determining the expected life and number of options to vest, historical exercise patterns have been used, together with an assumption that a certain percentage of options will lapse due to leavers.
The assumed dividend yield for Barclays PLC is the average annual dividend yield on the date of grant of 2%.
Analysis of the movement in the number and weighted average exercise price of options is set out below:
Sharesave a | Sharepurchase a, c | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | |||||||||||||
Outstanding at beginning of year |
94,131 | 74,027 | 1.83 | 4.48 | 6,961 | 3,824 | | | ||||||||||||
Granted in the year |
28,005 | 56,024 | 2.70 | 2.51 | 6,832 | 3,834 | | | ||||||||||||
Adjustment in grants for open offer |
| 1,354 | | 4.33 | | | | | ||||||||||||
Exercised/released in the year |
(153 | ) | (3,357 | ) | 2.83 | 3.71 | (952 | ) | (64 | ) | | | ||||||||
Less: forfeited in the year |
(30,672 | ) | (33,917 | ) | 3.58 | 4.35 | (521 | ) | (633 | ) | | | ||||||||
Less: expired in the year |
| | | | | | | | ||||||||||||
Outstanding at end of year |
91,311 | 94,131 | 3.01 | 1.83 | 12,320 | 6,961 | | | ||||||||||||
Of which exercisable: |
7,537 | 4,025 | 4.19 | 3.71 | 1,621 | 737 | | | ||||||||||||
ESAS a, c | PSP a, c | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | |||||||||||||
Outstanding at beginning of year |
267,937 | 182,200 | | | 50,729 | 63,163 | | | ||||||||||||
Granted in the year |
311,977 | 141,269 | | | 4,794 | 8,528 | | | ||||||||||||
Adjustment in grants for open offer |
| 6,884 | | | | 1,370 | | | ||||||||||||
Exercised/released in the year |
(90,296 | ) | (56,231 | ) | | | (6,496 | ) | (1,467 | ) | | | ||||||||
Less: forfeited in the year |
(25,107 | ) | (6,185 | ) | | | (17,765 | ) | (20,865 | ) | | | ||||||||
Less: expired in the year |
| | | | | | | | ||||||||||||
Outstanding at end of year |
464,511 | 267,937 | | | 31,262 | 50,729 | | | ||||||||||||
Of which exercisable: |
12,714 | 15,131 | | | | | | | ||||||||||||
ISP a, c | Absa BEE b | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | |||||||||||||
Outstanding at beginning of year/acquisition date |
7,100 | | | | 73,152 | 73,152 | 3.16-4.55 | 3.40-3.89 | ||||||||||||
Granted in the year |
50,652 | 6,923 | | | | | | | ||||||||||||
Adjustment in grants for open offer |
| 177 | | | | | | | ||||||||||||
Exercised/released in the year |
(19 | ) | | | | (36,649 | ) | | 5.42 | | ||||||||||
Less: repurchased in the year |
| | | | (36,503 | ) | | | | |||||||||||
Less: forfeited in the year |
(2,755 | ) | | | | | | | | |||||||||||
Less: expired in the year |
| | | | | | | | ||||||||||||
Outstanding at end of year |
54,978 | 7,100 | | | | 73,152 | | 3.16-4.55 | ||||||||||||
Of which exercisable: |
| | | | | 73,152 | | 3.16-4.55 |
Notes
a | Options/award granted over Barclays PLC shares. |
b | Options/award granted over Absa Group Limited shares. |
c | Nil cost award. |
238 |
Notes to the accounts
For the year ended 31st December 2009
continued
44 Share-based payments continued
AGLSIT b | AGLSOT b | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | |||||||||||||
Outstanding at beginning of year/acquisition date |
9,967 | 13,618 | 4.91 | 4.81 | 559 | 946 | 3.16-4.55 | 3.40-3.89 | ||||||||||||
Exercised/released in the year |
(3,569 | ) | (3,252 | ) | 5.10 | 3.37 | (539 | ) | (368 | ) | 5.33 | | ||||||||
Less: forfeited in the year |
(100 | ) | (399 | ) | 6.99 | 4.96 | (20 | ) | (19 | ) | 3.81-5.48 | 3.16-4.55 | ||||||||
Outstanding at end of year |
6,298 | 9,967 | 6.28 | 4.91 | | 559 | | 3.16-4.55 | ||||||||||||
Of which exercisable: |
5,016 | 5,944 | 5.67 | 3.86 | | 559 | | 3.16-4.55 | ||||||||||||
AGLPSP b, c | AGLESAS b, c | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | |||||||||||||
Outstanding at beginning of year |
2,008 | | | | 1,015 | 37 | | | ||||||||||||
Granted in the year |
1,589 | 2,134 | | | 1,324 | 1,019 | | | ||||||||||||
Less: forfeited in the year |
(180 | ) | (126 | ) | | | (155 | ) | (41 | ) | | | ||||||||
Outstanding at end of year |
3,417 | 2,008 | | | 2,184 | 1,015 | | | ||||||||||||
Of which exercisable: |
| | | | | | | | ||||||||||||
ISOP a | ESOS a | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | |||||||||||||
Outstanding at beginning of year |
20,547 | 20,549 | 4.44 | 4.56 | 473 | 1,423 | 4.33 | 4.13 | ||||||||||||
Adjustment in grants for open offer |
| 537 | | 4.44 | | 12 | | 4.33 | ||||||||||||
Exercised/released in the year |
(253 | ) | (539 | ) | 3.17 | 4.06 | | (70 | ) | | 3.97 | |||||||||
Less: forfeited in the year |
(7,648 | ) | | 4.54 | | (473 | ) | (892 | ) | 4.33 | 3.97 | |||||||||
Outstanding at end of year |
12,646 | 20,547 | 4.41 | 4.44 | | 473 | | 4.33 | ||||||||||||
Of which exercisable: |
12,646 | 20,547 | 4.41 | 4.44 | | 473 | | 4.33 | ||||||||||||
Woolwich ESOP a | BGI EOP d | |||||||||||||||||||
Number (000s) |
Weighted average ex. price (£) |
Number (000s) |
Weighted average ex. price (£) | |||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | |||||||||||||
Outstanding at beginning of year |
442 | 540 | 3.70 | 3.81 | 6,584 | 7,502 | 78.50 | 75.66 | ||||||||||||
Adjustment in grants for open offer |
| 12 | | 3.70 | | | | | ||||||||||||
Exercised/released in the year |
(7 | ) | (104 | ) | 3.20 | 3.10 | (6,417 | ) | (550 | ) | 78.16 | 34.55 | ||||||||
Less: forfeited in the year |
(89 | ) | (6 | ) | 3.80 | 3.65 | (167 | ) | (368 | ) | 91.54 | 86.57 | ||||||||
Less: expired in the year |
(281 | ) | | | | | | | | |||||||||||
Outstanding at end of year |
65 | 442 | 3.20 | 3.70 | | 6,584 | | 78.50 | ||||||||||||
Of which exercisable: |
65 | 442 | 3.20 | 3.70 | | 3,631 | | 69.29 |
Notes
a | Options/award granted over Barclays PLC shares. |
b | Options/award granted over Absa Group Limited shares. |
c | Nil cost award. |
d | Options/award granted over Barclays Global Investors UK Holdings Limited shares. |
239 |
44 Share-based payments continued
The table below shows the weighted average share price at the date of exercise/release of shares:
2009 £ |
2008 £ | |||
Sharesave a |
3.21 | 4.70 | ||
Sharepurchase a, c |
2.64 | 1.59 | ||
ESAS a, c |
2.02 | 4.07 | ||
PSP a, c |
1.77 | 2.07 | ||
BGI EOP d |
109.45 | 87.22 | ||
Absa BEE b |
7.92 | | ||
AGLSIT b |
9.18 | 6.78 | ||
AGLSOT b |
7.86 | 6.79 | ||
ISP a, c |
3.43 | | ||
ISOP a |
3.61 | 4.59 | ||
ESOS a |
| 4.74 | ||
Woolwich ESOP a |
3.52 | 4.72 |
The exercise price range, the weighted average contractual remaining life and number of options outstanding (including those exercisable) at the balance sheet date are as follows:
Exercise price range | 2009 | 2008 | ||||||
Weighted average remaining contractual life in years |
Number of options outstanding |
Weighted average remaining contractual life in years |
Number of options outstanding | |||||
Sharesave a |
||||||||
£1.44-£2.49 |
2 | 1,817,640 | 3 | 2,121,926 | ||||
£2.50-£3.49 |
3 | 69,543,729 | 4 | 54,437,940 | ||||
£3.50-£4.49 |
1 | 9,057,990 | 1 | 19,986,642 | ||||
£4.50-£5.49 |
2 | 10,892,016 | 3 | 17,584,689 | ||||
Sharepurchase a, c |
2 | 12,319,993 | 2 | 6,960,593 | ||||
ESAS a, c |
3 | 464,511,395 | 3 | 267,936,513 | ||||
ISP a, c |
2 | 54,978,012 | 2 | 7,099,655 | ||||
PSP a, c |
1 | 31,261,898 | 1 | 50,729,245 | ||||
AGLSIT b |
||||||||
£1.66-£7.50 |
5 | 6,298,491 | 6 | 9,967,000 | ||||
AGLESAS b, c |
3 | 2,184,286 | 3 | 1,015,000 | ||||
AGLPSP b, c |
2 | 3,417,488 | 2 | 2,008,000 | ||||
ISOP a |
||||||||
£2.50-£3.49 |
3 | 2,701,442 | 4 | 3,862,322 | ||||
£3.50-£4.49 |
1 | 955,045 | 2 | 1,558,449 | ||||
£4.50-£5.49 |
3 | 8,989,576 | 4 | 14,899,933 | ||||
£5.50-£6.49 |
| | 7 | 225,894 | ||||
ESOS a |
||||||||
£3.50-£4.49 |
| | 1 | 472,561 | ||||
Woolwich ESOP a |
||||||||
£2.50-£3.49 |
| 65,024 | 1 | 89,644 | ||||
£3.50-£4.49 |
| | 1 | 352,961 |
There were no modifications to the share-based payment arrangements in the years 2009, 2008 and 2007. As at 31st December 2009, the total liability arising from cash-settled share-based payment transactions was £13m (2008: £23m).
In accordance with the scheme rules, all options awarded vested and were exercised by the holders following the disposal of the BGI business on 1st December 2009. The options were all exercised during December 2009.
Notes
a | Options/award granted over Barclays PLC shares. |
b | Options/award granted over Absa Group Limited shares. |
c | Nil cost award. |
d | Options/award granted over Barclays Global Investors UK Holdings Limited shares. |
240 |
Notes to the accounts
For the year ended 31st December 2009
continued
45 Off-balance sheet arrangements
In the ordinary course of business and primarily to facilitate client transactions, the Group enters into transactions which may involve the use of off-balance sheet arrangements and special purpose entities (SPEs). These arrangements include the provision of guarantees, loan commitments, retained interests in assets which have been transferred to an unconsolidated SPE or obligations arising from the Groups involvements with such SPEs.
Guarantees
The Group issues guarantees on behalf of its customers. In the majority of cases, the Group will hold collateral against the exposure, have a right of recourse to the customer or both. In addition, the Group issues guarantees on its own behalf. The main types of guarantees provided are: financial guarantees given to banks and financial institutions on behalf of customers to secure loans; overdrafts; and other banking facilities, including stock borrowing indemnities and standby letters of credit. Other guarantees provided include performance guarantees, advance payment guarantees, tender guarantees, guarantees to Her Majestys Revenue and Customs and retention guarantees. The nominal principal amount of contingent liabilities with off-balance sheet risk is set out in Note 34 (Contingent liabilities and commitments).
Loan commitments
The Group enters into commitments to lend to its customers subject to certain conditions. Such loan commitments are made either for a fixed period or are cancellable by the Group subject to notice conditions. Information on loan commitments and similar facilities is set out in Note 34 (Contingent liabilities and commitments).
Leasing
The Group leases various offices, branches, other premises and equipment under non-cancellable operating lease arrangements. With such operating lease arrangements, the asset is kept on the lessors balance sheet and the Group reports the future minimum lease payments as an expense over the lease term. Information on leasing can be found in Note 37 (Leasing).
Special purpose entities
SPEs are entities that are created to accomplish a narrow and well defined objective. There are often specific restrictions or limits around their ongoing activities. The Groups transactions with SPEs take a number of forms, including:
| The provision of financing to fund asset purchases, or commitments to provide finance for future purchases. |
| Derivative transactions to provide investors in the SPE with a specified exposure. |
| The provision of liquidity or backstop facilities which may be drawn upon if the SPE experiences future funding difficulties. |
| Direct investment in the notes issued by SPEs. |
Depending on the nature of the Groups resulting exposure, it may consolidate the SPE on to the Groups balance sheet. The consolidation of SPEs is considered at inception, based on the arrangements in place and the assessed risk exposures at that time. In accordance with IFRS, SPEs are consolidated when the substance of the relationship between the Group and the entity indicates control. Potential indicators of control include, amongst others, an assessment of the Groups exposure to the risks and benefits of the SPE. The initial consolidation analysis is revisited at a later date if:
i) | the Group acquires additional interests in the entity; |
ii) | the contractual arrangements of the entity are amended such that the relative exposures to risks and rewards change; or |
iii) | the Group acquires control over the main operating and financial decisions of the entity. |
A number of the Groups transactions have recourse only to the assets of unconsolidated SPEs. Typically, the majority of the exposure to these assets is borne by third parties and the Groups risk is mitigated through over-collateralisation, unwind features and other protective measures.
The business activities within the Group where SPEs are used include multi-seller conduit programmes, asset securitisations, client intermediation, credit structuring, asset realisations and fund management. These activities are described below. In addition, later sections provide quantative information on the Groups involvements with CDOs,SIVs SIV-Lites and conduits.
Multi-seller conduit programmes
Barclays creates, administers and provides liquidity and credit enhancements to several commercial paper conduit programmes, primarily in the United States. These conduits provide clients access to liquidity in the commercial paper markets by allowing them to sell consumer or trade receivables to the conduit, which then issues commercial paper to investors to fund the purchase. The conduits have sufficient collateral, credit enhancements and liquidity support to maintain an investment grade rating for the commercial paper.
Asset securitisations
The Group has assisted its customers with the formation of asset securitisations, some of which are effected through the use of SPEs. These entities have minimal equity and rely on funding in the form of notes to purchase the assets for securitisation. As these SPEs are created for other companies, the Group does not usually control these entities and therefore does not consolidate them. The Group may provide financing in the form of senior notes or junior notes and may also provide derivatives to the SPE. These transactions are included on the balance sheet.
The Group has also used SPEs to securitise part of its originated and purchased retail and commercial lending portfolios and credit card receivables. These SPEs are usually consolidated and derecognition only occurs when the Group transfers its contractual right to receive cash flows from the financial assets, or retains the contractual rights to receive the cash flows, but assumes a contractual obligation to pay the cash flows to another party without material delay or reinvestment, and also transfers substantially all the risks and rewards of ownership, including credit risk, prepayment risk and interest rate risk. The carrying amount of securitised assets together with the associated liabilities are set out in Note 29.
241 |
45 Off-balance sheet arrangements continued
Client intermediation
The Group has structured transactions as a financial intermediary to meet investor and client needs. These transactions involve entities structured by either the Group or the client and they are used to modify cash flows of third party assets to create investments with specific risk or return profiles or to assist clients in the efficient management of other risks. Such transactions will typically result in a derivative being shown on the balance sheet, representing the Groups exposure to the relevant asset. The Group also invests in lessor entities specifically to acquire assets for leasing. Client intermediation also includes arrangements to fund the purchase or construction of specific assets (most common in the property industry).
Credit structuring
The Group structures investments to provide specific risk profiles to investors. This may involve the sale of credit exposures, often by way of derivatives, to an entity which subsequently funds those exposures by issuing securities. These securities may initially be held by Barclays prior to sale outside of the Group.
Asset realisations
The Group establishes SPEs to facilitate the recovery of loans in circumstances where the borrower has suffered financial loss.
To the extent that there are guarantees and commitments in relation to SPEs the details are included in Note 34 Contingent liabilities and commitments.
Collateralised debt obligations (CDOs)
The Group has structured and underwritten CDOs. At inception, the Group's exposure principally takes the form of a liquidity facility provided to support future funding difficulties or cash shortfalls in the vehicles. If required by the vehicle, the facility is drawn with the amount advanced included within loans and advances on the balance sheet. Upon an event of default or other triggering event, the Group may acquire control of a CDO and, therefore, be required to fully consolidate the vehicle for accounting purposes. The potential for transactions to hit default triggers before the end of 2010 has been assessed and is included in the determination of £714m impairment charges and other credit provisions in relation to ABS CDO Super Senior and other credit market exposures for the year ended 31st December 2009.
The Group's exposure to ABS CDO Super Senior positions before hedging was £1,931m as at 31st December 2009, equivalent to an aggregate 50.83% decline in value on average for all investors. This represents the Group's exposure to High Grade CDOs, stated net of write-downs and charges. These facilities are fully drawn and included within loans and advances on the balance sheet.
Collateral
The collateral underlying unconsolidated CDOs comprised 78% residential mortgage-backed securities, 3% non-residential asset-backed securities and 19% in other categories (a proportion of which will be backed by residential mortgage collateral).
The remaining Weighted Average Life (WAL) of all collateral is 5.9 years. The combined Net Asset Value (NAV) for all of the CDOs was £0.9bn.
Funding
The CDOs were funded with senior unrated notes and rated notes up to AAA. The capital structure senior to the AAA notes on cash CDOs was supported by a liquidity facility provided by the Group. The senior portion covered by liquidity facilities is on average 88% of the capital structure.
The initial WAL of the notes in issue averaged 6.7 years. The full contractual maturity is 38.2 years.
Interests in third party CDOs
The Group has purchased securities in and entered into derivative instruments with third party CDOs. These interests are held as trading assets or liabilities on the Group's balance sheet and measured at fair value. The Group has not provided liquidity facilities or similar agreements to third party CDOs.
Structured investment vehicles (SIVs)
The Group does not structure or manage SIVs. Group exposure to third party SIVs comprised:
| £16m (2008: £52m) of senior liquidity facilities. |
| Derivative exposures included on the balance sheet at their net fair value of £53m (2008: £273m). |
SIV-Lites
The Group has exposure to two SIV-Lite transactions. The Group is not involved in their ongoing management. Exposures have decreased to £461m (2008: £638m) representing drawn liquidity facilities of £106m and assets designated at fair value of £355m.
242 |
Notes to the accounts
For the year ended 31st December 2009
continued
45 Off-balance sheet arrangements continued
Commercial paper and medium-term note conduits
The Group provided £16bn in undrawn backstop liquidity facilities to its own sponsored CP conduits. The Group fully consolidates these entities such that the underlying assets are reflected on the Group balance sheet.
These consolidated entities in turn provide facilities of £753m to third party conduits containing prime UK buy-to-let RMBS. As at 31st December 2009, the entire facility had been drawn and is included in available for sale financial investments.
The Group provided backstop facilities to support the paper issued by four third party conduits. These facilities totalled £287m, with underlying collateral comprising 100% auto loans. Drawings on these facilities were £125m as at 31st December 2009 and are included within loans and advances to customers.
The Group provided backstop facilities to four third party SPEs that fund themselves with medium-term notes. These notes are sold to investors as a series of 12-month securities and remarketed to investors annually. If investors decline to renew their holdings at a price below a pre-agreed spread, the backstop facility requires the Group to purchase the outstanding notes at scheduled maturity. The Group has provided facilities of £1.6bn to SPEs holding prime UK and Australian owner-occupied Residential Mortgage Back Securities (RMBS) assets. As at the balance sheet date these facilities had been drawn and were included in loans and advances.
46 Financial risks
Financial risk management
The Group is a major global financial services provider engaged in retail and commercial banking, credit cards, investment banking, wealth management and investment management services. Financial instruments are fundamental to the Groups business and managing financial risks, especially credit risk, is a fundamental part of its business activity.
The Groups risk management policies and processes are designed to identify and analyse risk, to set appropriate risk appetite, limits, and controls, and to monitor the risks and adherence to limits by means of reliable and up-to-date data. Risk management policies, models and systems are regularly reviewed to reflect changes to markets, products and best market practice.
Risk responsibilities
The Board approves risk appetite and the Board Risk Committee (BRC) monitors the Groups risk profile against this appetite:
| The Chief Risk Officer, under delegated authority from the Group Chief Executive and Group Finance Director, has responsibility for ensuring effective risk management and control; |
| Business Heads are responsible for the identification and management of risk in their businesses; |
| Business risk teams, each under the management of a Business Risk Director, are responsible for assisting Business Heads in the identification and management of their business risk profiles for implementing appropriate controls. These risk management teams also assist Group Risk in the formulation of Group Risk policy and the implementation of it across the businesses; |
| Within Group Risk, Risk-Type Heads and their teams are responsible for establishing a risk control framework and risk oversight; and |
| Internal Audit is responsible for the independent review of risk management and the control environment. |
Oversight of risk management is exercised by the Group Risk Oversight Committee which is chaired by the Chief Risk Officer under authority delegated by the Group Finance Director. The Group Risk Oversight Committee oversees management of the Groups risk profile, exercised through the setting, review and challenge of the size and constitution of the profile when viewed against the Group risk appetite.
The Executive Committee monitors and manages risk-adjusted performance of businesses and receives a regular update on forward risk trends and the Group Risk Profile Report.
The BRC reviews the Group risk profile, approves the Group Control Framework and approves minimum control requirements for principal risks.
The Board Audit Committee (BAC) considers the adequacy and effectiveness of the Group Control Framework and receives quarterly reports on control issues of significance and half-yearly reports on impairment allowances and regulatory reports.
Both BRC and BAC also receive reports dealing in more depth with specific issues relevant at the time. The proceedings of both Committees are reported to the full Board. The Board approves the overall Group risk appetite.
The Group Risk Oversight Committee is chaired by the Chief Risk Officer and oversees the management of the Groups risk profile and all of its significant risks. Oversight is exercised through the setting, review and challenge of the size and constitution of the profile when viewed against the Groups risk appetite. It has delegated and apportioned responsibility for credit risk management to the Retail and Wholesale Credit Risk Management Committees.
The main financial risks affecting the Group are discussed in Notes 47 to 49.
243 |
47 Credit risk
Credit risk is the risk of suffering financial loss, should any of the Groups customers, clients or market counterparties fail to fulfil their contractual obligations to the Group. Credit risk arises mainly from commercial and consumer loans and advances, credit cards, and loan commitments arising from such lending activities, but can also arise from credit enhancement provided, such as financial guarantees, letters of credit, endorsements and acceptances.
The Group is also exposed to other credit risks arising from investments in debt securities and other exposures arising from its trading activities (trading exposures) including, non-equity trading portfolio assets, derivatives as well as settlement balances with market counterparties and reverse repurchase loans.
Losses arising from exposures held for trading (derivatives, debt securities) are accounted for as trading losses, rather than impairment charges, even though the fall in value causing the loss may be attributable to credit deterioration.
Maximum exposure to credit risk before collateral held or other credit enhancements
The following table presents the maximum exposure at 31st December 2009 and 2008 to credit risk of balance sheet and off-balance sheet financial instruments, before taking account of any collateral held or other credit enhancements and after allowance for impairment and netting where appropriate.
For financial assets recognised on the balance sheet, the exposure to credit risk equals their carrying amount. For financial guarantees granted, the maximum exposure to credit risk is the maximum amount that Barclays would have to pay if the guarantees were to be called upon. For loan commitments and other credit related commitments that are irrevocable over the life of the respective facilities, the maximum exposure to credit risk is the full amount of the committed facilities.
This analysis and all subsequent analyses of credit risk include only financial assets subject to credit risk. They exclude other financial assets, mainly equity securities held in trading portfolio or available for sale as well as non-financial assets. The nominal value of off-balance sheet credit related instruments are also shown, where appropriate.
Financial assets designated at fair value held in respect of linked liabilities to customers under investment contracts have not been included as the Group is not exposed to credit risk on these assets. Credit losses in these portfolios, if any, would lead to a reduction in the linked liabilities and result in no direct loss to the Group.
Whilst the Groups maximum exposure to credit risk is the carrying value of the assets or, in the case of off-balance sheet items, the amount guaranteed, committed, accepted or endorsed, in most cases the likely exposure is far less due to collateral, credit enhancements and other actions taken to mitigate the Groups exposure.
244 |
Notes to the accounts
For the year ended 31st December 2009
continued
47 Credit risk continued
A description of the credit risk management and measurement methodologies, the credit quality of the assets and the collateral and other credit enhancements held against them is included in the relevant sections within this Note, for each of the categories in the following table:
At 31st December 2009 |
Loans and £m |
Debt £m |
Derivatives £m |
Reverse £m |
Others £m |
Total £m | |||||||
On-balance sheet: |
||||||||||||
Cash and balances at central banks |
81,483 | 81,483 | ||||||||||
Items in course of collection from other banks |
1,593 | 1,593 | ||||||||||
Trading portfolio: |
||||||||||||
Treasury and other eligible bills |
9,926 | 9,926 | ||||||||||
Debt securities |
116,594 | 116,594 | ||||||||||
Traded loans |
2,962 | 2,962 | ||||||||||
Total trading portfolio |
2,962 | 126,520 | 129,482 | |||||||||
Financial assets designated at fair value held on own account: |
||||||||||||
Loans and advances |
22,390 | 22,390 | ||||||||||
Debt securities |
4,007 | 4,007 | ||||||||||
Other financial assets |
557 | 7,757 | 344 | 8,658 | ||||||||
Total financial assets designated at fair value held on own account |
22,947 | 4,007 | 7,757 | 344 | 35,055 | |||||||
Derivative financial instruments |
416,815 | 416,815 | ||||||||||
Loans and advances to banks |
41,135 | 41,135 | ||||||||||
Loans and advances to customers: |
||||||||||||
Residential mortgage loans |
149,099 | 149,099 | ||||||||||
Credit card receivables |
21,889 | 21,889 | ||||||||||
Other personal lending |
25,435 | 25,435 | ||||||||||
Wholesale and corporate loans and advances |
212,928 | 212,928 | ||||||||||
Finance lease receivables |
10,873 | 10,873 | ||||||||||
Total loans and advances to customers |
420,224 | 420,224 | ||||||||||
Available for sale financial investments: |
||||||||||||
Treasury and other eligible bills |
5,919 | 5,919 | ||||||||||
Debt securities |
43,888 | 43,888 | ||||||||||
Total available for sale financial investments |
49,807 | 49,807 | ||||||||||
Reverse repurchase agreements |
143,431 | 143,431 | ||||||||||
Other assets |
3,476 | 3,476 | ||||||||||
Total on-balance sheet |
487,268 | 180,334 | 416,815 | 151,188 | 86,896 | 1,322,501 | ||||||
Off-balance sheet: |
||||||||||||
Acceptances and endorsements |
375 | |||||||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | 42,812 | |||||||||||
Commitments |
207,275 | |||||||||||
Total off-balance sheet |
250,462 | |||||||||||
Total maximum exposure |
1,572,963 |
245 |
47 Credit risk continued
At 31st December 2008 |
Loans and £m |
Debt £m |
Derivatives £m |
Reverse £m |
Others £m |
Total £m | |||||||
On-balance sheet: |
||||||||||||
Cash and balances at central banks |
30,019 | 30,019 | ||||||||||
Items in course of collection from other banks |
1,695 | 1,695 | ||||||||||
Trading portfolio: |
||||||||||||
Treasury and other eligible bills |
4,544 | 4,544 | ||||||||||
Debt securities |
148,686 | 148,686 | ||||||||||
Traded loans |
1,070 | 1,070 | ||||||||||
Total trading portfolio |
1,070 | 153,230 | 154,300 | |||||||||
Financial assets designated at fair value held on own account: |
||||||||||||
Loans and advances |
30,057 | 130 | 30,187 | |||||||||
Debt securities |
8,628 | 8,628 | ||||||||||
Other financial assets |
1,469 | 7,283 | 479 | 9,231 | ||||||||
Total financial assets designated at fair value held on own account |
31,526 | 8,628 | 7,283 | 609 | 48,046 | |||||||
Derivative financial instruments |
984,802 | 984,802 | ||||||||||
Loans and advances to banks |
47,707 | 47,707 | ||||||||||
Loans and advances to customers: |
||||||||||||
Residential mortgage loans |
139,845 | 139,845 | ||||||||||
Credit card receivables |
22,304 | 22,304 | ||||||||||
Other personal lending |
27,270 | 27,270 | ||||||||||
Wholesale and corporate loans and advances |
259,699 | 259,699 | ||||||||||
Finance lease receivables |
12,697 | 12,697 | ||||||||||
Total loans and advances to customers |
461,815 | 461,815 | ||||||||||
Available for sale financial investments: |
||||||||||||
Treasury and other eligible bills |
4,003 | 4,003 | ||||||||||
Debt securities |
58,831 | 58,831 | ||||||||||
Total available for sale financial investments |
62,834 | 62,834 | ||||||||||
Reverse repurchase agreements |
130,354 | 130,354 | ||||||||||
Other assets |
3,096 | 3,096 | ||||||||||
Total on-balance sheet |
542,118 | 224,692 | 984,802 | 137,637 | 35,419 | 1,924,668 | ||||||
Off-balance sheet: |
||||||||||||
Acceptances and endorsements |
585 | |||||||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | 53,942 | |||||||||||
Commitments |
260,816 | |||||||||||
Total off-balance sheet |
315,343 | |||||||||||
Total maximum exposure |
2,240,011 |
246 |
Notes to the accounts
For the year ended 31st December 2009
continued
47 Credit risk continued
Credit risk concentrations
A concentration of credit risk exists when a number of counterparties are engaged in similar activities and have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions.
The analyses of credit risk concentrations presented below are based on the location of the counterparty or customer or the industry in which they are engaged.
Credit risk concentrations by geographical sector | ||||||||||||
United Kingdom £m |
Other £m |
United £m |
Africa £m |
Rest of the World £m |
Total £m | |||||||
2009 |
||||||||||||
On-balance sheet: |
||||||||||||
Cash and balances at central banks |
37,697 | 5,584 | 32,279 | 1,742 | 4,181 | 81,483 | ||||||
Items in the course of collection from other banks |
1,340 | 56 | | 196 | 1 | 1,593 | ||||||
Trading portfolio |
12,232 | 35,088 | 52,229 | 1,414 | 28,519 | 129,482 | ||||||
Financial assets designated at fair value held on own account |
13,945 | 3,986 | 10,800 | 2,352 | 3,972 | 35,055 | ||||||
Derivative financial instruments |
133,713 | 128,881 | 111,269 | 2,511 | 40,441 | 416,815 | ||||||
Loans and advances to banks |
5,117 | 12,697 | 13,137 | 2,388 | 7,796 | 41,135 | ||||||
Loans and advances to customers |
203,582 | 84,343 | 58,355 | 47,495 | 26,449 | 420,224 | ||||||
Available for sale financial investments |
16,752 | 14,028 | 7,175 | 4,993 | 6,859 | 49,807 | ||||||
Reverse repurchase agreements |
22,222 | 44,014 | 60,759 | 527 | 15,909 | 143,431 | ||||||
Other assets |
1,565 | 417 | 651 | 661 | 182 | 3,476 | ||||||
Total on-balance sheet |
448,165 | 329,094 | 346,654 | 64,279 | 134,309 | 1,322,501 | ||||||
Off-balance sheet: |
||||||||||||
Acceptances and endorsements |
134 | 5 | | 26 | 210 | 375 | ||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | 3,337 | 2,783 | 32,849 | 1,795 | 2,048 | 42,812 | ||||||
Commitments |
95,120 | 26,344 | 57,598 | 19,480 | 8,733 | 207,275 | ||||||
Total off-balance sheet |
98,591 | 29,132 | 90,447 | 21,301 | 10,991 | 250,462 | ||||||
Total |
546,756 | 358,226 | 437,101 | 85,580 | 145,300 | 1,572,963 | ||||||
2008 |
||||||||||||
On-balance sheet: |
||||||||||||
Cash and balances at central banks |
8,406 | 11,039 | 8,381 | 1,712 | 481 | 30,019 | ||||||
Items in the course of collection from other banks |
1,447 | 59 | | 169 | 20 | 1,695 | ||||||
Trading portfolio |
23,865 | 35,396 | 66,084 | 2,770 | 26,185 | 154,300 | ||||||
Financial assets designated at fair value held on own account |
14,158 | 7,388 | 19,738 | 2,904 | 3,858 | 48,046 | ||||||
Derivative financial instruments |
317,621 | 215,054 | 366,161 | 4,403 | 81,563 | 984,802 | ||||||
Loans and advances to banks |
7,524 | 12,591 | 13,616 | 2,189 | 11,787 | 47,707 | ||||||
Loans and advances to customers |
213,079 | 91,109 | 75,826 | 44,373 | 37,428 | 461,815 | ||||||
Available for sale financial investments |
15,423 | 18,928 | 16,583 | 3,351 | 8,549 | 62,834 | ||||||
Reverse repurchase agreements |
22,659 | 41,724 | 47,034 | 848 | 18,089 | 130,354 | ||||||
Other assets |
1,198 | 548 | 550 | 520 | 280 | 3,096 | ||||||
Total on-balance sheet |
625,380 | 433,836 | 613,973 | 63,239 | 188,240 | 1,924,668 | ||||||
Off-balance sheet: |
||||||||||||
Acceptances and endorsements |
274 | | 6 | 41 | 264 | 585 | ||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | 4,433 | 3,742 | 42,227 | 1,738 | 1,802 | 53,942 | ||||||
Commitments |
103,548 | 32,445 | 90,298 | 23,210 | 11,315 | 260,816 | ||||||
Total off-balance sheet |
108,255 | 36,187 | 132,531 | 24,989 | 13,381 | 315,343 | ||||||
Total |
733,635 | 470,023 | 746,504 | 88,228 | 201,621 | 2,240,011 |
247 |
47 Credit risk continued
Credit risk concentrations by industrial sector | ||||||||||||||||||||
Government £m |
Financial Services £m |
Transport, Postal and £m |
Agriculture, £m |
Construction Property £m |
Energy and water £m |
Residential £m |
Other personal lending £m |
Finance lease receivables £m |
Total £m | |||||||||||
2009 |
||||||||||||||||||||
On-balance sheet: | ||||||||||||||||||||
Cash and balances at central banks | 81,483 | | | | | | | | | 81,483 | ||||||||||
Items in the course of collection from other banks | 7 | 1,586 | | | | | | | | 1,593 | ||||||||||
Trading portfolio | 76,454 | 41,482 | 2,811 | 4,536 | 1,063 | 3,136 | | | | 129,482 | ||||||||||
Financial assets designated at fair value held on own account | 5,435 | 13,366 | 2,893 | 948 | 11,929 | 330 | 150 | 4 | | 35,055 | ||||||||||
Derivative financial instruments | 6,119 | 379,901 | 8,424 | 7,805 | 2,416 | 12,081 | | 69 | | 416,815 | ||||||||||
Loans and advances to banks | 4,425 | 36,710 | | | | | | | | 41,135 | ||||||||||
Loans and advances to customers | 4,800 | 93,370 | 40,034 | 41,645 | 29,175 | 10,727 | 149,099 | 40,501 | 10,873 | 420,224 | ||||||||||
Available for sale financial investments | 16,320 | 30,398 | 1,962 | 377 | 269 | 57 | 416 | | 8 | 49,807 | ||||||||||
Reverse repurchase agreements | 5,347 | 136,184 | 608 | 366 | 926 | | | | | 143,431 | ||||||||||
Other assets
|
414 | 1,588 | 543 | 64 | 60 | 13 | 106 | 682 | 6 | 3,476 | ||||||||||
Total on-balance sheet
|
200,804
|
734,585
|
57,275
|
55,741
|
45,838
|
26,344
|
149,771
|
41,256
|
10,887
|
1,322,501
| ||||||||||
Off-balance sheet: |
||||||||||||||||||||
Acceptances and endorsements | | 85 | 95 | 155 | 2 | 33 | | 5 | | 375 | ||||||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | | 33,117 | 2,805 | 2,308 | 715 | 2,872 | 584 | 411 | | 42,812 | ||||||||||
Commitments
|
1,687
|
39,806
|
18,670
|
28,552
|
10,647
|
13,502
|
15,356
|
79,055
|
|
207,275
| ||||||||||
Total off-balance sheet
|
1,687
|
73,008
|
21,570
|
31,015
|
11,364
|
16,407
|
15,940
|
79,471
|
|
250,462
| ||||||||||
Total
|
202,491
|
807,593
|
78,845
|
86,756
|
57,202
|
42,751
|
165,711
|
120,727
|
10,887
|
1,572,963
|
248 |
Notes to the accounts
For the year ended 31st December 2009
continued
47 Credit risk continued
Credit risk concentrations by industrial sector | ||||||||||||||||||||
Government £m |
Financial services £m |
Transport, postal and £m |
Agriculture, £m |
Construction £m |
Energy £m |
Residential £m |
Other £m |
Finance £m |
Total £m | |||||||||||
2008 |
||||||||||||||||||||
On-balance sheet: | ||||||||||||||||||||
Cash and balances at central banks | 30,019 | | | | | | | | | 30,019 | ||||||||||
Items in the course of collection from other banks | 10 | 1,685 | | | | | | | | 1,695 | ||||||||||
Trading portfolio | 68,962 | 73,729 | 3,320 | 2,590 | 1,404 | 4,272 | | 4 | 19 | 154,300 | ||||||||||
Financial assets designated at fair value held on own account | 5,871 | 21,860 | 1,080 | 1,286 | 17,415 | 271 | | 263 | | 48,046 | ||||||||||
Derivative financial instruments | 10,370 | 928,793 | 9,265 | 14,420 | 3,779 | 18,054 | | 121 | | 984,802 | ||||||||||
Loans and advances to banks | 2,794 | 44,913 | | | | | | | | 47,707 | ||||||||||
Loans and advances to customers | 5,296 | 112,506 | 52,243 | 49,068 | 29,988 | 14,078 | 139,845 | 46,094 | 12,697 | 461,815 | ||||||||||
Available for sale financial investments | 14,891 | 44,865 | 1,288 | 436 | 333 | 354 | 569 | 98 | | 62,834 | ||||||||||
Reverse repurchase agreements | 17,939 | 110,645 | 536 | 428 | 806 | | | | | 130,354 | ||||||||||
Other assets
|
103 | 1,397 | 602 | 260 | 8 | 12 | 155 | 554 | 5 | 3,096 | ||||||||||
Total on-balance sheet
|
156,255
|
1,340,393
|
68,334
|
68,488
|
53,733
|
37,041
|
140,569
|
47,134
|
12,721
|
1,924,668
| ||||||||||
Off-balance sheet: |
||||||||||||||||||||
Acceptances and endorsements | | 151 | 180 | 231 | 14 | 3 | | 6 | | 585 | ||||||||||
Guarantees and letters of credit pledged as collateral security and securities lending arrangements | | 44,858 | 4,161 | 2,275 | 778 | 1,604 | | 266 | | 53,942 | ||||||||||
Commitments |
5,096
|
33,746
|
32,769
|
36,815
|
11,405
|
16,279
|
12,196
|
112,510
|
|
260,816
| ||||||||||
Total off-balance sheet
|
5,096
|
78,755
|
37,110
|
39,321
|
12,197
|
17,886
|
12,196
|
112,782
|
|
315,343
| ||||||||||
Total |
161,351
|
1,419,148
|
105,444
|
107,809
|
65,930
|
54,927
|
152,765
|
159,916
|
12,721
|
2,240,011
|
249 |
47 Credit risk continued
Loans and advances
Credit risk management
Governance and responsibilities
The credit risk management teams in each business are accountable to the Business Risk Directors in those businesses who, in turn, report to the heads of their businesses and also to the Chief Risk Officer.
The credit risk function provides Group-wide direction of credit risk-taking. The teams within this function manage the resolution of all significant credit policy issues and run the Credit Committee, which approves major credit decisions. Each business segment has an embedded credit risk management team. These teams assist Group Risk in the formulation of Group Risk policy and its implementation across the businesses.
The principal committees that review credit risk management, formulate overall Group credit policy and resolve all significant credit policy issues are the Board Risk Committee, the Group Risk Oversight Committee, the Wholesale Credit Risk Management Committee and the Retail Credit Risk Management Committee.
The Wholesale Credit Risk Management Committee (WCRMC) oversees wholesale exposures, comprising lending to businesses, banks and other financial institutions. The WCRMC monitors exposure by country, industry sector, individual large exposures and exposures to sub-investment grade countries.
The Retail Credit Risk Management Committee (RCRMC) oversees exposures, which comprise unsecured personal lending (including small businesses), mortgages and credit cards. The RCRMC monitors the risk profile and performance of the retail portfolios by receipt of key risk measures and indicators at an individual portfolio level, ensuring mitigating actions taken to address performance are appropriate and timely. Metrics reviewed will consider portfolio composition and both an overall stock and new flow level.
The monthly Wholesale and Retail Credit Risk Management Committees exercise oversight through review and challenge of the size and constitution of the portfolios when viewed against Group Risk Appetite for wholesale and retail credit risks. They are chaired by the Wholesale and Retail Credit Risk Directors.
Credit monitoring
Wholesale and corporate loans which are deemed to contain heightened levels of risk are recorded on early-warning or watch lists. These lists are graded in line with the perceived severity of the risk attached to the lending and its probability of default. The lists are updated on a monthly basis and are closely monitored.
Regardless of whether they are recorded on early-warning or watch lists, all wholesale and corporate loans are subject to a full review of all facilities on, at least, an annual basis. More frequent interim reviews may be undertaken should circumstances dictate.
Retail loans (which tend to comprise homogeneous assets) are monitored on a portfolio basis.
Credit risk measurement
Barclays uses statistical modelling techniques throughout its business in its credit rating systems. They enable a coherent approach to risk measurement across all credit exposures, retail and wholesale. The key building blocks in the measurement system are the probability of customer default (PD), exposure in the event of default (EAD), and severity of loss-given-default (LGD). The models are reviewed regularly to monitor their robustness relative to actual performance and amended as necessary to optimise their effectiveness.
For wholesale and corporate lending, Barclays assesses the credit quality of borrowers and other counterparties and assigns them an internal risk rating. Barclays credit rating contains 21 grades, representing the Groups best estimate of credit risk for a counterparty based on current economic conditions. Retail customers are not all assigned internal risk ratings in this way for account management purposes, therefore their probability of default is considered.
The Group considers Credit Risk Loans (defined as all customers overdue by 90 days or more, and/or individually impaired or restructured) and loan loss rates when assessing the credit performance of its loan portfolios, other than those held at fair value. For the purposes of historical and business unit comparison, loan loss rates are defined as total annualised credit impairment charge (excluding available for sale assets and reverse repurchase agreements) divided by gross loans and advances to customers and banks (at amortised cost).
Credit risk mitigation
Where appropriate, the Group takes action to mitigate credit risk such as reducing amounts outstanding (in discussion with the customers, clients or counterparties if appropriate), using credit derivatives, securitising assets, and disposals.
Diversification to avoid unwanted credit risk concentrations is achieved through setting maximum exposure guidelines to individual counterparties. Excesses are reported to the Board Risk Committee and the Group Risk Oversight Committee. Mandate and scale limits are used to limit the stock of current exposures in a loan portfolio and the flow of new exposures into a loan portfolio. Limits are typically based on the tenor and nature of the lending.
Collateral and security
The Group routinely obtains collateral and security to mitigate credit risk.
The Group ensures that any collateral held is sufficiently liquid, legally effective, enforceable and regularly reassessed. Before attaching value to collateral, businesses holding specific, agreed classes of collateral must ensure that they are holding a correctly perfected charge.
Before reliance is placed on third party protection in the form of bank, government or corporate guarantees or credit derivative protection from financial intermediary counterparties, a credit assessment is undertaken.
Security structures and legal covenants are subject to regular review, at least annually, to ensure that they remain fit for purpose and remain consistent with accepted local market practice.
250 |
Notes to the accounts
For the year ended 31st December 2009
continued
47 Credit risk continued
All loans and advances are categorised as either:
neither past due nor individually impaired;
past due but not individually impaired; or
individually impaired, which includes restructured loans.
The impairment allowance includes allowances against financial assets that have been individually impaired and those subject to collective impairment.
Credit risk loans comprise loans and advances to banks and customers 90 days overdue or more and those subject to individual impairment. The coverage ratio is calculated by reference to the total impairment allowance and the carrying value (before impairment) of credit risk loans.
Neither past due nor individually impaired a £m |
Past due but not individually impaired b £m |
Individually impaired £m |
Total £m |
Impairment allowance £m |
Total carrying value £m |
Credit Risk Loans £m |
Coverage ratio % | ||||||||||
As at 31st December 2009 |
|||||||||||||||||
Trading portfolio: |
|||||||||||||||||
Traded loans |
2,962 | | | 2,962 | | 2,962 | | | |||||||||
Financial assets designated at fair value held on own account: | |||||||||||||||||
Loans and advances |
22,210 | 180 | | 22,390 | | 22,390 | | | |||||||||
Other financial assets |
557 | | | 557 | | 557 | | | |||||||||
Loans and advances to banks |
38,859 | 2,280 | 57 | 41,196 | (61 | ) | 41,135 | 57 | 100.0 | ||||||||
Loans and advances to customers: | |||||||||||||||||
Residential mortgage loans |
139,199 | 8,846 | 1,693 | 149,738 | (639 | ) | 149,099 | 3,604 | 17.7 | ||||||||
Credit card receivables |
20,195 | 1,544 | 2,459 | 24,198 | (2,309 | ) | 21,889 | 3,068 | 75.3 | ||||||||
Other personal lending |
23,796 | 2,175 | 2,372 | 28,343 | (2,908 | ) | 25,435 | 3,466 | 83.9 | ||||||||
Wholesale and corporate loans and advances | 199,800 | 7,598 | 10,088 | 217,486 | (4,558 | ) | 212,928 | 11,497 | 39.6 | ||||||||
Finance lease receivables
|
10,128 | 664 | 402 | 11,194 | (321 | ) | 10,873 | 696 | 46.1 | ||||||||
Total
|
457,706
|
23,287
|
17,071
|
498,064
|
(10,796
|
)
|
487,268
|
22,388
|
48.2
| ||||||||
As at 31st December 2008 | |||||||||||||||||
Trading portfolio: |
|||||||||||||||||
Traded loans |
1,070 | | | 1,070 | | 1,070 | | | |||||||||
Financial assets designated at fair value held on own account: | |||||||||||||||||
Loans and advances |
29,182 | 875 | | 30,057 | | 30,057 | | | |||||||||
Other financial assets |
1,469 | | | 1,469 | | 1,469 | | | |||||||||
Loans and advances to banks |
46,665 | 1,045 | 48 | 47,758 | (51 | ) | 47,707 | 48 | 100.0 | ||||||||
Loans and advances to customers c: | |||||||||||||||||
Residential mortgage loans |
131,017 | 7,481 | 1,668 | 140,166 | (321 | ) | 139,845 | 2,528 | 12.7 | ||||||||
Credit card receivables |
21,092 | 1,426 | 1,231 | 23,749 | (1,445 | ) | 22,304 | 1,990 | 72.6 | ||||||||
Other personal lending |
25,885 | 1,274 | 1,980 | 29,139 | (1,869 | ) | 27,270 | 2,560 | 73.0 | ||||||||
Wholesale and corporate loans and advances | 246,505 | 8,307 | 7,586 | 262,398 | (2,699 | ) | 259,699 | 8,277 | 32.6 | ||||||||
Finance lease receivables
|
12,367 | 285 | 234 | 12,886 | (189 | ) | 12,697 | 297 | 63.6 | ||||||||
Total
|
515,252
|
20,693
|
12,747
|
548,692
|
(6,574
|
)
|
542,118
|
15,700
|
41.9
|
Notes
a | Financial assets subject to collective impairment allowance are included in this column if they are not past due. |
b | Financial assets subject to collective impairment allowance are included in this column if they are past due. |
c | Loans and advances to customers in the above table have been reanalysed between Residential mortgage loans and Other personal lending. |
251 |
47 Credit risk continued
Credit quality of loans and advances neither past due nor individually impaired
2009 | 2008 | |||||||||||||||
Strong £m |
Satisfactory £m |
Higher risk £m |
Total £m |
Strong £m |
Satisfactory £m |
Higher risk £m |
Total £m | |||||||||
Trading portfolio: |
||||||||||||||||
Traded loans |
1,366 | 1,290 | 306 | 2,962 | 759 | 220 | 91 | 1,070 | ||||||||
Financial assets designated at fair value held on own account: | ||||||||||||||||
Loans and advances |
15,909 | 3,809 | 2,492 | 22,210 | 25,665 | 2,792 | 725 | 29,182 | ||||||||
Other financial assets |
261 | | 296 | 557 | | 1,469 | | 1,469 | ||||||||
Loans and advances to banks |
35,825 | 2,492 | 542 | 38,859 | 40,181 | 6,384 | 100 | 46,665 | ||||||||
Loans and advances to customers: |
||||||||||||||||
Residential mortgage loans |
66,956 | 69,919 | 2,324 | 139,199 | 86,937 | 42,770 | 1,310 | 131,017 | ||||||||
Credit card receivables |
| 20,038 | 157 | 20,195 | | 20,426 | 666 | 21,092 | ||||||||
Other personal lending |
3,417 | 18,108 | 2,271 | 23,796 | 2,975 | 21,750 | 1,160 | 25,885 | ||||||||
Wholesale and corporate loans and advances |
119,764 | 70,132 | 9,904 | 199,800 | 141,868 | 94,453 | 10,184 | 246,505 | ||||||||
Finance lease receivables
|
2,664 | 7,082 | 382 | 10,128 | 4,214 | 7,504 | 649 | 12,367 | ||||||||
Total loans and advances
|
246,162 |
192,870 |
18,674 |
457,706 |
302,599 |
197,768 |
14,885 |
515,252 |
For the purposes of the analysis of credit quality, the following internal measures of credit quality have been used:
Retail lending | Wholesale lending | |||||
Financial statements description
|
Probability of default
|
Probability of default
|
Default grade
| |||
Strong |
0.0-0.60% |
0.0-0.05%
|
1-3
| |||
Satisfactory |
0.60-10.00% |
0.60-2.15%
|
12-14
| |||
Higher risk
|
10.00% +
|
11.35% +
|
20-21
|
Financial statement descriptions can be summarised as follows:
Strong there is a very high likelihood of the asset being recovered in full.
Satisfactory whilst there is a high likelihood that the asset will be recovered and therefore, of no cause for concern to the Group, the asset may not be collateralised, or may relate to retail facilities, such as credit card balances and unsecured loans, which have been classified as satisfactory, regardless of the fact that the output of internal grading models may have indicated a higher classification. At the lower end of this grade there are customers that are being more carefully monitored, for example, corporate customers which are indicating some evidence of some deterioration, mortgages with a high loan to value ratio, and unsecured retail loans operating outside normal product guidelines.
Higher risk there is concern over the obligors ability to make payments when due. However, these have not yet converted to actual delinquency. There may also be doubts over value of collateral or security provided. However, the borrower or counterparty is continuing to make payments when due and is expected to settle all outstanding amounts of principal and interest.
252 |
Notes to the accounts
For the year ended 31st December 2009
continued
47 Credit risk continued
Loans and advances that are past due but not individually impaired
An age analysis of loans and advances that are past due but not individually impaired is set out below.
For the purposes of this analysis an asset is considered past due and included below when any payment due under strict contractual terms is received late or missed. The amount included is the entire financial asset, not just the payment, of principal or interest or both, overdue.
The table below provides a breakdown of total financial assets past due but not individually impaired. In general, retail and wholesale loans fall into this category for two separate reasons. Retail loans and advances to customers may come under this category because the impairment allowance on such loans is calculated on a collective not individual basis. This reflects the homogenous nature of the assets, which allows statistical techniques to be used, rather than individual assessment.
In contrast, some loans to wholesale and corporate customers and banks may come under this category because of instances where a payment on a loan is past due without requiring an individual impairment allowance. For example, an individual impairment allowance will not be required when a loss is not expected due to a corporate loan being fully secured or collateralised. As a result, it is past due but not individually impaired.
Past due up to 1 month £m |
Past due 1-2 months £m |
Past due 2-3 months £m |
Past due 3-6 months £m |
Past due 6 months and over £m |
Total £m |
Of which Credit Risk Loans £m | ||||||||
2009 |
||||||||||||||
Financial assets designated at fair value held on own account: |
||||||||||||||
Loans and advances
|
170 | | 1 | | 9 | 180 | | |||||||
Loans and advances to banks
|
2,280 |
|
|
|
|
2,280 |
| |||||||
Loans and advances to customers: |
||||||||||||||
Residential mortgage loans |
4,849 | 1,453 | 633 | 1,410 | 501 | 8,846 | 1,911 | |||||||
Credit card receivables |
501 | 214 | 220 | 459 | 150 | 1,544 | 609 | |||||||
Other personal lending |
369 | 295 | 417 | 413 | 681 | 2,175 | 1,094 | |||||||
Wholesale and corporate loans and advances |
5,403 | 292 | 494 | 866 | 543 | 7,598 | 1,409 | |||||||
Finance lease receivables
|
186 | 86 | 98 | 282 | 12 | 664 | 294 | |||||||
Total loans and advances to customers
|
11,308 |
2,340 |
1,862 |
3,430 |
1,887 |
20,827 |
5,317 | |||||||
Total financial assets past due but not individually impaired
|
13,758 |
2,340 |
1,863 |
3,430 |
1,896 |
23,287 |
5,317 | |||||||
2008 |
||||||||||||||
Financial assets designated at fair value held on own account: |
||||||||||||||
Loans and advances
|
315 | 147 | 81 | 82 | 250 | 875 | | |||||||
Loans and advances to banks
|
1,044 |
1 |
|
|
|
1,045 |
| |||||||
Loans and advances to customers: |
||||||||||||||
Residential mortgage loans |
4,421 | 1,570 | 630 | 713 | 147 | 7,481 | 860 | |||||||
Credit card receivables |
293 | 224 | 150 | 291 | 468 | 1,426 | 759 | |||||||
Other personal lending |
219 | 202 | 273 | 338 | 242 | 1,274 | 580 | |||||||
Wholesale and corporate loans and advances |
6,229 | 540 | 847 | 477 | 214 | 8,307 | 691 | |||||||
Finance lease receivables
|
130 | 53 | 39 | 63 | | 285 | 63 | |||||||
Total loans and advances to customers
|
11,292
|
2,589
|
1,939
|
1,882
|
1,071
|
18,773
|
2,953
| |||||||
Total financial assets past due but not individually impaired
|
12,651
|
2,737
|
2,020
|
1,964
|
1,321
|
20,693
|
2,953
|
253 |
47 Credit risk continued
Loans and advances individually assessed as impaired
An analysis of financial assets individually assessed as impaired is as follows:
2009 |
2008 | |||||||||||||
Original carrying amount £m |
Impairment allowance £m |
Revised carrying amount £m |
Original carrying amount £m |
Impairment allowance £m |
Revised carrying amount £m | |||||||||
Loans and advances to banks individually impaired
|
57
|
(49
|
)
|
8
|
48
|
(44
|
)
|
4
| ||||||
Loans and advances to customers: |
||||||||||||||
Residential mortgage loans |
1,693 | (317 | ) | 1,376 | 1,668 | (240 | ) | 1,428 | ||||||
Credit card receivables |
2,459 | (1,690 | ) | 769 | 1,231 | (727 | ) | 504 | ||||||
Other personal lending |
2,372 | (1,531 | ) | 841 | 1,980 | (1,237 | ) | 743 | ||||||
Wholesale and corporate loans and advances |
10,088 | (3,837 | ) | 6,251 | 7,586 | (2,310 | ) | 5,276 | ||||||
Finance lease receivables |
402 | (233 | ) | 169 | 234 | (140 | ) | 94 | ||||||
Total loans and advances individually impaired
|
17,071
|
(7,657
|
)
|
9,414
|
12,747
|
(4,698
|
)
|
8,049
| ||||||
Collective impairment allowance
|
(3,139
|
)
|
(1,876
|
)
|
||||||||||
Total impairment allowance
|
(10,796
|
)
|
(6,574
|
)
|
The movements on the impairment allowance during the year were as follows:
At beginning of year £m |
Acquisitions and disposals £m |
Unwind of discount £m |
Exchange and other adjustments £m |
Amounts £m |
Recoveries £m |
Amounts charged to income statement £m |
Balance at 31st December £m | ||||||||||||
2009 |
|||||||||||||||||||
Loans and advances to banks
|
51 |
|
|
|
(11) |
|
|
|
10 |
11 |
61 | ||||||||
Loans and advances to customers: |
|||||||||||||||||||
Residential mortgage loans |
321 | 19 | (59 | ) | 46 | (82 | ) | 3 | 391 | 639 | |||||||||
Credit card receivables |
1,445 | 415 | (79 | ) | (28 | ) | (1,009 | ) | 78 | 1,487 | 2,309 | ||||||||
Other personal lending |
1,869 | | (26 | ) | (89 | ) | (633 | ) | 21 | 1,766 | 2,908 | ||||||||
Wholesale and corporate loans and advances | 2,699 | | (15 | ) | (48 | ) | (1,538 | ) | 28 | 3,432 | 4,558 | ||||||||
Finance lease receivables
|
189 | | (6) | 3 | (118) | 10 | 243 | 321 | |||||||||||
Total loans and advances to customers
|
6,523 |
434 |
(185) |
|
(116) |
|
(3,380) |
|
140 |
7,319 |
10,735 | ||||||||
Total impairment allowance
|
6,574 |
434 |
(185) |
|
(127) |
|
(3,380) |
|
150 |
7,330 |
10,796 | ||||||||
At £m |
Acquisitions £m |
Unwind of discount £m |
Exchange and other adjustments £m |
Amounts £m |
Recoveries £m |
Amounts charged to income statement £m |
Balance at 31st December £m | ||||||||||||
2008 |
|||||||||||||||||||
Loans and advances to banks
|
3 | | | 1 | | 7 | 40 | 51 | |||||||||||
Loans and advances to customers: |
|||||||||||||||||||
Residential mortgage loans |
137 | | (35 | ) | 19 | (44 | ) | 3 | 241 | 321 | |||||||||
Credit card receivables |
841 | 306 | (68 | ) | 94 | (845 | ) | 69 | 1,048 | 1,445 | |||||||||
Other personal lending | 1,368 | 1 | (32 | ) | 134 | (525 | ) | 42 | 881 | 1,869 | |||||||||
Wholesale and corporate loans and advances | 1,310 | | | 506 | (1,428 | ) | 41 | 2,270 | 2,699 | ||||||||||
Finance lease receivables
|
113 | | | 37 | (77 | ) | 12 | 104 | 189 | ||||||||||
Total loans and advances to customers
|
3,769 |
307 |
(135 |
) |
790 |
|
(2,919 |
) |
167 |
4,544 |
6,523 | ||||||||
Total impairment allowance
|
3,772 |
307 |
(135 |
) |
791 |
|
(2,919 |
) |
174 |
4,584 |
6,574 |
Loan Loss Rates |
|||||||||||
Gross loans and advances £m |
Impairment allowance £m |
Loans and advances |
Impairment £m |
Loan Loss Rate basis points | |||||||
As at 31st December 2009 |
472,155 | (10,796 | ) | 461,359 | 7,358 | 156 | |||||
As at 31st December 2008 |
516,096 | (6,574 | ) | 509,522 | 4,913 | 95 |
254 |
Notes to the accounts
For the year ended 31st December 2009
continued
47 Credit risk continued
Renegotiated loans and advances
Loans and advances are generally renegotiated either as part of an ongoing customer relationship or in response to an adverse change in the circumstances of the borrower. In the latter case renegotiation can result in an extension of the due date of payment or repayment plans under which the Group offers a concessionary rate of interest to genuinely distressed borrowers. This will result in the asset continuing to be overdue and will be individually impaired where the renegotiated payments of interest and principal will not recover the original carrying amount of the asset. In other cases, renegotiation will lead to a new agreement, which is treated as a new loan.
Collateral and other credit enhancements held
Financial assets that are past due or individually assessed as impaired may be partially or fully collateralised or subject to other forms of credit enhancement.
Assets in these categories subject to collateralisation are mainly corporate loans, residential mortgage loans and finance lease receivables. Credit card receivables and other personal lending are generally unsecured (although in some instances a charge over the borrowers property of other assets may be sought).
Corporate loans
Security is usually taken in the form of a fixed charge over the borrowers property or a floating charge over the assets of the borrower. Loan covenants may be put in place to safeguard the Groups financial position. If the exposure is sufficiently large, either individually or at the portfolio level, credit protection in the form of guarantees, credit derivatives or insurance may be taken out.
For these and other reasons collateral given is only accurately valued on origination of the loan or in the course of enforcement actions and as a result it is not practicable to estimate the fair value of the collateral held.
Residential mortgage loans
These are secured by a fixed charge over the property.
A description and the estimated fair value of collateral held in respect of residential mortgage loans that are past due or individually assessed as impaired is as follows:
Nature of assets |
||||
2009 Fair value |
2008 Fair value | |||
Residential property
|
9,628 |
7,264 |
Collateral included in the above table reflects the Groups interest in the property in the event of default. That held in the form of charges against residential property in the UK is restricted to the outstanding loan balance. In other territories, where the Group is not obliged to return any sale proceeds to the mortgagee, the full estimated fair value has been included.
Finance lease receivables
The net investment in the lease is secured through retention of legal title to the leased assets.
Collateral and other credit enhancements obtained
The carrying value of assets held by the Group as at 31st December 2009 as a result of the enforcement of collateral was as follows:
Nature of assets |
||||
2009 Carrying |
2008 Carrying | |||
Residential property |
71 | 171 | ||
Commercial and industrial property |
66 | 2 | ||
Other credit enhancements
|
248 | 61 | ||
Total
|
385 |
234 |
Any properties repossessed are made available for sale in an orderly and timely fashion, with any proceeds realised being used to reduce or repay the outstanding loan. For business customers, in some circumstances, where excess funds are available after repayment in full of the outstanding loan, they are offered to any other, lower ranked, secured lenders. Any additional funds are returned to the customer. Barclays does not, as a rule, occupy repossessed properties for its business use.
The Group does not use assets obtained in its operations. Assets obtained are normally sold, generally at auction, or realised in an orderly manner for the maximum benefit of the Group, the borrower and the borrowers other creditors in accordance with the relevant insolvency regulations.
255 |
47 Credit risk continued
Debt securities
Trading portfolio assets, financial assets designated at fair value and available for sale assets are measured on a fair value basis. The fair value will reflect, among other things, the credit risk of the issuer.
Most listed and some unlisted securities are rated by external rating agencies. The Group mainly uses external credit ratings provided by Standard & Poors or Moodys. Where such ratings are not available or are not current, the Group will use its own internal ratings for the securities.
An analysis of the credit quality of the Groups debt securities is set out below:
2009 | 2008 | |||||||||||||||
AAA to BBB- (investment grade) £m |
BB+ to B £m |
B- and below £m |
Total £m |
AAA to BBB- (investment grade) £m |
BB+ to B £m |
B-and below £m |
Total £m | |||||||||
Trading portfolio: |
||||||||||||||||
Treasury and other eligible bills |
9,901 | 25 | | 9,926 | 4,491 | 53 | | 4,544 | ||||||||
Debt securities
|
109,237 | 5,321 | 2,036 | 116,594 | 141,454 | 5,556 | 1,676 | 148,686 | ||||||||
Total trading portfolio
|
119,138 |
5,346 |
2,036 |
126,520 |
145,945 |
5,609 |
1,676 |
153,230 | ||||||||
Financial assets designated at fair value held on own account: |
||||||||||||||||
Debt securities
|
2,200 | 1,791 | 16 | 4,007 | 1,222 | 7,406 | | 8,628 | ||||||||
Available for sale financial investments: |
||||||||||||||||
Treasury and other eligible bills |
4,049 | 1,870 | | 5,919 | 2,823 | 1,180 | | 4,003 | ||||||||
Debt securities
|
40,184 | 3,185 | 519 | 43,888 | 55,817 | 2,347 | 667 | 58,831 | ||||||||
Total available for sale financial investments
|
44,233
|
5,055 |
519 |
49,807 |
58,640 |
3,527 |
667 |
62,834 | ||||||||
Total debt securities
|
165,571 |
12,192 |
2,571 |
180,334 |
205,807 |
16,542 |
2,343 |
224,692 | ||||||||
%
|
91.8 |
6.8 |
1.4 |
100.0 |
91.6 |
7.4 |
1.0 |
100.0 |
Included in the table above, there are impaired available for sale debt securities with a carrying value at 31st December 2009 of £265m (2008: £329m), after a write-down of £692m (2008: £363m).
Collateral is not generally obtained directly from the issuers of debt securities. Certain debt securities may be collateralised by specifically identified assets that would be obtainable in the event of default.
Derivatives
Derivatives are measured on a fair value basis.
The credit quality of the Groups derivative assets according to the credit quality of the counterparty at 31st December 2009 and 2008 was as follows:
2009 | 2008 | |||||||||||||||
AAA to BBB- (investment grade) £m |
BB+ to B £m |
B- and below £m |
Total £m |
AAA to BBB- (investment grade) £m |
BB+ to B £m |
B- and below £m |
Total £m | |||||||||
Derivatives
|
399,534
|
15,565 |
1,716 |
416,815 |
939,071 |
42,266 |
3,465 |
984,802 | ||||||||
%
|
95.9 |
3.7 |
0.4 |
100.0 |
95.3 |
4.3 |
0.4 |
100.0 |
Credit risk from derivatives is mitigated where possible through netting agreements whereby derivative assets and liabilities with the same counterparty can be offset. Group policy requires all netting arrangements to be legally documented. The ISDA Master Agreement is the Groups preferred agreement for documenting OTC derivatives. It provides the contractual framework within which dealing activities across a full range of OTC products are conducted and contractually binds both parties to apply close-out netting across all outstanding transactions covered by an agreement if either party defaults or other predetermined events occur.
Collateral is obtained against derivative assets, depending on the creditworthiness of the counterparty and/or nature of the transaction. Any collateral taken in respect of OTC trading exposures will be subject to a haircut which is negotiated at the time of signing the collateral agreement. A haircut is the valuation percentage applicable to each type of collateral and will be largely based on liquidity and price volatility of the underlying security. The collateral obtained for derivatives is either cash, direct debt obligation government (G14+) bonds denominated in the domestic currency of the issuing country, debt issued by supranationals or letters of credit issued by an institution with a long-term unsecured debt rating of A+/A3 or better. Where the Group has ISDA master agreements, the collateral document will be the ISDA Credit Support Annex (CSA). The collateral document must give Barclays the power to realise any collateral placed with it in the event of the failure of the counterparty, and to place further collateral when requested or in the event of insolvency, administration or similar processes, as well as in the case of early termination.
Derivative assets and liabilities would be £374bn (2008: £917bn) lower than reported if netting were permitted for assets and liabilities with the same counterparty or for which the Group holds cash collateral.
256 |
Notes to the accounts
For the year ended 31st December 2009
continued
47 Credit risk continued
Reverse repurchase agreements
Reverse repurchase agreements and securities borrowing arrangements are collateralised loans typically of short maturities.
The loans are fully collateralised with highly liquid securities legally transferred to the Group. The level of collateral is monitored daily and further collateral called when required.
2009 | 2008 | |||||||||||||||
AAA to BBB- (investment grade) £m |
BB+ to B £m |
B- and below £m |
Total £m |
AAA to BBB- (investment grade) £m |
BB+ to B £m |
B- and below £m |
Total £m | |||||||||
Financial assets designated at fair value held on own account: |
||||||||||||||||
Other financial assets |
4,749 | 1,955 | 1,053 | 7,757 | 3,882 | 3,401 | | 7,283 | ||||||||
Reverse repurchase agreements
|
136,366 | 6,674 | 391 | 143,431 | 122,188 | 6,101 | 2,065 | 130,354 | ||||||||
Total reverse repurchase agreements
|
141,115 |
8,629 |
1,444 |
151,188 |
126,070 |
9,502 |
2,065 |
137,637 | ||||||||
%
|
93.3 |
5.7 |
1.0 |
100.0 |
91.6 |
6.9 |
1.5 |
100.0 |
No reverse repurchase agreements held by the Group at 31st December 2009 or 2008 were individually impaired, however during the year, the Group wrote off £43m of reverse repurchase agreements (2008: 124m).
Other credit risk assets
The Groups other assets that are subject to credit risk are cash with central banks of £81,483m (2008: £30,019m), items in course of collection from other Banks £1,593m (2008: £1,695m), other financial assets £3,476m (2008: £3,096m).
Cash and balances at central banks
Substantially all balances are held with central banks. There is limited credit risk in relation to balances at central banks.
Items in the course of collection from other banks
There is limited credit risk in relation to items in the course of collection through the clearing system from other banks. Other financial assets
Other financial assets
Other financial assets comprise £3,476m (2008: £3,096m) of other assets and £344m (2008 £609m) of assets held at fair value.
Off-balance sheet
The Group applies fundamentally the same risk management policies for off-balance sheet risks as it does for its on-balance sheet risks. In the case of commitments to lend, customers and counterparties will be subject to the same credit management policies as for loans and advances. Collateral may be sought depending on the strength of the counterparty and the nature of the transaction.
Credit market exposures
Barclays Capitals credit market exposures primarily relate to US residential mortgages, commercial mortgages and leveraged finance businesses that have been significantly impacted by the continued deterioration in the global credit markets. The exposures include both significant positions subject to fair value movements in the profit and loss account and positions that are classified as loans and advances and available for sale.
The exposures are set out by asset class below:
US Residential Mortgages | As at 31.12.09 £m |
As at 31.12.08 £m | ||
ABS CDO Super Senior
|
1,931 |
3,104 | ||
Other US sub-prime and Alt-A
|
1,392 |
7,729 | ||
Monoline wrapped US RMBS
|
6 |
1,639 | ||
Commercial mortgages
|
||||
Commercial real estate loans and properties |
7,734 | 11,578 | ||
Commercial mortgage-backed securities |
471 | 735 | ||
Monoline wrapped CMBS
|
30 | 1,854 | ||
Other Credit Market Exposures
|
||||
Leveraged finance a
|
5,507 |
9,048 | ||
SIVs, SIV-Lites and CDPCs
|
553 |
1,113 | ||
Monoline wrapped CLO and other
|
2,126 |
4,939 | ||
Total exposures
|
19,750 |
41,739 | ||
Loan to Protium
|
7,859 |
|
On 16th September 2009, Barclays Capital sold assets of £7,454m, including £5,087m in credit market assets, to Protium Finance LP (Protium), a newly established fund. As part of the transaction, Barclays extended a £7,669m 10-year loan to Protium Finance LP. At 31st December 2009, this loan had a carrying value of £7,859m (including accrued interest).
Note
a | This is a change in presentation from 31st December 2008, which reflected certain loan facilities originated post 1st July 2007. |
257 |
48 Market risk
Market risk management
Market risk is the risk that the Groups earnings or capital, or its ability to meet business objectives, will be adversely affected by changes in the level or volatility of market rates or prices such as interest rates, credit spreads, commodity prices, equity prices and foreign exchange rates. The majority of market risk exposure resides in Barclays Capital. Barclays is also exposed to market risk through interest rate risk on its non-trading activities and through the pension fund.
Organisation and structure
The Board approves market risk appetite for trading and non-trading activities. The Market Risk Director is responsible for the Market Risk Control Framework and, under delegated authority from the Chief Risk Officer, sets a limit framework within the context of the approved market risk appetite. A daily market risk report summarises Barclays market risk exposures against agreed limits. This daily report is sent to the Chief Risk Officer, the Market Risk Director, the Group Finance Director and the appropriate Business Risk Directors.
The head of each business, assisted by the business risk management team, is accountable for all market risks associated with its activities. Each business is responsible for the identification, measurement, management, control and reporting of market risk as outlined in Barclays Market Risk Control Framework. Oversight and support is provided to the business by the Market Risk Director, assisted by the Group Market Risk team. The Market Risk Committee reviews, approves, and makes recommendations concerning the market risk profile across Barclays including risk appetite, limits and utilisation. The Committee meets monthly and is chaired by the Market Risk Director. Attendees include the Chief Risk Officer, respective business risk managers and Group Market Risk.
Traded market risk
Barclays policy is to concentrate trading activities in Barclays Capital. This includes transactions where Barclays Capital acts as principal with clients or with the market. For maximum efficiency, client and market activities are managed together.
Risk measurement and control
The measurement techniques used to measure and control traded market risk include Daily Value at Risk (DVaR), Expected Shortfall , average of the three worst hypothetical losses from the DVaR simulation (3W), Global Asset Class stress testing and Global Scenario stress testing.
DVaR is an estimate of the potential loss arising from unfavourable market movements, if the current positions were to be held unchanged for one business day. Barclays Capital uses the historical simulation methodology with a two-year unweighted historical period at the 95% confidence level.
The historical simulation calculation can be split into three parts:
Calculate hypothetical daily profit or loss for each position over the most recent two years, using observed daily market moves.
Sum all hypothetical profit or losses for day one across all positions, giving one total profit or loss. Repeat for all other days in the two-year history.
DVaR is the 95th percentile selected from the two years of daily hypothetical total profit or loss.
The DVaR model has been approved by the FSA to calculate regulatory capital for the trading book. The approval covers general market risk in interest rate, foreign exchange, commodities and equity products, and issuer specific risk for the majority of single name and portfolio traded credit products.
DVaR is an important market risk measurement and control tool and consequently the model is regularly assessed. The main approach employed is the technique known as back-testing which counts the number of days when a loss (as defined by the FSA), exceeds the corresponding DVaR estimate, measured at the 99% confidence level.
The FSA categorises a DVaR model as green, amber or red. A green model is consistent with a good working DVaR model and is achieved for models that have four or less back-testing exceptions in a 12-month period. For Barclays Capitals trading book, green model status was maintained for 2009 and 2008.
Expected Shortfall is the average of all hypothetical losses from the historical simulation beyond DVaR. To improve the control framework, formal monitoring of 3W (average of the three worst observations from the DVaR historical simulation) was started in the first half of 2009.
Stress testing provides an indication of the potential size of losses that could arise in extreme conditions. Global Asset Class stress testing has been designed to cover major asset classes including interest rate, credit spread, commodity, equity and foreign exchange rates. They are based on past stress moves in respective asset class prices and rates. Global Scenario stress testing is based on hypothetical events which could lead to extreme yet plausible stress type moves, under which profitability is seriously challenged.
Market Risk is controlled through the use of limits where appropriate on the above risk measures. Limits are set at the total Barclays Capital level, risk factor level such as interest rate risk, and business line level. Book limits such as foreign exchange and interest rate sensitivity limits are also in place.
258 |
Notes to the accounts
For the year ended 31st December 2009
continued
48 Market risk continued
Analysis of traded market risk exposures
Barclays Capital's market risk exposure, as measured by average total DVaR, increased by 45% to £77m (2008: £53m). The rise was mainly due to volatility considerations, increased interest rate and credit spread exposure, and the Lehman Brothers North America businesses acquisition. Volatility impacted average DVaR because 2008s extreme volatility impacted DVaR throughout 2009 but only impacted 2008 DVaR in the last four months of 2008.
Expected shortfall and 3W averaged £121m and £209m respectively representing increases of £51m (73%) and £93m (80%) compared to 2008. The daily average, maximum and minimum values of DVaR, Expected Shortfall and 3W were calculated as below.
DVaR (95%) | ||||||||||||||
12 months to 31st December 2009 |
12 months to 31st December 2008 | |||||||||||||
Average |
High a £m |
Low a £m |
Average £m |
High a £m |
Low a £m | |||||||||
Interest rate risk |
44 | 83 | 23 | 29 | 48 | 15 | ||||||||
Credit spread risk |
58 | 102 | 35 | 31 | 72 | 15 | ||||||||
Commodity risk |
14 | 20 | 11 | 18 | 25 | 13 | ||||||||
Equity risk |
13 | 27 | 5 | 9 | 21 | 5 | ||||||||
Foreign exchange risk |
8 | 15 | 3 | 6 | 13 | 2 | ||||||||
Diversification effect a
|
(60 | ) | n/a | n/a | (40 | ) | n/a | n/a | ||||||
Total DVaR
|
77
|
|
119
|
50
|
53
|
|
95
|
36
| ||||||
Expected shortfall
|
121
|
|
188
|
88
|
70
|
|
146
|
41
| ||||||
3W
|
209
|
|
301
|
148
|
116
|
|
282
|
61
|
Non-traded interest rate risk
Non-traded interest rate risk arises from the provision of retail and wholesale (non-traded) banking products and services.
Barclays objective is to minimise non-traded risk. This is achieved by transferring risk from the business to a local treasury or Group Treasury, who in turn hedge the net exposure with the external market. Limits exist to ensure no material risk is retained within any business or product area. The majority of non-trading interest rate market exposures are within Global Retail and Commercial Banking, and Group Treasury. Trading activity is not permitted outside Barclays Capital.
Risk measurement and control
The risk in each business is measured and controlled using both an income metric (Annual Earnings at Risk) and a present value metric (Daily Value at Risk or stress testing). In addition scenario stress analysis is carried out by the business and reviewed by senior management and business-level asset and liability committees, when required.
Annual Earnings at Risk (AEaR) measures the sensitivity of net interest income (NII) over the next 12 months. It is calculated as the difference between the estimated income using the current yield curve and the lowest estimated income following a 100 basis points increase or decrease in interest rates, subject to a minimum interest rate of 0%. Balances are adjusted for an assumed behavioural profile. This includes the treatment of non-maturity deposits.
Daily Value at Risk and stress testing is calculated using a Barclays Capital consistent approach. Both these metrics are calculated by each respective business area with oversight provided by Group Market Risk.
Risk exposures are monitored by respective business risk managers with oversight provided by Group Market Risk. The main business limits are approved by Market Risk Committee. Book limits such as foreign exchange and interest rate sensitivity limits are also in place where appropriate.
To further improve the market risk control framework, Group Market Risk initiated an ongoing programme of conformance visits to non-traded Treasury operations. These visits review both the current market risk profile and potential market risk developments, as well as verifying conformance with Barclays policies and standards as detailed in the market risk control framework.
Note
a | The high (and low) DVaR figures reported for each category did not necessarily occur on the same day as the high (and low) DVaR reported as a whole. Consequently, a diversification effect number for the high (and low) DVaR figures would not be meaningful and it is therefore omitted from the above table. |
259 |
48 Market risk continued
Analysis of net interest income sensitivity
The tables below show the pre-tax net interest income sensitivity for the non-trading financial assets and financial liabilities held at 31st December 2009. The sensitivity has been measured using AEaR methodology as described above. The benchmark interest rate for each currency is set as at 31st December 2009. The figures include the effect of hedging instruments but exclude exposures held or issued by Barclays Capital as these are measured and managed using DVaR.
Net interest income sensitivity (AEaR) by currency |
| |||||||||||
+100 basis points 2009 £m |
100 basis points 2009 £m |
+100 basis points 2008 £m |
100 basis points 2008 £m |
|||||||||
GBP |
30 | (360 | ) | 3 | (273 | ) | ||||||
USD |
(43 | ) | 14 | (25 | ) | 7 | ||||||
EUR |
(34 | ) | | (34 | ) | 30 | ||||||
ZAR |
29 | (27 | ) | 13 | (13 | ) | ||||||
Others
|
(1 | ) | 4 | | (8 | ) | ||||||
Total
|
(19 | ) | (369 | ) | (43 | ) | (257 | ) | ||||
As percentage of net interest income
|
(0.16% | ) | (3.10% | ) | (0.37% | ) | (2.24% | ) |
Non-traded interest rate risk, as measured by AEaR, was £369m in 2009, an increase of £112m compared to 2008. This estimate takes into account the rates in place as at 31st December 2009. The increase mainly reflects the reduced spread generated on retail and commercial banking liabilities in the lower interest rate environment. If the interest rate hedges had not been in place then the AEaR risk for 2009 would have been £704m (2008: £670m).
DVaR is also used to control market risk in Global Retail and Commercial Banking Western Europe and in Group Treasury. The indicative average DVaRs for 2009 are £1.4m (2008: £1.3m) for Western Europe and £1.0m (2008: £0.6m) for Group Treasury.
Analysis of equity sensitivity
+100 basis points 2009 £m |
100 basis points 2009 £m |
+100 basis points 2008 £m |
100 basis points 2008 £m |
|||||||||
Net interest income |
(19 | ) | (369 | ) | (43 | ) | (257 | ) | ||||
Taxation effects on the above
|
4 | 86 | 6 | 33 | ||||||||
Effect on profit for the year
|
(15 | ) | (283 | ) | (37 | ) | (224 | ) | ||||
As percentage of net profit after tax
|
(0.15% | ) | (2.75% | ) | (0.70% | ) | (4.24% | ) | ||||
Effect on profit for the year (per above) |
(15 | ) | (283 | ) | (37 | ) | (224 | ) | ||||
Available for sale reserve |
(527 | ) | 527 | (806 | ) | 806 | ||||||
Cash flow hedge reserve |
(929 | ) | 957 | (473 | ) | 474 | ||||||
Taxation effects on the above
|
341 | (347 | ) | 166 | (166 | ) | ||||||
Effect on equity
|
(1,130 | ) | 854 | (1,150 | ) | 890 | ||||||
As percentage of equity
|
(1.93% | ) | 1.46% | (2.43% | ) | 1.88% |
260 |
Notes to the accounts
For the year ended 31st December 2009
continued
48 Market risk continued
Foreign exchange risk
The Group is exposed to two sources of foreign exchange risk.
a) Transactional foreign currency exposure
Transactional foreign exchange exposures represent exposure on banking assets and liabilities, denominated in currencies other than the functional currency of the transacting entity.
The Groups risk management policies prevent the holding of significant open positions in foreign currencies outside the trading portfolio managed by Barclays Capital which is monitored through DVaR.
There were no material net transactional foreign currency exposures outside the trading portfolio at either 31st December 2009 or 2008. Due to the low level of non-trading exposures no reasonably possible change in foreign exchange rates would have a material effect on either the Groups profit or movements in equity for the year ended 31st December 2009 or 2008.
b) Translational foreign exchange exposure
The Groups translational foreign currency exposure arises from both its capital resources (including investments in subsidiaries and branches, intangible assets, non-controlling interests, deductions from capital and debt capital instruments) and risk weighted assets (RWAs) being denominated in foreign currencies. Changes in foreign exchange rates result in changes in the Sterling equivalent value of foreign currency denominated capital resources and risk weighted assets. As a result, the Groups regulatory capital ratios are sensitive to foreign exchange rate movements.
The Groups capital ratio hedge strategy is to minimise the volatility of the capital ratios caused by foreign exchange rate movements. To achieve this, the Group aims to maintain the ratio of foreign currency Core Tier 1, Tier 1 and Total Capital resources to foreign currency RWAs the same as the Groups capital ratios.
The Groups foreign currency capital resources include investments in subsidiaries and branches, intangible assets, non-controlling interests, deductions from capital and debt capital instruments.
The Groups investments in foreign currency subsidiaries and branches create capital resources denominated in foreign currencies. Changes in the Sterling value of the investments due to foreign currency movements are captured in the currency translation reserve, resulting in a movement in Core Tier 1 capital.
During 2009, structural currency exposures net of hedging instruments increased from £6.4bn to £12.5bn primarily as a result of US Dollar hedging decisions taken in accordance with the Groups capital ratio hedge strategy for foreign exchange rate movements.
To create foreign currency Tier 1 and Total Capital resources additional to the Core Tier 1 capital resources, the Group issues, where possible, debt capital in non sterling currencies. This is primarily achieved by the issuance of debt capital from Barclays Bank PLC, but can also be achieved by subsidiaries issuing capital in local currencies.
The carrying value of the Groups foreign currency net investments in subsidiaries and branches and the foreign currency borrowings and derivatives used to hedge them as at 31st December 2009 were as follows:
At 31st December 2009 Functional currency of the operation involved
|
Foreign currency net investments £m |
Borrowings which hedge the net investments £m |
Derivatives which hedge the net investments £m |
Structural currency exposures pre economic hedges £m |
Economic hedges £m |
Remaining structural currency exposures £m |
||||||||
US Dollar |
16,677 | 3,205 | | 13,472 | 6,056 | 7,416 | ||||||||
Euro |
6,772 | 3,418 | | 3,354 | 2,902 | 452 | ||||||||
Rand |
4,055 | | 1,542 | 2,513 | 189 | 2,324 | ||||||||
Japanese Yen |
4,436 | 3,484 | 940 | 12 | | 12 | ||||||||
Swiss Franc |
2,840 | 2,734 | 92 | 14 | | 14 | ||||||||
Other
|
2,983 | | 677 | 2,306 | | 2,306 | ||||||||
Total
|
37,763 | 12,841 | 3,251 | 21,671 | 9,147 | 12,524 | ||||||||
At 31st December 2008
|
||||||||||||||
US Dollar |
14,577 | 6,019 | | 8,558 | 6,720 | 1,838 | ||||||||
Euro |
6,336 | 2,922 | | 3,414 | 3,125 | 289 | ||||||||
Rand |
3,725 | | 1,306 | 2,419 | 164 | 2,255 | ||||||||
Japanese Yen |
5,009 | 801 | 4,212 | (4 | ) | | (4 | ) | ||||||
Swiss Franc |
3,042 | 2,936 | 101 | 5 | | 5 | ||||||||
Other
|
2,940 | | 880 | 2,060 | | 2,060 | ||||||||
Total
|
35,629 | 12,678 | 6,499 | 16,452 | 10,009 | 6,443 |
261 |
48 Market risk continued
The economic hedges represent the US Dollar and Euro Preference Shares and Reserve Capital Instruments in issue that are treated as equity under IFRS, and do not qualify as hedges for accounting purposes.
The impact of a change in the exchange rate between Sterling and any of the major currencies would be:
A higher or lower Sterling equivalent value of non-Sterling denominated capital resources and risk weighted assets. This includes a higher or lower currency translation reserve within equity, representing the retranslation of non-Sterling subsidiaries, branches and associated undertakings net of the impact of foreign exchange rate changes on derivatives and borrowings designated as hedges of net investments.
A higher or lower profit after tax, arising from changes in the exchange rates used to translate items in the consolidated income statement.
A higher or lower value of available for sale investments denominated in foreign currencies, impacting the available for sale reserve.
49 Liquidity risk
Liquidity management
Liquidity risk is the risk that the Group is unable to meet its obligations when they fall due as a result of a sudden, and potentially protracted, increase in net cash outflows. Such outflows would deplete available cash resources for client lending, trading activities, investments and deposits. In extreme circumstances lack of liquidity could result in reductions in balance sheet and sales of assets, or potentially an inability to fulfil lending commitments. The risk that it will be unable to do so is inherent in all banking operations and can be affected by a range of institution-specific and market-wide events.
Organisation and structure
Barclays Treasury operates a centralised governance and control process that covers all of the Groups liquidity risk management activities. Businesses assist Barclays Treasury in policy formation and limit setting by providing relevant and expert input for their local markets and customers.
Execution of the Groups liquidity risk management strategy is carried out at country level within agreed policies, controls and limits, with the Country Treasurer providing reports directly to Barclays Treasury to evidence conformance with the agreed risk profile. Liquidity risk is a standing agenda item at Country and Cluster Asset and Liability Committees and on a consolidated basis is reported to the Groups Treasury Committee.
The objective of the Groups liquidity risk management strategy is to ensure that the funding profile of individual businesses and the Group as a whole is appropriate to underlying market conditions and the profile of our business in each given country. Liquidity risk limits and controls are flexed to achieve that profile and are based on regular qualitative and quantitative assessments of conditions under both normal and stressed conditions. Businesses are only allowed to have funding exposure to wholesale markets where they can demonstrate that their market is sufficiently deep and liquid and then only relative to the size and complexity of their business.
Liquidity limits reflect both local regulatory requirements as well as the behavioural characteristics of their balance sheets. Breaches of limits are reported to Treasury Committee together with details of the requirements to return to compliance.
Liquidity risk framework
Barclays has a comprehensive Liquidity Risk Management Framework (the Liquidity Framework) for managing the Groups liquidity risk. The objective of the Liquidity Framework is for the Group to have sufficient liquidity to continue to operate for at least the minimum period specified by the FSA in the event that the wholesale funding markets are neither open to Barclays nor to the market as a whole. Many of the stress tests currently applied under the Liquidity Framework will also be applied under the FSAs new regime, although the precise calibration may differ in Barclays final Individual Liquidity Guidance to be set by the FSA. The framework considers a range of possible wholesale and retail factors leading to loss of financing including:
| maturing of wholesale liabilities; |
| loss of secured financing and widened haircuts on remaining book; |
| retail and commercial outflows from savings and deposit accounts; |
| drawdown of loans and commitments; |
| potential impact of a two-notch ratings downgrade; and |
| withdrawal of initial margin amounts by counterparties. |
These stressed scenarios are used to assess the appropriate level for the Groups liquidity pool, which comprises unencumbered assets and cash. Barclays regularly uses these assets to access secured funding markets, thereby testing the liquidity assumptions underlying pool composition. The Group does not presume the availability of central bank facilities to monetise the liquidity pool in any of the stress scenarios under the Liquidity Framework.
Liquidity pool
The Group liquidity pool as at 31st December 2009 was £127bn gross (31st December 2008: £43bn) and comprised the following cash and unencumbered assets:
Composition of Group liquidity pool |
||||||||||
Cash and deposits with central banks £bn |
Government guaranteed bonds £bn |
Government and supranational bonds £bn |
Other available liquidity £bn |
Total £bn | ||||||
As at 31st December 2009 |
81 | 3 | 31 | 12 | 127 | |||||
As at 31st December 2008 a |
30 | | 2 | 11 | 43 |
The cost of maintaining the liquidity pool is a function of the source of funding for the buffer and the reinvestment spread.
Note |
a | Previously disclosed as Barclays Capital only. |
262 |
Notes to the accounts
For the year ended 31st December 2009
continued
49 Liquidity risk continued
Term financing
Raising term funding is important in meeting the risk appetite of the Barclays Liquidity Framework. Barclays has continued to increase the term of issued liabilities during 2009 by issuing:
| £15bn equivalent of public senior term funding |
| £1.8bn equivalent of public covered bonds |
| £21bn equivalent of structured notes |
The Group has £4bn of publicly issued debt and £11bn of structured notes maturing in 2010.
Intraday liquidity
The need to monitor, manage and control intraday liquidity in real time is recognised by the Group as a critical process: any failure to meet specific intraday commitments would have significant consequences, such as a visible market disruption.
The Group policy is that each operation must ensure that it has access to sufficient intraday liquidity to meet any obligations it may have to clearing and settlement systems. Major currency payment flows and payment system collateral are monitored and managed in real time to ensure that at all times there is sufficient collateral to make payments. In practice the Group maintains a significant buffer of surplus intraday liquidity to ensure that payments are made on a timely basis. The Group actively engages in payment system development to help ensure that new payment systems are robust.
Day to day funding
Day to day funding is managed through limits on wholesale borrowings, secured borrowings and funding mismatches. These ensure that on any day and over any period there is a limited amount of refinancing requirement. These requirements include replenishment of funds as they mature or are borrowed by customers.
In addition to cash flow management, Treasury also monitors term mismatches between assets and liabilities, as well as the level and type of undrawn lending commitments, the usage of overdraft facilities and the impact of contingent liabilities such as standby letters of credit and guarantees.
Diversification of liquidity sources
Sources of liquidity are regularly reviewed to maintain a wide diversification by currency, geography, provider, product and term. In addition, to avoid reliance on a particular group of customers or market sectors, the distribution of sources and the maturity profile of deposits are also carefully managed. Important factors in assuring liquidity are competitive rates and the maintenance of depositors confidence. Such confidence is based on a number of factors including the Groups reputation and relationship with those clients, the strength of earnings and the Groups financial position.
Wholesale depositor split by counterparty type Barclays Capital |
||||||||||||
Banks % |
Corporates % |
Governments % |
Other central banks % |
Other financial institutions % |
Total % | |||||||
As at 31st December 2009 |
36 | 15 | 2 | 16 | 31 | 100 | ||||||
As at 31st December 2008 |
32 | 15 | 11 | 9 | 33 | 100 |
Wholesale depositor split by geography Barclays Capital |
||||||||||||||
US % |
UK % |
Other EU % |
Japan % |
Africa % |
World % |
Rest of Total % | ||||||||
As at 31st December 2009 |
9 | 25 | 23 | 3 | 16 | 24 | 100 | |||||||
As at 31st December 2008 |
13 | 22 | 16 | 9 | 17 | 23 | 100 |
Funding structure
Global Retail and Commercial Banking, Barclays Wealth and Head Office Functions are structured to be self-funded through customer deposits and Barclays equity and other long-term capital. The Barclays Capital and Absa businesses are funded through the wholesale secured and unsecured funding markets.
The ratio of customer loans to customer deposits and long-term funding has improved to 81% at 31st December 2009, from 93% at 31st December 2008.
263 |
49 Liquidity risk continued
Global retail and commercial banking, Barclays Wealth and Head Office functions
An important source of structural liquidity is provided by our core retail deposits in the UK, Europe and Africa; mainly current accounts and savings accounts. Although contractually current accounts are repayable on demand and savings accounts at short notice, the Groups broad base of customers numerically and by depositor type helps to protect against unexpected fluctuations. Such accounts form a stable funding base for the Groups operations and liquidity needs.
Group policy is to ensure that the assets of the retail, wealth and corporate bank, together with Head Office functions, on a global basis, do not exceed customer deposits and subordinated funding so that these businesses place no reliance on wholesale markets. The exception to this policy is Absa, which has a large portion of wholesale funding due to the structure of the South African financial sector.
In order to assess liquidity risk, the balance sheet is modelled to reflect behavioural experience in both assets and liabilities and is managed to maintain a cash surplus. The maturity profile, excluding Absa, resulting from this behavioural modelling is set out below. This shows that there is a funding surplus of £94.5bn, and that there are expected outflows of £10.2bn within one year from asset repayments being less than liability attrition. For subsequent years the expected repayments on assets are larger than the roll off of liabilities resulting in cash inflows. Maturities of net liabilities are, therefore, behaviourally expected to occur after five years.
Behavioural maturity profile of assets and liabilities a |
||||||||||||||||
Cash inflow/(outflow) | ||||||||||||||||
Funding surplus £bn |
Not more than 1 year £bn |
Over 1 year but not more than 2 years £bn |
Over 2 years but not more than 3 years £bn |
Over 3 years but not more than 4 years £bn |
Over 4 years but not more than 5 years £bn |
Over 5 years £bn |
||||||||||
As at 31st December 2009 | 94.5 | (10.2 | ) | 17.8 | 21.2 | 7.8 | 1.8 | (132.9 | ) |
Barclays Capital
Barclays Capital manages its liquidity to be primarily funded through wholesale sources, managing access to liquidity to ensure that potential cash outflows in a stressed environment are covered.
73% of the inventory is funded on a secured basis (31st December 2008: 50%). Additionally, much of the short-term funding is invested in highly liquid assets and central bank cash and therefore contributes towards the Group liquidity pool.
Barclays Capital undertakes secured funding in the repo markets based on liquidity characteristics. Limits are in place for each security asset class reflecting liquidity in the cash and financing markets for these assets. The percentage of secured funding using each asset class as collateral is set out below:
Secured funding by asset class |
||||||||||||||
Government % |
Agency % |
MBS % |
ABS % |
Corporate % |
Equity % |
Other % | ||||||||
As at 31st December 2009 | 59 | 7 | 7 | 6 | 10 | 8 | 3 | |||||||
As at 31st December 2008 |
49 | 9 | 11 | 9 | 15 | 4 | 3 |
Unsecured wholesale funding for the Group (excluding Absa) is managed by Barclays Capital within specific term limits. Excluding short-term deposits that are included within the Groups liquidity pool, the term of unsecured liabilities has been extended, with average life improving from at least 14 monthsb at 31st December 2008 to at least 26 months at 31st December 2009.
Contractual maturity of unsecured liabilitiesa (Net of assets available from the Group liquidity pool) |
||||||||||||
Not more than 1 month % |
Not more than 2 months % |
Not more than 3 months % |
Not more than 6 months % |
Not more than 1 year % |
Over 1 year % | |||||||
As at 31st December 2009 | | | | | 19 | 81 |
The extension of the term of the wholesale financing has meant that, as at 31st December 2009, 81% of net wholesale funding had remaining maturity of greater than one year and, as at the same date, there was no net wholesale unsecured refinancing required within six months.
Notes
a | In accordance with IFRS 7, prior year figures have not been provided as these measures have not previously been reported on a comparable basis. |
b | The 31st December 2008 average unsecured liability term has been restated to at least 14 months to reflect refinements in the underlying calculation. |
264 |
Notes to the accounts
For the year ended 31st December 2009
continued
49 Liquidity risk continued
Contractual maturity of financial assets and liabilities
Details of contractual maturities for assets and liabilities form an important source of information for the management of liquidity risk. Such information is used (amongst other things) as the basis for modelling a behavioural balance sheet, for input into the liquidity framework, as discussed above.
The table below provides detail on the contractual maturity of all financial instruments and other assets and liabilities. Derivatives (other than those designated in a hedging relationship) and trading portfolio assets and liabilities are included in the on demand column at their fair value. Liquidity risk on these items is not managed on the basis of contractual maturity since they are not held for settlement according to such maturity and will frequently be settled before contractual maturity at fair value. Derivatives designated in a hedging relationship are included according to their contractual maturity.
Financial assets designated at fair value in respect of linked liabilities to customers under investment contracts have been included in Other assets and Other liabilities as the Group is not exposed to liquidity risk arising from them; any request for funds from creditors would be met by simultaneously liquidating or transferring the related investment.
At 31st December 2009
On demand £m |
Not more than three months £m |
Over three months but not more than six months £m |
Over six months but not more than one year £m |
Over one year but not more than three years £m |
Over three years but not more than five years £m |
Over five years but not more than ten years £m |
Over ten years £m |
Total £m | ||||||||||||||||
Assets |
||||||||||||||||||||||||
Cash and balances at central banks | 80,592 | 891 | | | | | | | 81,483 | |||||||||||||||
Items in the course of collection from other banks | 1,243 | 350 | | | | | | | 1,593 | |||||||||||||||
Trading portfolio assets | 151,344 | | | | | | | | 151,344 | |||||||||||||||
Financial assets designated at fair value: | ||||||||||||||||||||||||
held on own account |
679 | 10,795 | 1,679 | 2,456 | 5,514 | 3,998 | 2,293 | 13,897 | 41,311 | |||||||||||||||
Derivative financial instruments: | ||||||||||||||||||||||||
held for trading |
415,638 | | | | | | | | 415,638 | |||||||||||||||
designated for risk management | | 216 | 115 | 89 | 236 | 101 | 334 | 86 | 1,177 | |||||||||||||||
Loans and advances to banks | 5,114 | 30,385 | 314 | 1,787 | 2,396 | 544 | 98 | 497 | 41,135 | |||||||||||||||
Loans and advances to customers | 44,826 | 68,876 | 8,987 | 17,848 | 51,886 | 38,357 | 63,180 | 126,264 | 420,224 | |||||||||||||||
Available for sale financial investments | 1,157 | 6,999 | 8,356 | 3,434 | 20,530 | 5,871 | 6,802 | 3,334 | 56,483 | |||||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed | 248 | 129,095 | 3,558 | 5,604 | 4,680 | 31 | 210 | 5 | 143,431 | |||||||||||||||
Other financial assets
|
|
2,816
|
|
|
|
|
|
660
|
|
|
|
|
|
|
3,476
| |||||||||
Total financial assets
|
700,841 | 250,423 | 23,009 | 31,218 | 85,902 | 48,902 | 72,917 | 144,083 | 1,357,295 | |||||||||||||||
Other assets
|
21,634 | |||||||||||||||||||||||
Total assets
|
1,378,929 | |||||||||||||||||||||||
Liabilities |
||||||||||||||||||||||||
Deposits from other banks | 3,861 | 50,020 | 4,850 | 15,558 | 1,325 | 200 | 420 | 212 | 76,446 | |||||||||||||||
Items in the course of collection due to other banks | 1,373 | 93 | | | | | | | 1,466 | |||||||||||||||
Customer accounts | 205,868 | 86,481 | 8,226 | 11,940 | 2,954 | 3,049 | 2,864 | 1,047 | 322,429 | |||||||||||||||
Trading portfolio liabilities | 51,252 | | | | | | | | 51,252 | |||||||||||||||
Financial liabilities designated at fair value: | ||||||||||||||||||||||||
held on own account |
1,219 | 17,599 | 5,755 | 7,145 | 18,780 | 14,701 | 14,647 | 6,356 | 86,202 | |||||||||||||||
Derivative financial instruments: | ||||||||||||||||||||||||
held for trading |
402,019 | | | | | | | | 402,019 | |||||||||||||||
designated for risk management | | 186 | 68 | 37 | 111 | 433 | 394 | 168 | 1,397 | |||||||||||||||
Debt securities in issue | 64 | 43,390 | 17,761 | 19,408 | 29,904 | 11,607 | 7,838 | 5,930 | 135,902 | |||||||||||||||
Repurchase agreements and cash collateral on securities lent | 502 | 189,843 | 5,446 | 2,525 | 326 | 108 | 29 | 2 | 198,781 | |||||||||||||||
Subordinated liabilities | | 173 | 1 | 27 | 1,234 | 1,375 | 9,871 | 13,135 | 25,816 | |||||||||||||||
Other financial liabilities | | 4,959 | | | 1,135 | | | | 6,094 | |||||||||||||||
Total financial liabilities
|
666,158 | 392,744 | 42,107 | 56,640 | 55,769 | 31,473 | 36,063 | 26,850 | 1,307,804 | |||||||||||||||
Other liabilities
|
12,647 | |||||||||||||||||||||||
Total liabilities
|
1,320,451 | |||||||||||||||||||||||
Cumulative liquidity gap
|
34,683 | (107,638 | ) | (126,736 | ) | (152,158 | ) | (122,025 | ) | (104,596 | ) | (67,742 | ) | 49,491 | 58,478 |
265 |
49 Liquidity risk continued
At 31st December 2008 |
||||||||||||||||||||||||
On demand £m |
Not more than three months £m |
Over three |
Over six months but not more than one year £m |
Over one year but not more than three years £m |
Over three years but not more than five years £m |
Over five years but not more than ten years £m |
Over ten years £m |
Total £m | ||||||||||||||||
Assets |
||||||||||||||||||||||||
Cash and balances at central banks | 29,774 | 245 | | | | | | | 30,019 | |||||||||||||||
Items in the course of collection from other banks | 1,619 | 76 | | | | | | | 1,695 | |||||||||||||||
Trading portfolio assets | 185,637 | | | | | | | | 185,637 | |||||||||||||||
Financial assets designated at fair value: | ||||||||||||||||||||||||
held on own account |
661 | 13,861 | 1,648 | 5,861 | 5,420 | 6,738 | 4,159 | 16,194 | 54,542 | |||||||||||||||
Derivative financial instruments: | ||||||||||||||||||||||||
held for trading |
981,996 | | | | | | | | 981,996 | |||||||||||||||
designated for risk management | | 381 | 91 | 542 | 505 | 336 | 419 | 532 | 2,806 | |||||||||||||||
Loans and advances to banks | 4,882 | 35,690 | 505 | 1,892 | 1,887 | 1,854 | 52 | 945 | 47,707 | |||||||||||||||
Loans and advances to customers | 51,155 | 87,624 | 12,447 | 21,976 | 60,927 | 44,982 | 57,409 | 125,295 | 461,815 | |||||||||||||||
Available for sale financial investments | 132 | 11,539 | 5,129 | 13,461 | 10,266 | 6,660 | 9,779 | 8,010 | 64,976 | |||||||||||||||
Reverse repurchase agreements and cash collateral on securities borrowed | 29 | 107,415 | 8,947 | 2,582 | 10,124 | 1,019 | 238 | | 130,354 | |||||||||||||||
Other financial assets |
|
2,459
|
|
|
|
|
|
637
|
|
|
|
|
|
|
3,096
| |||||||||
Total financial assets
|
1,255,885 | 259,290 | 28,767 | 46,314 | 89,766 | 61,589 | 72,056 | 150,976 | 1,964,643 | |||||||||||||||
Other assets
|
88,337 | |||||||||||||||||||||||
Total assets
|
2,052,980 | |||||||||||||||||||||||
Liabilities |
||||||||||||||||||||||||
Deposits from other banks | 10,850 | 94,083 | 6,040 | 1,273 | 1,585 | 461 | 433 | 185 | 114,910 | |||||||||||||||
Items in the course of collection due to other banks | 1,633 | 2 | | | | | | | 1,635 | |||||||||||||||
Customer accounts | 195,728 | 112,582 | 9,389 | 10,099 | 2,451 | 1,555 | 1,395 | 2,306 | 335,505 | |||||||||||||||
Trading portfolio liabilities | 59,474 | | | | | | | | 59,474 | |||||||||||||||
Financial liabilities designated at fair value: | ||||||||||||||||||||||||
held on own account |
1,043 | 16,573 | 10,630 | 5,115 | 12,229 | 12,041 | 11,825 | 7,436 | 76,892 | |||||||||||||||
Derivative financial instruments: | ||||||||||||||||||||||||
held for trading |
964,071 | | | | | | | | 964,071 | |||||||||||||||
designated for risk management | | 222 | 141 | 1,345 | 1,197 | 108 | 781 | 207 | 4,001 | |||||||||||||||
Debt securities in issue | 2,567 | 79,600 | 10,049 | 17,197 | 23,355 | 9,856 | 2,528 | 4,415 | 149,567 | |||||||||||||||
Repurchase agreements and cash collateral on securities lent | 69 | 176,169 | 3,409 | 2,067 | 245 | 267 | 59 | | 182,285 | |||||||||||||||
Subordinated liabilities | | 260 | 49 | 281 | 1,345 | 999 | 10,176 | 16,732 | 29,842 | |||||||||||||||
Other financial liabilities | | 4,573 | | | 1,572 | | | | 6,145 | |||||||||||||||
Total financial liabilities
|
1,235,435 | 484,064 | 39,707 | 37,377 | 43,979 | 25,287 | 27,197 | 31,281 | 1,924,327 | |||||||||||||||
Other liabilities
|
81,242 | |||||||||||||||||||||||
Total liabilities
|
2,005,569 | |||||||||||||||||||||||
Cumulative liquidity gap
|
20,450 | (204,324 | ) | (215,264 | ) | (206,327 | ) | (160,540 | ) | (124,238 | ) | (79,379 | ) | 40,316 | 47,411 |
Expected maturity dates do not differ significantly from the contract dates, except for:
| Trading Portfolio Assets and Liabilities and derivative financial instruments, which may not be held to maturity as part of the Groups trading strategies. For these instruments, which are mostly held by Barclays Capital, liquidity and repricing risk is managed through the Daily Value at Risk (DVaR) methodology. |
| Retail deposits, which are included within customer accounts, are repayable on demand or at short notice on a contractual basis. In practice, these instruments form a stable base for the Groups operations and liquidity needs because of the broad base of customers both numerically and by depositor type. |
| Financial assets designated at fair value held in respect of linked liabilities, which are managed with the associated liabilities. |
266 |
Notes to the accounts
For the year ended 31st December 2009
continued
49 Liquidity risk continued
Contractual maturity of financial liabilities on an undiscounted basis
The table below presents the cash flows payable by the Group under financial liabilities by remaining contractual maturities at the balance sheet date. The amounts disclosed in the table are the contractual undiscounted cash flows of all financial liabilities (i.e nominal values), whereas the Group manages the inherent liquidity risk based on discounted expected cash inflows. Derivative financial instruments held for trading and trading portfolio liabilities are included in the on demand column at their fair value.
At 31st December 2009
On demand |
Within one year £m |
Over one year but less than five years £m |
Over five years £m |
Total £m | ||||||
Deposits from other banks |
3,861 | 70,645 | 1,607 | 773 | 76,886 | |||||
Items in the course of collection due to other banks |
1,373 | 93 | | | 1,466 | |||||
Customer accounts |
205,868 | 106,991 | 6,898 | 5,488 | 325,245 | |||||
Trading portfolio liabilities |
51,252 | | | | 51,252 | |||||
Financial liabilities designated at fair value: |
||||||||||
held on own account |
1,219 | 31,030 | 35,733 | 34,206 | 102,188 | |||||
Derivative financial instruments: |
||||||||||
held for trading |
402,019 | | | | 402,019 | |||||
designated for risk management |
| 311 | 627 | 998 | 1,936 | |||||
Debt securities in issue |
64 | 82,215 | 46,055 | 22,243 | 150,577 | |||||
Repurchase agreements and cash collateral on securities lent |
502 | 197,864 | 450 | 37 | 198,853 | |||||
Subordinated liabilities |
| 2,101 | 6,295 | 26,842 | 35,238 | |||||
Other financial liabilities
|
| 4,959 | 1,135 | | 6,094 | |||||
Total financial liabilities
|
666,158 | 496,209 | 98,800 | 90,587 | 1,351,754 | |||||
Off-balance sheet items |
||||||||||
Loan commitments |
127,540 | 74,111 | 4,181 | 861 | 206,693 | |||||
Other commitments
|
386 | 384 | 19 | | 789 | |||||
Total off-balance sheet items
|
127,926 | 74,495 | 4,200 | 861 | 207,482 | |||||
Total financial liabilities and off-balance sheet items
|
794,084 | 570,704 | 103,000 | 91,448 | 1,559,236 | |||||
At 31st December 2008 | ||||||||||
Deposits from other banks |
10,850 | 101,537 | 2,224 | 671 | 115,282 | |||||
Items in the course of collection due to other banks |
1,633 | 2 | | | 1,635 | |||||
Customer accounts |
195,728 | 132,927 | 5,249 | 5,807 | 339,711 | |||||
Trading portfolio liabilities |
59,474 | | | | 59,474 | |||||
Financial liabilities designated at fair value: |
||||||||||
held on own account |
1,043 | 33,860 | 28,300 | 30,427 | 93,630 | |||||
Derivative financial instruments: |
||||||||||
held for trading |
964,071 | | | | 964,071 | |||||
designated for risk management |
| 1,809 | 1,671 | 1,206 | 4,686 | |||||
Debt securities in issue |
2,567 | 108,955 | 34,510 | 11,853 | 157,885 | |||||
Repurchase agreements and cash collateral on securities lent |
69 | 181,895 | 547 | 24 | 182,535 | |||||
Subordinated liabilities a |
| 1,273 | 5,114 | 28,726 | 35,113 | |||||
Other financial liabilities
|
| 4,573 | 1,572 | | 6,145 | |||||
Total financial liabilities
|
1,235,435 | 566,831 | 79,187 | 78,714 | 1,960,167 | |||||
Off-balance sheet items |
||||||||||
Loan commitments |
222,801 | 30,502 | 5,799 | 917 | 260,019 | |||||
Other commitments
|
493 | 318 | 340 | | 1,151 | |||||
Total off-balance sheet items
|
223,294 | 30,820 | 6,139 | 917 | 261,170 | |||||
Total financial liabilities and off-balance sheet items
|
1,458,729 | 597,651 | 85,326 | 79,631 | 2,221,337 |
Financial liabilities designated at fair value in respect of linked liabilities under investment contracts have been excluded from this analysis as the Group is not exposed to liquidity risk arising from them. Any request for funds from investors would be met simultaneously from the linked assets.
The balances in the above table do not agree directly to the balances in the consolidated balance sheet as the table incorporates all cash flows, on an undiscounted basis, related to both principal as well as those associated with all future coupon payments.
The principal due under perpetual subordinated liability instruments has been included in the over five years category. Further interest payments have not been included on this amount, which according to their strict contractual terms, could carry on indefinitely.
Note
a | Subordinated liabilities maturity has been reanalysed to reflect the date on which the counterparty can require repayment as opposed to the date of first call. |
267 |
50 Fair value of financial instruments
The fair value of a financial instrument is the amount for which an asset could be exchanged, or a liability settled, in an arms length transaction between knowledgeable willing parties.
Comparison of carrying amounts and fair values
The following table summarises the carrying amounts of financial assets and liabilities presented on the Groups balance sheet, and their fair values differentiating between financial assets and liabilities subsequently measured at fair value and those subsequently measured at amortised cost:
2009 | 2008 | |||||||||
Notes | Carrying amount £m |
Fair value £m |
Carrying amount £m |
Fair value £m | ||||||
Financial assets: |
||||||||||
Cash and balances at central banks |
a | 81,483 | 81,483 | 30,019 | 30,019 | |||||
Items in the course of collection from other banks |
a | 1,593 | 1,593 | 1,695 | 1,695 | |||||
Trading portfolio assets |
||||||||||
Treasury and other eligible bills |
b | 9,926 | 9,926 | 4,544 | 4,544 | |||||
Debt securities |
b | 116,594 | 116,594 | 148,686 | 148,686 | |||||
Equity securities |
b | 19,602 | 19,602 | 30,535 | 30,535 | |||||
Traded loans |
b | 2,962 | 2,962 | 1,070 | 1,070 | |||||
Commodities |
b | 2,260 | 2,260 | 802 | 802 | |||||
Financial assets designated at fair value: |
||||||||||
held in respect of linked liabilities under investment contracts |
b | 1,257 | 1,257 | 66,657 | 66,657 | |||||
held under own account: |
||||||||||
Equity securities |
b | 6,256 | 6,256 | 6,496 | 6,496 | |||||
Loans and advances |
b | 22,390 | 22,390 | 30,187 | 30,187 | |||||
Debt securities |
b | 4,007 | 4,007 | 8,628 | 8,628 | |||||
Other financial assets designated at fair value |
b | 8,658 | 8,658 | 9,231 | 9,231 | |||||
Derivative financial instruments |
b | 416,815 | 416,815 | 984,802 | 984,802 | |||||
Loans and advances to banks |
c | 41,135 | 41,135 | 47,707 | 47,594 | |||||
Loans and advances to customers |
||||||||||
Residential mortgage loans |
c | 149,099 | 142,726 | 139,845 | 138,373 | |||||
Credit card receivables |
c | 21,889 | 21,889 | 22,304 | 22,312 | |||||
Other personal lending |
c | 25,435 | 25,430 | 27,270 | 26,496 | |||||
Wholesale and corporate loans and advances |
c | 212,928 | 207,648 | 259,699 | 247,798 | |||||
Finance lease receivables |
c | 10,873 | 10,898 | 12,697 | 12,697 | |||||
Available for sale financial instruments |
||||||||||
Treasury and other eligible bills |
b | 5,919 | 5,919 | 4,003 | 4,003 | |||||
Debt securities |
b | 43,888 | 43,888 | 58,831 | 58,831 | |||||
Equity securities |
b | 6,676 | 6,676 | 2,142 | 2,142 | |||||
Reverse repurchase agreements and cash collateral on securities borrowed |
c | 143,431 | 142,524 | 130,354 | 129,296 | |||||
Financial liabilities: |
||||||||||
Deposits from banks |
d | 76,446 | 76,457 | 114,910 | 114,912 | |||||
Items in the course of collection due to other banks |
a | 1,466 | 1,466 | 1,635 | 1,635 | |||||
Customer accounts: |
||||||||||
Current and demand accounts |
d | 100,710 | 100,710 | 82,515 | 82,515 | |||||
Savings accounts |
d | 81,188 | 81,188 | 76,008 | 76,008 | |||||
Other time deposits |
d | 140,531 | 140,544 | 176,982 | 176,966 | |||||
Trading portfolio liabilities: |
||||||||||
Treasury and other eligible bills |
b | 381 | 381 | 79 | 79 | |||||
Debt securities |
b | 44,327 | 44,327 | 44,309 | 44,309 | |||||
Equity securities |
b | 6,468 | 6,468 | 14,919 | 14,919 | |||||
Commodities |
b | 76 | 76 | 167 | 167 | |||||
Financial liabilities designated at fair value: |
||||||||||
Held on own account |
b | 86,202 | 86,202 | 76,892 | 76,892 | |||||
Liabilities to customers under investment contracts |
b | 1,679 | 1,679 | 69,183 | 69,183 | |||||
Derivative financial instruments |
b | 403,416 | 403,416 | 968,072 | 968,072 | |||||
Debt securities in issue |
d | 135,902 | 135,405 | 149,567 | 148,736 | |||||
Repurchase agreements and cash collateral on securities lent |
d | 198,781 | 198,781 | 182,285 | 182,285 | |||||
Subordinated liabilities |
d | 25,816 | 25,299 | 29,842 | 22,944 |
268 |
Notes to the accounts
For the year ended 31st December 2009
continued
50 Fair value of financial instruments continued
Notes
a) | Fair value approximates carrying value due to the short-term nature of these financial assets and liabilities. |
b) | The carrying value of financial instruments subsequently measured at fair value (including those held for trading, designated at fair value, derivatives and available for sale) is determined in accordance with accounting policy as noted on pages 168 and 169 and further description and analysis of these fair values are set out below. |
c) | The carrying value of financial assets subsequently measured at amortised cost (including loans and advances, and other lending such as reverse repurchase agreements and cash collateral on securities borrowed) is determined in accordance with the accounting policy as noted on page 169. In many cases the fair value disclosed approximates the carrying value because the instruments are short-term in nature or have interest rates that reprice frequently. In other cases, fair value is determined using discounted cash flows, applying either market derived interest rates or, where the counterparty is a bank, rates currently offered by other financial institutions for placings with similar characteristics. Alternatively, fair value can be determined by applying an average of available regional and industry segmental credit spreads to the loan portfolio, taking the contractual maturity of the loan facilities into consideration. |
d) | The carrying value of financial liabilities subsequently measured at amortised cost (including customer accounts and other deposits such as repurchase agreements and cash collateral on securities lent, debt securities in issue, subordinated liabilities) is determined in accordance with the accounting policy as noted on page 169. In many cases, the fair value disclosed approximates the carrying value because the instruments are short-term in nature or have interest rates that reprice frequently such as customer accounts and other deposits and short-term debt securities. Fair values of other debt securities in issue are based on quoted prices where available, or where these are unavailable, are estimated using a valuation model. Fair values for dated and undated convertible and non convertible loan capital are based on quoted market rates for the issue concerned or similar issues with similar terms and conditions. |
Valuation inputs
During the year, the Group adopted the requirements of IFRS 7 Financial Instruments: Disclosures. This requires an entity to classify its financial assets and liabilities held at fair value according to a hierarchy that reflects the significance of observable market inputs. The classification of these instruments is based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined below.
Quoted market prices Level 1
Financial instruments, the valuation of which are determined by reference to unadjusted quoted prices for identical assets or liabilities in active markets where the quoted price is readily available, and the price represents actual and regularly occurring market transactions on an arms length basis. An active market is one in which transactions occur with sufficient volume and frequency to provide pricing information on an ongoing basis.
This category includes highly liquid government bonds, short dated US agency securities, active listed equities and actively exchange-traded derivatives.
Valuation technique using observable inputs Level 2
Financial instruments that have been valued using inputs other than quoted prices as described for level 1 but which are observable for the asset or liability, either directly or indirectly.
This category includes most investment grade and liquid high yield bonds; asset backed securities; long dated US agency securities; certain government bonds, less liquid listed equities; bank, corporate, and municipal obligations; certain OTC derivatives; certain convertible bonds; certificates of deposit and commercial paper; certain collateralised debt obligations (CDOs) (cash and synthetic underlyings); collateralised loan obligations (CLOs); commodities based derivatives; credit derivatives, certain credit default swaps (CDSs); most fund units; certain loans; foreign exchange spot and forward transactions; and certain issued notes.
Valuation technique using significant unobservable inputs Level 3
Financial instruments, the valuation of which incorporate significant inputs for the asset or liability that are not based on observable market data (unobservable inputs). Unobservable inputs are those not readily available in an active market due to market illiquidity or complexity of the product. These inputs are generally determined based on observable inputs of a similar nature, historic observations on the level of the input or analytical techniques.
This category includes certain corporate debt securities; highly distressed debt; private equity investments; commercial real estate loans; certain OTC derivatives (requiring complex and unobservable inputs such as correlations and long dated volatilities); certain convertible bonds; some CDOs (cash and synthetic underlyings); certain credit default swaps; derivative exposures to Monoline insurers; fund units; certain asset backed securities; certain issued notes; certain collateralised loan obligations (CLOs) and certain loans.
269 |
50 Fair value of financial instruments continued
The following table shows the Groups financial assets and liabilities that are recognised and measured at fair value and analysed by level within the fair value hierarchy.
Financial assets and liabilities measured at fair value |
||||||||||||
Valuation technique using | ||||||||||||
Quoted market prices (Level 1) £m |
Observable inputs (Level 2) £m |
Significant unobservable inputs (Level 3) £m |
Total £m |
|||||||||
31st December 2009 |
||||||||||||
Trading portfolio assets |
76,256 | 69,010 | 6,078 | 151,344 | ||||||||
Financial assets designated at fair value: |
||||||||||||
held on own account |
5,766 | 24,845 | 10,700 | 41,311 | ||||||||
held in respect of linked liabilities to customers under investment contracts |
1,209 | 48 | | 1,257 | ||||||||
Derivative financial assets |
3,163 | 401,451 | 12,201 | 416,815 | ||||||||
Available for sale assets |
19,919 | 35,287 | 1,277 | 56,483 | ||||||||
Total assets
|
106,313
|
|
530,641
|
|
30,256
|
|
667,210
|
| ||||
Trading portfolio liabilities |
(42,238 | ) | (8,936 | ) | (78 | ) | (51,252 | ) | ||||
Financial liabilities designated at fair value |
| (82,374 | ) | (3,828 | ) | (86,202 | ) | |||||
Liabilities to customers under investment contracts |
(109 | ) | (1,570 | ) | | (1,679 | ) | |||||
Derivative financial liabilities |
(2,386 | ) | (391,916 | ) | (9,114 | ) | (403,416 | ) | ||||
Total liabilities
|
(44,733
|
)
|
(484,796
|
)
|
(13,020
|
)
|
(542,549
|
)
| ||||
31st December 2008 |
||||||||||||
Trading portfolio assets |
72,120 | 98,892 | 14,625 | 185,637 | ||||||||
Financial assets designated at fair value: |
||||||||||||
held on own account |
5,129 | 32,340 | 17,073 | 54,542 | ||||||||
held in respect of linked liabilities to customers under investment contracts |
33,554 | 32,495 | 608 | 66,657 | ||||||||
Derivative financial assets |
5,548 | 956,348 | 22,906 | 984,802 | ||||||||
Available for sale assets |
14,391 | 47,448 | 3,137 | 64,976 | ||||||||
Total assets
|
130,742
|
|
1,167,523
|
|
58,349
|
|
1,356,614
|
| ||||
Trading portfolio liabilities |
(42,777 | ) | (16,439 | ) | (258 | ) | (59,474 | ) | ||||
Financial liabilities designated at fair value |
(23 | ) | (73,698 | ) | (3,171 | ) | (76,892 | ) | ||||
Liabilities to customers under investment contracts |
(32,640 | ) | (35,935 | ) | (608 | ) | (69,183 | ) | ||||
Derivative financial liabilities |
(3,516 | ) | (949,143 | ) | (15,413 | ) | (968,072 | ) | ||||
Total liabilities
|
(78,956
|
)
|
(1,075,215
|
)
|
(19,450
|
)
|
(1,173,621
|
)
|
The table above has been compiled using the new definitions required by IFRS 7 revised and, as a result, the classifications of assets and liabilities are not directly comparable to the Groups previously published tables of fair value measurement.
The following table shows the Groups financial assets and liabilities that are recognised and measured at fair value disaggregated by valuation techniques and by product type.
Financial assets and liabilities measured at fair value by product type At 31st December 2009 |
|||||||||||||||
Assets Valuation technique using |
Liabilities Valuation technique using |
||||||||||||||
Quoted market prices Level 1 £m |
Observable inputs Level 2 £m |
Significant unobservable inputs Level 3 £m |
Quoted market prices Level 1 £m |
Observable inputs Level 2 £m |
Significant unobservable inputs Level 3 £m |
||||||||||
Commercial real estate loans |
| | 7,170 | | | | |||||||||
Asset backed products |
| 34,779 | 5,840 | | (6,165 | ) | (2,334 | ) | |||||||
Other credit products |
1 | 47,202 | 2,020 | | (47,904 | ) | (2,827 | ) | |||||||
Derivative exposure to Monoline insurers |
| | 2,027 | | | | |||||||||
Non-asset backed debt instruments |
72,578 | 66,885 | 3,127 | (35,760 | ) | (73,371 | ) | (3,202 | ) | ||||||
Equity products |
28,053 | 11,772 | 1,536 | (8,788 | ) | (13,737 | ) | (1,922 | ) | ||||||
Private equity |
73 | 176 | 1,978 | | | | |||||||||
Funds and fund-linked products |
3,856 | 5,387 | 1,241 | | (2,049 | ) | | ||||||||
FX products |
| 24,885 | 761 | | (25,159 | ) | (379 | ) | |||||||
Interest rate products |
176 | 288,718 | 2,357 | | (275,684 | ) | (1,775 | ) | |||||||
Commodity products |
1,414 | 31,562 | 748 | (76 | ) | (37,091 | ) | (581 | ) | ||||||
Other |
162 | 19,275 | 1,451 | (109 | ) | (3,636 | ) | | |||||||
Total |
106,313 | 530,641 | 30,256 | (44,733 | ) | (484,796 | ) | (13,020 | ) |
270 |
Notes to the accounts
For the year ended 31st December 2009
continued
50 Fair value of financial instruments continued
Level 3 financial assets and liabilities by balance sheet classification and product type | |||||||||||||||
As at 31st December 2009 | Non-derivative assets | Non-derivative liabilities | Derivatives | ||||||||||||
Trading portfolio assets £m |
Financial assets designated at fair value £m |
Available for sale assets £m |
Trading portfolio liabilities £m |
Financial liabilities designated at fair value £m |
Net derivative financial instruments a £m |
||||||||||
Commercial real estate loans |
| 7,170 | | | | | |||||||||
Asset backed products |
1,840 | 423 | 205 | (5 | ) | (63 | ) | 1,106 | |||||||
Other credit products |
| 92 | | | (595 | ) | (304 | ) | |||||||
Derivative exposure to Monoline insurers |
| | | | | 2,027 | |||||||||
Non-asset backed debt instruments |
2,461 | 438 | 166 | (73 | ) | (3,081 | ) | 14 | |||||||
Equity products |
190 | | 157 | | | (733 | ) | ||||||||
Private equity |
104 | 1,237 | 637 | | | | |||||||||
Funds and fund-linked products |
1,128 | 8 | 105 | | | | |||||||||
FX products |
| | | | | 382 | |||||||||
Interest rate products |
| 64 | | | (25 | ) | 543 | ||||||||
Commodity products |
| 12 | 4 | | (64 | ) | 215 | ||||||||
Other |
355 | 1,256 | 3 | | | (163 | ) | ||||||||
Total |
6,078 | 10,700 | 1,277 | (78 | ) | (3,828 | ) | 3,087 |
Level 3 Movement Analysis
The following table summarises the movements in the level 3 balance during the year ended 31st December 2009. The table shows gains and losses and includes amounts for all financial assets and liabilities transferred to level 3 during the year. The table does not reflect gains and losses for level 3 financial assets and liabilities that were transferred out during the year. Transfers have been reflected as if they had taken place at the beginning of the year.
Analysis of movement in level 3 financial assets and
liabilities For the period ended 31st December 2009 |
|||||||||||||||||||||
Trading portfolio assets £m |
Financial assets designated at fair value £m |
Available for sale assets £m |
Trading portfolio liabilities £m |
Financial liabilities designated at fair value £m |
Net derivative financial instruments a £m |
Total £m |
|||||||||||||||
As at 1st January 2009 |
14,625 | 17,681 | 3,137 | (258 | ) | (3,779 | ) | 7,493 | 38,899 | ||||||||||||
Purchases |
2,021 | 700 | 459 | (70 | ) | (313 | ) | 2,334 | 5,131 | ||||||||||||
Sales |
(7,018 | ) | (4,875 | ) | (9 | ) | 172 | 690 | (3,548 | ) | (14,588 | ) | |||||||||
Issues |
| | | | (1,343 | ) | (1,718 | ) | (3,061 | ) | |||||||||||
Settlements |
(410 | ) | (804 | ) | (347 | ) | | 763 | (100 | ) | (898 | ) | |||||||||
Total gains and losses in the period |
|||||||||||||||||||||
Recognised in the income statement |
|||||||||||||||||||||
trading income |
(2,290 | ) | (3,356 | ) | | 27 | 1,574 | (3,516 | ) | (7,561 | ) | ||||||||||
other income |
| (434 | ) | (131 | ) | | | | (565 | ) | |||||||||||
Total gains or losses recognised in other comprehensive income |
| | (103 | ) | | | | (103 | ) | ||||||||||||
Transfers in/transfers out |
(850 | ) | 1,788 | (1,729 | ) | 51 | (1,420 | ) | 2,142 | (18 | ) | ||||||||||
As at 31st December 2009 |
6,078 | 10,700 | 1,277 | (78 | ) | (3,828 | ) | 3,087 | 17,236 |
The following table discloses the gains and losses recognised in the period arising on level 3 financial assets and liabilities held as at 31st December 2009.
Gains and losses recognised during the period on level 3 financial assets and liabilities held As at 31st December 2009 |
||||||||||||||||||||
Trading portfolio assets £m |
Financial assets designated at fair value £m |
Available for sale assets £m |
Trading portfolio liabilities £m |
Financial liabilities designated at fair value £m |
Net derivative financial instruments £m |
Total £m |
||||||||||||||
Total gains and losses held as at 31st December 2009 |
||||||||||||||||||||
Recognised in the income statement |
||||||||||||||||||||
trading income |
(736 | ) | (3,034 | ) | | 8 | (269 | ) | (2,817 | ) | (6,848 | ) | ||||||||
other income |
| (452 | ) | (140 | ) | | | | (592 | ) | ||||||||||
Total gains or losses recognised in other comprehensive income |
| | (65 | ) | | | | (65 | ) | |||||||||||
Total |
(736 | ) | (3,486 | ) | (205 | ) | 8 | (269 | ) | (2,817 | ) | (7,505 | ) |
Note
a | The derivative financial instruments in the tables above are represented on a net basis of £3,087m. On a gross basis derivative financial assets are £12,201m, derivative financial liabilities are £9,114m. |
271 |
50 Fair value of financial instruments continued
The significant movements in the level 3 positions during the year ended 31st December 2009 are explained below:
Purchases of £5.1bn were primarily composed of £1.7bn of asset backed products, £1.5bn of credit derivatives and £0.6bn of equity products.
Sales of £14.6bn include the disposal of £7.5bn of assets backed products and Monoline exposures through the Protium transaction.
The Crescent debt restructuring, disclosed in Note 40, resulted in the sale of £1.0bn of commercial real estate loans and there were additional sales of £3.8bn asset backed products and £0.6bn Monoline exposures during the period.
Issuances of £3.1bn were driven by £1.3bn of new credit-linked notes and equity, credit and commodity derivatives of £1.7bn.
Losses in Trading Income of £7.6bn were primarily attributable to the £4.4bn of writedowns on the credit market exposures summarised in Note 47, along with writedowns on other asset backed products, funds and other Monoline insurers. These were offset by gains on interest rate and commodity products.
Losses in Other Income of £0.6bn were driven by the writedown and impairment of commercial real estate loans.
Transfers into level 3 were largely due to the lack of observable valuation inputs for certain securities as well as curves becoming unobservable for certain derivative products.
Transfers out of level 3 were principally due to unobservable valuation inputs being deemed insignificant to the overall valuation of certain instruments particularly on investment grade asset backed products.
There were no significant transfers between level 1 and level 2.
Valuation techniques
Valuations based on observable inputs include financial instruments such as swaps and forwards which are valued using market standard pricing techniques; and options that are commonly traded in markets where all the inputs to the market standard pricing models are observable.
Valuation models are reviewed at least annually for model performance and calibration. Current year valuation methodologies were consistent with the prior year unless otherwise noted below. These methodologies are commonly used by market participants.
The main products whose valuation includes unobservable inputs are described below.
Commercial real estate loans
This category includes lending on a range of commercial property types including retail, hotels, office and development properties.
The valuations are considered unobservable due to the bespoke nature of the instruments and the high level of volatility in the commercial real estate market at present. Fair value is calculated using a risk adjusted spread based methodology performed on a loan by loan basis with consideration of characteristics such as property type, geographic location, yields, credit quality and property performance reviews.
The valuation inputs are reviewed with reference to CMBX and CMBS bond indices. Initial spreads are sourced from market quoted origination spreads by property type and classified into Loan-to-Value (LTV) buckets which are adjusted for internal credit rating and subordination of the loans. The internal credit ratings used in the valuation model are subject to a monthly review process. The model is calibrated monthly based on external quotes of new origination property type spreads and the latest internal credit ratings.
The methodology used differs to the prior period in that internal credit ratings, additional risk factors and property performance reviews are now incorporated. The changes were made to take advantage of data that has become available and to enhance the assessment of credit risk.
Asset backed products
These are debt and derivative products that are linked to the cash flows of a pool of referenced assets. This category includes asset backed loans; CDOs (cash underlyings); CLOs; asset backed credit derivatives; asset and mortgage backed securities.
Within this population, valuation inputs are unobservable for non-investment grade ABS; non-agency residential mortgage backed securities (RMBS) and asset backed credit derivatives. The valuations are determined using industry standard cash flow models that calculate fair value based on loss projections, prepayment, recovery and discount rates. These parameters are determined by reference to underlying collateral performance, independent research, ABX indices, broker quotes, observable trades on similar securities and third party pricing sources.
The determination of parameter levels takes account of a range of factors such as deal vintage, underlying asset composition (historical losses; borrower characteristics; various loan attributes such as loan-to-value and debt-to-income ratios and geographic concentration), credit ratings (original and current), home price changes and interest rates.
272 |
Notes to the accounts
For the year ended 31st December 2009
continued
50 Fair value of financial instruments continued
Other credit products
These products are linked to the credit spread of a referenced entity, index or basket of referenced entities. This category includes synthetic CDOs; single name and index CDS and Nth to default basket swaps. Within this population, valuation inputs are unobservable for certain synthetic CDOs and CDS with illiquid reference assets.
Synthetic CDOs are valued using a model that calculates fair value based on observable and unobservable parameters including credit spreads, recovery rates, correlations and interest rates and is calibrated daily. For index and bespoke synthetic CDOs with unobservable inputs, correlation is set with reference to index tranche market.
CDS with illiquid reference assets are valued using an industry standard hazard-type model that calculates fair value of the credit protection using interest rates, credit spreads and recovery rates of the underlying issuers. Interest rates are observable and sourced from liquid interest rate instruments. Credit spreads are unobservable and are determined with reference to recent transactions or bond spreads from observable issuances of the same issuer or other similar obligors as a proxy.
Derivative exposure to Monoline insurers
These products comprise securities, principally CLOs, on which default protection has been purchased. Credit spreads of the counterparty providing protection are unobservable.
The derivative positions are valued with reference to the price of the underlying security. As the security and derivative are hedged, the net present value of the derivative increases as the net present value of the security decreases. The derivative valuation is then adjusted to reflect the credit quality of the counterparty.
Non-asset backed debt instruments
These are government bonds; US agency bonds; corporate bonds; commercial paper; certificates of deposit; convertible bonds; notes and other non-asset backed bonds. Within this population, valuation inputs are unobservable for certain convertible bonds, corporate bonds and issued notes.
Convertible bonds are valued using prices observed through broker sources, market data services and trading activity. Prices are validated against liquid external sources. Where liquid external sources are not available, fair value is determined using a spread to the equity conversion value or the value of the bond without the additional equity conversion. The spread level is determined with reference to similar proxy assets. Positions are valued on a daily basis.
Corporate bonds are valued on a price basis or using spreads over risk free interest rate curves built from liquid instruments. Where unobservable, bond spreads are determined by reference to either issuances or alternatively CDS spreads of the same issuer are used as proxy inputs to obtain discounted cash flows and accordingly the value of the bond. In the absence of observable bond or CDS spreads of the respective issuer, similar reference assets or sector averages are applied as a proxy.
Fixed and floating rate notes issued, in certain emerging markets, are valued using models that discount expected future cash flows. These proprietary models calculate fair value based on observable interest rates and unobservable funding or credit spreads. The interest rates are derived from broker and bank notes rates. Funding spreads up to five years are sourced from negotiable commercial deposit rates in the market as a proxy. Funding spreads greater than five years are determined by applying linear extrapolation.
Equity products
This category includes listed equities; exchange traded derivatives; OTC equity derivatives; preference shares and contracts for difference. Within this population, valuation inputs for certain OTC equity derivatives are unobservable.
OTC equity derivatives valuation are determined using industry standard models. The models calculate fair value based on input parameters such as stock prices, dividends, volatilities, interest rates, equity repo curves and, for multi-asset products, correlations. In general, input parameters are deemed observable up to liquid maturities which are determined separately for each parameter and underlying instrument. Unobservable model inputs are set by referencing liquid market instruments and applying extrapolation techniques to match the risk profile of the trading portfolio. These are validated against consensus market data services for the same or similar underlying instrument. Models are calibrated daily based on liquid market instrument prices.
Private equity
Private equity investments are valued in accordance with the International Private Equity and Venture Capital Valuation Guidelines. This requires the use of a number of individual pricing benchmarks such as the prices of recent transactions in the same or similar instruments, discounted cash flow analysis, and comparison with the earnings multiples of listed comparative companies. Unobservable inputs include earnings estimates, multiples of comparative companies, marketability discounts and discount rates. Model inputs are based on market conditions at the reporting date. The valuation of unquoted equity instruments is subjective by nature. However, the relevant methodologies are commonly applied by other market participants and have been consistently applied over time. Full valuations are performed bi-annually, with the portfolio reviewed on a monthly basis for material events that might impact upon fair value.
273 |
50 Fair value of financial instruments continued
Fund and fund-linked products
This category includes holdings in hedge funds; funds of funds; and fund derivatives. Fund derivatives are derivatives whose underlyings include mutual funds, hedge funds, indices and multi-asset portfolios. They are valued using underlying fund prices, yield curves and other available market information.
In general fund holdings are valued based on the latest available valuation received from the fund administrator. Funds are deemed unobservable where the fund is either suspended, in wind-down, has a redemption restriction that severely affects liquidity, or where the latest Net Asset Value (NAV) from the fund administrators is more than three months old. In the case of illiquid fund holdings the valuation will take account of all available information in relation to the underlying fund or collection of funds and may be adjusted relative to the performance of relevant index benchmarks. Prices are marked based on available valuation data and any adjustments are reviewed on a monthly basis.
FX products
These products are derivatives linked to the foreign exchange market. This category includes Forward contracts, FX swaps and FX options.
Exotic derivatives are valued using industry standard and proprietary models. Fair value is based on input parameters that include FX rates, interest rates, FX volatilities, interest rate volatilities, FX interest rate correlations and other model parameters. Unobservable model inputs are set by referencing liquid market instruments and applying extrapolation techniques to match the risk profile of the trading portfolio. These are validated against consensus market data services on a monthly basis.
Interest rate products
These are products with a payoff linked to interest rates for example Libor (London interbank offer rate) or inflation rates and indices. This category includes interest rate and inflation swaps; swaptions; caps; floors; inflation options; Bank of England base rate derivatives and other exotic interest rate derivatives.
Inflation structured and property index-linked products are valued using an industry standard model. The model calculates fair value based on observable and unobservable parameters such as inflation index levels, volatilities and correlations sourced from trading information, broker data and historical analysis. The assumptions and inputs applied reflect observable parameters such as yield curves, interpolation adjustments for the seasonal nature of inflation and volatility surfaces. The most significant unobservable input is correlation between inflation indices. The suitability of the models employed is reviewed on an annual basis.
Bank of England base rate derivatives are valued using standard discounted cash flows techniques. Bank of England forward base rates are used as inputs into the valuation model. These forward base rates are constructed from the base rate yield curve set from market data up to five years. For maturities greater than five years, spreads to observable proxies are applied. The base rate yield curve used is updated daily.
Commodity products
These products are exchange traded and OTC derivatives based on an underlying commodity such as metals, oil and oil related, power and natural gas. Within this population, valuation inputs of certain commodity swaps and options are unobservable.
Valuation inputs of certain commodity swaps and options are determined using models incorporating discounting of cash flows, closed form Black models and Monte-Carlo simulation. The models calculate fair value based on inputs such as forward curves, volatility surfaces and tenor correlation. Unobservable inputs are set with reference to similar observable products or by applying extrapolation techniques from the observable market. As markets close at different times, curves are constructed using a spread to the primary market benchmark to ensure that all curves are valued using the dominant market base price.
The frequency and method used to calibrate the model is based on an assessment of observable option and swap prices.
Other
This category is primarily made up of fixed rate loans, which are valued using models that discount expected future cash flows. These models calculate the fair value based on observable interest rates and unobservable funding or credit spreads. Unobservable funding or credit spreads are determined by applying linear extrapolation of observable spreads.
Fair value adjustments
The main adjustments to model or system balances to arrive at a fair value are described below:
Bid-Offer valuation adjustments
Portfolios are valued to reflect the most advantageous market price to which Barclays has immediate access. For assets and liabilities where the firm is not a market maker, mid prices are adjusted to bid and offer prices respectively. The bid-offer adjustment factors reflect the expected close out strategy and, for derivatives, that they are managed on a portfolio basis. The methodology for determining the bid-offer adjustment for a derivative portfolio will generally involve netting between long and short positions and the bucketing of risk by strike and term in accordance with hedging strategy. Bid-offer levels are derived from market sources, such as broker data, and are reviewed periodically. For those assets and liabilities where the firm is a market maker (which is the case for certain equity, bond and vanilla derivative markets), since the bid-offer spread does not represent a transaction cost, mid prices are used.
274 |
Notes to the accounts
For the year ended 31st December 2009
continued
50 Fair value of financial instruments continued
Model valuation adjustments
New models used for valuing the firms positions are reviewed under the firms Model Validation Policy. This assesses the assumptions used in modelling and recommends any model fair value adjustments. Such adjustments take account of any model limitations which may include additional model factors such as volatility skew or uncertainties such as prepayment rates. These adjustments calibrate the carrying value to fair value. The magnitude of the valuation adjustment is dependant on the size of portfolio, complexity of the model, whether the model is market standard and to what extent it incorporates all known risk factors. Models and model value adjustment recommendations are subject to an annual review process.
Credit and debit valuation adjustments
Credit Valuation Adjustments (CVAs) and Debit valuation adjustments (DVAs) are incorporated into derivative valuations to reflect the impact on the fair value of counterparty risk and Barclays own credit quality. These adjustments are modelled for OTC derivatives across all asset classes.
Probability of Default (PD) and Loss Given Default (LGD) are applied to expected exposures at a counterparty level to arrive at a CVA and DVA adjustment.
Monoline credit valuation adjustments
Expected exposure is calculated by simulating default losses on the underlying assets, calibrated to market observable parameters and forward looking market research. This exposure is then adjusted for any spread between prices derived from observable proxies and expected exposure based on the PD or regulatory intervention.
The PD used to calculate the CVA is derived from external ratings cross referenced to internal default grades and is based on internal simulations of credit-factor indices by region and industry designations, calibrated to historical time-series and forecast on the basis of current values. The LGD used to calculate the CVA is a function of available historical data, the monolines credit quality and risk concentration.
Other credit and debit valuation adjustments
CVAs and DVAs for non Monoline exposures are calculated using Monte-Carlo simulation to generate an expected exposure profile. The expected exposure is calculated at a counterparty level after netting and collateral are applied.
For counterparties with an observable credit market, the PD and LGD are derived from single name credit default swap prices. For all other counterparties, PDs are derived from a combination of industry curves; indices; and loan/note pricing taking into account geographic factors, internal credit ratings, loss assumptions and ratings agency data. Where the curve is unobservable and the CVA is significant to the overall value of the underlying derivative, the full value of the derivative and its associated credit valuation adjustment has been deemed unobservable.
CVAs are not incorporated into the fair value of certain counterparties where the market does not apply a credit charge. The categories of counterparties excluded are as follows:
| Strongly collateralised counterparties this is any counterparty with a collateral agreement with minimum weekly calls and the collateral threshold plus minimum transfer amount below a defined level; |
| Certain highly-rated sovereigns, supra-nationals and government agencies; and |
| Liquidity providers when trading on the interbank market with certain collateralised market making counterparties no counterparty spreads are applied. |
Where counterparty credit quality and exposure to that counterparty are linked, wrong way risk may arise. In these instances, wrong way risk suggests that exposure to the counterparty is likely to increase as counterparty credit quality deteriorates. Exposure to wrong way risk is limited via internal governance processes and deal pricing.
Own credit adjustments
The carrying amount of issued notes that are designated under the IAS 39 fair value option is adjusted to reflect the effect of changes in own credit spreads. The resulting gain or loss is recognised in the income statement.
For funded instruments such as issued notes, credit spreads on Barclays issued bonds represent the most appropriate basis for this adjustment. However, from 30th September 2007 to 30th June 2009, Barclays credit default swap spreads were used to calculate the carrying amount of issued notes, since there were insufficient observable own credit spreads through secondary trading prices in issued bonds. From 1st July 2009, the carrying amount of issued notes has been calculated using credit spreads derived from secondary trading in Barclays issued bonds.
At 31st December 2009, the own credit adjustment arose from the fair valuation of £61.5bn of Barclays Capital structured notes (31st December 2008: £54.5bn). Barclays credit spreads improved during 2009, leading to a loss of £1,820m (2008: gain £1,663m) from the fair value of changes in own credit. If Barclays had calculated the carrying amount of issued notes using credit default swap spreads at 31st December 2009, the fair value of changes in own credit would have been a loss of £2,448m in the year.
Barclays Capital also uses credit default swap spreads to determine the impact of Barclays own credit quality on the fair value of derivative liabilities. At 31st December 2009, cumulative adjustments of £307m (31st December 2008: £1,176m) were netted against derivative liabilities. The impact of these adjustments in both periods was more than offset by the impact of the credit valuation adjustments to reflect counterparty creditworthiness that were netted against derivative assets.
275 |
50 Fair value of financial instruments continued
Unrecognised gains as a result of the use of valuation models using unobservable inputs
The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial recognition, less amounts subsequently recognised, was as follows:
Year ended 31st December |
||||||
2009 £m |
2008 £m |
|||||
Opening balance |
128 | 154 | ||||
Additions |
39 | 77 | ||||
Amortisation and releases |
(68 | ) | (103 | ) | ||
Closing balance |
99 | 128 |
Sensitivity analysis of valuations using unobservable inputs
At 31st December 2009 | Fair value | Favourable changes |
Unfavourable change |
||||||||||||
Product type | Total assets £m |
Total liabilities £m |
Profit and loss £m |
Equity £m |
Profit and loss £m |
Equity £m |
|||||||||
Commercial real estate loans |
7,170 | | 429 | | (437 | ) | | ||||||||
Asset backed products |
5,840 | (2,334 | ) | 175 | 4 | (175 | ) | (4 | ) | ||||||
Other credit products |
2,020 | (2,827 | ) | 171 | | (152 | ) | | |||||||
Derivative exposure to Monoline insurers |
2,027 | | 336 | | (532 | ) | | ||||||||
Non-asset backed debt instruments |
3,127 | (3,202 | ) | 145 | 2 | (141 | ) | (2 | ) | ||||||
Equity products |
1,536 | (1,922 | ) | 28 | 15 | (28 | ) | (15 | ) | ||||||
Private equity |
1,978 | | 267 | 73 | (339 | ) | (95 | ) | |||||||
Funds and fund-linked products |
1,241 | | 100 | | (100 | ) | | ||||||||
FX products |
761 | (379 | ) | 33 | | (33 | ) | | |||||||
Interest rate products |
2,357 | (1,775 | ) | 78 | | (78 | ) | | |||||||
Commodity products |
748 | (581 | ) | 36 | | (36 | ) | | |||||||
Other |
1,451 | | 52 | | (52 | ) | | ||||||||
Total |
30,256 | (13,020 | ) | 1,850 | 94 | (2,103 | ) | (116 | ) |
As part of risk management processes, an analysis is performed on unobservable parameters to generate a range of reasonably possible alternative valuations.
The effect of stressing the unobservable assumptions to a range of reasonably possible alternatives would be to increase the fair values by up to £1.9bn (2008: £2.4bn) or to decrease the fair values by up to £2.2bn (2008: £3bn) with substantially all the potential effect impacting profit or loss rather than equity. The metric has not been offset for the effect of hedging.
The stresses applied take account of the nature of valuation techniques used, as well as the availability and reliability of observable proxy and historic data. In all cases, an assessment is made to determine the suitability of available data. The sensitivity methodologies are based on a range, standard deviation or spread data of a reliable reference source or a scenario based on alternative market views. The level of shift or scenarios applied is considered for each product and varied according to the quality of the data and variability of underlying market. The approach adopted in determining these sensitivities has evolved during the year, in the context of changing market conditions.
Commercial real estate loans
The unobservable inputs include but are not limited to market quoted origination spreads, internal credit ratings and subordination of the loans. The sensitivity is determined by applying a +/- 6% shift for each underlying position based on the largest upward and downward price movement of observable published indices of a similar nature in the preceding 12-month period.
Asset backed products
For non-agency RMBS and non-investment grade ABS, sensitivity is calculated on the price movement on observable ABX.HE indices. For asset backed credit derivatives, sensitivity is calculated on price movements within the ABX.HE.AAA indices. Sensitivity is based on the average of the largest price movement upward and the largest price movement downward in the preceding 12-month period.
276 |
Notes to the accounts
For the year ended 31st December 2009
continued
50 Fair value of financial instruments continued
Other credit products
Sensitivity of synthetic CDOs is determined by using valuations based on different assumptions for recovery and tranche mapping. The sensitivity represents the impact of the application of different modelling assumptions. These model assumptions change the distribution of losses on the trades.
The sensitivity of valuations of the illiquid CDS portfolio is determined by applying a +/- 0.5% stress to the DV01 for each underlying reference asset. The stress is based upon the average bid offer spreads observed in the market for similar CDS.
Derivative exposure to Monoline insurers
The main unobservable input in the valuation of the derivative exposure to Monoline insurers is the credit quality of the Monoline insurers. The approach to determine downside sensitivity is dependent on the credit quality of the Monoline insurer. For higher quality Monoline insurers a shift in internal credit ratings has been applied. For lower quality Monoline insurers the impact has been assessed by a shift to default and recovery rates. The recovery rate was set to 10% and risk of default to 100%. To assess the upside risk to Monoline insurers, the underlying assets were flexed by 3%, based on the average monthly move for the LCDX index over the preceding 12 month period.
Non-asset backed debt instruments
The sensitivity on convertible bonds, is determined by applying a +/- 1% shift for each underlying value. The shift is based upon the bid offer spreads observed in the market for similar bonds.
The sensitivity on corporate bonds portfolio is determined by applying a +/- 1% shift for each underlying value. The shift is based upon the average bid offer spreads observed in the market for similar bonds.
The sensitivity for fixed and floating rate notes is calculated using a +/- 1% shift in credit spreads.
Equity products
The sensitivity is estimated based on the statistical spread of consensus data services either directly or through proxies. The estimate has been calculated using 1 standard deviation of the consensus returns.
Private equity
The relevant valuation models are sensitive to each of the key assumptions, such as projected future earnings, comparator multiples, marketability discounts and discount rates. Valuation sensitivity is estimated by flexing such assumptions to reasonable alternative levels and determining the impact to the outcome of the valuation, for example comparator multiples for a range of similar companies.
Fund and fund-linked products
The sensitivity measure is based on observing the largest monthly move in the main hedge fund index (HFRX) over the prior two-year period.
FX products
The sensitivity is based on the statistical spread of consensus data services. The estimate has been calculated using consensus data service statistical standard deviation and this represents 2 standard deviations of the mid correlations.
Interest rate products
For inflation products, the sensitivity is calculated by stressing the correlation parameters. The sensitivity was determined by applying a +/- 8% shift to the correlation risks and this was based on the historical observation of correlation levels over the preceeding month.
For base rate derivatives, the sensitivity is based on bid offer spreads of base rates swaps. The sensitivity was determined by applying a +/- 0.125% shift to the PV01 for each underlying position.
Commodity products
The sensitivity is determined by applying values based on historic variability over two years. The estimate has been calculated using data for shortdated forward volatility curves to generate a best and worst case likely scenario. The sensitivities are based on a 25% probability of occurrence over two years, and taking 50% of the difference between the best and worst multiplied by exposure to the relevant risk factor.
Other
The sensitivity for fixed rate loans is calculated using a +/- 1% shift in credit spreads.
Valuation control framework
The independent price verification process is a key control in ensuring the material accuracy of valuation. Price verification procedures cover all fair value positions. Data sources that are most representative of the market and readily available are used. The data sources are assessed against the following characteristics: independence; reliability; consistency between sources and evidence that it represents executable levels. This control process assists in the determination of whether market levels represent forced transactions which should not be considered in the assessment of fair value.
277 |
51 Reclassification of financial assets held for trading
On 25th November 2009 the Group reclassified certain financial assets, originally classified as held for trading that were deemed to be no longer held for trading purposes, and thus considered as loans and receivables. The reclassified assets comprised Collateralised Loan Obligations (CLOs) against which the Group held credit protection with monoline counterparties rated below investment grade.
As at the 25th November, the assets had a carrying value of £8,027m. The effective interest rates on these assets ranged from 0.50% to 2.99% with undiscounted interest and principal cash flows of £8,769m.
In the period prior to reclassification, £1,500m of fair value gains were recognised in the consolidated income statement. Since the 25th November, paydowns and maturities of £26m along with foreign exchange movements on the assets and accrued interest resulted in a carrying value as at 31st December 2009 of £8,099m.
The carrying value of the securities reclassified during 2008 into loans and receivables has decreased from £3,986m to £1,279m primarily as a result of paydowns and maturities of the underlying securities of £2,733m. No impairment has been identified on these securities.
The following table provides a summary of the assets reclassified from held for trading to loans and advances.
As at 31st December 2009 | As at 31st December 2008 | |||||||
Carrying value £m |
Fair value £m |
Carrying value £m |
Fair value £m | |||||
Trading assets reclassified to loans and receivables |
||||||||
Reclassification 25th November 2009 |
8,099 | 7,994 | | | ||||
Reclassification 16th December 2008 |
1,279 | 1,335 | 3,986 | 3,984 | ||||
Total financial assets reclassified to loans and receivables |
9,378 | 9,329 | 3,986 | 3,984 |
If the reclassifications had not been made, the Group's income statement for 2009 would have included net losses on the reclassified trading assets of £49m (2008: £2m).
After reclassification, the reclassified financial assets contributed £192m (2008: £4m) to interest income.
52 Capital Management
Barclays operates a centralised capital management model, considering both regulatory and economic capital. The capital management strategy is to continue to maximise shareholder value through optimising both the level and mix of capital resources. Decisions on the allocation of capital resources are conducted as part of the strategic planning review.
The Groups capital management objectives are to:
| maintain sufficient capital resources to meet the minimum regulatory capital requirements set by the FSA and the US Federal Reserve Banks requirements that a financial holding company be well capitalised; |
| maintain sufficient capital resources to support the Groups risk appetite and economic capital requirements; |
| support the Groups credit rating; |
| ensure locally regulated subsidiaries can meet their minimum capital requirements; and |
| allocate capital to businesses to support the Groups strategic objectives, including optimising returns on economic and regulatory capital. |
External regulatory capital requirements
The Group is subject to minimum capital requirements imposed by the Financial Services Authority (FSA), following guidelines developed by the Basel Committee on Banking Supervision (the Basel Committee) and implemented in the UK via European Union Directives.
Under Basel II, effective from 1st January 2008, the Group has approval by the FSA to use the advanced approaches to credit and operational risk management. Pillar 1 capital requirements are generated using the Groups risk models.
Under Pillar 2 of Basel II, the Group is subject to an overall regulatory capital requirement based on individual capital guidance (ICG) received from the FSA. The ICG imposes additional capital requirements in excess of Pillar 1 minimum capital.
278 |
Notes to the accounts
For the year ended 31st December 2009
continued
52 Capital Management continued
Outside the UK, the Group has operations (and main regulators) located in continental Europe, in particular France, Germany, Spain, Portugal and Italy (local central banks and other regulatory authorities); Asia Pacific (various regulatory authorities including the Hong Kong Monetary Authority, the Japanese FSA and the Monetary Authority of Singapore); Africa, where the Groups operations are headquartered in Johannesburg, South Africa (The South African Reserve Bank and the Financial Services Board (FSB)) and the United States of America (the Board of Governors of the Federal Reserve System (FRB) and the Securities and Exchange Commission).
The Group manages its capital resources to ensure that those Group entities that are subject to local capital adequacy regulation in individual countries meet their minimum capital requirements. Local management manages compliance with subsidiary entity minimum regulatory capital requirements with reporting to local Asset and Liability Committees and to Treasury Committee, as required.
Regulatory capital
The table below provides details of the regulatory capital resources managed by the Group.
Basel ll 2009 £m |
Basel II 2008 £m |
|||||
Total qualifying Tier 1 capital |
49,637 | 37,250 | ||||
Total qualifying Tier 2 capital |
14,703 | 22,333 | ||||
Total deductions |
(880 | ) | (856 | ) | ||
Total net capital resources |
63,460 | 58,727 |
53 Segmental reporting
The following section analyses the Groups performance by business. For management reporting purposes during 2009, Barclays was organised into the following business groupings:
Global Retail and Commercial Banking
| UK Retail Banking |
| Barclays Commercial Bank |
| Barclaycard |
| GRCB Western Europe |
| GRCB Emerging Markets |
| GRCB Absa |
Investment Banking and Investment Management
| Barclays Capital |
| Barclays Global Investors |
| Barclays Wealth |
Head Office Functions and Other Operations
UK Retail Banking
UK Retail Banking comprises Personal Customers, Home Finance, Local Business, Consumer Lending and Barclays Financial Planning. This cluster of businesses aims to build broader and deeper relationships with its Personal and Local Business customers through providing a wide range of products and financial services. Personal Customers and Home Finance provide access to current account and savings products, Woolwich branded mortgages and general insurance.
Consumer Lending provides unsecured loan and protection products and Barclays Financial Planning provides investment advice and products. Local Business provides banking services, including money transmission, to small businesses.
Barclays Commercial Bank
Barclays Commercial Bank provides banking services to organisations with an annual turnover of more than £1m. Customers are served via a network of relationship and industry sector specialists, which provides solutions constructed from a comprehensive suite of banking products, support, expertise and services, including specialist asset financing and leasing facilities. Customers are also offered access to the products and expertise of other businesses in the Group, particularly Barclays Capital, Barclaycard and Barclays Wealth.
279 |
53 Segmental reporting continued
Barclaycard
Barclaycard is a multi-brand credit card and consumer lending business which also processes card payments for retailers and merchants and issues credit and charge cards to corporate customers and the UK Government. It is one of Europes leading credit card businesses and has an increasing presence in the United States and South Africa.
In the UK, Barclaycard comprises Barclaycard UK Cards, Barclaycard Partnerships, Barclays Partner Finance and FirstPlus.
Outside the UK, Barclaycard provides credit cards in the United States, Germany, South Africa (through management of the Absa credit card portfolio) and in the Scandinavian region, where Barclaycard operates through Entercard, a joint venture with Swedbank.
Barclaycard works closely with other parts of the Group, including UK Retail Banking, Barclays Commercial Bank and GRCB Western Europe and GRCB Emerging Markets, to leverage their distribution capabilities.
Global Retail and Commercial Banking Western Europe
GRCB Western Europe encompasses Barclays Global Retail and Commercial Banking, as well as Barclaycard operations, in Spain, Italy, Portugal, France and Russia. GRCB Western Europe serves customers through a variety of distribution channels. GRCB Western Europe provides a variety of products including retail mortgages, current and deposit accounts, commercial lending, unsecured lending, credit cards, investments, and insurance serving the needs of Barclays retail, mass affluent, and corporate customers.
Global Retail and Commercial Banking Emerging Markets
GRCB Emerging Markets serves retail and commercial banking customers in Botswana, Egypt, Ghana, India, Kenya, Mauritius, Pakistan, Seychelles, Tanzania, Uganda, the UAE, Zambia, Indonesia and Zimbabwe. Through a network of more than 683 distribution points and 1,023 ATMs, we provide 3.7 million customers and clients with a full range of products and services. This includes current accounts, savings, investments, mortgages and secured and unsecured lending.
Global Retail and Commercial Banking Absa
GRCB Absa represents Barclays consolidation of Absa, excluding Absa Capital and Absa Card and Absa Wealth which is included as part of Barclays Capital, Barclaycard and Barclays Wealth respectively. Absa Group Limited is a South African financial services organisation serving personal, commercial and corporate customers predominantly in South Africa. GRCB Absa serves retail customers through a variety of distribution channels and offers a full range of banking services, including current and deposit accounts, mortgages, instalment finance, credit cards, bancassurance products and wealth management services. It also offers customised business solutions for commercial and large corporate customers.
Barclays Capital
Barclays Capital is the investment banking division of Barclays that provides large corporate, institutional and government clients with solutions to their financing and risk management needs.
Barclays Capital services a wide variety of client needs, covering strategic advisory and M&A; equity and fixed income capital raising and corporate lending; and risk management across foreign exchange, interest rates, equities and commodities.
Activities are organised into three principal areas: Global Markets, which includes commodities, credit products, equities, foreign exchange, interest rate products; Investment Banking, which includes corporate advisory, Mergers and Acquisitions, equity and fixed-income capital raising and corporate lending; and Private Equity and Principal Investments. Barclays Capital includes Absa Capital, the investment banking business of Absa. Barclays Capital works closely with all other parts of the Group to leverage synergies from client relationships and product capabilities.
Barclays Global Investors
The majority of the BGI business, which was previously reported as a separate business segment, was sold on 1st December 2009 to BlackRock, Inc. and represents the Groups discontinued operations. The continuing operations of BGI disclosed in the segmental analysis represent residual obligations under the cash support arrangements and associated liquidity support charges and, from 1st December 2009, include the Groups 19.9% ongoing economic interest in BlackRock, Inc. This investment is accounted for as an available for sale equity investment, with no dividends being received during 2009.
Barclays Wealth
Barclays Wealth focuses on private and intermediary clients worldwide providing international and private banking, fiduciary services, investment management, and brokerage.
Barclays Wealth works closely with all other parts of the Group to leverage synergies from client relationships and product capabilities.
Head Office Functions and Other Operations
Head Office Functions and Other Operations comprises head office and central support functions, businesses in transition and inter-segment adjustments.
Head office and central support functions comprises the following areas: Executive Management, Finance, Treasury, Corporate Affairs, Human Resources, Strategy and Planning, Internal Audit, Legal, Corporate Secretariat, Property, Tax, Compliance and Risk. Costs incurred wholly on behalf of the businesses are recharged to them.
Businesses in transition principally relate to certain lending portfolios that are centrally managed with the objective of maximising recovery from the assets.
280 |
Notes to the accounts
For the year ended 31st December 2009
continued
53 Segmental reporting continued
As at 31st December 2009 |
UK Retail Banking £m |
|
Barclays Commercial Bank £m |
|
Barclaycard £m |
|
GRCB Western Europe £m |
|
GRCB Emerging Markets £m |
|
GRCB Absa £m |
|
Barclays Capital £m |
|
Barclays Global Investors a £m |
|
Barclays Wealth £m |
|
Head office functions and other operations £m |
|
Total Continuing Operations £m |
| |||||||||||
Interest income from external customers | 2,421 | 1,568 | 2,573 | 1,083 | 765 | 1,385 | 1,002 | (37 | ) | 470 | 688 | 11,918 | |||||||||||||||||||||
Other income from external customers | 1,550 | 1,096 | 1,456 | 640 | 280 | 1,166 | 10,097 | 76 | 966 | (122 | ) | 17,205 | |||||||||||||||||||||
Income from external customers, net of insurance claims | 3,971 | 2,664 | 4,029 | 1,723 | 1,045 | 2,551 | 11,099 | 39 | 1,436 | 566 | 29,123 | ||||||||||||||||||||||
Inter-segment income |
14 | 89 | 13 | | | (2 | ) | 526 | 1 | (103 | ) | (538 | ) | | |||||||||||||||||||
Total income net of insurance claims | 3,985 | 2,753 | 4,042 | 1,723 | 1,045 | 2,549 | 11,625 | 40 | 1,333 | 28 | 29,123 | ||||||||||||||||||||||
Impairment charges and other credit provisions | (936 | ) | (974 | ) | (1,798 | ) | (667 | ) | (471 | ) | (567 | ) | (2,591 | ) | | (51 | ) | (16 | ) | (8,071 | ) | ||||||||||||
Segment expenses external | (2,187 | ) | (838 | ) | (1,440 | ) | (1,318 | ) | (934 | ) | (1,743 | ) | (6,559 | ) | 2 | (1,015 | ) | (683 | ) | (16,715 | ) | ||||||||||||
Inter-segment expenses |
(253 | ) | (192 | ) | (54 | ) | 205 | 82 | 274 | (33 | ) | (19 | ) | (123 | ) | 113 | | ||||||||||||||||
Total expenses |
(2,440 | ) | (1,030 | ) | (1,494 | ) | (1,113 | ) | (852 | ) | (1,469 | ) | (6,592 | ) | (17 | ) | (1,138 | ) | (570 | ) | (16,715 | ) | |||||||||||
Share of post-tax results of associates and joint ventures | 3 | | 8 | 4 | | (4 | ) | 22 | | | 1 | 34 | |||||||||||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures | | | 3 | 157 | 24 | (3 | ) | | (1 | ) | 1 | 7 | 188 | ||||||||||||||||||||
Gains on acquisitions |
| | | 26 | | | | | | | 26 | ||||||||||||||||||||||
Business segment profit before tax | 612 | 749 | 761 | 130 | (254 | ) | 506 | 2,464 | 22 | 145 | (550 | ) | 4,585 | ||||||||||||||||||||
Additional information |
|||||||||||||||||||||||||||||||||
Depreciation and amortisation | 146 | 69 | 133 | 110 | 77 | 143 | 452 | | 51 | 25 | 1,206 | ||||||||||||||||||||||
Impairment loss intangible assets | 4 | 1 | 17 | 1 | 1 | 2 | | | | 1 | 27 | ||||||||||||||||||||||
Impairment of goodwill |
| 1 | | | | | | | | | 1 | ||||||||||||||||||||||
Investments in associates and joint ventures | 2 | (1 | ) | (5 | ) | 88 | | 34 | 170 | | | 134 | 422 | ||||||||||||||||||||
Total assets |
105,228 | 75,547 | 30,220 | 64,185 | 11,874 | 45,8241,019,120 | 5,406 | 15,095 | 6,430 | 1,378,929 | |||||||||||||||||||||||
Total liabilities |
102,934 | 68,108 | 5,543 | 48,049 | 9,836 | 25,769 | 951,192 | 416 | 41,648 | 66,956 | 1,320,451 |
Note
a | The discontinued operations of the Barclays Global Investors business are disclosed in Note 39. |
281 |
53 Segmental reporting continued
As at 31st December 2008 |
UK Retail Banking £m |
|
Barclays Commercial Bank £m |
|
Barclaycard £m |
|
GRCB Western Europeb Marketsb £m |
|
GRCB Emerging £m |
|
GRCB Absa £m |
|
Barclays Capital £m |
|
Barclays Global Investorsa £m |
|
Barclays Wealth £m |
|
Head office functions and other operations £m |
|
Total Continuing Operations £m |
| |||||||||||
Interest income from external customers | 2,816 | 1,589 | 1,677 | 831 | 621 | 1,223 | 2,026 | (52 | ) | 496 | 242 | 11,469 | |||||||||||||||||||||
Other income from external customers | 1,702 | 1,068 | 1,492 | 627 | 373 | 946 | 2,989 | (26 | ) | 914 | (355 | ) | 9,730 | ||||||||||||||||||||
Income from external customers, net of insurance claims | 4,518 | 2,657 | 3,169 | 1,458 | 994 | 2,169 | 5,015 | (78 | ) | 1,410 | (113 | ) | 21,199 | ||||||||||||||||||||
Inter-segment income |
(36 | ) | 88 | 50 | (3 | ) | | 29 | 216 | 6 | (86 | ) | (264 | ) | | ||||||||||||||||||
Total income net of insurance claims | 4,482 | 2,745 | 3,219 | 1,455 | 994 | 2,198 | 5,231 | (72 | ) | 1,324 | (377 | ) | 21,199 | ||||||||||||||||||||
Impairment charges and other credit provisions | (602 | ) | (414 | ) | (1,097 | ) | (297 | ) | (165 | ) | (347 | ) | (2,423 | ) | | (44 | ) | (30 | ) | (5,419 | ) | ||||||||||||
Segment expenses external | (2,138 | ) | (934 | ) | (1,405 | ) | (1,139 | ) | (825 | ) | (1,576 | ) | (3,789 | ) | (256 | ) | (809 | ) | (520 | ) | (13,391 | ) | |||||||||||
Inter-segment expenses |
(381 | ) | (129 | ) | (17 | ) | 179 | 137 | 271 | 15 | (18 | ) | (126 | ) | 69 | | |||||||||||||||||
Total expenses |
(2,519 | ) | (1,063 | ) | (1,422 | ) | (960 | ) | (688 | ) | (1,305 | ) | (3,774 | ) | (274 | ) | (935 | ) | (451 | ) | (13,391 | ) | |||||||||||
Share of post-tax results of associates and joint ventures | 8 | (2 | ) | (3 | ) | | | 5 | 6 | | | | 14 | ||||||||||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures | | | | | | 1 | | | 326 | | 327 | ||||||||||||||||||||||
Gains on acquisitions |
| | 92 | 52 | | | 2,262 | | | | 2,406 | ||||||||||||||||||||||
Business segment profit before tax | 1,369 | 1,266 | 789 | 250 | 141 | 552 | 1,302 | (346 | ) | 671 | (858 | ) | 5,136 | ||||||||||||||||||||
Additional information |
|||||||||||||||||||||||||||||||||
Depreciation and amortisation | 111 | 69 | 114 | 75 | 52 | 117 | 272 | 1 | 40 | 31 | 882 | ||||||||||||||||||||||
Impairment loss intangible assets | | | | | | | | | (3 | ) | | (3 | ) | ||||||||||||||||||||
Impairment of goodwill | | | 37 | | | | 74 | 1 | | | 112 | ||||||||||||||||||||||
Investments in associates and joint ventures | 1 | (3 | ) | (13 | ) | | | 84 | 150 | | | 122 | 341 | ||||||||||||||||||||
Total assets |
101,384 | 84,029 | 30,925 | 65,519 | 13,866 | 40,391 | 1,629,117 | 71,340 | 13,263 | 3,146 | 2,052,980 | ||||||||||||||||||||||
Total liabilities |
104,640 | 64,997 | 3,004 | 37,632 | 10,135 | 20,720 | 1,603,093 | 68,372 | 45,846 | 47,130 | 2,005,569 |
Note
a | The discontinued operations of the Barclays Global Investors business are disclosed in Note 39. |
b | Figures have been restated for Barclays Russia, which was transferred from GRCB Emerging Markets to GRCB Western Europe during 2009. |
282 |
Notes to the accounts
For the year ended 31st December 2009
continued
53 Segmental reporting continued
As at 31st December 2007 |
UK Retail Banking £m |
|
Barclays Commercial Bank £m |
|
Barclaycard £m |
|
GRCB Western Europe £m |
|
GRCB Emerging Markets £m |
|
GRCB Absa £m |
|
Barclays Capital £m |
|
Barclays Global Investors a £m |
|
Barclays Wealth £m |
|
Head office functions and other operations £m |
|
Total Continuing Operations £m |
| |||||||||||
Interest income from external customers | 2,725 | 1,624 | 1,303 | 472 | 344 | 1,140 | 1,536 | (14 | ) | 453 | 15 | 9,598 | |||||||||||||||||||||
Other income from external customers | 1,652 | 922 | 1,086 | 474 | 189 | 832 | 5,398 | (27 | ) | 890 | 30 | 11,446 | |||||||||||||||||||||
Income from external customers, net of insurance claims | 4,377 | 2,546 | 2,389 | 946 | 533 | 1,972 | 6,934 | (41 | ) | 1,343 | 45 | 21,044 | |||||||||||||||||||||
Inter-segment income |
(80 | ) | 18 | 141 | (9 | ) | | 27 | 185 | 11 | (56 | ) | (237 | ) | | ||||||||||||||||||
Total income net of insurance claims |
4,297 | 2,564 | 2,530 | 937 | 533 | 1,999 | 7,119 | (30 | ) | 1,287 | (192 | ) | 21,044 | ||||||||||||||||||||
Impairment charges and other credit provisions | (559 | ) | (292 | ) | (827 | ) | (76 | ) | (39 | ) | (146 | ) | (846 | ) | | (7 | ) | (3 | ) | (2,795 | ) | ||||||||||||
Segment expenses external |
(2,154 | ) | (785 | ) | (1,079 | ) | (859 | ) | (553 | ) | (1,518 | ) | (3,989 | ) | (77 | ) | (829 | ) | (253 | ) | (12,096 | ) | |||||||||||
Inter-segment expenses |
(316 | ) | (144 | ) | (14 | ) | 186 | 158 | 251 | 16 | (12 | ) | (144 | ) | 19 | | |||||||||||||||||
Total expenses |
(2,470 | ) | (929 | ) | (1,093 | ) | (673 | ) | (395 | ) | (1,267 | ) | (3,973 | ) | (89 | ) | (973 | ) | (234 | ) | (12,096 | ) | |||||||||||
Share of post-tax results of associates and joint ventures |
7 | | (7 | ) | | 1 | 6 | 35 | | | | 42 | |||||||||||||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
| 14 | | 8 | | 5 | | | | 1 | 28 | ||||||||||||||||||||||
Business segment profit before tax |
1,275 | 1,357 | 603 | 196 | 100 | 597 | 2,335 | (119 | ) | 307 | (428 | ) | 6,223 | ||||||||||||||||||||
Additional information |
|||||||||||||||||||||||||||||||||
Depreciation and amortisation |
101 | 33 | 79 | 42 | 30 | 121 | 181 | | 18 | 26 | 631 | ||||||||||||||||||||||
Impairment loss intangible assets | | 13 | | | | 1 | | | | | 14 | ||||||||||||||||||||||
Investments in associates and joint ventures | (7 | ) | 1 | (8 | ) | | | 108 | 171 | | | 112 | 377 | ||||||||||||||||||||
Total assets |
88,477 | 74,566 | 22,121 | 43,702 | 9,188 | 36,368 | 839,850 | 89,218 | 18,188 | 5,683 | 1,227,361 | ||||||||||||||||||||||
Total liabilities |
101,516 | 66,251 | 1,952 | 24,004 | 7,507 | 17,176 | 811,704 | 87,096 | 44,152 | 33,527 | 1,194,885 |
Revenue by products and services
Details of revenue from external customers by product or service are disclosed in Notes 2 to 6 on pages 186 and 187.
Geographical information
(i) A geographical analysis of revenues from external customers is presented below:
2009 £m |
2008 £m |
2007 £m | |||||
Continuing operations |
|||||||
Attributed to the UK |
12,850 | 11,958 | 12,744 | ||||
Other European Union |
4,397 | 3,514 | 3,232 | ||||
United States |
5,547 | (471 | ) | 1,119 | |||
South Africa |
2,980 | 2,618 | 2,374 | ||||
Other Africa |
917 | 1,015 | 814 | ||||
Rest of the World |
2,432 | 2,565 | 761 | ||||
Total |
29,123 | 21,199 | 21,044 | ||||
Discontinued operations |
|||||||
Attributed to the UK |
432 | 319 | 383 | ||||
Other European Union |
100 | 119 | 142 | ||||
United States |
1,084 | 1,181 | 1,090 | ||||
Rest of the World |
247 | 297 | 341 |
There are no individual countries included in Other European Union, Other Africa, or Rest of the World contributing more than 5% of income from external customers.
Note
a | The discontinued operations of the Barclays Global Investors business are disclosed in Note 39. |
283 |
284 |
Independent Registered Public Accounting Firms Report
285 |
Barclays Bank PLC data
For the year ended 31st December
Notes | 2009 £m |
2008 £m |
2007 £m |
||||||||
Continuing operations |
|||||||||||
Interest income |
a | 21,236 | 28,010 | 25,296 | |||||||
Interest expense
|
a | (9,567 | ) | (16,595 | ) | (15,707 | ) | ||||
Net interest income
|
11,669 | 11,415 | 9,589 | ||||||||
Fee and commission income |
b | 9,946 | 7,573 | 6,745 | |||||||
Fee and commission expense
|
b | (1,528 | ) | (1,082 | ) | (970 | ) | ||||
Net fee and commission income
|
8,418 | 6,491 | 5,775 | ||||||||
Net trading income |
c | 6,994 | 1,270 | 3,754 | |||||||
Net investment income
|
c | 283 | 680 | 1,216 | |||||||
Principal transactions
|
7,277 | 1,950 | 4,970 | ||||||||
Net premiums from insurance contracts |
5 | 1,172 | 1,090 | 1,011 | |||||||
Other income
|
f | 1,389 | 444 | 222 | |||||||
Total income |
29,925 | 21,390 | 21,567 | ||||||||
Net claims and benefits incurred on insurance contracts
|
5 | (831 | ) | (237 | ) | (492 | ) | ||||
Total income net of insurance claims |
29,094 | 21,153 | 21,075 | ||||||||
Impairment charges and other credit provisions
|
7 | (8,071 | ) | (5,419 | ) | (2,795 | ) | ||||
Net income
|
21,023 | 15,734 | 18,280 | ||||||||
Staff costs |
8 | (9,948 | ) | (7,204 | ) | (7,611 | ) | ||||
Administration and general expenses |
d | (5,558 | ) | (5,301 | ) | (3,854 | ) | ||||
Depreciation of property, plant and equipment |
23 | (759 | ) | (606 | ) | (453 | ) | ||||
Amortisation of intangible assets
|
22 | (447 | ) | (276 | ) | (178 | ) | ||||
Operating expenses
|
(16,712 | ) | (13,387 | ) | (12,096 | ) | |||||
Share of post-tax results of associates and joint ventures |
20 | 34 | 14 | 42 | |||||||
Profit on disposal of subsidiaries, associates and joint ventures |
188 | 327 | 28 | ||||||||
Gains on acquisitions
|
40 | 26 | 2,406 | | |||||||
Profit before tax |
4,559 | 5,094 | 6,254 | ||||||||
Tax
|
e | (1,047 | ) | (449 | ) | (1,699 | ) | ||||
Profit after tax from continuing operations
|
3,512 | 4,645 | 4,555 | ||||||||
Discontinued operations |
|||||||||||
Profit after tax for the year from discontinued operations, including gain on disposal
|
6,777 | 604 | 571 | ||||||||
Net profit for the year |
10,289 | 5,249 | 5,126 | ||||||||
Profit attributable to equity holders of the Parent from: |
|||||||||||
Continuing operations |
3,228 | 4,259 | 4,218 | ||||||||
Discontinued operations
|
6,765 | 587 | 531 | ||||||||
Total
|
9,993 | 4,846 | 4,749 | ||||||||
Profit attributable to non-controlling interests
|
296 | 403 | 377 | ||||||||
10,289
|
|
5,249
|
|
5,126
|
|
The note numbers refer to the notes on pages 186 to 282, whereas the note letters refer to those on pages 290 to 298.
286 |
Barclays Bank PLC data
Consolidated statement of comprehensive income
continued
For the year ended 31st December
2009 £m |
2008 £m |
2007 £m |
|||||||
Net profit for the year
|
10,289 | 5,249 | 5,126 | ||||||
Other comprehensive income: |
|||||||||
Continuing operations |
|||||||||
Currency translation differences |
(853 | ) | 2,233 | 34 | |||||
Available for sale financial assets |
1,320 | (1,577 | ) | (94 | ) | ||||
Cash flow hedges |
165 | 376 | 359 | ||||||
Other |
(1 | ) | (56) | 22 | |||||
Tax relating to components of other comprehensive income
|
(26 | ) | 851 | 40 | |||||
Other comprehensive income for the year, net of tax from continuing operations |
605 | 1,827 | 361 | ||||||
Other comprehensive income for the year, net of tax from discontinued operations
|
(58 | ) | 114 | 26 | |||||
Total comprehensive income for the year
|
10,836 | 7,190 | 5,513 | ||||||
Attributable to: |
|||||||||
Equity holders of the Parent |
10,286 | 6,654 | 5,135 | ||||||
Non-controlling interests
|
550 | 536 | 378 | ||||||
10,836
|
|
7,190
|
|
5,513
|
|
287 |
Barclays Bank PLC data
As at 31st December
Notes | 2009 £m |
2008 £m | ||||
Assets |
||||||
Cash and balances at central banks |
81,483 | 30,019 | ||||
Items in the course of collection from other banks |
1,593 | 1,695 | ||||
Trading portfolio assets |
g | 151,395 | 185,646 | |||
Financial assets designated at fair value: |
||||||
held on own account |
13 | 41,311 | 54,542 | |||
held in respect of linked liabilities to customers under investment contracts |
13 | 1,257 | 66,657 | |||
Derivative financial instruments |
14 | 416,815 | 984,802 | |||
Loans and advances to banks |
15 | 41,135 | 47,707 | |||
Loans and advances to customers |
15 | 420,224 | 461,815 | |||
Available for sale financial investments |
h | 56,651 | 65,016 | |||
Reverse repurchase agreements and cash collateral on securities borrowed |
17 | 143,431 | 130,354 | |||
Other assets |
18 | 6,358 | 6,302 | |||
Current tax assets |
349 | 389 | ||||
Investments in associates and joint ventures |
20 | 422 | 341 | |||
Goodwill |
21 | 6,232 | 7,625 | |||
Intangible assets |
22 | 2,563 | 2,777 | |||
Property, plant and equipment |
23 | 5,626 | 4,674 | |||
Deferred tax assets
|
19 | 2,303 | 2,668 | |||
Total assets
|
1,379,148 | 2,053,029 | ||||
Liabilities |
||||||
Deposits from banks |
76,446 | 114,910 | ||||
Items in the course of collection due to other banks |
1,466 | 1,635 | ||||
Customer accounts |
322,455 | 335,533 | ||||
Trading portfolio liabilities |
12 | 51,252 | 59,474 | |||
Financial liabilities designated at fair value |
24 | 86,202 | 76,892 | |||
Liabilities to customers under investment contracts |
13 | 1,679 | 69,183 | |||
Derivative financial instruments |
14 | 403,416 | 968,072 | |||
Debt securities in issue |
135,902 | 153,426 | ||||
Repurchase agreements and cash collateral on securities lent |
17 | 198,781 | 182,285 | |||
Other liabilities |
25 | 12,101 | 12,640 | |||
Current tax liabilities |
964 | 1,215 | ||||
Insurance contract liabilities, including unit-linked liabilities |
26 | 2,140 | 2,152 | |||
Subordinated liabilities |
27 | 25,816 | 29,842 | |||
Deferred tax liabilities |
19 | 470 | 304 | |||
Provisions |
28 | 590 | 535 | |||
Retirement benefit liabilities
|
30 | 769 | 1,357 | |||
Total liabilities
|
1,320,449 | 2,009,455 | ||||
Shareholders equity |
||||||
Called up share capital |
i | 2,402 | 2,398 | |||
Share premium account |
i | 12,092 | 12,060 | |||
Other reserves |
j | 1,783 | 1,723 | |||
Other shareholders equity |
k | 2,559 | 2,564 | |||
Retained earnings |
j | 37,089 | 22,457 | |||
Shareholders equity excluding non-controlling interests |
55,925 | 41,202 | ||||
Non-controlling interests
|
l | 2,774 | 2,372 | |||
Total shareholders equity
|
58,699 | 43,574 | ||||
Total liabilities and shareholders equity
|
1,379,148 | 2,053,029 |
The note numbers refer to the notes on pages 186 to 282, whereas the note letters refer to those on pages 290 to 298.
These financial statements have been approved for issue by the Board of Directors on 9th March 2009.
288 |
Barclays Bank PLC data
Consolidated statement of changes in equity
. | Share capital and share premium a £m |
Other reserves b and shareholders equity £m |
Retained earnings c £m |
Total £m |
Non- controlling interests £m |
Total equity £m |
|||||||||||
Balance at 1st January 2009 |
14,458 | 4,287 | 22,457 | 41,202 | 2,372 | 43,574 | |||||||||||
Net profit for the year |
| | 9,993 | 9,993 | 296 | 10,289 | |||||||||||
Other comprehensive income: |
|||||||||||||||||
Currency translation differences |
| (1,138 | ) | | (1,138 | ) | 285 | (853 | ) | ||||||||
Available for sale financial assets |
| 1,334 | | 1,334 | (14 | ) | 1,320 | ||||||||||
Cash flow hedges |
| 194 | | 194 | (29 | ) | 165 | ||||||||||
Tax relating to components of other comprehensive income |
| (209 | ) | 171 | (38 | ) | 12 | (26 | ) | ||||||||
Other |
| | (1 | ) | (1 | ) | | (1 | ) | ||||||||
Other comprehensive income net of tax from discontinued operations
|
|
(75 |
) |
17 |
|
(58 |
) |
|
|
(58 |
) | ||||||
Total comprehensive income
|
| 106 | 10,180 | 10,286 | 550 | 10,836 | |||||||||||
Issue of new ordinary shares |
25 | | | 25 | | 25 | |||||||||||
Issue of new preference shares |
| | | | | | |||||||||||
Equity settled share schemes |
| | 298 | 298 | | 298 | |||||||||||
Vesting of Barclays PLC shares under share-based payment schemes | | | (80 | ) | (80 | ) | | (80 | ) | ||||||||
Capital injection from Barclays PLC |
| | 4,850 | 4,850 | | 4,850 | |||||||||||
Dividends paid |
| | (103 | ) | (103 | ) | (132 | ) | (235 | ) | |||||||
Dividends on preference shares and other shareholders equity |
| | (599 | ) | (599 | ) | | (599 | ) | ||||||||
Net increase/decrease in non-controlling interest arising on acquisitions, disposals and capital issuances | | | | | (82 | ) | (82 | ) | |||||||||
Other
|
11 | (51 | ) | 86 | 46 | 66 | 112 | ||||||||||
Balance at 31st December 2009
|
14,494 | 4,342 | 37,089 | 55,925 | 2,774 | 58,699 | |||||||||||
Balance at 1st January 2008 |
13,133 | 2,517 | 14,222 | 29,872 | 1,949 | 31,821 | |||||||||||
Net profit for the year |
| | 4,846 | 4,846 | 403 | 5,249 | |||||||||||
Other comprehensive income: |
|||||||||||||||||
Currency translation differences |
| 2,174 | | 2,174 | 59 | 2,233 | |||||||||||
Available for sale financial assets |
| (1,575 | ) | | (1,575 | ) | (2 | ) | (1,577 | ) | |||||||
Cash flow hedges |
| 271 | | 271 | 105 | 376 | |||||||||||
Tax relating to components of other comprehensive income |
| 926 | (46 | ) | 880 | (29 | ) | 851 | |||||||||
Other |
| | (56 | ) | (56 | ) | | (56 | ) | ||||||||
Other comprehensive income net of tax from discontinued operations
|
| 124 | (10 | ) | 114 | | 114 | ||||||||||
Total comprehensive income
|
| 1,920 | 4,734 | 6,654 | 536 | 7,190 | |||||||||||
Issue of new ordinary shares |
16 | | | 16 | | 16 | |||||||||||
Issue of new preference shares |
1,309 | | | 1,309 | | 1,309 | |||||||||||
Equity settled share schemes |
| | 463 | 463 | | 463 | |||||||||||
Vesting of Barclays PLC shares under share-based payment schemes | | | (437 | ) | (437 | ) | | (437 | ) | ||||||||
Capital injection from Barclays PLC |
| | 5,137 | 5,137 | | 5,137 | |||||||||||
Dividends paid |
| | (1,160 | ) | (1,160 | ) | (134 | ) | (1,294 | ) | |||||||
Dividends on preference shares and other shareholders equity |
| | (502 | ) | (502 | ) | | (502 | ) | ||||||||
Net increase/decrease in non-controlling interest arising on acquisitions, disposals and capital issuances | | | | | 4 | 4 | |||||||||||
Other
|
| (150 | ) | | (150 | ) | 17 | (133 | ) | ||||||||
Balance at 31st December 2008
|
14,458 | 4,287 | 22,457 | 41,202 | 2,372 | 43,574 |
Notes
a | Details of share capital and share premium are shown in Note i. |
b | Details of other reserves are shown in Note j. |
c | Details of retained earnings are shown in Note j. |
289 |
Barclays Bank PLC data
Consolidated cash flow statement
For the year ended 31st December | |||||||||||||
2009 £m |
2008 £m |
2007 £m |
|||||||||||
Continuing operations |
|||||||||||||
Reconciliation of profit before tax to net cash flows from operating activities: |
|||||||||||||
Profit before tax |
4,559 | 5,094 | 6,254 | ||||||||||
Adjustment for non-cash items: |
|||||||||||||
Allowance for impairment |
8,071 | 5,419 | 2,795 | ||||||||||
Depreciation and amortisation and impairment of property, plant, equipment and intangibles |
1,196 | 885 | 651 | ||||||||||
Other provisions, including pensions |
428 | 804 | 753 | ||||||||||
Net profit from associates and joint ventures |
(34 | ) | (14 | ) | (42 | ) | |||||||
Net profit on disposal of investments and property, plant and equipment |
(610 | ) | (371 | ) | (862 | ) | |||||||
Net profit from disposal of associates and joint ventures |
3 | | (26 | ) | |||||||||
Net profit from disposal of subsidiaries |
(191 | ) | (327 | ) | (2 | ) | |||||||
Net gains on acquisitions |
(26 | ) | (2,406 | ) | | ||||||||
Other non-cash movements |
4,255 | 994 | (1,519 | ) | |||||||||
Changes in operating assets and liabilities: |
|||||||||||||
Net decrease/(increase) in loans and advances to banks and customers |
25,482 | (58,432 | ) | (77,987 | ) | ||||||||
Net (decrease)/increase in deposits and debt securities in issue |
(49,014 | ) | 76,886 | 91,451 | |||||||||
Net decrease/(increase) in derivative financial instruments |
3,321 | (17,529 | ) | (2,144 | ) | ||||||||
Net decrease/(increase) in trading assets |
34,292 | 26,945 | (18,245 | ) | |||||||||
Net decrease in trading liabilities |
(8,222 | ) | (5,928 | ) | (6,472 | ) | |||||||
Net increase/(decrease) in financial investments |
20,459 | 5,229 | (4,379 | ) | |||||||||
Net (increase)/decrease in other assets |
(465 | ) | (3,013 | ) | 1,113 | ||||||||
Net decrease in other liabilities |
(907 | ) | (492 | ) | (1,056 | ) | |||||||
Tax paid
|
(1,176 | ) | (1,398 | ) | (1,254 | ) | |||||||
Net cash from operating activities |
41,421 |
|
32,346 |
|
(10,971 |
) | |||||||
Purchase of available for sale financial investments |
(78,420 | ) | (57,756 | ) | (26,947 | ) | |||||||
Proceeds from sale or redemption of available for sale financial investments |
88,931 | 51,429 | 38,423 | ||||||||||
Net addition of intangible assets |
(226 | ) | (666 | ) | (227 | ) | |||||||
Purchase of property, plant and equipment |
(1,150 | ) | (1,643 | ) | (1,182 | ) | |||||||
Proceeds from sale of property, plant and equipment |
372 | 799 | 617 | ||||||||||
Acquisition of subsidiaries, net of cash acquired |
(28 | ) | (961 | ) | (270 | ) | |||||||
Disposal of subsidiaries, net of cash disposed |
339 | 238 | 383 | ||||||||||
Disposal of discontinued operation, net of cash acquired |
2,469 | | | ||||||||||
Increase in investment in subsidiaries |
| (157 | ) | (668 | ) | ||||||||
Decrease in investment in subsidiaries |
| 19 | 57 | ||||||||||
Acquisition of associates and joint ventures |
(81 | ) | (96 | ) | (220 | ) | |||||||
Disposal of associates and joint ventures |
69 | 137 | 145 | ||||||||||
Other cash flows associated with investing activities |
(15 | ) | (5 | ) | 153 | ||||||||
Net cash from investing activities |
12,260 | (8,662 | ) | 10,264 | |||||||||
Dividends paid |
(590 | ) | (1,446 | ) | (3,010 | ) | |||||||
Proceeds from borrowings and issuance of debt securities |
3,549 | 9,645 | 4,646 | ||||||||||
Repayments of borrowings and redemption of debt securities |
(4,383 | ) | (1,207 | ) | (683 | ) | |||||||
Net issue of shares and other equity instruments |
14 | 1,339 | 1,355 | ||||||||||
Capital injection from Barclays PLC |
800 | 5,137 | 1,434 | ||||||||||
Net issues of shares to non-controlling interests
|
| 11 | 199 | ||||||||||
Net cash from financing activities |
(610 | ) | 13,479 | 3,941 | |||||||||
Effect of exchange rates on cash and cash equivalents |
(2,864 | ) | (6,018 | ) | (641 | ) | |||||||
Net cash from discontinued operations |
(376 | ) | 286 | 83 | |||||||||
Net increase in cash and cash equivalents |
49,831 | 31,431 | 2,676 | ||||||||||
Cash and cash equivalents at beginning of year |
64,509 | 33,078 | 30,402 | ||||||||||
Cash and cash equivalents at end of year |
114,340 | 64,509 | 33,078 | ||||||||||
Cash and cash equivalents comprise: |
|||||||||||||
Cash and balances at central banks |
81,483 | 30,019 | 5,801 | ||||||||||
Loans and advances to banks |
41,135 | 47,707 | 40,120 | ||||||||||
Less: non-cash amounts and amounts with original maturity greater than three months |
(10,674 | ) | (15,428 | ) | (19,376 | ) | |||||||
30,461 | 32,279 | 20,744 | |||||||||||
Available for sale treasury and other eligible bills |
56,483 | 64,976 | 43,256 | ||||||||||
Less: non-cash and amounts with original maturity greater than three months |
(54,239 | ) | (62,876 | ) | (41,872 | ) | |||||||
2,244 | 2,100 | 1,384 | |||||||||||
Trading portfolio assets |
151,344 | 185,637 | 193,726 | ||||||||||
Less: non-cash and amounts with maturity greater than three months |
(151,192 | ) | (185,526 | ) | (188,591 | ) | |||||||
152 | 111 | 5,135 | |||||||||||
Other |
| | 14 | ||||||||||
114,340 | 64,509 | 33,078 |
290 |
Barclays Bank PLC data
a Net interest income
2009 £m |
2008 £m |
2007 £m |
|||||||
Cash and balances with central banks |
131 | 174 | 145 | ||||||
Available for sale investments |
1,937 | 2,355 | 2,580 | ||||||
Loans and advances to banks |
513 | 1,267 | 1,416 | ||||||
Loans and advances to customers |
18,456 | 23,754 | 19,559 | ||||||
Other |
199 | 460 | 1,596 | ||||||
Interest income |
21,236 | 28,010 | 25,296 | ||||||
Deposits from banks |
(634 | ) | (2,189 | ) | (2,720 | ) | |||
Customer accounts |
(2,720 | ) | (6,714 | ) | (4,110 | ) | |||
Debt securities in issue |
(4,134 | ) | (5,947 | ) | (6,651 | ) | |||
Subordinated liabilities |
(1,718 | ) | (1,349 | ) | (878 | ) | |||
Other |
(361 | ) | (396 | ) | (1,348 | ) | |||
Interest expense |
(9,567 | ) | (16,595 | ) | (15,707 | ) | |||
Net interest income |
11,669 | 11,415 | 9,589 |
Interest income includes £185m (2008: £135m, 2007: £113m) accrued on impaired loans.
Other interest income principally includes interest income relating to reverse repurchase agreements. Similarly, other interest expense principally includes interest expense relating to repurchase agreements and hedging activity.
Included in net interest income is hedge ineffectiveness as detailed in Note 14.
b Net fee and commission income
2009 £m |
|
2008 £m |
|
2007 £m |
| ||||
Fee and commission income |
|||||||||
Brokerage fees |
88 | 56 | 78 | ||||||
Investment management fees |
133 | 120 | 122 | ||||||
Banking and credit related fees and commissions |
9,578 | 7,208 | 6,367 | ||||||
Foreign exchange commissions |
147 | 189 | 178 | ||||||
Fee and commission income |
9,946 | 7,573 | 6,745 | ||||||
Fee and commission expense |
(1,528 | ) | (1,082 | ) | (970 | ) | |||
Net fee and commission income |
8,418 | 6,491 | 5,775 |
c Principal transactions
2009 £m |
|
2008 £m |
2007 £m | ||||
Net trading income |
6,994 | 1,270 | 3,754 | ||||
Net gain from disposal of available for sale assets |
576 | 212 | 560 | ||||
Dividend income |
6 | 196 | 26 | ||||
Net (loss)/gain from financial instruments designated at fair value |
(208 | ) | 33 | 293 | |||
Other investment (losses)/income |
(91 | ) | 239 | 337 | |||
Net investment income |
283 | 680 | 1,216 | ||||
Principal transactions |
7,277 | 1,950 | 4,970 |
291 |
d Administration and general expenses
2009 £m |
|
2008 £m |
|
2007 £m |
| ||||
Administrative expenses |
4,886 | 4,787 | 3,691 | ||||||
Impairment charges/(releases): |
|||||||||
property and equipment (Note 23) |
34 | 33 | 2 | ||||||
intangible assets (Note 22) |
27 | (3 | ) | 14 | |||||
goodwill (Note 21) |
1 | 112 | | ||||||
Operating lease rentals |
639 | 520 | 414 | ||||||
Gain on property disposals |
(29 | ) | (148 | ) | (267 | ) | |||
Administration and general expenses |
5,558 | 5,301 | 3,854 |
Auditors remuneration
2009 | ||||||||||
Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||
Audit of the Groups annual accounts |
12 | | | | 12 | |||||
Other services: |
||||||||||
Fees payable for the audit of the Banks associates pursuant to legislation |
23 | | | | 23 | |||||
Other services supplied pursuant to such legislation |
| 2 | | | 2 | |||||
Other services relating to taxation |
| | 7 | | 7 | |||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Bank or any of its associates | | | | 3 | 3 | |||||
Other |
| 4 | | 1 | 5 | |||||
Total auditors remuneration |
35 | 6 | 7 | 4 | 52 | |||||
2008 | ||||||||||
Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||
Audit of the Groups annual accounts |
12 | | | | 12 | |||||
Other services: |
||||||||||
Fees payable for the audit of the Banks associates pursuant to legislation |
19 | | | | 19 | |||||
Other services supplied pursuant to such legislation |
| 2 | | | 2 | |||||
Other services relating to taxation |
| | 9 | | 9 | |||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Bank or any of its associates | | | | 2 | 2 | |||||
Other |
| 4 | | 1 | 5 | |||||
Total auditors remuneration |
31 | 6 | 9 | 3 | 49 | |||||
2007 | ||||||||||
Audit £m |
Audit related £m |
Taxation services £m |
Other services £m |
Total £m | ||||||
Audit of the Groups annual accounts |
7 | | | | 7 | |||||
Other services: |
||||||||||
Fees payable for the audit of the Banks associates pursuant to legislation |
11 | | | | 11 | |||||
Other services supplied pursuant to such legislation |
6 | 2 | | | 8 | |||||
Other services relating to taxation |
| | 3 | | 3 | |||||
Services relating to corporate finance transactions entered into or proposed to be entered into by or on behalf of the Bank or any of its associates | | | | 5 | 5 | |||||
Other |
| 1 | | 1 | 2 | |||||
Total auditors remuneration |
24 | 3 | 3 | 6 | 36 |
The figures shown in the above tables relate to fees paid to PricewaterhouseCoopers LLP and its associates for continuing operations of business. Fees paid to other auditors not associated with PricewaterhouseCoopers LLP in respect of the audit of the Banks subsidiaries were £3m (2008: £3m, 2007: £2m).
292 |
Barclays Bank PLC data
continued
d Administration and general expenses continued
Fees payable for the audit of the Banks associates pursuant to legislation comprise the fees for the statutory audit of the subsidiaries and associated pension schemes both inside and outside Great Britain and fees for the work performed by the associates of PricewaterhouseCoopers LLP in respect of the consolidated financial statements of the Bank. The fees relating to the audit of the associated pension schemes were £0.5m (2008: £0.2m, 2007: £0.3m).
Other services supplied pursuant to such legislation comprise services in relation to statutory and regulatory filings. These includes audit services for the review of the interim financial information under the Listing Rules of the UK listing authority and fees paid for reporting under Section 404 of the US Sarbanes-Oxley Act (Section 404). In 2008 and 2009 fees paid for reporting under Section 404 are not separately identifiable from the fees of the audit of the Banks annual accounts and the Banks associates. Fees for the audit of Barclays Bank PLC Group accounts are not separately identifiable from Barclays PLC, therefore there is no difference in the amounts reported in both Annual Reports.
Other services related to taxation include compliance services such as tax return preparation and advisory services such as consultation on tax matters, tax advice relating to transactions and other tax planning and advice.
Services relating to corporate finance transactions comprise due diligence related to transactions and other work in connection with such transactions.
Excluded from the total auditors remuneration above are fees paid to PricewaterhouseCoopers LLP and associates relating to BGI (discontinued operations) of £4m (2008: £3m, 2007: £8m).
e Tax
The charge for tax is based upon the UK corporation tax rate of 28% (2008: 28.5%, 2007: 30%) and comprises:
2009 £m |
2008 £m |
2007 £m |
|||||||
Current tax charge/(credit) |
|||||||||
Current year |
1,235 | 1,197 | 2,013 | ||||||
Adjustment for prior years |
(131 | ) | 98 | 10 | |||||
1,104 | 1,295 | 2,023 | |||||||
Deferred tax (credit)/charge |
|||||||||
Current year |
45 | (577 | ) | (297 | ) | ||||
Adjustment for prior years |
(102 | ) | (269 | ) | (27 | ) | |||
(57 | ) | (846 | ) | (324 | ) | ||||
Total charge |
1,047 | 449 | 1,699 |
The effective tax rate for the years 2009, 2008 and 2007 is lower than the standard rate of corporation tax in the UK of 28% (2008: 28.5%, 2007: 30%). The differences are set out below:
2009 £m |
2008 £m |
2007 £m |
|||||||
Profit before tax
|
4,560
|
|
5,094
|
|
6,254
|
| |||
Tax charge at standard UK corporation tax rate of 28% (2008: 28.5%, 2007: 30%) |
1,277 | 1,452 | 1,876 | ||||||
Adjustment for prior years |
(233 | ) | (171 | ) | (17 | ) | |||
Differing overseas tax rates |
(27 | ) | 175 | (82 | ) | ||||
Non-taxable gains and income (including amounts offset by unrecognised tax losses) |
(119 | ) | (851 | ) | (145 | ) | |||
Share-based payments |
(38 | ) | 201 | 71 | |||||
Deferred tax assets not recognised/(previously not recognised) |
27 | (504 | ) | (159 | ) | ||||
Change in tax rates |
(12 | ) | (1 | ) | 24 | ||||
Other non-allowable expenses |
172 | 148 | 131 | ||||||
Overall tax charge |
1,047 | 449 | 1,699 | ||||||
Effective tax rate |
23% | 9% | 27% |
The effective tax rate for 2009, based on profit before tax on continuing operations was 23.0% (2008: 8.8%). The effective tax rate differs from the UK tax rate of 28% (2008: 28.5%) because of non-taxable gains and income, different tax rates applied to taxable profits and losses outside the UK, disallowed expenditure and adjustments in respect of prior years. The low effective tax rate of 8.8% on continuing operations in 2008 mainly resulted from the Lehman Brothers North American business acquisition.
293 |
f Other income
2009 £m |
2008 £m |
2007 £m |
|||||||
Increase/(decrease) in fair value of assets held in respect of linked liabilities to customers under investment contracts |
102 | (1,219 | ) | 23 | |||||
(Increase)/decrease in liabilities to customers under investment contracts |
(102 | ) | 1,219 | (23 | ) | ||||
Property rentals |
64 | 73 | 53 | ||||||
Gain on debt buy backs and extinguishments |
1,255 | 24 | | ||||||
Other income |
70 | 347 | 169 | ||||||
Other income |
1,389 | 444 | 222 |
g Trading portfolio assets
2009 £m |
2008 £m |
|||||
Trading portfolio assets |
||||||
Treasury and other eligible bills |
9,926 | 4,544 | ||||
Debt securities |
116,594 | 148,686 | ||||
Equity securities |
19,653 | 30,544 | ||||
Traded loans |
2,962 | 1,070 | ||||
Commodities |
2,260 | 802 | ||||
Trading portfolio assets |
151,395 | 185,646 | ||||
h Available for sale financial investments | ||||||
2009 £m |
2008 £m |
|||||
Debt securities |
43,888 | 58,831 | ||||
Treasury bills and other eligible bills |
5,919 | 4,003 | ||||
Equity securities |
6,844 | 2,182 | ||||
Available for sale financial investments |
56,651 | 65,016 | ||||
Movement in available for sale financial investments |
||||||
2009 £m |
2008 £m |
|||||
At beginning of year |
65,016 | 43,256 | ||||
Exchange and other adjustments |
(4,439 | ) | 14,275 | |||
Acquisitions and transfers |
83,915 | 59,703 | ||||
Disposals (through sale and redemption) |
(88,999 | ) | (50,629 | ) | ||
Gains/(losses) from changes in fair value recognised in equity |
1,889 | (1,190 | ) | |||
Impairment charge |
(670 | ) | (382 | ) | ||
Amortisation charge |
(6 | ) | (17 | ) | ||
Business disposals/discontinued operations |
(55 | ) | | |||
At end of year |
56,651 | 65,016 |
294 |
Barclays Bank PLC data
Notes to the accounts
continued
i Called up share capital
Ordinary Shares
The authorised ordinary share capital of Barclays Bank PLC, as at 31st December 2009, was 3,000 million ordinary shares of £1 each (2008: 3,000 million). During the year 4 million ordinary shares were issued for cash consideration of £25m.
Preference Shares
The authorised preference share capital of Barclays Bank PLC, as at 31st December 2009, was 1,000 Preference Shares of £1 each (2008: 1,000); 400,000 Preference Shares of ¤100 each (2008: 400,000); 400,000 Preference Shares of £100 each (2008: 400,000); 400,000 Preference Shares of US$100 each (2008: 400,000); 300 million Preference Shares of US$0.25 each (2008: 300 million).
The issued preference share capital of Barclays Bank PLC, as at 31st December 2009, comprised 1,000 Sterling Preference Shares of £1 each (2008: 1,000); 240,000 Euro Preference Shares of ¤100 each (2008: 240,000); 75,000 Sterling Preference Shares of £100 each (2008: 75,000); 100,000 US Dollar Preference Shares of US$100 each (2008: 100,000); 237 million US Dollar Preference Shares of US$0.25 each (2008: 237 million).
2009 £m |
2008 £m | |||
Called up share capital, allotted and fully paid |
||||
At beginning of year |
2,338 | 2,336 | ||
Issued for cash |
4 | 2 | ||
At end of year |
2,342 | 2,338 | ||
Called up preference share capital, allotted and fully paid |
||||
At beginning of year |
60 | 46 | ||
Issued for cash |
| 14 | ||
At end of year |
60 | 60 | ||
Called up share capital |
2,402 | 2,398 | ||
Share premium |
||||
2009 £m |
2008 £m | |||
At beginning of year |
12,060 | 10,751 | ||
Ordinary shares issued for cash |
21 | 15 | ||
Preference shares issued for cash |
| 1,294 | ||
Preference shares other movement |
11 | | ||
At end of year |
12,092 | 12,060 |
Sterling £1 Preference Shares
1,000 Sterling cumulative callable preference shares of £1 each (the £1 Preference Shares) were issued on 31st December 2004 at nil premium.
The £1 Preference Shares entitle the holders thereof to receive Sterling cumulative cash dividends out of distributable profits of Barclays Bank PLC, semi-annually at a rate reset semi-annually equal to the Sterling interbank offered rate for six-month sterling deposits.
Barclays Bank PLC shall be obliged to pay such dividends if: (1) it has profits available for the purpose of distribution under the Companies Act 2006 as at each dividend payment date; and (2) it is solvent on the relevant dividend payment date, provided that a capital regulations condition is satisfied on such dividend payment date. The dividends shall not be due and payable on the relevant dividend payment date except to the extent that Barclays Bank PLC could make such payment and still be solvent immediately thereafter. Barclays Bank PLC shall be considered solvent on any date if: (1) it is able to pay its debts to senior creditors as they fall due; and (2) its auditors have reported within the previous six months that its assets exceed its liabilities. If Barclays Bank PLC shall not pay, or shall pay only in part, a dividend for a period of seven days or more after the due date for payment, the holders of the £1 Preference Shares may institute proceedings for the winding-up of Barclays Bank PLC. No remedy against Barclays Bank PLC shall be available to the holder of any £1 Preference Shares for the recovery of amounts owing in respect of £1 Preference Shares other than the institution of proceedings for the winding-up of Barclays Bank PLC and/or proving in such winding-up. On a winding-up or other return of capital (other than a redemption or purchase by Barclays Bank PLC of any of its issued shares, or a reduction of share capital, permitted by the Articles of Barclays Bank PLC and under applicable law), the assets of Barclays Bank PLC available to shareholders shall be applied in priority to any payment to the holders of ordinary shares and any other class of shares in the capital of Barclays Bank PLC then in issue ranking junior to the £1 Preference Shares on such a return of capital and pari passu on such a return of capital with the holders of any other class of shares in the capital of Barclays Bank PLC then in issue (other than any class of shares in the capital of Barclays Bank PLC then in issue ranking in priority to the £1 Preference Shares on a winding-up or other such return of capital), in payment to the holders of the £1 Preference Shares of a sum equal to the aggregate of: (1) an amount equal to the dividends accrued thereon for the then current dividend period (and any accumulated arrears thereof) to the date of the commencement of the winding-up or other such return of capital; and (2) an amount equal to £1 per £1 Preference Share. After payment of the full amount of the liquidating distributions to which they are entitled, the holders of the £1 Preference Shares wil have no right or claim to any of the remaining assets of Barclays Bank PLC and will not be entitled to any further participation in such return of capital. The £1 Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, subject to the Companies Act 2006 and its Articles. Holders of the £1 Preference Shares are not entitled to receive notice of, or to attend, or vote at, any general meeting of Barclays Bank PLC.
295 |
i Called up share capital continued
Euro Preference Shares
100,000 Euro 4.875% non-cumulative callable preference shares of 100 each (the 4.875% Preference Shares) were issued on 8th December 2004 for a consideration of 993.6m (£688.4m), of which the nominal value was 10m and the balance was share premium. The 4.875% Preference Shares entitle the holders thereof to receive Euro non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, annually at a fixed rate of 4.875% per annum on the amount of 10,000 per preference share until 15th December 2014, and thereafter quarterly at a rate reset quarterly equal to 1.05% per annum above the Euro interbank offered rate for three-month Euro deposits.
The 4.875% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th December 2014, and on each dividend payment date thereafter at 10,000 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
140,000 Euro 4.75% non-cumulative callable preference shares of 100 each (the 4.75% Preference Shares) were issued on 15th March 2005 for a consideration of 1,383.3m (£966.7m), of which the nominal value was 14m and the balance was share premium. The 4.75% Preference Shares entitle the holders thereof to receive Euro non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, annually at a fixed rate of 4.75% per annum on the amount of ¤10,000 per preference share until 15th March 2020, and thereafter quarterly at a rate reset quarterly equal to 0.71% per annum above the Euro interbank offered rate for three-month Euro deposits.
The 4.75% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th March 2020, and on each dividend payment date thereafter at 10,000 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
Sterling Preference Shares
75,000 Sterling 6.0% non-cumulative callable preference shares of £100 each (the 6.0% Preference Shares) were issued on 22nd June 2005 for a consideration of £743.7m, of which the nominal value was £7.5m and the balance was share premium. The 6.0% Preference Shares entitle the holders thereof to receive Sterling non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, annually at a fixed rate of 6.0% per annum on the amount of £10,000 per preference share until 15th December 2017, and thereafter quarterly at a rate reset quarterly equal to 1.42% per annum above the London interbank offered rate for three-month Sterling deposits.
The 6.0% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th December 2017, and on each dividend payment date thereafter at £10,000 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
US Dollar Preference Shares
100,000 US Dollar 6.278% non-cumulative callable preference shares of US$100 each (the 6.278% Preference Shares), represented by 100,000 American Depositary Shares, Series 1, were issued on 8th June 2005 for a consideration of US$995.4m (£548.1m), of which the nominal value was US$10m and the balance was share premium. The 6.278% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, semi-annually at a fixed rate of 6.278% per annum on the amount of US$10,000 per preference share until 15th December 2034, and thereafter quarterly at a rate reset quarterly equal to 1.55% per annum above the London interbank offered rate for three-month US Dollar deposits.
The 6.278% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th December 2034, and on each dividend payment date thereafter at US$10,000 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
30 million US Dollar 6.625% non-cumulative callable preference shares of US$0.25 each (the 6.625% Preference Shares), represented by 30 million American Depositary Shares, Series 2, were issued on 25th and 28th April 2006 for a consideration of US$727m (£406m), of which the nominal value was US$7.5m and the balance was share premium. The 6.625% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, quarterly at a fixed rate of 6.625% per annum on the amount of US$25 per preference share.
The 6.625% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole but not in part only, on 15th September 2011, and on each dividend payment date thereafter at US$25 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
55 million US Dollar 7.1% non-cumulative callable preference shares of US$0.25 each (the 7.1% Preference Shares), represented by 55 million American Depositary Shares, Series 3, were issued on 13th September 2007 for a consideration of US$1,335m (£657m), of which the nominal value was US$13.75m and the balance was share premium. The 7.1% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, quarterly at a fixed rate of 7.1% per annum on the amount of US$25 per preference share.
The 7.1% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole or in part, on 15th December 2012, and on each dividend payment date thereafter at US$25 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
46 million US Dollar 7.75% non-cumulative callable preference shares of US$0.25 each (the 7.75% Preference Shares), represented by 46 million American Depositary Shares, Series 4, were issued on 7th December 2007 for a consideration of US$1,116m (£550m), of which the nominal value was US$11.5m and the balance was share premium. The 7.75% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, quarterly at a fixed rate of 7.75% per annum on the amount of US$25 per preference share.
296 |
Barclays Bank PLC data
Notes to the accounts
continued
i Called up share capital continued
The 7.75% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole or in part, on 15th December 2013, and on each dividend payment date thereafter at US$25 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
106 million US Dollar 8.125% non-cumulative callable preference shares of US$0.25 each (the 8.125% Preference Shares), represented by 106 million American Depositary Shares, Series 5, were issued on 11th April 2008 and 25th April 2008 for a total consideration of US$2,650m (£1,345m), of which the nominal value was US$26.5m and the balance was share premium. The 8.125% Preference Shares entitle the holders thereof to receive US Dollar non-cumulative cash dividends out of distributable profits of Barclays Bank PLC, quarterly at a fixed rate of 8.125% per annum on the amount of US$25 per preference share.
The 8.125% Preference Shares are redeemable at the option of Barclays Bank PLC, in whole or in part, on 15th June 2013, and on each dividend payment date thereafter at US$25 per share plus any dividends accrued for the then current dividend period to the date fixed for redemption.
No redemption or purchase of any 4.875% Preference Shares, the 4.75% Preference Shares, the 6.0% Preference Shares, the 6.278% Preference Shares, the 6.625% Preference Shares, the 7.1% Preference Shares, the 7.75% Preference Shares and the 8.125% Preference Shares (together, the Preference Shares) may be made by Barclays Bank PLC without the prior notification to the UK FSA and any such redemption will be subject to the Companies Act 2006 and the Articles of Barclays Bank PLC.
On a winding-up of Barclays Bank PLC or other return of capital (other than a redemption or purchase of shares of Barclays Bank PLC, or a reduction of share capital), a holder of Preference Shares will rank in the application of assets of Barclays Bank PLC available to shareholders: (1) junior to the holder of any shares of Barclays Bank PLC in issue ranking in priority to the Preference Shares; (2) equally in all respects with holders of other preference shares and any other shares of Barclays Bank PLC in issue ranking pari passu with the Preference Shares; and (3) in priority to the holders of ordinary shares and any other shares of Barclays Bank PLC in issue ranking junior to the Preference Shares.
The holders of the £400m 6% Callable Perpetual Core Tier One Notes and the US$1,000m 6.86% Callable Perpetual Core Tier One Notes of Barclays Bank PLC (together, the TONs) and the holders of the US$1,250m 8.55% Step-up Callable Perpetual Reserve Capital Instruments, the US$750m 7.375% Step-up Callable Perpetual Reserve Capital Instruments, the ¤850m 7.50% Step-up Callable Perpetual Reserve Capital Instruments, the £500m 5.3304% Step-up Callable Perpetual Reserve Capital Instruments, the US$1,350m 5.926% Step-up Callable Perpetual Reserve Capital Instruments, the £500m 6.3688% Step-up Callable Perpetual Reserve Capital Instruments, the US$1,250m 7.434% Step-up Callable Perpetual Reserve Capital Instruments and the £3,000m 14% Step-up Callable Perpetual Reserve Capital Instruments of Barclays Bank PLC (together, the RCIs) would, for the purposes only of calculating the amounts payable in respect of such securities on a winding-up of Barclays Bank PLC, subject to limited exceptions and to the extent that the TONs and the RCIs are then in issue, rank pari passu with the holders of the most senior class or classes of preference shares then in issue in the capital of Barclays Bank PLC. Accordingly, the holders of the preference shares would rank equally with the holders of such TONs and RCIs on such a winding-up of Barclays Bank PLC (unless one or more classes of shares of Barclays Bank PLC ranking in priority to the preference shares are in issue at the time of such winding-up, in which event the holders of such TONs and RCIs would rank equally with the holders of such shares and in priority to the holders of the preference shares).
Subject to such ranking, in such event, holders of the preference shares will be entitled to receive out of assets of Barclays Bank PLC available for distributions to shareholders, liquidating distributions in the amount of ¤10,000 per 4.875% Preference Share, ¤10,000 per 4.75% Preference Share, £10,000 per 6.0% Preference Share, US$10,000 per 6.278% Preference Share, US$25 per 6.625% Preference Share, US$25 per 7.1% Preference Share, US$25 per 7.75% Preference Share and US$0.25 per 8.125% Preference Share, plus, in each case, an amount equal to the accrued dividend for the then current dividend period to the date of the commencement of the winding-up or other such return of capital. If a dividend is not paid in full on any preference shares on any dividend payment date, then a dividend restriction shall apply.
This dividend restriction will mean that neither Barclays Bank PLC nor Barclays PLC may (a) declare or pay a dividend (other than payment by Barclays PLC of a final dividend declared by its shareholders prior to the relevant dividend payment date, or a dividend paid by Barclays Bank PLC to Barclays PLC or to a wholly owned subsidiary) on any of their respective ordinary shares, other preference shares or other share capital or (b) redeem, purchase, reduce or otherwise acquire any of their respective share capital, other than shares of Barclays Bank PLC held by Barclays PLC or a wholly owned subsidiary, until the earlier of: (1) the date on which Barclays Bank PLC next declares and pays in full a preference dividend; and (2) the date on or by which all the preference shares are redeemed in full or purchased by Barclays Bank PLC.
Holders of the preference shares are not entitled to receive notice of, or to attend, or vote at, any general meeting of Barclays Bank PLC. Barclays Bank PLC is not permitted to create a class of shares ranking as regards participation in the profits or assets of Barclays Bank PLC in priority to the preference shares, save with the sanction of a special resolution of a separate general meeting of the holders of the preference shares (requiring a majority of not less than three-fourths of the holders of the preference shares voting at the separate general meeting) or with the consent in writing of the holders of three-fourths of the preference shares.
Except as described above, the holders of the preference shares have no right to participate in the surplus assets of Barclays Bank PLC.
297 |
j Reserves
Other reserves |
||||||||||||
Available for sale |
Cash flow hedging |
Translation £m |
Total £m |
|||||||||
At 1st January 2009 |
(1,249 | ) | 132 | 2,840 | 1,723 | |||||||
Net gains from changes in fair value |
1,506 | 287 | | 1,793 | ||||||||
Net gains transferred to net profit |
(642 | ) | (92 | ) | | (734 | ) | |||||
Currency translation differences |
| | (1,223 | ) | (1,223 | ) | ||||||
Net losses transferred to net profit due to impairment |
670 | | | 670 | ||||||||
Changes in insurance liabilities |
(67 | ) | | | (67 | ) | ||||||
Net gains transferred to net profit due to fair value hedging |
(123 | ) | | | (123 | ) | ||||||
Tax |
(179) | (75) | (2) | (256) | ||||||||
At 31st December 2009 |
(84) | 252 | 1,615 | 1,783 |
Retained earnings |
|||
Retained earnings |
|||
At 1st January 2009 |
22,457 | ||
Profit attributable to equity holders |
9,993 | ||
Equity-settled share schemes |
298 | ||
Tax on equity-settled shares schemes |
156 | ||
Other taxes |
32 | ||
Vesting of Barclays PLC shares under share-based payment schemes |
(80 | ) | |
Dividends paid |
(103 | ) | |
Dividends on preference shares and other shareholders equity |
(599 | ) | |
Capital injection from Barclays PLC |
4,850 | ||
Other movements |
85 | ||
At 31st December 2009 |
37,089 | ||
At 1st January 2008 |
14,222 | ||
Profit attributable to equity holders |
4,846 | ||
Equity-settled share schemes |
463 | ||
Tax on equity-settled shares schemes |
(4 | ) | |
Other taxes |
(52 | ) | |
Vesting of Barclays PLC shares under share-based payment schemes |
(437 | ) | |
Dividends paid |
(1,160 | ) | |
Dividends on preference shares and other shareholders equity |
(502 | ) | |
Capital injection from Barclays PLC |
5,137 | ||
Other movements |
(56 | ) | |
At 31st December 2008 |
22,457 |
Transfers from the cash flow hedging reserve to the income statement were: interest income £22m loss (2008: £4m loss), interest expense £272m gain (2008: £74m loss), net trading income £165m loss (2008: £119m gain) and administration and general expenses of £7m gain (2008: £60m loss).
k Other shareholders equity
2009 £m |
2008 £m | |||
At 1st January |
2,564 | 2,687 | ||
Appropriations |
| 23 | ||
Tax credits |
47 | 44 | ||
Other movements |
(52) | (190) | ||
At 31st December |
2,559 | 2,564 |
Included in other shareholders equity are:
Issuances of reserve capital instruments which bear a fixed rate of interest ranging between 7.375%-8.55% until 2010 or 2011. After these dates, in the event that the reserve capital instruments are not redeemed, they will bear interest at rates fixed periodically in advance, based on London or European interbank rates. These instruments are repayable, at the option of the Bank, in whole on any coupon payment date falling in or after June or December 2010 or 2011. The Bank may elect to defer any payment of interest on the reserve capital instruments for any period of time. Whilst such deferral is continuing, neither the Bank nor Barclays PLC may declare or pay a dividend, subject to certain exceptions, on any of its ordinary shares or preference shares.
Issuance of capital notes which bear interest at rates fixed periodically in advance, based on London interbank rates. These notes are repayable in each case, at the option of the Bank, in whole on any interest payment date. The Bank is not obliged to make a payment of interest on its capital notes if, in the preceding six months, a dividend has not been declared or paid on any class of shares of Barclays PLC.
298 |
Barclays Bank PLC data
Notes to the accounts
continued
l Non-controlling interests
2009 £m |
2008 £m |
|||||
At beginning of year |
2,372 | 1,949 | ||||
Share of profit after tax |
296 | 403 | ||||
Dividend and other payments |
(132 | ) | (134 | ) | ||
Equity issued by subsidiaries |
| 4 | ||||
Available for sale reserve: net (loss)/gain from changes in fair value |
(12 | ) | (1 | ) | ||
Cash flow hedges: net (loss)/gain from changes in fair value |
(19 | ) | 76 | |||
Currency translation differences |
285 | 59 | ||||
Additions |
9 | | ||||
Disposals |
(91 | ) | (11 | ) | ||
Other |
66 | 27 | ||||
At end of year |
2,774 | 2,372 |
m Dividends
2009 £m |
2008 £m | |||
On ordinary shares |
||||
Final dividend |
| 1,030 | ||
Interim dividends |
103 | 130 | ||
Dividends |
103 | 1,160 |
These dividends are paid to enable Barclays PLC to fund its dividends to its shareholders.
Dividends paid on preference shares amounted to £477m (2008: £390m). Dividends paid on other equity instruments as detailed in Note k amounted to £122m (2008: £112m).
n Financial risks
The only significant financial instruments that are held by Barclays Bank PLC and not Barclays PLC are investments in Barclays PLC ordinary shares, dealt with as trading portfolio equity assets, debt securities and available for sale financial investments as appropriate.
There consequently are no significant differences in exposures to market risk, credit risk, liquidity risk and the fair value of financial instruments between Barclays PLC and Barclays Bank PLC, and no differences in the manner in which these financial risks are managed. Therefore the disclosures regarding financial risks appearing in Notes 46 to 49 are in all material respects the same for Barclays Bank PLC and Barclays PLC.
o Capital
The Barclays Bank PLC Groups policies and objectives for managing capital are the same as those for the Barclays PLC Group, disclosed in Note 52.
The table below provides details of the Barclays Bank PLC Group at 31st December 2009 and 2008.
2009 Basel II £m |
2008 Basel II £m |
|||||
Total qualifying Tier 1 capital |
49,722 | 37,101 | ||||
Total qualifying Tier 2 capital |
14,620 | 22,356 | ||||
Total deductions |
(880 | ) | (964 | ) | ||
Total net capital resources |
63,462 | 58,493 |
p Segmental reporting
Segmental reporting by Barclays Bank PLC is the same as that presented in Note 53 to the Barclays PLC financial statements, except for:
| the difference in profit before tax of £26m (2008: £42m) between Barclays PLC and Barclays Bank PLC is included in Head office functions and other operations; and |
| the difference in total assets of £219m (2008: £49m) is represented by holdings of Barclays PLC shares held by the businesses. |
299 |
Barclays Bank PLC data
IFRS | |||||||||||||||
Selected financial statistics | 2009 % |
2008 % |
2007 % |
2006 % |
2005 % |
||||||||||
Attributable profit from continuing operations as a percentage of: |
|||||||||||||||
average total assets |
0.2 | 0.3 | 0.4 | 0.4 | 0.4 | ||||||||||
average shareholders equity |
6.5 | 12.1 | 14.5 | 18.8 | 15.9 | ||||||||||
Average shareholders equity as a percentage of average total assets
|
2.9 | 2.0 | 2.2 | 2.2 | 2.2 | ||||||||||
Selected income statement data
|
£m
|
£m
|
£m
|
£m
|
£m
|
||||||||||
Continuing operations |
|||||||||||||||
Interest income |
21,236 | 28,010 | 25,296 | 21,795 | 17,217 | ||||||||||
Interest expense |
(9,567 | ) | (16,595 | ) | (15,707 | ) | (12,662 | ) | (9,157 | ) | |||||
Non-interest income |
18,256 | 9,975 | 11,948 | 11,433 | 8,631 | ||||||||||
Operating expenses |
(16,712 | ) | (13,387 | ) | (12,096 | ) | 11,723 | (9,748 | ) | ||||||
Impairment charges |
(8,071 | ) | (5,419 | ) | (2,795 | ) | (2,154 | ) | (1,571 | ) | |||||
Share of post-tax results of associates and joint ventures |
34 | 14 | 42 | 46 | 45 | ||||||||||
Profit on disposal of subsidiaries, associates and joint ventures |
188 | 327 | 28 | 323 | | ||||||||||
Gains on acquisitions |
26 | 2,406 | | | | ||||||||||
Profit before tax from continuing operations |
4,559 | 5,094 | 6,254 | 6,483 | 4,772 | ||||||||||
Profit for the year from discontinued operations, including gain on disposal |
6,777 | 604 | 571 | 384 | 351 | ||||||||||
Profit attributable to equity holders of the Parent from: |
|||||||||||||||
Continuing operations |
3,228 | 4,259 | 4,218 | 4,578 | 3,385 | ||||||||||
Discontinued operations
|
6,765
|
|
587
|
|
531
|
|
336
|
|
310
|
| |||||
Selected balance sheet data
|
£m
|
£m
|
£m
|
£m
|
£m
|
||||||||||
Total shareholders equity |
58,699 | 43,574 | 31,821 | 27,106 | 24,243 | ||||||||||
Subordinated liabilities |
25,816 | 29,842 | 18,150 | 13,786 | 12,463 | ||||||||||
Deposits from banks, customer accounts and debt securities in issue |
534,803 | 603,869 | 506,623 | 447,453 | 417,139 | ||||||||||
Loans and advances to banks and customers |
461,359 | 509,522 | 385,518 | 313,226 | 300,001 | ||||||||||
Total assets
|
1,379,148 | 2,053,029 | 1,227,583 | 996,503 | 924,170 |
300 |
Barclays Bank PLC data
Financial data
Ratio of earnings to fixed charges Barclays Bank PLC
2009 | 2008 | 2007 | 2006 | 2005 | |||||||||||
(in £m except for ratios) | |||||||||||||||
Ratio of earnings to fixed charges |
|||||||||||||||
Fixed charges |
|||||||||||||||
Interest expense |
20,962 | 38,197 | 37,903 | 30,385 | 20,965 | ||||||||||
Rental expense
|
256 | 235 | 158 | 135 | 124 | ||||||||||
Total fixed charges
|
21,218 | 38,432 | 38,061 | 30,520 | 21,089 | ||||||||||
Earnings |
|||||||||||||||
Income before taxes and non-controlling interests |
4,559 | 5,094 | 6,254 | 6,483 | 4,772 | ||||||||||
Less: Unremitted pre-tax income of associated companies and joint ventures
|
(43 | ) | (19 | ) | (45 | ) | (41 | ) | (28 | ) | |||||
4,516 | 5,075 | 6,209 | 6,442 | 4,744 | |||||||||||
Fixed charges
|
21,218 | 38,432 | 38,061 | 30,520 | 21,089 | ||||||||||
Total earnings including fixed charges
|
25,734 | 43,507 | 44,270 | 36,962 | 25,833 | ||||||||||
Ratio of earnings to fixed charges
|
1.21 | 1.13 | 1.16 | 1.21 | 1.22 |
Ratio of earnings to fixed charges and preference shares Barclays Bank PLC
2009 | 2008 | 2007 | 2006 | 2005 | |||||||||||
(in £m except for ratios) | |||||||||||||||
Combined fixed charges, preference share dividends and similar appropriations |
|||||||||||||||
Interest expense |
20,962 | 38,197 | 37,903 | 30,385 | 20,965 | ||||||||||
Rental expense
|
256 | 235 | 158 | 135 | 124 | ||||||||||
Fixed charges |
21,218 | 38,432 | 38,061 | 30,520 | 21,089 | ||||||||||
Preference share dividends and similar appropriations
|
646 | 583 | 345 | 395 | 304 | ||||||||||
Total fixed charges
|
21,864 | 39,015 | 38,406 | 30,915 | 21,393 | ||||||||||
Earnings |
|||||||||||||||
Income before taxes and non-controlling interests |
4,559 | 5,094 | 6,254 | 6,483 | 4,772 | ||||||||||
Less: Unremitted pre-tax income of associated companies and joint ventures
|
(43 | ) | (19 | ) | (45 | ) | (41 | ) | (28 | ) | |||||
4,516 | 5,075 | 6,209 | 6,442 | 4,744 | |||||||||||
Fixed charges
|
21,864 | 39,015 | 38,406 | 30,915 | 21,393 | ||||||||||
Total earnings including fixed charges
|
26,380 | 44,090 | 44,615 | 37,357 | 26,137 | ||||||||||
Ratio of earnings to combined fixed charges, preference share dividends and similar appropriations
|
1.21 | 1.13 | 1.16 | 1.21 | 1.22 |
301 |
302 |
Dividends on the ordinary shares of Barclays PLC
Barclays PLC has paid dividends on its ordinary shares every year since its incorporation in 1896.
As announced on 10th November 2009, the Board resumed dividend payments with an interim cash dividend of 1p per ordinary share paid on 11th December 2009. A final cash dividend for the full-year ended 31st December 2009 of 1.5p per ordinary share was announced on 16th February 2010 for payment on 19th March 2010.
We intend to make three quarterly fixed payments in 2010 and a final variable payment relating to the calendar year 2010 in March 2011. Given uncertainty about the full consequences of regulatory reform, prudence dictates that our dividend policy should be conservative. But, subject to that caveat, we intend our dividend policy to be progressive relative to a 2009 annualised dividend of 4.5p per share.
The dividends declared for each of the last five years were:
Pence per 25p ordinary share |
||||||||||
2009 | 2008 | 2007 | 2006 | 2005 | ||||||
Interim |
1.00 | 11.50 | 11.50 | 10.50 | 9.20 | |||||
Final
|
1.50 | | 22.50 | 20.50 | 17.40 | |||||
Total
|
2.50 | 11.50 | 34.00 | 31.00 | 26.60 |
US Dollars per 25p ordinary share |
||||||||||
2009 | 2008 | 2007 | 2006 | 2005 | ||||||
Interim |
0.02 | 0.20 | 0.23 | 0.20 | 0.16 | |||||
Final
|
0.02 | | 0.45 | 0.41 | 0.31 | |||||
Total
|
0.04 | 0.20 | 0.68 | 0.61 | 0.47 |
The gross dividends applicable to an American Depositary Share (ADS) representing four ordinary shares, before deduction of withholding tax, are as follows:
US Dollars per American Depositary Share |
||||||||||
2009 | 2008 | 2007 | 2006 | 2005 | ||||||
Interim |
0.07 | 0.82 | 0.93 | 0.80 | 0.65 | |||||
Final
|
0.09 | | 1.78 | 1.64 | 1.24 | |||||
Total
|
0.16 | 0.82 | 2.71 | 2.44 | 1.89 |
For years prior to 2009, final dividends expressed in Dollars have been translated at the Noon Buying Rates in New York City for cable transfers in Pounds Sterling as certified for customs purposes by the Federal Reserve Bank of New York (the Noon Buying Rate). From January 2009, the Federal Reserve Bank of New York discontinued the publication of Noon Buying Rates. The final dividend for 2009 is expressed in Dollars translated at the closing spot rate for Pounds Sterling as determined by Bloomberg at 5pm in New York City (the Closing Spot Rate) on 5th March 2010. No representation is made that Pounds Sterling amounts have been, or could have been, or could be, converted into Dollars at these rates.
Trading market for ordinary shares of Barclays PLC
The nominal capital of Barclays PLC is divided into 20,996,000,000 ordinary shares of 25p each (ordinary shares), 0.4 million Sterling preference shares of £100 each, 0.4 million US Dollar preference shares of $100 each, 150 million US Dollar preference shares of $0.25 each, 0.4 million Euro preference shares of 100 each, 0.4 million Yen preference shares of ¥10,000 each and 1 million staff shares of £1 each. At the close of business on 31st December 2009, 11,411,577,230 ordinary shares were outstanding.
The principal trading market for Barclays PLC ordinary shares is the London Stock Exchange. Ordinary share listings were also obtained on the New York Stock Exchange (NYSE) with effect from 9th September 1986.
Trading on the NYSE is in the form of ADSs under the symbol BCS. Each ADS represents four ordinary shares and is evidenced by an American Depositary Receipt (ADR). The ADR depositary is J P Morgan Chase Bank, N.A. Details of trading activity are published in the stock tables of leading daily newspapers in the US.
There were 891 ADR holders and 1,595 recorded holders of ordinary shares with US addresses at 31st December 2009, whose shareholdings represented approximately 12.08% of total outstanding ordinary shares on that date. Since certain of the ordinary shares and ADRs were held by brokers or other nominees, the number of recorded holders in the US may not be representative of the number of beneficial holders or of their country of residence.
303 |
The following table shows the high and low sales price for the ordinary shares during the periods indicated, based on mid-market prices at close of business on the London Stock Exchange and the high and low sale price for ADSs as reported on the NYSE composite tape.
25p ordinary shares | American Depositary Shares | |||||||
High p |
Low p |
High US$ |
Low US$ | |||||
2010 |
||||||||
By month: |
||||||||
January |
320.6 | 265.0 | 21.1 | 17.0 | ||||
February |
316.3 | 262.0 | 19.9 | 16.3 | ||||
2009 |
||||||||
By month: |
||||||||
July |
314.8 | 287.0 | 20.9 | 18.4 | ||||
August |
380.3 | 322.6 | 24.7 | 22.2 | ||||
September |
380.0 | 351.3 | 25.4 | 22.9 | ||||
October |
383.6 | 319.0 | 25.2 | 20.6 | ||||
November |
342.9 | 291.1 | 23.2 | 19.6 | ||||
December |
304.5 | 264.3 | 20.1 | 17.4 | ||||
By quarter: |
||||||||
First quarter |
184.6 | 51.2 | 11.0 | 3.1 | ||||
Second quarter |
316.3 | 157.0 | 20.5 | 9.3 | ||||
Third quarter |
380.3 | 287.0 | 25.4 | 18.4 | ||||
Fourth quarter |
383.6 | 264.3 | 25.2 | 17.4 | ||||
2008 |
||||||||
First quarter |
506.4 | 382.3 | 41.4 | 32.3 | ||||
Second quarter |
490.8 | 291.5 | 39.9 | 23.2 | ||||
Third quarter |
389.0 | 260.5 | 32.5 | 20.8 | ||||
Fourth quarter |
368.0 | 127.7 | 25.9 | 7.4 | ||||
2008 |
506.4 | 127.7 | 41.4 | 7.4 | ||||
2007 |
790.0 | 474.5 | 62.5 | 39.9 | ||||
2006 |
737.0 | 586.0 | 61.5 | 41.8 | ||||
2005 |
615.0 | 520.0 | 47.0 | 37.2 | ||||
2004 |
586.0 | 443.0 | 46.0 | 32.8 |
This section incorporates information on the prices at which securities of Barclays PLC have traded. It is emphasised that past performance cannot be relied upon as a guide to future performance.
Shareholdings at 31st December 2009 a |
||||||||
Number of shareholders |
Percentage of holders |
Shares held (millions) |
Percentage of capital | |||||
Classification of shareholders |
||||||||
Personal holders |
732,028 | 97.34 | 762.49 | 6.68 | ||||
Banks and nominees |
18,083 | 2.40 | 9,537.83 | 83.58 | ||||
Other companies |
1,859 | 0.25 | 1,111.18 | 9.74 | ||||
Insurance companies |
12 | | 0.05 | | ||||
Pensions funds |
18 | | 0.03 | | ||||
Totals
|
752,000 | 100.00 | 11,411.58 | 100 | ||||
Shareholding range |
||||||||
1-100 |
30,251 | 4.02 | 1.28 | 0.01 | ||||
101-250 |
230,779 | 30.69 | 48.54 | 0.43 | ||||
251-500 |
238,196 | 31.68 | 81.45 | 0.71 | ||||
501-1,000 |
116,153 | 15.45 | 81.71 | 0.72 | ||||
1,001-5,000 |
104,331 | 13.87 | 215.08 | 1.88 | ||||
5,001-10,000 |
17,538 | 2.33 | 123.89 | 1.09 | ||||
10,001-25,000 |
10,192 | 1.36 | 154.08 | 1.35 | ||||
25,001-50,000 |
2,296 | 0.31 | 78.57 | 0.69 | ||||
50,001 and over |
2,264 | 0.30 | 10,626.98 | 93.12 | ||||
Totals
|
752,000 | 100.00 | 11,411.58 | 100 | ||||
United States holdings
|
1,595 | 0.21 | 3.39 | 0.03 |
Note
a | These figures include Barclays Sharestore members. |
304 |
Shareholder information
continued
Currency of presentation
In this report, unless otherwise specified, all amounts are expressed in Pound Sterling. For the months of September 2009 through to February 2010, the highest and lowest closing spot rates as determined by Bloomberg at 5:00pm (New York time) (the Closing Spot Rate), expressed in US Dollars per Pound Sterling were:
(US Dollars per Pound Sterling) | ||||||||||||
February | January | December | November | October | September | |||||||
2010 | 2009 | |||||||||||
High |
1.60 | 1.64 | 1.66 | 1.68 | 1.66 | 1.67 | ||||||
Low |
1.52 | 1.59 | 1.59 | 1.64 | 1.58 | 1.59 |
For the years 2005 through to 2008 the average of the noon buying rates on the last day of each month is shown in the table below. From January 2009, the Federal Reserve Bank of New York discontinued the publication of Noon Buying Rates. For 2009 the average Closing Spot Rate on the last day of each month is shown in the table below.
(US Dollars per Pound Sterling) | ||||||||||
Average |
2009 | 2008 | 2007 | 2006 | 2005 | |||||
1.57 | 1.84 | 2.0 | 1.86 | 1.81 |
On 5th March 2010, the Closing Spot Rate in Pound Sterling was $1.51.
No representation is made that Pounds Sterling amounts have been, or could have been, or could be, converted into US Dollars at any of the above rates. For the purpose of presenting financial information in this report, exchange rates other than those shown above may have been used.
305 |
306 |
Shareholder information
continued
307 |
308 |
Shareholder information
continued
309 |
310 |
Shareholder information
continued
Fees and Charges Payable by a Holder of ADSs
The ADR depositary collects fees for delivery and surrender of ADSs directly from investors depositing ordinary shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The ADR depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of the distributable property to pay the fees.
The charges of the ADR depositary payable by investors are as follows:
Type of Service | ADR Depositary Actions | Fee | ||
ADR depositary or substituting the underlying shares |
Issuance of ADSs against the deposit of ordinary shares, including deposits and issuances in respect of:
Share distributions, stock splits, rights, merger Exchange of securities or other transactions or event or other distribution affecting the ADSs or deposited securities |
$5.00 or less per 100 ADSs (or portion thereof) evidenced by the new ADSs delivered | ||
Receiving or distributing cash dividends |
Distribution of cash dividends | No fee currently payable | ||
Selling or exercising rights |
Distribution or sale of securities, the fee being in an amount equal to the fee for the execution and delivery of ADSs which would have been charged as a result of the deposit of such securities | $5.00 or less per each 100 ADSs (or portion thereof) | ||
Withdrawing an underlying ordinary share |
Acceptance of ADSs surrendered for withdrawal of deposited ordinary shares | $5.00 or less for each 100 ADSs (or portion thereof) evidenced by the ADSs surrendered | ||
General depositary services, particularly those charged on an annual basis |
Other services performed by the ADS depositary in administering the ADS program | No fee currently payable | ||
Expenses of the ADR depositary |
Expenses incurred on behalf of Holders in connection with:
Taxes and other governmental charges Cable, telex and facsimile transmission/delivery Transfer or registration fees, if applicable, for the registration of transfers or underlying ordinary shares Expenses of the Depositary in connection with the conversion of foreign currency into US dollars (which are paid out of such foreign currency) Any other charge payable by ADR depositary or its agents |
Expenses payable at the sole discretion of the ADR depositary by billing Holders or by deducting charges from one or more cash dividends or other cash distributions |
311 |
Fees and Payments made by the ADR depositary to Barclays
The ADR depositary has agreed to reimburse certain Barclays expenses related to Barclays ADS program and incurred by Barclays in connection with the program. In the year ended 31 December 2009, the ADR depositary reimbursed to Barclays, or paid amounts on its behalf to third parties, a total sum of $1,000,000.1 The table below sets out the types of expenses that the ADR depositary has agreed to reimburse and the amounts reimbursed in the year ended 31 December 2009, which include certain expenses paid by the ADR depositary to third parties on behalf of Barclays:
Category of expense reimbursed to Barclays |
||
Amount Reimbursed for the Year ended 31 (000s) | ||
Legal fees |
$298 | |
Investor relations |
$212 | |
Distribution of voting documentation AGM |
$138 | |
Distribution of voting documentation General Meeting |
$169 | |
NYSE listing fees |
$98 | |
US Share Plans |
$82 | |
Form 6-K filing fees
|
$3 | |
Total |
$1,000 |
Under certain circumstances, including removal of the ADR depositary or termination of the ADR program by Barclays, Barclays is required to repay the ADR depositary certain amounts reimbursed and/or expenses paid to or on behalf of Barclays.
The ADR depositary has also agreed to waive certain of its fees for standard costs associated with the administration of the ADR program.
1 | In early 2009, Barclays also received certain reimbursements from the ADR depositary with respect to services provided in the year ended 31 December 2008 in connection with the program. |
312 |
Investors who have any questions about their investment in Barclays, or
about Barclays in general, may write to the Director, Investor Relations
at our Head office as follows:
Director, Investor Relations
Barclays PLC
1 Churchill Place
London
E14 5HP
or, in the United States of America,
The Corporate Communications Department
Barclays Bank PLC
745 Seventh Avenue
New York, NY 10019, USA
Registered and Head office:
1 Churchill Place
London
E14 5HP
Tel: +44 (0) 20 7116 1000
Registrar:
The Registrar to Barclays
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA
Tel: 0871 384 2055* or +44 (0) 121 415 7004 (from overseas)
Email: questions@share-registers.co.uk
ADR Depositary:
JP Morgan Chase Bank, N.A.
PO Box 64504 St.
Paul MN
55164-0504
USA
Tel: 1-800-990-1135 (toll-free for US domestic callers)
or +1 651 453 2128
Email: jpmorgan.adr@wellsfargo.com
*Calls to this number are charged at 8p per minute if using a BT landline.
Call charges may vary if using other telephone providers.
313 |
314 |
Index
continued
315 |
316 |
Glossary of terms
continued
317 |
318 |
Glossary of terms
continued
319 |
Signatures
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorised the undersigned to sign this annual report on its behalf.
Date March 19th, 2010 | Barclays PLC (Registrant)
| |||
By | /s/ Chris Lucas | |||
Chris Lucas, Group Finance Director |
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorised the undersigned to sign this annual report on its behalf.
Date March 19th, 2010 | Barclays Bank PLC (Registrant) | |||
By | /s/ Chris Lucas | |||
Chris Lucas, Group Finance Director |
BACK COVER
EXHIBIT INDEX
EXHIBIT |
DESCRIPTION | |
1.1 | Memorandum of Association of Barclays PLC | |
1.2 | Articles of Association of Barclays PLC (incorporated by reference to the 2008 Form 20-F filed on March 24th, 2009) | |
1.3 | Memorandum and Articles of Association of Barclays Bank PLC (incorporated by reference to the 2008 Form 20-F filed on March 24th, 2009) | |
2.1 | Long term debt instruments | |
4.1 | Rules of the Barclays Group Performance Share Plan (2005) (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.2 | Rules of the Barclays PLC Renewed 1986 Executive Share Option Scheme (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.3 | Rules of the Barclays PLC Approved Incentive Share Option Plan (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29 th, 2008) | |
4.4 | Rules of the Barclays PLC Unapproved Incentive Share Option Plans (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.5 | Rules of the Barclays PLC Executive Share Award Scheme (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.6 | Rules of the Barclays Group Special Award Performance Share Plan (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008 | |
4.7 | Rules of the Barclays Group Incentive Share Plan (incorporated by reference to the Barclays PLC Registration Statement on Form S-8 (File no. 333-153723) filed on September 29th, 2008) | |
4.8 | Rules of Barclays Bank PLC 1999 Directors Deferred Compensation Plan (amended and restated, effective January 1, 2008) (incorporated by reference to Barclays Bank PLCs Registration Statement on Form S-8 (File no. 333-149301) filed on February 19, 2008) | |
4.9 | Rules of Barclays Bank PLC Senior Management Deferred Compensation Plan (amended and restated, effective January 1, 2008) (incorporated by reference to Barclays Bank PLCs Registration Statement on Form S-8 (File no. 333-149302) filed on February 19, 2008) | |
4.10 | Service Contract John Varley (incorporated by reference to the 2003 Form 20-F filed on March 26th, 2004) | |
4.11 | Service Contract and Subsequent Side Letter to Service Contract Gary Hoffman (incorporated by reference to the 2005 Form 20-F filed on March 29th , 2006) |
EXHIBIT |
DESCRIPTION | |
4.12 | Service Contract Robert E. Diamond Jr (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.13 | Contract of Employment Christopher Lucas (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.14 | Addendum to contract of employment between Barclays Bank plc and Gary Hoffman (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.15 | Addendum to contract of employment between Barclays Bank plc and John Varley (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.16 | Appointment Letter and Subsequent Amendment to appoint as Senior Independent Director Sir Richard Broadbent (incorporated by reference to the 2004 Form 20-F filed on March 24th, 2005) | |
4.17 | Appointment Letter Leigh Clifford (incorporated by reference to the 2004 Form 20-F filed on March 24th, 2005) | |
4.18 | Appointment Letter Sir Andrew Likierman (incorporated by reference to the 2004 Form 20-F filed on March 24th, 2005) | |
4.19 | Appointment Letter Dr Daniël Cronjé (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.20 | Appointment Letter John Sunderland (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.21 | Appointment Letter Marcus Agius (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.22 | Appointment Letter Fulvio Conti (incorporated by reference to the 2006 Form 20-F filed on March 26th, 2007) | |
4.23 | Appointment Letter David Booth (incorporated by reference to the 2007 20-F filed on March 26th, 2008) | |
4.24 | Appointment Letter Sir Michael Rake (incorporated by reference to the 2007 20-F filed on March 26th, 2008) | |
4.25 | Appointment Letter Simon Fraser (incorporated by reference to the 2008 Form 20-F filed on March 24th, 2008) | |
4.26 | Appointment Letter Reuben Jeffery III | |
4.27 | Indemnity Letter John Varley (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.28 | Indemnity Letter Gary Hoffman (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) |
EXHIBIT |
DESCRIPTION | |
4.29 | Indemnity Letter Robert E. Diamond Jr (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.30 | Indemnity Letter Sir Richard Broadbent (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.31 | Indemnity Letter Leigh Clifford (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.32 | Indemnity Letter Sir Andrew Likierman (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.33 | Indemnity Letter Dr Daniël Cronjé (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.34 | Indemnity Letter John Sunderland (incorporated by reference to the 2005 Form 20-F filed on March 29th, 2006) | |
4.35 | Term sheet for Barclays PLC Warrants (incorporated by reference to the 2008 Form 20-F filed March 24th, 2008) | |
4.36 | Amended and Restated Stock Purchase Agreement, dated as of June 16, 2009, by and among Barclays Bank PLC, Barclays PLC (solely for the purposes of Section 6.16, Section 6.18 and Section 6.24) and BlackRock, Inc. | |
4.37 | Stockholder Agreement, dated as of December 1, 2009, by and among BlackRock, Inc., Barclays Bank PLC and Barclays BR Holdings S.à r.l. | |
7.1 | Ratios of earnings to fixed charges | |
7.2 | Ratios of earnings to combined fixed charges, preference share dividends and similar appropriations | |
8.1 | List of subsidiaries | |
11.1 | Code of Ethics (incorporated by reference to the 2003 Form 20-F filed on March 26th, 2004) | |
12.1 | Certifications filed pursuant to 17 CFR 240. 13(a)-14(a) | |
13.1 | Certifications filed pursuant to 17 CFR 240. 13(a) and 18 U.S.C 1350(a) and 1350(b) | |
15.1 | Consent of PricewaterhouseCoopers LLP for incorporation by reference of reports in certain securities registration statements of Barclays PLC and Barclays Bank PLC. |